Sentence,class,file
"The 20-item survey was distributed in English to working e-mail addresses (n = 1835), and results were collected using commercially http://dx.doi.org/10.1016/j.gore.2017.02.005 2352-5789/© 2017 The Authors.",OADS,/arxiv_data1/oa_pdf/90/bf/main.PMC5344220.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/90/bf/main.PMC5344220.pdf
available online software ( http://www.surveymonkey.com ).,OADS,/arxiv_data1/oa_pdf/90/bf/main.PMC5344220.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Understanding neratinib resistance BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.445 625,Non-OADS,/arxiv_data1/oa_pdf/55/69/bjc2016445a.PMC5344284.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Circular RNA 0000096 in gastric cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.451 633,Non-OADS,/arxiv_data1/oa_pdf/c6/60/bjc2016451a.PMC5344286.pdf
"In Canada, a credible private pathway is available which provides reimbursable testing at a national level led by global experts in the field such as Dr. Samuel Aparicio (http://contextualgenomics.com).",Non-OADS,/arxiv_data1/oa_pdf/47/ee/bjc2016452a.PMC5344287.pdf
Available at: https://www.ncbi.nlm.nih.gov/ pubmed/27333361 (accessed 2 January 2017).,Non-OADS,/arxiv_data1/oa_pdf/47/ee/bjc2016452a.PMC5344287.pdf
"In there (http://kmplot.com/analysis/index.php?p=service&cancer=lung) when selecting all NSCLC, AURKB expression significantly reduces survival ( Po10/C016).",Non-OADS,/arxiv_data1/oa_pdf/b6/5d/bjc2016453a.PMC5344288.pdf
"The relevant entries in COSMIC database (http://cancer.sanger.ac.uk/ cosmic) report low number of point mutations (5 out of 1985, 0.2%), copy number variations (4 out of 843, 0.4%) and frequent overexpression (139 out of 1008, 13.8%).",Non-OADS,/arxiv_data1/oa_pdf/b6/5d/bjc2016453a.PMC5344288.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)AURKB in NSCLC taxane response BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.453 599,Non-OADS,/arxiv_data1/oa_pdf/b6/5d/bjc2016453a.PMC5344288.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Methylated microRNAs detect urothelial carcinoma in urines BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.454 639,Non-OADS,/arxiv_data1/oa_pdf/75/cd/bjc2016454a.PMC5344289.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Tenascin-C and fibronectin in tongue cancer 648 www.bjcancer.com | DOI:10.1038/bjc.2016.455,Non-OADS,/arxiv_data1/oa_pdf/fb/36/bjc2016455a.PMC5344290.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Erlotinib vsgefitinib in EGFR -mutant NSCLC 574 www.bjcancer.com | DOI:10.1038/bjc.2016.456,Non-OADS,/arxiv_data1/oa_pdf/97/94/bjc2016456a.PMC5344291.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER 5hmC regulates lncRNAs in colorectal cancer 668 www.bjcancer.com | DOI:10.1038/bjc.2016.457,Non-OADS,/arxiv_data1/oa_pdf/40/36/bjc2016457a.PMC5344292.pdf
"Vessel size was measured using ImageJ software (U.S. National Institutes of Health, Bathesda, Maryland, USA, http://imagej.nih.gov/ij/) in 50 vessels per tumour from representative images of at least three different tumours per group.",OADS,/arxiv_data1/oa_pdf/c6/ce/bjc201713a.PMC5344294.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Improving vascular normalisation and ECM 608 www.bjcancer.com | DOI:10.1038/bjc.2017.13,Non-OADS,/arxiv_data1/oa_pdf/c6/ce/bjc201713a.PMC5344294.pdf
http://www.controlled- trials.com/ISRCTN89034131/.,Non-OADS,/arxiv_data1/oa_pdf/09/f5/bjc201717a.PMC5344295.pdf
"Hence, we performed in silico analysis using the algorithms TargetScan (http://www.targetscan.org) and miRanda (http://www.microrna.org) to shortlist DCK -targeting miRNAs.",OADS,/arxiv_data1/oa_pdf/74/4b/bjc201718a.PMC5344296.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Exosomes promote chemoresistance in pancreatic cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2017.18 619,Non-OADS,/arxiv_data1/oa_pdf/74/4b/bjc201718a.PMC5344296.pdf
"For information on how to submit an applica- tion for gaining access to EPIC data and/or bio-specimens, please follow the instructions at http://epic.iarc.fr/access/index.php.",Non-OADS,/arxiv_data1/oa_pdf/57/08/bjc20171a.PMC5344297.pdf
"For information on how to submit an application for gaining access to EPIC data and/or bio-specimens, please follow the instructions at http://epic.iarc.fr/ access/index.php.",Non-OADS,/arxiv_data1/oa_pdf/57/08/bjc20171a.PMC5344297.pdf
Globocan (2012) Estimated Age-Standardised Incidence and Mortality Rates: Both Sexes http://globocan.iarc.fr/Pages/fact_sheets_population.aspx (accessed on 1 July 2015).,Non-OADS,/arxiv_data1/oa_pdf/57/08/bjc20171a.PMC5344297.pdf
"Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Cancer.Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), 08908 Barcelona, Spain;30Escuela Andaluza de Salud Pu ´blica, Instituto de Investigacio ´n Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada/ Universidad de Granada, 18080 Granada, Spain;31Consortium for Biomedical Research in Epidemiology and Public Health (CIBER- CIBERESP), 28029 Madrid, Spain;32Public Health Direction and Biodonostia Research Institute–Ciberesp Basque Regional Health Department, s/n 20014 San Sebastian, Spain;33Department of Epidemiology, Murcia Regional Health Council, IMIB- Arrixaca, E-30008 Murcia, Spain;34Navarra Public Health Institute, Pamplona, Spain;35Navarra Institute for Health Research (IdiSNA), 31003 Pamplona, Spain;36Department of Internal Medicine, Skåne University Hospital, Lund University, SE-205 92 Malmo ¨, Sweden;37Department of Gastroenterology and Nutrition, Skåne University Hospital, Lund University, SE-205 92 Malmo ¨, Sweden;38Department of Public Health and Medicine, Umeå University, SE-901 85 Umeå, Sweden;39Department of Public Health and Clinical Medicine and Institute of Odontology Umeå University, SE-901 85 Umeå, Sweden;40MRC Epidemiology Unit, University of Cambridge, CB2 0QQ Cambridge, UK;41Clinical Gerontology, School of Clinical Medicine, University of Cambridge, CB2 0QQ Cambridge, UK and42Cancer Epidemiology Unit, Nuffield Department of Population Health University of Oxford, OX3 7LF Oxford, UKBRITISH JOURNAL OF CANCER Serum copper and zinc and hepatobiliary cancer risk 696 www.bjcancer.com | DOI:10.1038/bjc.2017.1",Non-OADS,/arxiv_data1/oa_pdf/57/08/bjc20171a.PMC5344297.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Tumour necrosis in muscle invasive bladder cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2017.2 657,Non-OADS,/arxiv_data1/oa_pdf/19/a7/bjc20172a.PMC5344298.pdf
Available at: https://monographs.iarc.fr/ENG/Monographs/vol83/ mono83.pdf.,Non-OADS,/arxiv_data1/oa_pdf/72/8b/bjc20177a.PMC5344300.pdf
Available at: http://monographs.iarc.fr/ENG/Monographs/vol96/mono96.pdf.,Non-OADS,/arxiv_data1/oa_pdf/72/8b/bjc20177a.PMC5344300.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Composite lifestyle factors and risk of gastric cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2017.7 687,Non-OADS,/arxiv_data1/oa_pdf/72/8b/bjc20177a.PMC5344300.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2017.01.008,OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.3181/0703-mr-72 .,Non-OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.4161/cam.28733 .,Non-OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.1016/j.surg.2006.10.010.Use .,OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.1002/jemt.20567 .,Non-OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.1165/ajrcmb/3.4.275 .,Non-OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.1128/MCB.25.15.6846-6856.2005 .,Non-OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.1006/jmbi.1998.2004 .,OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.1111/j.1432-1033.1993.tb18316.x .,Non-OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.1242/jcs.01127 .,Non-OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.1038/nrc1949 .,Non-OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
"Biochim Biophys Acta-Proteins Proteomics 1824,6 8–88.http://dx.doi.org/10.1016/j.bbapap.2011.10.002 .",OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.1038/ncb3011.Analysis .,OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.1016/j.bbrc.2012.07.013 .,OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.1021/pr100492x .,Non-OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.1093/jjco/hyu187 .,Non-OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.1016/j.clinbiochem.2011.08.1135 .,OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.1016/j.lungcan.2011.04.009 .Neoplasia Vol.,Non-OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.1161/01.RES.0000060485.20318.96 .,Non-OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.1016/j.tcb.2010.12.002 .,OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
http://dx.doi.org/10.1016/j.biochi.2011.08.017 .,OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC5344320.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.02.001 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/89/main.PMC5344321.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 192 e194,Non-OADS,/arxiv_data1/oa_pdf/c8/89/main.PMC5344321.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.02.0262211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
Pediatrics 138 (2):1 –10.http://dx.doi.org/10.1542/peds.2015-3983 .,Non-OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
119:45 –52.http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
Addiction 112 (1):6 –7.http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
Rep. 4:4133. http://dx.doi.org/10.1038/srep04133 .,Non-OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
12:21. http://dx.doi.org/10.1186/s12954-015-0055-0 .,Non-OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
BMC Public Health 16:432. http://dx.doi.org/10.1186/s12889-016-3079-9 .,Non-OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
Drug Policy 32:17 –23.http://dx.doi.org/10.1016/j.drugpo.2016.03.014 .,OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
http://dx.doi.org/10.1016/ j.amepre.2016.08.039 .,OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
"Public Health England https://www.gov.uk/ government/uploads/system/uploads/attachment_data/ ﬁle/457102/Ecigarettes_an_ evidence_update_A_report_commissioned_by_Public_Health_England_FINAL.pdf (Accessed February 20, 2017).",Non-OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
"Truth Initiative, Washington, DC http://truthinitiative.org/sites/default/ ﬁles/ReThinking-Nicotine.pdf (Accessed Feb- ruary 20, 2017).",Non-OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
59:30 –34.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
"RCP, London https://www.rcplondon.ac.uk/projects/outputs/nicotine-without- smoke-tobacco-harm-reduction-0 (Accessed February 20, 2017).",Non-OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
54:33 –39.http://dx.doi.org/10.1016/j.addbeh.2015.11.012 .,OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
http://dx.doi.org/10.15585/mmwr.mm6514a1 .,OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
158: 67–75.http://dx.doi.org/10.1016/j.drugalcdep.2015.11.003 .,OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
"Health http://dx.doi.org/ 10.1515/reveh-2015-0075 .Table 1 Two ordinal logistic regression models predicting use of e-cigarettes (1 = Triers, 2 = NotDaily users, 3 = Daily users); Product-type was determinable for only 67 participants(New York State, USA, 2014 –2016).",OADS,/arxiv_data1/oa_pdf/bf/6b/main.PMC5344323.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/61/main.PMC5344324.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2017.01.005,OADS,/arxiv_data1/oa_pdf/36/61/main.PMC5344324.pdf
"http://dx.doi.org/10.1016/j.redox.2017.02.024 Received 29 December 2016; Received in revised form 24 February 2017; Accepted 27 February 2017⁎Correspondence to: Facultad de Medicina, Ponti ﬁcia Universidad Católica de Chile, Alameda 340, Santiago 8331010, Chile.",Non-OADS,/arxiv_data1/oa_pdf/98/2a/main.PMC5344325.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/98/2a/main.PMC5344325.pdf
"http://dx.doi.org/10.1016/j.redox.2017.02.020 Received 30 January 2017; Received in revised form 12 February 2017; Accepted 24 February 2017⁎Correspondence to: Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, MS 1018 3901 Rainbow Blvd., Kansas City, Kansas 66160,.",Non-OADS,/arxiv_data1/oa_pdf/a0/07/main.PMC5344326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/07/main.PMC5344326.pdf
"< http://www.tobaccoreport.ca/2015/TobaccoUseinCanada_2015.pdf > Wilson, S., L. Rosella, J. Wang, N. Le Saux, N. Crowcroft, T. Harris et al.",Non-OADS,/arxiv_data1/oa_pdf/7a/77/policy-12-008.PMC5344358.pdf
<https://www.cihi.ca/fr/performance-du-systeme-de-sante >.,Non-OADS,/arxiv_data1/oa_pdf/4f/ca/policy-12-010.PMC5344359.pdf
"< http://www.tobaccoreport.ca/2015/TobaccoUseinCanada_2015.pdf > Wilson, S., L. Rosella, J. Wang, N. Le Saux, N. Crowcroft, T. Harris et al.",Non-OADS,/arxiv_data1/oa_pdf/4f/ca/policy-12-010.PMC5344359.pdf
< http://aisel.aisnet.org/cgi/viewcontent.cgi?article=1333&context=icis2014 >.,Non-OADS,/arxiv_data1/oa_pdf/42/49/policy-12-019.PMC5344361.pdf
< http://www.health.gov.on.ca/en/ pro/programs/publichealth/orgstandards >.,Non-OADS,/arxiv_data1/oa_pdf/b5/d4/policy-12-034.PMC5344362.pdf
< https://accreditation.ca/primary-care-services-standalone-clinics >.,Non-OADS,/arxiv_data1/oa_pdf/e4/92/policy-12-066.PMC5344364.pdf
< http://www.hqontario.ca/portals/0/Documents/pr/pc-performance-measurement-report-en.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/e4/92/policy-12-066.PMC5344364.pdf
< http://www.google.ca/url?sa=t&rct=j&q =&esrc=s&source=web&cd=2&ved=0CCUQFjAB&url=http%3A%2F%2Fwww.trilliumresearchday.,OADS,/arxiv_data1/oa_pdf/e4/92/policy-12-066.PMC5344364.pdf
"For more information on RHs  in Ontario, including a searchable database of facilities, see  http://www.rhra.ca/en/register/ .",OADS,/arxiv_data1/oa_pdf/1a/b0/policy-12-080.PMC5344365.pdf
< http://ocsco.ca/uploads/Image/ OANHSS_Provincial_Snapshot.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/1a/b0/policy-12-080.PMC5344365.pdf
<https://www.ontario.ca/page/get-coverage-prescription-drugs>.,Non-OADS,/arxiv_data1/oa_pdf/dd/b1/policy-12-095.PMC5344366.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/62/58/opth-11-487.PMC5344407.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 487–492Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  487Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12983 0 Corneal flap thickness with the Moria M2   single-use head 90 microkeratome in 72   consecutive lasiK procedures Yunus Karabela1 Orkun Muftuoglu2 Faruk Kaya1 1Department of Ophthalmology,   Medipol University, 2Department  of Ophthalmology, Vehbi Koç Vakfı  Amerikan Hospital, Istanbul, T urkeyPurpose:  This study aimed to evaluate the accuracy and consistency of corneal flap  thickness in laser-assisted in situ keratomileusis (LASIK) with the Moria M2 single-use head  90 microkeratome.",Non-OADS,/arxiv_data1/oa_pdf/62/58/opth-11-487.PMC5344407.pdf
"Creating a cor - neal flap is the most important step for successful LASIK.1–7 However, the use of  microkeratome to create a corneal flap increases the risk of intraoperative flap-related  complications, such as free flaps, irregular flaps, buttonhole flaps, incomplete flaps,  and lacerated flaps.8–13 Many different microkeratomes can be used to create the corneal flap.14–29 The  Moria M2 (Moria, Antony, France) is a popular compact, automated, plastic, single-use Correspondence: Yunus Karabela Department of Ophthalmology,  Istanbul Medipol University, Esenler  Hospital, Birlik Mahallesi, Bahceler  Caddesi, Number 5, Esenler 34230,  Istanbul, Turkey Tel +90 212 440 1000 Fax +90 212 440 1010 email mrsbela@yahoo.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Karabela et al Running head recto: Corneal flap thickness with the Moria M2 single-use head 90 DOI: http://dx.doi.org/10.2147/OPTH.S129830",Non-OADS,/arxiv_data1/oa_pdf/62/58/opth-11-487.PMC5344407.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/62/58/opth-11-487.PMC5344407.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/62/58/opth-11-487.PMC5344407.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/63/3c/cia-12-459.PMC5344408.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 459–465Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  459OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12327 8 Association of genetic variations in the  mitochondrial DnA control region with  presbycusis Masoumeh Falah1 Mohammad Farhadi1 seyed Kamran Kamrava1 saeid Mahmoudian1 Ahmad Daneshi1 Maryam Balali1 Alimohamad Asghari2 Massoud houshmand1,3 1enT and head & neck research  Center and Department, Iran  University of Medical sciences,   T ehran, Iran; 2skull Base research  Center, Iran University of Medical  sciences, T ehran, Iran; 3Department  of Medical genetics, national  Institute of genetic engineering  and Biotechnology, T ehran, IranBackground:  The prominent role of mitochondria in the generation of reactive oxygen  species, cell death, and energy production contributes to the importance of this organelle in  the intracellular mechanism underlying the progression of the common sensory disorder of the  elderly, presbycusis.",Non-OADS,/arxiv_data1/oa_pdf/63/3c/cia-12-459.PMC5344408.pdf
"Correspondence: Masoumeh Falah enT and head & neck research  Center and Department, Iran  University of Medical sciences, hazrat  rasool Akram hospital, niayesh st,  sattarkhan st, Tehran, Iran Tel +98 912 422 4834 Fax +98 21 6652 5329 email falah.m@tak.iums.ac.i r  Massoud houshmand Department of Medical genetics,  national Institute of genetic engineering  and Biotechnology, shahrak-e Pajoohesh,  km 15, Tehran – Karaj highway,  Tehran, Iran email massoudh@nigeb.ac.i r Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Falah et al Running head recto: mtDNA control region in presbycusis DOI: http://dx.doi.org/10.2147/CIA.S123278",Non-OADS,/arxiv_data1/oa_pdf/63/3c/cia-12-459.PMC5344408.pdf
The Mitomap  (http://www.mitomap.or g) and mtDB ( http://www.mtdb.,OADS,/arxiv_data1/oa_pdf/63/3c/cia-12-459.PMC5344408.pdf
Available from: http://www.aoa.acl.,Non-OADS,/arxiv_data1/oa_pdf/63/3c/cia-12-459.PMC5344408.pdf
Avail - able from: http://www.mitomap.org/foswiki/bin/view/MITOMAP/ Submissions/2016080600 4  20.,Non-OADS,/arxiv_data1/oa_pdf/63/3c/cia-12-459.PMC5344408.pdf
Avail - able from: http://www.mitomap.org/foswiki/bin/view/MITOMAP/ Submissions/2016080600 5  21.,Non-OADS,/arxiv_data1/oa_pdf/63/3c/cia-12-459.PMC5344408.pdf
Avail - able from: http://www.mitomap.org/foswiki/bin/view/MITOMAP/ Submissions/2016080600 6  22.,Non-OADS,/arxiv_data1/oa_pdf/63/3c/cia-12-459.PMC5344408.pdf
Avail - able from: http://www.mitomap.org/foswiki/bin/view/MITOMAP/ Submissions/2016080600 7  23.,Non-OADS,/arxiv_data1/oa_pdf/63/3c/cia-12-459.PMC5344408.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/63/3c/cia-12-459.PMC5344408.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/63/3c/cia-12-459.PMC5344408.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/25/09/jpr-10-507.PMC5344409.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/25/09/jpr-10-507.PMC5344409.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research 2017:10 507–514Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  507 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S127019Parents’ relationship to pain during children’s  cancer treatment – a preliminary validation of  the Pain Flexibility Scale for Parents Jenny Thorsell Cederberg1  Sandra Weineland  Strandskov2  JoAnne Dahl3  Gustaf Ljungman1 1Department of Women’s and  Children’s Health, Uppsala University,   Uppsala, 2Närhälsan, Research and  Development Center, Primary Health Care, Södra Älvsborg, Borås,   3Department of Psychology, Uppsala  University, Uppsala, SwedenObjectives:  Pain is one of the most frequent and burdensome symptoms for children with  cancer.",Non-OADS,/arxiv_data1/oa_pdf/25/09/jpr-10-507.PMC5344409.pdf
"12,13 ACT aims to create psychological flexibility around Correspondence: Jenny Thorsell  Cederberg   Department of Women’s and Children’s Health, Uppsala University, Uppsala University Hospital, SE-751 85 Uppsala, Sweden Tel +46 18 611 0197   Fax +46 18 50 8680   Email jenny.thorsell.cederberg@kbh.uu.seJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Thorsell Cederberg et alRunning head recto: Parents’ relationship to pain during children’ s cancer treatmentDOI: http://dx.doi.org/10.2147/JPR.S127019",Non-OADS,/arxiv_data1/oa_pdf/25/09/jpr-10-507.PMC5344409.pdf
Available from: http://www.iasp-pain.org/GlobalY ear/CancerPain.,Non-OADS,/arxiv_data1/oa_pdf/25/09/jpr-10-507.PMC5344409.pdf
Available from:  http://www.div12.org/psychological-treatments/disorders/chronic-or-persistent-pain/acceptance-and-commitment-therapy-for-chronic-pain/.,Non-OADS,/arxiv_data1/oa_pdf/25/09/jpr-10-507.PMC5344409.pdf
"Journal of Pain Research 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/25/09/jpr-10-507.PMC5344409.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 514 Thorsell Cederberg et al 28.,Non-OADS,/arxiv_data1/oa_pdf/25/09/jpr-10-507.PMC5344409.pdf
Available from: https://thewinnower.com/papers/1113-com-puting-intraclass-correlations-icc-as-estimates-of-interrater-reliability-in-spss.,OADS,/arxiv_data1/oa_pdf/25/09/jpr-10-507.PMC5344409.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/69/9e/dddt-11-585.PMC5344410.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 585–592Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  585Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12789 7 rifapentine-linezolid-loaded Plga microspheres  for interventional therapy of cavitary pulmonary  tuberculosis: preparation and in vitro  characterization Jieyun huang1,* Zhi chen2,* Ying li3 li li2 guangyu Zhang2 1The second clinical Medical  college, shanxi Medical University,   Taiyuan, People’s republic of china;   2institute for T uberculosis research,   The 309th hospital of chinese P la,   Beijing, People’s republic of china;   3Department of Drug Delivery  research center, institute of  Medicinal Plant Development, chinese  academy of Medical sciences and  Peking Union Medical college, Beijing,   People’s republic of china *These authors contributed equally  to this workAbstract:  In this study, we aimed to design controlled-release microspheres for the treatment of  cavitary pulmonary tuberculosis (TB) for solving the issues of poor drug delivery and short dura - tion maintained at effective drug concentration during bronchoscopic interventional therapy.",Non-OADS,/arxiv_data1/oa_pdf/69/9e/dddt-11-585.PMC5344410.pdf
"However, the drugs selected currently for bronchoscopic local injection have poor correspondence: guangyu Zhang institute for Tuberculosis research, The  309th hospital of chinese Pla, no 17  heishanhu road, haidian District, Beijing  100091, People’s republic of china Tel +86 10 6677 5143 Fax +86 10 6677 5143 email gy_zhang5686@sina.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Huang et al Running head recto: Rifapentine-linezolid-loaded microspheres for cavitary TB treatment DOI: http://dx.doi.org/10.2147/DDDT.S127897",Non-OADS,/arxiv_data1/oa_pdf/69/9e/dddt-11-585.PMC5344410.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/69/9e/dddt-11-585.PMC5344410.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/9e/dddt-11-585.PMC5344410.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cd/7c/ijwh-9-145.PMC5344411.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2017:9 145–150International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  145OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S12691 6 Immunological and hematological reference  intervals among HIV-seronegative pregnant  women in northwest ethiopia Meaza genetu1 Debasu Damtie1 Meseret Workineh1 Biniam Mathewos T ebeje1,2 Bamlaku enawgaw3 T ekalign Deressa1 1Department of Immunology  and Molecular Biology, school of  Biomedical and laboratory sciences,   college of Medicine and Health  science, University of gondar, gondar,   ethiopia; 2Molecular Parasitology  laboratory, Queensland Institute of  Medical research, Brisbane, australia;   3Department of Hematology and  Immunohematology, school of  Biomedical and laboratory sciences,   college of Medicine and Health  science, University of gondar, gondar,   ethiopiaBackground:  Pregnancy is a state characterized by profound physiological hematological  changes.",Non-OADS,/arxiv_data1/oa_pdf/cd/7c/ijwh-9-145.PMC5344411.pdf
"Keywords:  immunological parameter, hematological parameter, pregnant women, refer - ence range, immunohematological reference intervals Introduction Hematological and immunological reference intervals play a critical role as clinical  guides in the diagnosis or monitoring of several diseases as well as adverse reactions  during clinical trials.1,2 These parameters have been reported to vary by age, sex, preg - nancy, dietary patterns, genetic background, and geographical factors.3–5 For example, correspondence: Tekalign Deressa Department of Immunology and  Molecular Biology, school of Biomedical  and laboratory sciences, college of  Medicine and Health science, University  of gondar, PO Box 196, gondar,  ethiopia email tekalign09@gmail.co m Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2017 Volume: 9 Running head verso: Genetu et al Running head recto: Immunological–hematological reference intervals for HIV -negative pregnant women DOI: http://dx.doi.org/10.2147/IJWH.S126916",Non-OADS,/arxiv_data1/oa_pdf/cd/7c/ijwh-9-145.PMC5344411.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/cd/7c/ijwh-9-145.PMC5344411.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/7c/ijwh-9-145.PMC5344411.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4c/51/dddt-11-599.PMC5344412.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 599–616Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  599Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S11948 8 Metal complexes in cancer therapy – an update  from drug design perspective Umar Ndagi Ndumiso Mhlongo Mahmoud e Soliman Molecular Modelling and Drug Design  Research Group, School of Health  Sciences, University of KwaZulu- Natal, westville, Durban, South AfricaAbstract:  In the past, metal-based compounds were widely used in the treatment of disease  conditions, but the lack of clear distinction between the therapeutic and toxic doses was a  major challenge.",Non-OADS,/arxiv_data1/oa_pdf/4c/51/dddt-11-599.PMC5344412.pdf
"This  was supported by the information handed down by Pliny and Aulus Cornelius Celsus  (Roman physicians) on the use of cinnabar in the treatment of trachoma and venereal  diseases.1 In the 9th and 11th century BC, the contributions of ancient scientists such  as Rhazes (Al-Razi) and Avicenna (Ibn Sina) were applauded,1 sequel to the discovery  of toxicological effects of mercury in the animals and the use of mercury (quicksilver  ointment) for skin diseases respectively.Correspondence: Mahmoud e Soliman Molecular Modelling and Drug Design  Research Group, School of Health  Sciences, University of KwaZulu-Natal,  westville, Durban 4000, South Africa Tel +27 31 260 7413 Fax +27 31 260 779 email soliman@ukzn.ac.z a Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Ndagi et al Running head recto: Metal complexes in cancer therapy DOI: http://dx.doi.org/10.2147/DDDT.S119488",Non-OADS,/arxiv_data1/oa_pdf/4c/51/dddt-11-599.PMC5344412.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4c/51/dddt-11-599.PMC5344412.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/51/dddt-11-599.PMC5344412.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/95/64/copd-12-765.PMC5344413.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 765–772International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  765OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12623 3 Decreased levels of irisin, a skeletal muscle  cell-derived myokine, are related to emphysema  associated with chronic obstructive pulmonary  disease Yukari sugiyama Kazuhisa asai Kazuhiro Yamada Yuko Kureya naoki Ijiri T etsuya Watanabe hiroshi Kanazawa Kazuto hirata Department of respiratory Medicine,   graduate school of Medicine, Osaka  City University, Osaka, JapanBackground:  Cigarette smoking-induced oxidant–antioxidant imbalance is a factor that  contributes to the pathogenesis of COPD through epithelial cell apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/95/64/copd-12-765.PMC5344413.pdf
"This  pathological course induces to irreversible disease progression.4,5Correspondence: Kazuhisa asai Department of respiratory Medicine,  graduate school of Medicine, Osaka City  University, 1-4-3 asahimachi, abeno-ku,  Osaka 545-8585, Japan Tel +81 6 6645 3916 email kazuasai@med.osaka-cu.ac.j p Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Sugiyama et al Running head recto: Irisin and emphysema in COPD DOI: http://dx.doi.org/10.2147/COPD.S126233",Non-OADS,/arxiv_data1/oa_pdf/95/64/copd-12-765.PMC5344413.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/95/64/copd-12-765.PMC5344413.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/95/64/copd-12-765.PMC5344413.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1b/00/ceg-10-057.PMC5344414.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1b/00/ceg-10-057.PMC5344414.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical and Experimental Gastroenterology 2017:10 57–66Clinical and Experimental Gastroenterology Dovepress submit your manuscript | www.dovepress.com Dovepress  57 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S110547Vedolizumab: toward a personalized therapy  paradigm for people with ulcerative colitis Robin J Dart1–3,* Mark A Samaan1,* Nick Powell1,4 Peter M Irving1 1Department of Gastroenterology,   IBD Centre, St. Thomas’ Hospital,   2Immunosurveillance Laboratory,   The Francis Crick Institute, London,   3Division of Immunology, Infection,   and Inflammatory Disease (DIIID),   King’s College London, 4Department  of Experimental Immunobiology,  Division of Transplantation and Mucosal Biology, King’s College London, London, UK *These authors contributed equally to  this workAbstract:  Ulcerative colitis (UC) is a chronic relapsing and remitting inflammatory bowel  disease, with a characteristic leukocytic infiltration of the mucosa.",Non-OADS,/arxiv_data1/oa_pdf/1b/00/ceg-10-057.PMC5344414.pdf
"11Correspondence:  Peter M Irving Department of Gastroenterology, IBD  Centre, First Floor College House, North Wing, St. Thomas’ Hospital, Westminster Bridge Road, London SE1 7EH, UKTel +44 20 7188 2499Fax +44 20 7188 2484Email peter.irving@gstt.nhs.ukJournal name: Clinical and Experimental Gastroenterology Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Dart et alRunning head recto: Vedolizumab: personalized therapy in UCDOI: http://dx.doi.org/10.2147/CEG.S110547",Non-OADS,/arxiv_data1/oa_pdf/1b/00/ceg-10-057.PMC5344414.pdf
"Clinical and Experimental Gastroenterology 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical‑and‑experimental‑gastroenterology‑journalClinical and Experimental Gastroenterology is an international, peer- reviewed, open access, online journal publishing original research, reports, editorials, reviews and commentaries on all aspects of   gastroenterology in the clinic and laboratory.",Non-OADS,/arxiv_data1/oa_pdf/1b/00/ceg-10-057.PMC5344414.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 66 Dart et al 76.,Non-OADS,/arxiv_data1/oa_pdf/1b/00/ceg-10-057.PMC5344414.pdf
8 February 2017Molecular Genetics and Metabolism Reports 11 (2017) 1 http://dx.doi.org/10.1016/j.ymgmr.2017.02.003 2214-4269/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/da/37/main.PMC5344415.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/37/main.PMC5344415.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0a/79/ott-10-1381.PMC5344421.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1381–1388OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1381Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S12685 2 Arterial stiffness in hematologic malignancies ioana Mozos1 Georgiana Borzak2 Alexandru Caraba3 Rodica Mihaescu3 1Department of Functional Sciences,   “victor Babes” University of  Medicine and Pharmacy, 2Department  of Hematology, “Oncohelp”  Hospital, 3First Department of  internal Medicine, “ victor Babes”  University of Medicine and Pharmacy,   Timişoara, RomaniaAbstract:  Malignant and cardiovascular disorders are the top causes of mortality worldwide.",Non-OADS,/arxiv_data1/oa_pdf/0a/79/ott-10-1381.PMC5344421.pdf
"It is one of the earliest detectable signs of adverse structural Correspondence: ioana Mozos Department of Functional Sciences,  “victor Babes” University of Medicine  and Pharmacy, Tudor vladimirescu Street  14, 300173 Timişoara, Romania email ioanamozos@yahoo.d e Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2017 Volume: 10 Running head verso: Mozos et al Running head recto: Arterial stiffness in hematologic malignancies DOI: http://dx.doi.org/10.2147/OTT.S126852",Non-OADS,/arxiv_data1/oa_pdf/0a/79/ott-10-1381.PMC5344421.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0a/79/ott-10-1381.PMC5344421.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/79/ott-10-1381.PMC5344421.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/aa/67/ppa-11-449.PMC5344423.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 449–468Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  449Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12465 8 why do psychiatric patients stop antipsychotic  medication?",Non-OADS,/arxiv_data1/oa_pdf/aa/67/ppa-11-449.PMC5344423.pdf
"A meta-analysis of 65 clinical trials in patients with Correspondence: Dawn i velligan Department of Psychiatry, The University  of Texas Health Science Center, 7703  Floyd Curl Drive, Mail Stop 7797, San  Antonio, TX 78229-3900, USA Tel +1 210 567 5508 Fax +1 210 567 1291 email velligand@uthscsa.ed u Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Velligan et al Running head recto: Reasons for nonadherence to antipsychotics DOI: http://dx.doi.org/10.2147/PPA.S124658",Non-OADS,/arxiv_data1/oa_pdf/aa/67/ppa-11-449.PMC5344423.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/aa/67/ppa-11-449.PMC5344423.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f5/02/imcrj-10-069.PMC5344424.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f5/02/imcrj-10-069.PMC5344424.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2017:10 69–71International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 69 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S129253Traumatic reopening of macular hole following  successful surgical repair Margaret Wong Robert L Halpern James H Frank Vitreoretinal Department, Eye  Consultants of Atlanta, Atlanta,  GA, USAAbstract:  A 75-year-old Caucasian female with a full-thickness macular hole underwent a  successful surgical repair.",Non-OADS,/arxiv_data1/oa_pdf/f5/02/imcrj-10-069.PMC5344424.pdf
"Six weeks later, repeated pars plana vitrectomy and ILM peeling were performed with brilliant blue stain, and the patient again had C 3F8 Correspondence: Margaret Wong Eye Consultants of Atlanta, 3225 Cumberland Boulevard, Suite 800, Atlanta, GA 30339, USATel +1 770 329 9478Fax +1 404 355 4955Email margaret.oph@gmail.comJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2017V olume: 10Running head verso: Wong et alRunning head recto: Traumatic reopening of macular holeDOI: http://dx.doi.org/10.2147/IMCRJ.S129253",Non-OADS,/arxiv_data1/oa_pdf/f5/02/imcrj-10-069.PMC5344424.pdf
"International Medical Case Reports Journal 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/f5/02/imcrj-10-069.PMC5344424.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 71 Traumatic reopening of macular hole Acknowledgment The authors would like to thank Mr Ray S Swords for oph- thalmic photography.,Non-OADS,/arxiv_data1/oa_pdf/f5/02/imcrj-10-069.PMC5344424.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e6/9b/ott-10-1403.PMC5344425.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1403–1412OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1403Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S11168 1 Nonalcoholic steatohepatitis-related hepatocellular  carcinoma: is there a role for the androgen  receptor pathway?",Non-OADS,/arxiv_data1/oa_pdf/e6/9b/ott-10-1403.PMC5344425.pdf
"However, the incidence in developed countries has also been increasing owing to  the emergence of nonalcoholic steatohepatitis (NASH) as an important risk factor.3,4  In fact, recently, a large retrospective study demonstrated that the proportion of non- virus–related HCC increased from 10% in 1991 to 24.1% in 2010, with most cases  related to nonalcoholic fatty liver disease (NAFLD) and diabetes.5–7 In a Japanese  study, the 5-year HCC development rates in cirrhosis patients were 11.3% in NAFLD  cirrhosis, 12.5% in alcoholic cirrhosis, and 30.5% in hepatitis C virus cirrhosis, showing  similar rates of HCC development in both alcoholic and NAFLD-related cirrhosis.8 Correspondence: Ahmed O Kaseb Department of Gastrointestinal Medical  Oncology, Unit 426, The University of  Texas MD Anderson Cancer Center,  1515 Holcombe Blvd., Houston,  TX 77030, USA Tel +1 713 792 2828 Fax +1 713 745 1163 email akaseb@mdanderson.or gJournal name: OncoTargets and Therapy Article Designation: Review Y ear: 2017 Volume: 10 Running head verso: Ali et al Running head recto: Role of AR pathway in nonalcoholic steatohepatitis-related HCC DOI: http://dx.doi.org/10.2147/OTT.S111681",Non-OADS,/arxiv_data1/oa_pdf/e6/9b/ott-10-1403.PMC5344425.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e6/9b/ott-10-1403.PMC5344425.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/9b/ott-10-1403.PMC5344425.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c3/89/ott-10-1375.PMC5344426.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1375–1380OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1375Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12791 9 The world of targeted therapies in kidney cancers:  pitfalls, tips and tricks alexis Vallard Jane-Chloé Trone Julien Langrand-escure sophie espenel Jean-Baptiste Guy Chloé rancoule Yaoxiong Xia anis el Meddeb Hamrouni Majed Ben Mrad Nicolas Magné Department of radiation Oncology,   Lucien Neuwirth Cancer institute,   saint-Priest en Jarez, FranceAbstract:  In the past few years, metastatic renal cell carcinoma prognosis was improved by  the development of molecular targeted therapies (TTs).",Non-OADS,/arxiv_data1/oa_pdf/c3/89/ott-10-1375.PMC5344426.pdf
"The  main reported off-target effects (grade .2) with sunitinib are fatigue, diarrhea, hand- foot reaction, hypertension, peripheral edema, weight loss, dehydration, cough and  hematologic toxicities.8–10 It is a standard of care in first-line treatment of metastatic  kidney cancer.3,4,11,12 Sorafenib is a widely used multikinase inhibitor that blocks Correspondence: Nicolas Magné Department of radiation Oncology,  Lucien Neuwirth Cancer institute, 108  Bis, avenue albert raimond, BP 60008,  42271 saint-Priest en Jarez, France Tel +33 4 7791 7434 Fax +33 4 7791 7197 email nicolas.magne@icloire.f r Journal name: OncoTargets and Therapy Article Designation: Case Series Y ear: 2017 Volume: 10 Running head verso: Vallard et al Running head recto: Targeted therapies in kidney cancer DOI: http://dx.doi.org/10.2147/OTT.S127919",Non-OADS,/arxiv_data1/oa_pdf/c3/89/ott-10-1375.PMC5344426.pdf
Available  from: http://www.rhumatologie-bichat.com/Cours%20D3%20Goutte.,Non-OADS,/arxiv_data1/oa_pdf/c3/89/ott-10-1375.PMC5344426.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c3/89/ott-10-1375.PMC5344426.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/89/ott-10-1375.PMC5344426.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0d/9c/dddt-11-575.PMC5344427.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 575–583Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  575CliniC al Trial repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12334 0 Human papillomavirus (HpV): systemic treatment  with Gene-eden-Vir/novirin safely and effectively  clears virus Hanan p olansky edan itzkovitz adrian Javaherian The Center for the Biology of  Chronic Disease, Valley Cottage,   nY, USaPurpose:  This paper reports the results of a clinical study that tested the effect of systemic  treatment with the botanical product Gene-Eden-VIR/Novirin on the clearance rate (also called  time to clearance) of the human papillomavirus (HPV).",Non-OADS,/arxiv_data1/oa_pdf/0d/9c/dddt-11-575.PMC5344427.pdf
"More than 120 different  subtypes of the virus have been identified, with ~40 different subtypes capable of  infecting the anogenital tract.1,2 Approximately 15 subtypes of HPV were shown to  cause cervical cancer and cancers of the anus, vagina, vulva, penis, and oropharynx.3  These subtypes are called high-risk, oncogenic, or carcinogenic HPVs.4,5 In contrast,  the low-risk subtypes, also called nononcogenic or noncarcinogenic, rarely cause  cervical cancer, but may cause genital warts.1Correspondence: Hanan polansky The Center for the Biology of Chronic  Disease, 616 Corporate Way, Suite 2-3665,  Valley Cottage, nY 10989, USa Tel +1 585 250 9999 email hpolansky@cbcd.ne t Journal name: Drug Design, Development and Therapy Article Designation: Clinical Trial Report Y ear: 2017 Volume: 11 Running head verso: Polansky et al Running head recto: HPV natural treatment DOI: http://dx.doi.org/10.2147/DDDT.S123340",Non-OADS,/arxiv_data1/oa_pdf/0d/9c/dddt-11-575.PMC5344427.pdf
"2014;58(6):804–811, by permission  of oxford University press19), (C) Munoz et al (reprinted by permission from Macmillan publishers ltd: British Journal of Cancer http://www.nature.com/bjc/index.html.",Non-OADS,/arxiv_data1/oa_pdf/0d/9c/dddt-11-575.PMC5344427.pdf
"2014;58(6):804–811, by permission of oxford University press19), (C) Munoz et al ( adapted  by permission from Macmillan publishers ltd: British Journal of Cancer http://www.nature.com/bjc/index.html.",Non-OADS,/arxiv_data1/oa_pdf/0d/9c/dddt-11-575.PMC5344427.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/0d/9c/dddt-11-575.PMC5344427.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/9c/dddt-11-575.PMC5344427.pdf
Available from: http://www.fda.gov/downloads/drugs/ guidancecomplianceregulatoryinformation/guidances/ucm073139.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/9c/dddt-11-575.PMC5344427.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/95/2b/cia-12-475.PMC5344428.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 475–484Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  475RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12893 7 Perspectives of older people living in long-term  care facilities and of their family members toward  advance care planning discussions: a systematic  review and thematic synthesis veronica Mignani1 Francesca Ingravallo1 elena Mariani2 Rabih Chattat2 1Department of Medical and Surgical  Sciences, University of Bologna, via  Irnerio, Bologna, Italy; 2Department  of Psychology, University of Bologna,   viale Berti Pichat, Bologna, ItalyObjective:  We aimed to search and synthesize qualitative studies exploring the perspectives  of older people living in long-term care facilities and of their family members about advance  care planning (ACP) discussions.",Non-OADS,/arxiv_data1/oa_pdf/95/2b/cia-12-475.PMC5344428.pdf
"ACP is already  supported by legislation and endorsed by professional bodies in Australia, USA,2 and  in several European countries, although considerable disparities exist in legislation  among European Union member states.3 ACP is increasingly recognized as an: […] opportunity to help patients and their families to prepare, in their own terms, for  the changes wrought by serious progressive illness and work with them to plan nursing,  social and medical care so that it better fits their needs, hopes and aspirations.4Correspondence: Rabih Chattat Department of Psychology, University  of Bologna, viale Berti Pichat 5, 40127,  Bologna, Italy Tel +39 051 2091 821 Fax +39 051 243 086 email rabih.chattat@unibo.i t Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Mignani et al Running head recto: Advance care planning in long-term care facilities DOI: http://dx.doi.org/10.2147/CIA.S128937",Non-OADS,/arxiv_data1/oa_pdf/95/2b/cia-12-475.PMC5344428.pdf
"Available from: https://aspe.hhs.gov/pdf- report/advance-directives-and-advance-care-planning-report-congres s.  Accessed September 12, 2016.",Non-OADS,/arxiv_data1/oa_pdf/95/2b/cia-12-475.PMC5344428.pdf
Available from: https://www.coe.,Non-OADS,/arxiv_data1/oa_pdf/95/2b/cia-12-475.PMC5344428.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/95/2b/cia-12-475.PMC5344428.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/95/2b/cia-12-475.PMC5344428.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/27/c5/copd-12-785.PMC5344429.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 785–792International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  785OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12188 5 seasonal variability in clinical care of COPD  outpatients: results from the andalusian  COPD audit Jose luis lópez-Campos,1,2  Maria abad arranz,1 Carmen  Calero-acuña,1,2 Fernando  romero-Valero,3 ruth  ayerbe-garcía,4 antonio  hidalgo-Molina,3 ricardo  I aguilar-Pérez-grovas,4  Francisco garcía-gil,5  Francisco Casas-Maldonado,6  laura Caballero-Ballesteros,5  María sánchez-Palop,6 Dolores  Pérez-T ejero,7 alejandro  segado soriano,7 Jose  Calvo-Bonachera,8 Bárbara  hernández-sierra,8 adolfo  Doménech,9 Macarena arroyo- Varela,9 Francisco gonzález- Vargas,10 Juan J Cruz-rueda10 1Unidad Médico-Quirúrgica de enfermedades  respiratorias, Instituto de Biomedicina de  sevilla (IBi s), hospital Universitario Virgen del  rocío/Universidad de sevilla, seville, 2CIBer  de enfermedades respiratorias (CIBeres),  Instituto de salud Carlos III, Madrid, 3sección  de neumología, hospital Puerta del Mar,  Cádiz, 4servicio de neumología, hospital  Juan ramón Jiménez, huelva, 5servicio de  neumología, hospital Universitario reina  sofía, Córdoba, 6servicio de neumología,  hospital Universitario san Cecilio, granada,  7sección de neumología, hospital Infanta  Margarita, Cabra, Córdoba, 8servicio de  neumología, hospital T orrecárdenas, almería,  9servicio de neumología, hospital regional  Universitario de Málaga, Málaga, 10servicio de  neumología, hospital Universitario Virgen de  las nieves, granada,  spainObjectives:  Clinical practice in chronic obstructive pulmonary disease (COPD) can be  influenced by weather variability throughout the year.",Non-OADS,/arxiv_data1/oa_pdf/27/c5/copd-12-785.PMC5344429.pdf
"Manuel siurot, s/n 41013 seville, spain Tel +34 95 501 3166 email lopezcampos@separ.e sJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: López-Campos et al Running head recto: Seasonal variability in clinical care of COPD outpatients DOI: http://dx.doi.org/10.2147/COPD.S121885",Non-OADS,/arxiv_data1/oa_pdf/27/c5/copd-12-785.PMC5344429.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/27/c5/copd-12-785.PMC5344429.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/27/c5/copd-12-785.PMC5344429.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3d/3e/ijn-12-1791.PMC5344431.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1791–1802International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1791OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13040 4 Doxorubicin-loaded poly (lactic-co-glycolic acid)  nanoparticles coated with chitosan/alginate by  layer by layer technology for antitumor applications Fujuan chai1,* linlin sun2,3,* Xinyi he1 Jieli li1 Yuanfen liu4 Fei Xiong5 liang ge1 Thomas J Webster2,3 chunli Zheng1 1Department of Pharmaceutics,   china Pharmaceutical University,   Nanjing, 2Wenzhou Institute of  Biomaterials and engineering,   Wenzhou Medical University,   Wenzhou, Zhejiang, People’s republic  of china; 3Department of chemical  engineering, Northeastern University,   Boston, M a, Usa; 4Department of  Pharmacy, Jiangsu Jiankang Vocational  college, 5state Key laboratory of  Bioelectronics, Jiangsu laboratory  for Biomaterials and Devices, school  of Biological science and Medical  engineering, southeast University,   Nanjing, People’s republic of china *These authors contributed equally  to this workAbstract:  Natural polyelectrolyte multilayers of chitosan (CHI) and alginate (ALG) were  alternately deposited on doxorubicin (DOX)-loaded poly (lactic-co-glycolic acid) (PLGA)  nanoparticles (NPs) with layer by layer self-assembly to control drug release for antitumor  activity.",Non-OADS,/arxiv_data1/oa_pdf/3d/3e/ijn-12-1791.PMC5344431.pdf
"Entrapping drugs in nanocarriers can bypass the above impediments by modifying  drug biodistribution and controlling drug release.3–5 Santhi et al demonstrated that  methotrexate-loaded bovine serum albumin nanoparticles (NPs) caused a significant  increase in drug distribution to the spleen, liver and lungs, in comparison to the drug  power.6 Feng et al developed paclitaxel-loaded poly (lactic-co-glycolic acid) (PLGA)  nanospheres to achieve prolonged drug release profiles and better therapeutic effects.7  Moreover, NPs not only effectively protect drugs from ionic or enzymatic degradation,  but also increase their efficacy and stability and decrease their toxicity.4,8correspondence: Thomas J Webster Wenzhou Institute of Biomaterials and  engineering, Wenzhou Medical University,  16 Xin san road, gao Xin Ji shu chan Ye  Kai Fa Qu, Wenzhou, Zhejiang, 325001,  People’s republic of china email th.webster@neu.ed u  chunli Zheng Department of Pharmaceutics, china  Pharmaceutical University, 24  Tongjiaxiang,  Nanjing 210009, People’s republic of  china Tel/fax +86 25 8327 1293 email clz3330@hotmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Chai et al Running head recto: PLGA nanoparticles coated with chitosan/alginate DOI: http://dx.doi.org/10.2147/IJN.S130404",Non-OADS,/arxiv_data1/oa_pdf/3d/3e/ijn-12-1791.PMC5344431.pdf
The poster’s abstract was published in  “Poster Abstracts” on the website http://www3.aiche.org/ proceedings/Abstract.aspx?PaperID =47126 7.Disclosure The authors report no conflicts of interest in this work.,Non-OADS,/arxiv_data1/oa_pdf/3d/3e/ijn-12-1791.PMC5344431.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/3d/3e/ijn-12-1791.PMC5344431.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/3e/ijn-12-1791.PMC5344431.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fd/94/hiv-9-051.PMC5344433.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fd/94/hiv-9-051.PMC5344433.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).HIV/AIDS - Research and Palliative Care 2017:9 51–61HIV/AIDS - Research and Palliative Care Dovepress submit your manuscript | www.dovepress.com Dovepress 51 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S108756Response by gender of HIV-1-infected subjects  treated with abacavir/lamivudine plus atazanavir,  with or without ritonavir, for 144 weeks Kathleen E Squires1 Benjamin Y oung2,3 Lizette Santiago4 Robin H Dretler5 Sharon L Walmsley6 Henry H Zhao7 Gary E Pakes8 Lisa L Ross8 Mark S Shaefer8 On behalf of the ARIES Study T eam 1Thomas Jefferson University,   Philadelphia, PA, 2Apex Family  Medicine and Research, Denver,   CO, 3International Association of  Physicians in AIDS Care, Washington DC, USA;  4HOPE Clinic and Wellness  Center, San Juan, Puerto Rico; 5ID  Specialists of Atlanta, Decatur,  GA, USA;  6University Health  Network, T oronto, ON, Canada;   7GlaxoSmithKline, 8ViiV Healthcare,   Research Triangle Park, NC, USAPurpose: The 144-week results of the open-label, multicenter Atazanavir/Ritonavir Induction  with Epzicom Study (ARIES) were stratified by gender to compare treatment responses.",Non-OADS,/arxiv_data1/oa_pdf/fd/94/hiv-9-051.PMC5344433.pdf
"2 From a racial/ethnicity perspective, the rate of new HIV infections in the US is Correspondence: Kathleen E Squires Thomas Jefferson University, 1015 Chestnut Street, Suite 1020, Philadelphia, PA 19107, USATel +1 215 503 8575Fax +1 215 503 2624Email Kathleen.squires@jefferson.eduJournal name: HIV/AIDS - Research and Palliative Care Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Squires et alRunning head recto: Gender analysis of abacavir/lamivudine/atazanavir therapyDOI: http://dx.doi.org/10.2147/HIV .S108756",Non-OADS,/arxiv_data1/oa_pdf/fd/94/hiv-9-051.PMC5344433.pdf
Available from: http://www.amfar.org/about_hiv_and_aids/facts_and_stats/statistics__women_and_hiv_aids/.,Non-OADS,/arxiv_data1/oa_pdf/fd/94/hiv-9-051.PMC5344433.pdf
Available from: http://www.cdc.gov/features/womengirlshivaids/.,Non-OADS,/arxiv_data1/oa_pdf/fd/94/hiv-9-051.PMC5344433.pdf
Available from: https://www.nhlbi.nih.gov/files/docs/guidelines/atglance.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fd/94/hiv-9-051.PMC5344433.pdf
"HIV/AIDS - Research and Palliative Care 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/hivaids---research-and-palliative-care-journalHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open access journal focusing on advances in research in HIV , its clinical progression and management options including antiviral treatment, palliative care and public healthcare policies to control viral spread.",Non-OADS,/arxiv_data1/oa_pdf/fd/94/hiv-9-051.PMC5344433.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 61 Gender analysis of abacavir/lamivudine/atazanavir therapy Supplementary material Table S1  List of institutional review boards/independent ethics committee at each study site that approved the protocol Canada  1.,Non-OADS,/arxiv_data1/oa_pdf/fd/94/hiv-9-051.PMC5344433.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/16/e6/dddt-11-593.PMC5344434.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 593–598Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  593Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12473 6 awake craniotomy anesthetic management using  dexmedetomidine, propofol, and remifentanil andrea Prontera1 stefano Baroni2 andrea Marudi2 Franco Valzania3 alberto Feletti1 Francesca Benuzzi4 elisabetta Bertellini2 giacomo Pavesi1 1Department of n eurosurgery, nuovo  Ospedale civile sagostino-estense,   2Department of anesthesiology,   nuovo Ospedale civile sagostino- estense, 3Department of  neurology, nuovo Ospedale civile  s agostino-estense, 4Department of  neuroscience, University of Modena  and reggio emilia, Modena, italyIntroduction:  Awake craniotomy allows continuous monitoring of patients’ neurological  functions during open surgery.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/dddt-11-593.PMC5344434.pdf
"Bradycardia and moderate hypotension are the most common hemo - dynamic effects.correspondence: alberto Feletti Department of neurosurgery, nuovo  Ospedale civile s agostino-estense  Modena hospital, via Pietro giardini,  1355, Modena 41126, italy Tel +39 059 396 1471 Fax +39 059 396 2408 email alberto.feletti@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Prontera et al Running head recto: Dexmedetomidine in awake craniotomy DOI: http://dx.doi.org/10.2147/DDDT.S124736",Non-OADS,/arxiv_data1/oa_pdf/16/e6/dddt-11-593.PMC5344434.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/16/e6/dddt-11-593.PMC5344434.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/e6/dddt-11-593.PMC5344434.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7d/fe/cia-12-467.PMC5344435.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 467–473Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  467OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12370 4 Efficacy and safety of alcohol septal ablation  in patients over 65 years old with obstructive  hypertrophic cardiomyopathy Laila Cheddadi1 Olivier lairez1–4 Thibault Lhermusier1,5 Francisco Campelo-Parada1 Michel Galinier1,3,4 Didier Carrié1,3,5 nicolas Boudou1 1Department of Cardiology, University  hospital of rangueil, 2Department of  nuclear Medicine, 3Cardiac Imaging  Center, T oulouse University Hospital,   4Medical School of Rangueil, 5Medical  School of Purpan, University Paul  Sabatier, T oulouse, FranceBackground:  The performance of alcohol septal ablation (ASA) in elderly symptomatic  patients with drug-refractory obstructive hypertrophic cardiomyopathy is still to be confirmed.",Non-OADS,/arxiv_data1/oa_pdf/7d/fe/cia-12-467.PMC5344435.pdf
"It is nowadays admitted that short- and long-term outcomes of  ASA are mostly favorable.2,3 This is well validated for young- and middle-age patients.4 Correspondence: nicolas Boudou Department of Cardiology, University  hospital of rangueil, 1 Avenue Jean  Poulhès, Toulouse 31059 Cedex 9,  France Tel +33 56 132 3310 Fax +33 56 132 2754 email boudou.n@chu-toulouse.f r Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Cheddadi et al Running head recto: Alcohol septal ablation in elderly patients DOI: http://dx.doi.org/10.2147/CIA.S123704",Non-OADS,/arxiv_data1/oa_pdf/7d/fe/cia-12-467.PMC5344435.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/7d/fe/cia-12-467.PMC5344435.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/7d/fe/cia-12-467.PMC5344435.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/45/58/dddt-11-629.PMC5344436.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 629–641Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  629Original r esearchopen access to scientific and medical research Open a ccess Full T ext a rticle http: //dx.doi.org/10.2147/DDDT .S12534 9 Mc-PP ea  as a new and more potent inhibitor of  CLP-induced sepsis and pulmonary inflammation  than FK866 Peixin h uang1 Mark W l ee Jr2 Keivan s adrerafi2 Daniel P h eruth1 li Q Zhang1 Dev Maulik3,4 shui Qing Ye1,4 1Division of e xperimental and  Translational g enetics, Department  of Pediatrics, The c hildren’s Mercy  hospital, University of Missouri  Kansas c ity s chool of Medicine  Kansas c ity, 2Department of  chemistry, University of Missouri,   columbia, MO, 3Department of  Biomedical and h ealth i nformatics,   University of Missouri Kansas c ity  school of Medicine, 4Department of  Obstetrics and g ynecology, Truman  Medical c enter, Kansas c ity, MO, U saAbstract:  Our previous study indicated that overexpression of nicotinamide phosphoribosyl - transferase (NAMPT) aggravated acute lung injury, while knockdown of NAMPT expression  attenuated ventilator-induced lung injury.",Non-OADS,/arxiv_data1/oa_pdf/45/58/dddt-11-629.PMC5344436.pdf
"It catalyzes the key rate-limiting step in the nicotinamide  adenine dinucleotide (NAD +) synthetic salvage pathway, plays a central role in  cellular bioenergetics,1,2 and may indirectly control a number of signaling path - ways that depend on NAD levels, such as poly (ADP-ribose) polymerase (PARP)  and sirtuin activation.2 A secreted form of NAMPT was originally identified as  an extracellular proinflammatory cytokine that could induce cellular expression  of inflammatory cytokines, such as tumor necrosis factor α (TNF α), interleukin  (IL)1 β and IL6, and promote pre-B-cell colony formation.3,4 Lymphocytes, dendritic  cells, monocytes, and macrophages express NAMPT when presented with inflam - matory stimuli.1,5,6 Thus, NAMPT, either via the NAD salvage pathway or by other  unknown mechanisms relating to its secreted form, may modulate innate or acquired   immune functions.correspondence: s hui Qing Ye Division of e xperimental and  Translational g enetics, Department  of Pediatrics, The c hildren’s Mercy  hospital, University of Missouri Kansas  city s chool of Medicine, 2401 g ilham  road, Kansas c ity, MO, U sa Tel +1 816 983 6500 Fax +1 816 983 6501 email sqye@cmh.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Huang et al Running head recto: MC4 is a more potent NAMPT inhibitor than FK866 DOI: http://dx.doi.org/10.2147/DDDT.S125349",Non-OADS,/arxiv_data1/oa_pdf/45/58/dddt-11-629.PMC5344436.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/45/58/dddt-11-629.PMC5344436.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/58/dddt-11-629.PMC5344436.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/34/bd/ott-10-1363.PMC5344437.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1363–1373OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1363Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12900 4 Prognostic value of circulating tumor cells in the  peripheral blood of patients with esophageal  squamous cell carcinoma Yuanyuan Qiao,1,* Jun li,2,*  chenghe shi,1,* Wei Wang,2  Xiuhua Qu,1 Ming Xiong,1 Yulin  sun,3 Dandan li,1 Xiaohang  Zhao,1,3 Dajin Zhang1 1center of Basic Medical sciences, 2Department  of Thoracic surgery, navy general hospital of  chinese P la, 3state Key laboratory of Molecular  Oncology, cancer institute and hospital, chinese  academy of Medical sciences & Peking Union  Medical college, Beijing, People’s republic of china *These authors contributed equally to  this workObjective:  Circulating tumor cells (CTCs) of patients with malignant tumors can be used as a  prognostic marker.",Non-OADS,/arxiv_data1/oa_pdf/34/bd/ott-10-1363.PMC5344437.pdf
"However, the sensitivity of correspondence: Xiaohang Zhao  state Key laboratory of Molecular Oncology, cancer  institute and hospital, chinese academy of Medical  sciences & Peking Union Medical college, 17 Panjiayuan  road, chaoyang District, Beijing 100021, People’s  republic of china Tel +86 10 6695 1487   email zhaoxhtao@163.co m  Dajin Zhang center of Basic Medical sciences, navy general  hospital of chinese Pla, 6 Fucheng road, haidian  District, Beijing 100048, People’s republic of china  Tel +86 10 6695 1485  email dajinzhang@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Qiao et al Running head recto: Clinical value of CTCs in EC DOI: http://dx.doi.org/10.2147/OTT.S129004 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/34/bd/ott-10-1363.PMC5344437.pdf
Or use: http://youtu.be/Y9vd-A1MTR AVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/34/bd/ott-10-1363.PMC5344437.pdf
"Available from GLOBOCAN 2012,  Available from: http://globocan.iarc.fr/Default.aspx.",Non-OADS,/arxiv_data1/oa_pdf/34/bd/ott-10-1363.PMC5344437.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/34/bd/ott-10-1363.PMC5344437.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/bd/ott-10-1363.PMC5344437.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d2/7c/ott-10-1389.PMC5344438.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1389–1402OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1389Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12308 5 hMgB1 is negatively correlated with the  development of endometrial carcinoma and  prevents cancer cell invasion and metastasis  by inhibiting the process of epithelial-to- mesenchymal transition Xiaorong luan1,2 chunjing Ma2 Ping Wang2 Fenglan lou1 1nursing college, shandong University,   2Qilu hospital of shandong University,   Jinan, People’s republic of chinaAbstract:  High-mobility group box protein 1 (HMGB1), a nuclear protein that plays a significant  role in DNA architecture and transcription, was correlated with the progression of some types  of cancer.",Non-OADS,/arxiv_data1/oa_pdf/d2/7c/ott-10-1389.PMC5344438.pdf
"The molecular mechanism for growth and  metastasis of this cancer type is not well known.correspondence: Fenglan lou nursing college, shandong University,  44 Wenhua Xilu road, Jinan 250012,  People’s republic of china Tel +86 531 8694 2458 Fax +86 531 8694 2458 email fenglanlou666@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Luan et al Running head recto: HMGB1 prevents cancer cell invasion and metastasis inhibiting EMT DOI: http://dx.doi.org/10.2147/OTT.S123085",Non-OADS,/arxiv_data1/oa_pdf/d2/7c/ott-10-1389.PMC5344438.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d2/7c/ott-10-1389.PMC5344438.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/7c/ott-10-1389.PMC5344438.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e4/c0/jmdh-10-087.PMC5344440.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e4/c0/jmdh-10-087.PMC5344440.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2017:10 87–93Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 87 Review open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S126270interprofessional education for internationally  educated health professionals: an environmental  scan Mubashir Arain1 esther Suter1 Sara Mallinson1 Shelanne L Hepp1 Siegrid Deutschlander1 Shyama Dilani Nanayakkara2 elizabeth Louise Harrison3 Grace Mickelson4 Lesley Bainbridge5 Ruby e Grymonpre2 1workforce Research & evaluation,   Alberta Health Services, edmonton,   AB, 2College of Pharmacy, University  of Manitoba, winnipeg, MB, 3School  of Physical Therapy, College of  Medicine, University of Saskatchewan,  Saskatoon, SK,  4Provincial Health  Services Authority, v ancouver, BC,   5Department of Physical Therapy,   Faculty of Medicine, University of British Columbia, vancouver, BC,   CanadaObjective: The objective of this environmental scan was to identify Western Canadian inter - professional education (IPE) resources that currently exist for internationally educated health  professionals (IEHPs).",Non-OADS,/arxiv_data1/oa_pdf/e4/c0/jmdh-10-087.PMC5344440.pdf
"3 IPE is the process by which we train  practitioners to improve collaboration among health care providers.4 IPE helps with Correspondence: Mubashir Arain Alberta Health Services, 10301 Southport Tower, Calgary, AB T2w 1S7, CanadaTel +1 403 943 0783email MubashirAslam.Arain@ahs.caJournal name: Journal of Multidisciplinary Healthcare Article Designation: ReviewY ear: 2017V olume: 10Running head verso: Arain et alRunning head recto: Identify IPE resources for IEHPsDOI: http://dx.doi.org/10.2147/JMDH.S126270",Non-OADS,/arxiv_data1/oa_pdf/e4/c0/jmdh-10-087.PMC5344440.pdf
"Journal of Multidisciplinary Healthcare 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/e4/c0/jmdh-10-087.PMC5344440.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 93 identify iPe resources for ieHPs  2.,Non-OADS,/arxiv_data1/oa_pdf/e4/c0/jmdh-10-087.PMC5344440.pdf
Available from: http://www.who.int/hrh/resources/framework_action/en/.,OADS,/arxiv_data1/oa_pdf/e4/c0/jmdh-10-087.PMC5344440.pdf
Available from: http://www.cihc.ca/files/CIHC_EvalMethods_Final.pdf.,OADS,/arxiv_data1/oa_pdf/e4/c0/jmdh-10-087.PMC5344440.pdf
Available from: http://mcc.ca/wp-content/uploads/Blueprint-Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e4/c0/jmdh-10-087.PMC5344440.pdf
Available from: http://www.cihc.ca/files/CIHC_IPCompetencies_Feb1210.pdf.,OADS,/arxiv_data1/oa_pdf/e4/c0/jmdh-10-087.PMC5344440.pdf
Available from: http://www.hc-sc.gc.ca/hcs-sss/pubs/hhrhs/2008-ar-ra/index-eng.php.,OADS,/arxiv_data1/oa_pdf/e4/c0/jmdh-10-087.PMC5344440.pdf
Available from: http://www.tcen.com.au/sites/newtcen/files/files/CSSP/national-common-health-capability-resource.pdf.,OADS,/arxiv_data1/oa_pdf/e4/c0/jmdh-10-087.PMC5344440.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cb/d0/dddt-11-617.PMC5344441.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 617–627Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  617Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S13008 8 β3-adrenoceptor activation upregulates  apolipoprotein a-i expression in hepg2 cells,  which might further promote cholesterol efflux  from macrophage foam cells Xia-qing gao1,2 Yan-fang li1,2 Zhi-li Jiang1,2 1Department of cardiology, Beijing  anzhen hospital, capital Medical  University, 2Beijing institute of heart,   lung and Blood Vessel Diseases,   Beijing, People’s republic of chinaObjective:  The aim of this study was to explore the effects of β3-adrenoceptor ( β3-AR) activation  on HepG2 cells and its influence on cholesterol efflux from macrophage foam cells.",Non-OADS,/arxiv_data1/oa_pdf/cb/d0/dddt-11-617.PMC5344441.pdf
"Keywords:  β3-adrenoceptor, HepG2 cell, macrophage foam cell, atherosclerosis, cholesterol  efflux, reverse cholesterol transport Abbreviations ABC, adenosine triphosphate (ATP)-binding cassette transporter; Apo, apolipoprotein;  β3-AR, β3-adrenoceptor; AS, atherosclerosis; BAT, brown adipose tissue; BSA, bovine  serum albumin; cAMP, cyclic adenosine monophosphate; DMEM, Dulbecco’s Modi - fied Eagle’s Medium; ECL, enhanced chemiluminescence; ELISA, enzyme-linked  immunosorbent assay; FBS, fetal bovine serum; FC, free cholesterol; GAPDH, glyc - eraldehyde-3-phosphate dehydrogenase; HDL, high-density lipoprotein; LXR, liver X  receptor; MAPK, mitogen-activated protein kinase; P/S, penicillin-streptomycin antibi - otic; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate-buffered saline; PI3K,  phosphatidylinositol-3-kinase; PKC, protein kinase C; PMSF, phenylmethylsulfonyl correspondence: Yan-fang li Department of cardiology, Beijing  anzhen hospital, capital Medical  University, anzhen street, Beijing  100029, People’s republic of china Tel +86 01 82 012 5141 Fax +86 10 8400 5253 email liyf101@sohu.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Gao et al Running head recto: β3-Adrenoceptor activation upregulates ApoA-I expression in HepG2 cells DOI: http://dx.doi.org/10.2147/DDDT.S130088",Non-OADS,/arxiv_data1/oa_pdf/cb/d0/dddt-11-617.PMC5344441.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/cb/d0/dddt-11-617.PMC5344441.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/dddt-11-617.PMC5344441.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5c/88/ppa-11-381.PMC5344443.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 381–387Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  381OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11836 8 Physician’s recommendation and explanation is  important in the initiation and maintenance of  allergen immunotherapy Y oung-hee n am soo-Keol lee Department of internal Medicine,   college of Medicine, Dong-A  University, Busan, republic of KoreaBackground:  Allergen immunotherapy (AIT) is currently the only immune-modifying  treatment for allergic disease.",Non-OADS,/arxiv_data1/oa_pdf/5c/88/ppa-11-381.PMC5344443.pdf
"Moreover, treatment persistence and compliance of AIT are far from optimal.6–9 correspondence: soo-Keol lee  Department of internal Medicine,  college of Medicine, Dong-A University, 26 Daesingongwon-ro, seo-gu, Busan  602-715, republic of Korea Tel +82 51 240 2810 Fax +82 51 242 5852 email skleeai@dau.ac.k r Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Nam and Lee Running head recto: Patients’ perception of allergen immunotherapy in Korea DOI: http://dx.doi.org/10.2147/PPA.S118368",Non-OADS,/arxiv_data1/oa_pdf/5c/88/ppa-11-381.PMC5344443.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/5c/88/ppa-11-381.PMC5344443.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a8/1b/jpr-10-515.PMC5344444.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a8/1b/jpr-10-515.PMC5344444.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 515–525Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  515 ORiginal ReseaRch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S128508Evidence of both systemic inflammation and  neuroinflammation in fibromyalgia patients, as  assessed by a multiplex protein panel applied to  the cerebrospinal fluid and to plasma emmanuel Bäckryd1,*  lars Tanum2,*  anne-li lind3  anders larsson4  T orsten gordh3 1Pain and Rehabilitation Center,   Department of Medical and health  Sciences, Linköping University,   Linköping, Sweden; 2Department  of R&D in Mental Health, Akershus University Hospital, Lørenskog,  Norway;  3Department of Surgical  Sciences, 4Department of Medical  Sciences, Uppsala University, Uppsala,  sweden *These authors contributed equally to  this workAbstract:  In addition to central hyperexcitability and impaired top–down modulation, chronic  inflammation probably plays a role in the pathophysiology of fibromyalgia (FM).",Non-OADS,/arxiv_data1/oa_pdf/a8/1b/jpr-10-515.PMC5344444.pdf
"Drug therapy is not mandatory for the treatment of FM, 2 and  FM patients are often viewed from a rehabilitative perspective, multidisciplinary pain correspondence: emmanuel Bäckryd Pain and Rehabilitation Centre, University Hospital, SE-581 85 Linköping, Sweden Tel +46 10 103 3661   Fax +46 10 103 3682   email emmanuel.backryd@regionostergotland.seJournal name: Journal of Pain Research  Article Designation: Original ResearchY ear: 2017V olume: 10Running head verso: Bäckryd et alRunning head recto: Fibromyalgia and inflammationDOI: http://dx.doi.org/10.2147/JPR.S128508",Non-OADS,/arxiv_data1/oa_pdf/a8/1b/jpr-10-515.PMC5344444.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/a8/1b/jpr-10-515.PMC5344444.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 525 Fibromyalgia and inflammation 61.,Non-OADS,/arxiv_data1/oa_pdf/a8/1b/jpr-10-515.PMC5344444.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ec/87/cia-12-485.PMC5344445.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 485–486Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  485Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CIA.S13245 4 Omega-3 fatty acid supplementation can improve  both symptoms and signs of dry eye disease Jae-Woo Kwon1 Sang Beom Han2 1Department of Internal Medicine,   2Department of Ophthalmology,   Kangwon National University  Hospital, Kangwon National  University Graduate School of  Medicine, Chuncheon, South KoreaDear editor We read with great interest the article by Gatell-Tortajada1 entitled “Oral supplementation  with a nutraceutical formulation containing omega-3 fatty acids, vitamins, minerals,  and antioxidants in a large series of patients with dry eye symptoms: results of a  prospective study”.",Non-OADS,/arxiv_data1/oa_pdf/ec/87/cia-12-485.PMC5344445.pdf
"Disclosure The authors report no conflicts of interest in this communication.Correspondence: Sang Beom Han Department of Ophthalmology, Kangwon  National University Hospital, 156  Baengnyeong-ro, Chuncheon, Kangwon  200-722, South Korea tel +82 33 258 9210 Fax +82 33 258 2296 email m.sangbeom.han@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Letter Y ear: 2017 Volume: 12 Running head verso: Kwon and Han Running head recto: Omega-3 fatty acids and dry eye disease DOI: http://dx.doi.org/10.2147/CIA.S132454",Non-OADS,/arxiv_data1/oa_pdf/ec/87/cia-12-485.PMC5344445.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/ec/87/cia-12-485.PMC5344445.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/ec/87/cia-12-485.PMC5344445.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c3/46/ppa-11-469.PMC5344448.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 469–478Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  469OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12567 3 Patient perceptions of a comprehensive  telemedicine intervention to address persistent  poorly controlled diabetes sara M Andrews1 nina r sperber1,2 Jennifer M gierisch1,2 susanne Danus1 stephanie l Macy1 hayden B Bosworth1,2 David edelman1,2 Matthew J crowley1,3 1center for health services research  in Primary care, Durham Veterans  Affairs Medical center, 2Division  of general internal Medicine,   Department of Medicine, 3Division  of endocrinology, Diabetes, and  Metabolism, Department of Medicine,   Duke University, Durham, nc, UsAObjective:  We studied a telemedicine intervention for persistent poorly controlled diabetes  mellitus (PPDM) that combined telemonitoring, self-management support, and medication  management.",Non-OADS,/arxiv_data1/oa_pdf/c3/46/ppa-11-469.PMC5344448.pdf
"Keywords:  telemedicine, persistent poorly controlled diabetes, type 2 diabetes, patient per - spectives, treatment burden Introduction The complications and costs of diabetes rise exponentially as hemoglobin A1c (HbA1c)  increases.1–3 Because HbA1c reduction prevents diabetes complications,1,4 patients  with persistent poorly controlled diabetes mellitus (PPDM), or maintenance of an  HbA1c .9% for .1 year, despite clinic-based care,5 contribute disproportionately  to the nationwide diabetes burden.6,7 The prevalence of PPDM is ~10% of US adults  with diabetes.6,8,9 Clinic-based care is suboptimal for PPDM patients because the infrequent patient– provider contact achievable in the outpatient setting may not support patients in  accommodating the complex self-management demands PPDM requires.8,10,11 The  burden imposed by PPDM is substantial; PPDM patients are expected to check their  blood sugar several times daily, administer multiple daily insulin injections, modify correspondence: Matthew J crowley center for health services research in  Primary care, Durham Veterans Affairs  Medical center, 508 Fulton street (152),  Durham, nc 27705, UsA Tel +1 919 286 0411 ext 4066 Fax +1 919 416 5836 email m atthew.crowley@va.go v Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Andrews et al Running head recto: Patient perceptions of a comprehensive telemedicine intervention DOI: http://dx.doi.org/10.2147/PPA.S125673",Non-OADS,/arxiv_data1/oa_pdf/c3/46/ppa-11-469.PMC5344448.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/c3/46/ppa-11-469.PMC5344448.pdf
Available from: http://www.americantelemed.org/about/telehealth- faqs-.,Non-OADS,/arxiv_data1/oa_pdf/c3/46/ppa-11-469.PMC5344448.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/00/84/bctt-9-095.PMC5344452.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/00/84/bctt-9-095.PMC5344452.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 95–110Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 95 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S123785 An exploratory study of host polymorphisms in  genes that clinically characterize breast cancer  tumors and pretreatment cognitive performance  in breast cancer survivors Theresa A Koleck1,2 Catherine M Bender1 Beth Z Clark3,4 Christopher M Ryan5,6 Puja Ghotkar1 Adam Brufsky4,7,8 Priscilla F McAuliffe4,8,9 Priya Rastogi4,7 Susan M Sereika1,10,11 Yvette P Conley1,12 1School of Nursing, University of  Pittsburgh, Pittsburgh, PA, 2School  of Nursing, Columbia University,   New Y ork, NY, 3Division of  Gynecologic Pathology, Magee-Womens Hospital of University of Pittsburgh Medical Center (UPMC),   4School of Medicine, 5Department of  Psychiatry, University of Pittsburgh,  Pittsburgh, PA,  6Department of  Psychiatry, University of California San Francisco, San Francisco, CA,   7Division of Hematology/Oncology,   Magee-Womens Hospital of UPMC,   8University of Pittsburgh Cancer  Institute, 9Division of Breast Surgical  Oncology, Magee-Womens Hospital of UPMC,  10Department of Biostatistics,   11Department of Epidemiology,   12Department of Human Genetics,   Graduate School of Public Health,  University of Pittsburgh, Pittsburgh,  PA, USAPurpose: Inspired by the hypothesis that heterogeneity in the biology of breast cancers at the  cellular level may account for cognitive dysfunction symptom variability in survivors, the current  study explored relationships between host single-nucleotide polymorphisms (SNPs) in 25 breast  cancer-related candidate genes (AURKA, BAG1 , BCL2, BIRC5, CCNB1, CD68, CENP A, CMC2,  CTSL2, DIAPH3, ERBB2, ESR1, GRB7, GSTM1, MELK, MKI67, MMP11, MYBL2, NDC80,  ORC6, PGR, RACGAP1, RFC4, RRM2, and SCUBE2), identified from clinically relevant prog- nostic multigene-expression profiles for breast cancer, and pretreatment cognitive performance.Patients and methods: The sample (n=220) was comprised of 138 postmenopausal women  newly diagnosed with early stage breast cancer and 82 postmenopausal age- and education- matched healthy controls without breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/00/84/bctt-9-095.PMC5344452.pdf
"1 Cognitive  impairment related to cancer and cancer treatments is included in the guideline as a common and detrimental symptom experienced by BC survivors that can result in Correspondence: Theresa A Koleck School of Nursing, University of Pittsburgh, 3500 Victoria Street, Pittsburgh, PA 15261, USATel +1 412 383 7641Fax +1 412 624 8521Email tat30@pitt.eduJournal name: Breast Cancer - Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Koleck et alRunning head recto: BC-gene polymorphisms and cognitive performanceDOI: http://dx.doi.org/10.2147/BCTT.S123785",Non-OADS,/arxiv_data1/oa_pdf/00/84/bctt-9-095.PMC5344452.pdf
Available from: http://www.dnagenotek.com/US/pdf/PD-PR-015.pdf.,OADS,/arxiv_data1/oa_pdf/00/84/bctt-9-095.PMC5344452.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/00/84/bctt-9-095.PMC5344452.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 110 Koleck et al  59.,Non-OADS,/arxiv_data1/oa_pdf/00/84/bctt-9-095.PMC5344452.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ed/cd/nss-9-039.PMC5344488.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ed/cd/nss-9-039.PMC5344488.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep 2017:9 39–57Nature and Science of Sleep Dovepress submit your manuscript | www.dovepress.com Dovepress  39 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S103467New developments in the management of  narcolepsy Vivien C Abad Christian Guilleminault Department of Psychiatry and  Behavioral Sciences, Division of Sleep Medicine, Stanford University Outpatient Center, Redwood City,  CA, USAAbstract:  Narcolepsy is a life-long, underrecognized sleep disorder that affects 0.02%–0.18%  of the US and Western European populations.",Non-OADS,/arxiv_data1/oa_pdf/ed/cd/nss-9-039.PMC5344488.pdf
"Correspondence: Vivien C Abad  Division of Sleep Medicine, Stanford University Outpatient Center, 450 Broadway St. Pavilion C 2nd floor MC 5704, Redwood City, CA 94063, USATel +1 650 723 6601Fax +1 650 721 3448Email vivien.abad@stanford.eduJournal name: Nature and Science of Sleep Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Abad and GuilleminaultRunning head recto: Update on narcolepsy managementDOI: http://dx.doi.org/10.2147/NSS.S103467",Non-OADS,/arxiv_data1/oa_pdf/ed/cd/nss-9-039.PMC5344488.pdf
Available from http://www.fda.gov/down-loads/ForIndustry/UserFees/PrescriptionDrugUserFee/UCM402907.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ed/cd/nss-9-039.PMC5344488.pdf
Available from: http://www.pdr.,Non-OADS,/arxiv_data1/oa_pdf/ed/cd/nss-9-039.PMC5344488.pdf
Available from: https://clinicaltrials.gov/ct2/results ?term=narcolepsy&cond=%22Narcolepsy%22.,Non-OADS,/arxiv_data1/oa_pdf/ed/cd/nss-9-039.PMC5344488.pdf
"Nature and Science of Sleep 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nature-and-science-of-sleep-journalNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/ed/cd/nss-9-039.PMC5344488.pdf
Published by Elsevier Ltd. http://dx.doi.org/10.1016/j.cub.2017.01.033,Non-OADS,/arxiv_data1/oa_pdf/c3/c0/main.PMC5344686.pdf
"Tait,1Lionel Larue,6Cord H. Brakebusch,7Robert H. Insall,1and Laura M. Machesky1,9,* 1CRUK Beatson Institute, University of Glasgow, Switchback Road, Bearsden, Glasgow G61 1BD, UK 2Division of Molecular Cell Biology, Zoological Institute, Technische Universit €at Braunschweig, Spielmannstrasse 7, 38106 Braunschweig, Germany 3Molecular Cell Biology Group, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, 38124 Braunschweig, Germany 4Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599, USA 5Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27514, USA 6Institute Curie, CNRS UMR3347, INSERM U1021, Bat 110, Centre Universitaire, 91405 Orsay Cedex, France 7Biotech Research Center, University of Copenhagen, Ole Maaløes Vej 5, Copenhagen 2200, Denmark 8Co-ﬁrst author 9Lead Contact *Correspondence: l.machesky@beatson.gla.ac.uk http://dx.doi.org/10.1016/j.cub.2017.01.033 SUMMARY The individual molecular pathways downstream of Cdc42, Rac, and Rho GTPases are well docu-mented, but we know surprisingly little about howthese pathways are coordinated when cells move in a complex environment in vivo.",Non-OADS,/arxiv_data1/oa_pdf/c3/c0/main.PMC5344686.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/c0/main.PMC5344686.pdf
DAVID ( https://david.ncifcrf.,Non-OADS,/arxiv_data1/oa_pdf/c3/c0/main.PMC5344686.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, seven ﬁgures, six movies, and one dataset and can be found with this articleonline at http://dx.doi.org/10.1016/j.cub.2017.01.033 .",OADS,/arxiv_data1/oa_pdf/c3/c0/main.PMC5344686.pdf
CRISPR/Cas9-mediated genome editing in CWR-R1-AD1 The 20-nt guide sequences targeting intron 4 and intron 5 were designed using the CRISPR DESIGN software (http://crispr.mit.edu/).,OADS,/arxiv_data1/oa_pdf/57/af/onc2016313a.PMC5344735.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Novel exon-skipping androgen receptor variants TU o et al 1450 Oncogene (2017) 1440 –1450",Non-OADS,/arxiv_data1/oa_pdf/57/af/onc2016313a.PMC5344735.pdf
To view  please visit the journal online (http://dx.doi.org/10.1136/annrheumdis-2016-210242).,Non-OADS,/arxiv_data1/oa_pdf/5e/66/annrheumdis-2016-210242.PMC5344772.pdf
http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/5e/66/annrheumdis-2016-210242.PMC5344772.pdf
" Annals of Surgical Treatment and Research 117pISSN 2288-6575  • eISSN 2288-6796 https://doi.org/10.4174/astr.2017.92.3.117 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Significance of micrometastases in the calculation of the  lymph node ratio for papillary thyroid cancer Young Woo Chang, Hwan Soo Kim, Seung Pil Jung, Hoon Yub Kim, Jae Bok Lee, Jeoung Won Bae, Gil Soo Son Department of Breast Endocrine Surgery, Korea University College of Medicine, Seoul, Korea INTRODUCTION Papillary thyroid carcinoma (PTC) is the most common  histologic type of differentiated thyroid cancer and has a 10- year survival rate of greater than 90% [1-3].",Non-OADS,/arxiv_data1/oa_pdf/f1/93/astr-92-117.PMC5344800.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/93/astr-92-117.PMC5344800.pdf
" Annals of Surgical Treatment and Research 123pISSN 2288-6575  • eISSN 2288-6796 https://doi.org/10.4174/astr.2017.92.3.123 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Clinical characteristics of papillary thyroid carcinoma  arising from the pyramidal lobe Sang Gab Yoon1, Jin Wook Yi1,2, Chan-Yong Seong1, Jong-Kyu Kim1, Su-Jin Kim1,2, Young Jun Chai2,3,   June Young Choi2,4, Kyu Eun Lee1,2 1Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, 2Cancer  Research Institute, Seoul National University College of Medicine, Seoul, 3Department of Surgery, Seoul National University  Boramae Medical Center, Seoul, 4Department of Surgery, Seoul National University Bundang Hospital, Seoul National University  College of Medicine, Seongnam, Korea INTRODUCTION The pyramidal lobe of the thyroid gland is a remnant of the  inferior part of the thyroglossal duct [1].",Non-OADS,/arxiv_data1/oa_pdf/09/b7/astr-92-123.PMC5344801.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/b7/astr-92-123.PMC5344801.pdf
 Annals of Surgical Treatment and Research 129pISSN 2288-6575  • eISSN 2288-6796 https://doi.org/10.4174/astr.2017.92.3.129 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Is familial papillary thyroid microcarcinoma more  aggressive than sporadic form?,Non-OADS,/arxiv_data1/oa_pdf/48/bb/astr-92-129.PMC5344802.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/bb/astr-92-129.PMC5344802.pdf
"136pISSN 2288-6575  • eISSN 2288-6796 https://doi.org/10.4174/astr.2017.92.3.136 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Laparoscopic cholecystectomy under spinal-epidural  anesthesia vs. general anaesthesia: a prospective  randomised study Turgut Donmez, Vuslat Muslu Erdem1, Sinan Uzman2, Dogan Yildirim3, Huseyin Avaroglu, Sina Ferahman4,  Oguzhan Sunamak5 Department of General Surgery, Lutfiye Nuri Burat State Hospital, Istanbul, 1Department of Anesthesiology and Reanimation,  Lutfiye Nuri Burat Goverment Hospital, Istanbul, Departments of 2Anesthesiology and Reanimation, and 3General Surgery, Haseki  Training and Research Hospital, Istanbul, 4Department of General Surgery, Cerrahpasa Medicine Faculty, Istanbul University,  Istanbul, 5Department of General Surgery, Haydapasa Numune Training and Research Hospital, Istanbul, Turkey INTRODUCTION Laparoscopic cholecystectomy (LC) is a proven, gold standard  surgical procedure for management of gallbladder stones.",Non-OADS,/arxiv_data1/oa_pdf/fc/f0/astr-92-136.PMC5344803.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/f0/astr-92-136.PMC5344803.pdf
" Annals of Surgical Treatment and Research 143pISSN 2288-6575  • eISSN 2288-6796 https://doi.org/10.4174/astr.2017.92.3.143 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE The efficacy of laparoscopic cholecystectomy without  discontinuation in patients on antithrombotic therapy Jong Hyuk Yun, Hae Il Jung, Hyoung Uk Lee, Moo-Jun Baek, Sang Ho Bae Department of Surgery, Soonchunhyang University Cheonan Hospital, Cheonan, Korea INTRODUCTION Laparoscopic cholecystectomy (LC) is one of the most com - monly performed surgeries in the world today.",Non-OADS,/arxiv_data1/oa_pdf/86/6f/astr-92-143.PMC5344804.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/6f/astr-92-143.PMC5344804.pdf
" Annals of Surgical Treatment and Research 149pISSN 2288-6575  • eISSN 2288-6796 https://doi.org/10.4174/astr.2017.92.3.149 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Laparoscopic resection of retroperitoneal benign  neurilemmoma Jung Hwan Ji1, Joon Seong Park2, Chang Moo Kang1,3, Dong Sup Yoon2, Woo Jung Lee1,3 1Department of Surgery, Yonsei University College of Medicine, Seoul, 2Gangnam Severance Hospital, Seoul, 3Pancreaticobiliary  Cancer Clinic, Yonsei Cancer Center, Institute of Gastroenterology Severance Hospital, Seoul, Korea INTRODUCTION Neurilemmoma (NL) is a Schwann cell tumor arising from  the nerve sheath [1].",Non-OADS,/arxiv_data1/oa_pdf/f8/19/astr-92-149.PMC5344805.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/19/astr-92-149.PMC5344805.pdf
https://doi.org/10.1093/jscr/rjt122.,Non-OADS,/arxiv_data1/oa_pdf/f8/19/astr-92-149.PMC5344805.pdf
"156pISSN 2288-6575  • eISSN 2288-6796 https://doi.org/10.4174/astr.2017.92.3.156 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Radiation hazards to vascular surgeon and scrub nurse in  mobile fluoroscopy equipped hybrid vascular room  Jong Bin Kim, Jaehoon Lee, Kihyuk Park Division of Vascular Surgery, Department of Surgery, Catholic University of Daegu School of Medicine, Daegu, Korea INTRODUCTION The numbers of less invasive endovascular therapies  continues to increase, driven by patient preference and outcome  data in almost every vascular lesion.",Non-OADS,/arxiv_data1/oa_pdf/6d/ee/astr-92-156.PMC5344806.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/ee/astr-92-156.PMC5344806.pdf
"164pISSN 2288-6575  • eISSN 2288-6796 https://doi.org/10.4174/astr.2017.92.3.164 Annals of Surgical Treatment and ResearchCASE REPORT Encapsulating peritoneal sclerosis in liver transplant  recipients: a report of 2 cases Kyo Won Lee, Chan Woo Cho, Nuri Lee, Sanghoon Lee, Jong Man Kim, Gyu-Seong Choi,   Choon Hyuck David Kwon, Jae-Won Joh, Suk-Koo Lee Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea INTRODUCTION Encapsulating peritoneal sclerosis (EPS) is defined as ‘a  clinical syndrome with persistent, intermittent and recurrent  presence of intestinal obstruction with or without the existence of inflammation parameters and the existence of peritoneal thickening, sclerosis, calcifications and encapsulation con - firmed by macroscopic inspection or radiological findings’ and is a rare but severe complication most often related to peri toneal dialysis (PD) [1].",Non-OADS,/arxiv_data1/oa_pdf/15/7d/astr-92-164.PMC5344807.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/7d/astr-92-164.PMC5344807.pdf
"168pISSN 2288-6575  • eISSN 2288-6796 https://doi.org/10.4174/astr.2017.92.3.168 Annals of Surgical Treatment and ResearchCASE REPORT En bloc transplantation of horseshoe kidney in Korea Jun Bae Bang, Jae Myeong Lee, Chang-Kwon Oh, Kyo Won Lee1, Jae Berm Park1, Sung Joo Kim1, Su Hyung Lee Department of Surgery, Ajou University School of Medicine, Suwon, 1Samsung Medical Center, Sungkyunkwan University School  of Medicine, Seoul, Korea INTRODUCTION Kidney transplantation is the most desired and cost-effective  modality of renal replacement therapy for patients with end- stage renal disease (ESRD).",Non-OADS,/arxiv_data1/oa_pdf/a2/40/astr-92-168.PMC5344808.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/40/astr-92-168.PMC5344808.pdf
"INTRODUCTION Moyamoya disease (MMD) is a rare cause of stroke in children and young adults, characterized by an occlusive  arteriopathy involving the intracranial segments of the  internal carotid and proximal anterior cerebral arteries Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2017 ;41(1):1-8 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.",Non-OADS,/arxiv_data1/oa_pdf/0b/fb/arm-41-1.PMC5344810.pdf
"Tel: +82-2-3010-3800, Fax: +82-2-3010-6964, E-mail: mhchun@amc.seoul.kr ORCID: Chang Gu Kang  (http://orcid.org/ 0000-0002-2999-9474 ); Min Ho Chun  (http://orcid.org/ 0000-0001-8666-7225 ); Jung-A Kang  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/0b/fb/arm-41-1.PMC5344810.pdf
org/ 0000-0001-5275-278X ); Kyung Hee Do  (http://orcid.org/ 0000-0003-4235-8759 ); Su Jin Choi  (http://orcid.org/ 0000-0002-3443-2237 ).,Non-OADS,/arxiv_data1/oa_pdf/0b/fb/arm-41-1.PMC5344810.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/fb/arm-41-1.PMC5344810.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2017 ;41(1):104-112 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/e2/f2/arm-41-104.PMC5344811.pdf
"Tel: +82-53-650-4894, Fax: +82-53-622-4687, E-mail: cateyesn@naver.com ORCID: Jae Ki Ahn  (http://orcid.org/ 0000-0002-1728-181X ); Dong Rak Kwon  (http://orcid.org/ 0000-0003-4728-930X ); Gi-Young Park  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/e2/f2/arm-41-104.PMC5344811.pdf
org/ 0000-0003-0056-1556 ); Ki-Hoon Lee  (http://orcid.org/ 0000-0001-7445-832X ); Jae Hwal Rim  (http://orcid.org/ 0000-0002-4176-3253 ); Won Bin  Jung  (http://orcid.org/ 0000-0002-4660-0816 ); Dae Gil Kwon  (http://orcid.org/ 0000-0002-8423-8045 ).,Non-OADS,/arxiv_data1/oa_pdf/e2/f2/arm-41-104.PMC5344811.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/f2/arm-41-104.PMC5344811.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2017 ;41(1):113-120 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/3d/6c/arm-41-113.PMC5344812.pdf
"Tel: +82-2- 2290-9353, Fax: +82-2-2282-0772, E-mail: kimmjreh@hanyang.ac.kr ORCID: Kyeong Il Park  (http://orcid.org/ 0000-0001-8226-2044 ); Young-Ho Lee  (http://orcid.org/ 0000-0003-1498-2773 ); Wee-Jin Rah  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/3d/6c/arm-41-113.PMC5344812.pdf
org/ 0000-0001-6634-1420 ); Seung Hwi Jo  (http://orcid.org/ 0000-0002-5575-8914 ); Si-Bog Park  (http://orcid.org/ 0000-0001-8910-2262 ); Seung  Hoon Han  (http://orcid.org/ 0000-0002-9138-4059 ); Hani Koh  (http://orcid.org/ 0000-0002-2351-6443 ); Jin Young Suh  (http://orcid.org/ 0000-0001- 6786-0038 ); Jang soo Um  (http://orcid.org/ 0000-0001-5755-4328 ); Eun Hye Choi  (http://orcid.org/ 0000-0002-9887-5918 ); Un Jin Park  (http://orcid.,Non-OADS,/arxiv_data1/oa_pdf/3d/6c/arm-41-113.PMC5344812.pdf
org/ 0000-0002-2199-6287 ); Mi Jung Kim  (http://orcid.org/ 0000-0003-2920-9900 ).,Non-OADS,/arxiv_data1/oa_pdf/3d/6c/arm-41-113.PMC5344812.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/6c/arm-41-113.PMC5344812.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2017 ;41(1):121-128 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/48/14/arm-41-121.PMC5344813.pdf
"Tel: +82- 53-200-5311, Fax: +82-53-423-0389, E-mail: teeed0522@hanmail.net ORCID: Byung Joo Lee  (http://orcid.org/ 0000-0002-6385-9256 ); Jin Young Go  (http://orcid.org/ 0000-0002-6263-8355 ); Ae Ryung Kim  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/48/14/arm-41-121.PMC5344813.pdf
org/ 0000-0003-3765-3024 ); Seong Min Chun  (http://orcid.org/ 0000-0002-2174-8742 ); Minhyuk Park  (http://orcid.org/ 0000-0001-5204-5620 ); Dong  Heon Yang  (http://orcid.org/ 0000-0002-1646-6126 ); Hun Sik Park  (http://orcid.org/ 0000-0001-7138-1494 ); Tae-Du Jung  (http://orcid.org/ 0000-0002- 1636-8665 ).,Non-OADS,/arxiv_data1/oa_pdf/48/14/arm-41-121.PMC5344813.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/14/arm-41-121.PMC5344813.pdf
http://dx.doi.org/10.1016/j.physio.2015.12.002 13.,OADS,/arxiv_data1/oa_pdf/48/14/arm-41-121.PMC5344813.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2017 ;41(1):129-137 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/ff/9b/arm-41-129.PMC5344814.pdf
"Tel: +82-63-859-1620, Fax: +82-63-843-1385, E-mail: wonrehab@wonkwang.ac.kr ORCID: Eun Sun Lee  (http://orcid.org/ 0000-0002-9859-2563 ); Jin Seok Lee  (http://orcid.org/ 0000-0002-8580-490X ); Min Cheol Joo  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/ff/9b/arm-41-129.PMC5344814.pdf
org/ 0000-0003-2778-4194 ); Ji Hee Kim  (http://orcid.org/ 0000-0003-2758-124X ); Se Eung Noh  (http://orcid.org/ 0000-0002-8846-3282 ).,Non-OADS,/arxiv_data1/oa_pdf/ff/9b/arm-41-129.PMC5344814.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/9b/arm-41-129.PMC5344814.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2017 ;41(1):138-147 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/22/90/arm-41-138.PMC5344815.pdf
"Tel: +82-31-219-5284, Fax: +82-31-219-5209, E-mail: syyim@ajou.ac.kr ORCID: Ji Eun Woo  (http://orcid.org/ 0000-0002-3401-6890 ); Yul-Hyun Park  (http://orcid.org/ 0000-0003-3103-293X ); Eun Ji Park  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/22/90/arm-41-138.PMC5344815.pdf
org/ 0000-0002-4679-5553 ); Kyu Yong Park  (http://orcid.org/ 0000-0002-3872-2872 ); Sun Hee Kim  (http://orcid.org/ 0000-0002-5830-5910 ); Shin-Young  Yim  (http://orcid.org/ 0000-0002-8521-6331 ).,Non-OADS,/arxiv_data1/oa_pdf/22/90/arm-41-138.PMC5344815.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/90/arm-41-138.PMC5344815.pdf
Avail - able from: http://www.accessdata.fda.gov/scripts/cdrh/ cfdocs/cfrl/ldetails.cfm?lid=263752.,Non-OADS,/arxiv_data1/oa_pdf/22/90/arm-41-138.PMC5344815.pdf
Three days Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2017 ;41(1):148-152 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/5c/a4/arm-41-148.PMC5344816.pdf
"Tel: +82- 51-990-6261, Fax: +82-51-241-2019, E-mail: ghichan@hotmail.com ORCID: Jae Ho Kim  (http://orcid.org/ 0000-0002-3556-4194 ); Sae Hyun Kim  (http://orcid.org/ 0000-0002-3151-7227 ); Ho Joong Jeong  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/5c/a4/arm-41-148.PMC5344816.pdf
org/ 0000-0002-0607-2799 ); Young Joo Sim  (http://orcid.org/ 0000-0002-0640-8766 ); Dong Kyu Kim  (http://orcid.org/ 0000-0002-9484-6562 ); Ghi Chan  Kim  (http://orcid.org/ 0000-0002-4954-3175 ).,Non-OADS,/arxiv_data1/oa_pdf/5c/a4/arm-41-148.PMC5344816.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/a4/arm-41-148.PMC5344816.pdf
"A new MRI technique known  as diffusion tensor imaging (DTI) can reveal axonal or - ganization of the brain, such as the corticospinal tract  (CST), which was not possible with conventional imaging Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2017 ;41(1):153-157 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.",Non-OADS,/arxiv_data1/oa_pdf/ef/9e/arm-41-153.PMC5344817.pdf
"Tel: +82-2-6299-1883, Fax: +82-2-6298-1866, E-mail: sihyun92@cau.ac.kr ORCID: Hye Eun Shin  (http://orcid.org/ 0000-0003-4903-9283 ); Hoon Chang Suh  (http://orcid.org/ 0000-0001-5333-8986 ); Si Hyun Kang  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/ef/9e/arm-41-153.PMC5344817.pdf
org/ 0000-0003-0205-067X ); Kyung Mook Seo  (http://orcid.org/ 0000-0002-9762-085X ); Don-Kyu Kim  (http://orcid.org/ 0000-0001-8619-830X ); Hae- Won Shin  (http://orcid.org/ 0000-0001-6050-7733 ).,Non-OADS,/arxiv_data1/oa_pdf/ef/9e/arm-41-153.PMC5344817.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/9e/arm-41-153.PMC5344817.pdf
After Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2017 ;41(1):158-161 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/16/94/arm-41-158.PMC5344818.pdf
"Tel: +82-2-2276-8640, Fax: +82-2- 2276-7477, E-mail: sunnywind78@gmail.com ORCID: Seok Hyun Hong  (http://orcid.org/ 0000-0002-0572-090X ); Ju Sun Oh  (http://orcid.org/ 0000-0002-0994-3051 ); Chang Hyun Lee  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/16/94/arm-41-158.PMC5344818.pdf
org/ 0000-0003-0501-3663 ); Jae Ho Oh  (http://orcid.org/ 0000-0002-2203-897X ).,Non-OADS,/arxiv_data1/oa_pdf/16/94/arm-41-158.PMC5344818.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/94/arm-41-158.PMC5344818.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2017 ;41(1):16-24 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/63/d2/arm-41-16.PMC5344819.pdf
"Tel: +82-32- 890-2486, Fax: +82-32-890-2486, E-mail: rmjung@inha.ac.kr ORCID: Sang-Eun Hong  (http://orcid.org/ 0000-0002-9433-6642 ); Chang-Hwan Kim  (http://orcid.org/ 0000-0003-2557-6025 ); Ee-jin Kim  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/63/d2/arm-41-16.PMC5344819.pdf
org/ 0000-0001-6604-6907 ); Kyung-Lim Joa  (http://orcid.org/ 0000-0002-3747-9831 ); Tae-Hyun Kim  (http://orcid.org/ 0000-0002-1738-7729 ); Sang- Keun Kim  (http://orcid.org/ 0000-0002-1383-9943 ); Hee-Jun Han  (http://orcid.org/ 0000-0003-4326-1617 ); Eui-Chang Lee  (http://orcid.org/ 0000-0002- 7383-0713 ); Han-Young Jung  (http://orcid.org/ 0000-0003-1428-9821 ).,Non-OADS,/arxiv_data1/oa_pdf/63/d2/arm-41-16.PMC5344819.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/d2/arm-41-16.PMC5344819.pdf
Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2017 ;41(1):162-166 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/58/0f/arm-41-162.PMC5344820.pdf
"Tel: +82-42-611-3631, Fax: +82-42- 611-3633, E-mail: jylimmd@eulji.ac.kr ORCID: So Won Chung (http://orcid.org/0000-0003-2344-2832); Shin Who Park (http://orcid.org/0000-0002-7136-9644); Young Jae Seo (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/58/0f/arm-41-162.PMC5344820.pdf
org/0000-0003-3791-5012); Jae-Hyung Kim (http://orcid.org/0000-0002-7005-0113); Chan Ho Lee (http://orcid.org/0000-0002-5129-6652); Jong Youb  Lim (http://orcid.org/0000-0001-9100-4864).,Non-OADS,/arxiv_data1/oa_pdf/58/0f/arm-41-162.PMC5344820.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/0f/arm-41-162.PMC5344820.pdf
Annals of Rehabilitation MedicineErratum Ann Rehabil Med 2017 ;41(1):167 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/af/08/arm-41-167.PMC5344821.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/08/arm-41-167.PMC5344821.pdf
Annals of Rehabilitation MedicineCorrigendum Ann Rehabil Med 2017 ;41(1):168 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/69/89/arm-41-168.PMC5344822.pdf
"168 Correction: Risk Factors for Delirium During  Acute and Subacute States of Various Disorders  in Patients Admitted to Rehabilitation Units Soyeon Jang, MD, Kwang-Ik Jung, MD, PhD, Woo-Kyoung Yoo, MD, PhD,   Myung Hun Jung, MD, PhD, Suk Hoon Ohn, MD, PhD Department of Physical and Rehabilitation Medicine, Hallym University Sacred Heart Hospital,   Hallym University College of Medicine, Anyang, Korea https://doi.org/10.5535/arm.2016.40.6.1082  Ann Rehabil Med 2016;40(6):1082-1091 To the Editor, We found that the fourth author’s affiliation had been inadvertently omitted.",Non-OADS,/arxiv_data1/oa_pdf/69/89/arm-41-168.PMC5344822.pdf
"Tel: +82-31-380-3860, Fax: +82-31-380-3864, E-mail: ohnsh@hallym.ac.kr  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/89/arm-41-168.PMC5344822.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2017 ;41(1):25-33 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/99/8f/arm-41-25.PMC5344823.pdf
"Tel: +82-33-741-1765, Fax: +82-33-742- 1409, E-mail: eyeini@naver.com ORCID: Young Hee Lee  (http://orcid.org/ 0000-0001-6861-4250 ); Jin Hyeong Lee  (http://orcid.org/ 0000-0003-0474-4595 ); Sung Hoon Kim  (http:// orcid.org/ 0000-0001-6043-7640 ); Dongsoo Yi  (http://orcid.org/ 0000-0002-5764-0610 ); Kyung Joon Oh  (http://orcid.org/ 0000-0002-9662-1834 ); Ji Hyun  Kim  (http://orcid.org/ 0000-0001-9061-3350 ); Tae Jun Park  (http://orcid.org/ 0000-0003-4835-5778 ); Hanul Kim  (http://orcid.org/ 0000-0002-5590- 1899 ); Jae Seung Chang  (http://orcid.org/ 0000-0002-4047-1128 ); In Deok Kong  (http://orcid.org/ 0000-0002-9821-6103 ).",Non-OADS,/arxiv_data1/oa_pdf/99/8f/arm-41-25.PMC5344823.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/8f/arm-41-25.PMC5344823.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2017 ;41(1):34-41 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/3a/04/arm-41-34.PMC5344824.pdf
"Tel: +82-2-901- 1634, Fax: +82-2-990-8473, E-mail: Ludin80@naver.com ORCID: Seungwon Hwang  (http://orcid.org/ 0000-0001-8217-4714 ); Hye-Ri Kim  (http://orcid.org/ 0000-0003-4431-4549 ); Zee-A Han  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/3a/04/arm-41-34.PMC5344824.pdf
org/ 0000-0002-8070-2218 ); Bum-Suk Lee  (http://orcid.org/ 0000-0002-0506-0403 ); Soojeong Kim  (http://orcid.org/ 0000-0003-3951-6947 ); Hyunsoo  Shin  (http://orcid.org/ 0000-0002-9699-9132 ); Jae-Gun Moon  (http://orcid.org/ 0000-0002-3892-2751 ); Sung-Phil Yang  (http://orcid.org/ 0000-0002- 1988-8236 ); Mun-Hee Lim  (http://orcid.org/ 0000-0001-9902-0826 ); Duk-Youn Cho  (http://orcid.org/ 0000-0002-5170-5030 ); Hayeon Kim  (http://orcid.,Non-OADS,/arxiv_data1/oa_pdf/3a/04/arm-41-34.PMC5344824.pdf
org/ 0000-0002-1251-1102 ); Hye-Jin Lee (http://orcid.org/0000-0001-9400-6283) .,Non-OADS,/arxiv_data1/oa_pdf/3a/04/arm-41-34.PMC5344824.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/04/arm-41-34.PMC5344824.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2017 ;41(1):42-50 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/4b/cf/arm-41-42.PMC5344825.pdf
"Tel: +82-2-2001-2283, Fax: +82-2-2001-1284, E-mail: yongtaek1.lee@samsung.com ORCID: Joon-Youn Lee  (http://orcid.org/ 0000-0002-2962-527X ); Kyung Jae Yoon (http://orcid.org/ 0000-0002-2765-4309 ); Youbin Yi  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/4b/cf/arm-41-42.PMC5344825.pdf
org/ 0000-0001-5707-3815 ); Chul-Hyun Park  (http://orcid.org/ 0000-0002-9897-6612 ); Jung-Sang Lee  (http://orcid.org/ 0000-0001-5423-3772 ); Kyoung- Ho Seo  (http://orcid.org/ 0000-0002-9139-1638 ); Young Sook Park  (http://orcid.org/ 0000-0003-2752-7120 ); Yong-Taek Lee  (http://orcid.org/ 0000- 0001-6611-0999 ).,Non-OADS,/arxiv_data1/oa_pdf/4b/cf/arm-41-42.PMC5344825.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/cf/arm-41-42.PMC5344825.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2017 ;41(1):51-57 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/2d/b9/arm-41-51.PMC5344826.pdf
"Tel: +82-2-958-2307, Fax: +82-2-968-2307, E-mail: coltrane@catholic.ac.kr ORCID: Jae In So  (http://orcid.org/ 0000-0002-0115-6651 ); Dae Heon Song  (http://orcid.org/ 0000-0003-0653-8488 ); Joo Hyun Park  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/2d/b9/arm-41-51.PMC5344826.pdf
org/ 0000-0001-9257-8704 ); Eunseok Choi  (http://orcid.org/ 0000-0002-0921-3892 ); Jung Yoon Yoon  (http://orcid.org/ 0000-0002-4703-9266 ); Yeonji  Yoo  (http://orcid.org/ 0000-0003-1323-4503 ); Myung Eun Chung  (http://orcid.org/ 0000-0002-7308-2815 ).,Non-OADS,/arxiv_data1/oa_pdf/2d/b9/arm-41-51.PMC5344826.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/b9/arm-41-51.PMC5344826.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2017 ;41(1):58-65 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/d3/81/arm-41-58.PMC5344827.pdf
"Tel: +82-31-412-5330, Fax: +82-31-412-5344, E-mail: rmkdh@korea.ac.kr ORCID: Do Kyun Kim  (http://orcid.org/ 0000-0002-3257-6683 ); Beom Suk Kim  (http://orcid.org/ 0000-0003-4972-9508 ); Min Je Kim  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/d3/81/arm-41-58.PMC5344827.pdf
org/ 0000-0003-3794-2192 ); Ki Hoon Kim  (http://orcid.org/ 0000-0002-7257-3858 ); Byung Kyu Park  (http://orcid.org/ 0000-0001-8445-7099 ); Dong  Hwee Kim  (http://orcid.org/ 0000-0002-8116-0078 ).,Non-OADS,/arxiv_data1/oa_pdf/d3/81/arm-41-58.PMC5344827.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/81/arm-41-58.PMC5344827.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2017 ;41(1):66-71 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/4d/57/arm-41-66.PMC5344828.pdf
"Tel: +82-31-787-7739, Fax: +82-31-787-4051, E-mail: jseok337@snu.ac.kr ORCID: Hoon Hoon Lee  (http://orcid.org/ 0000-0002-5028-4318 ); Donghwi Park  (http://orcid.org/ 0000-0002-7724-4682 ); Yoongul Oh  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/4d/57/arm-41-66.PMC5344828.pdf
org/ 0000-0003-4324-9765 ); Ju Seok Ryu  (http://orcid.org/ 0000-0003-3299-3038 ).,Non-OADS,/arxiv_data1/oa_pdf/4d/57/arm-41-66.PMC5344828.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/57/arm-41-66.PMC5344828.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2017 ;41(1):72-79 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/2a/4b/arm-41-72.PMC5344829.pdf
"Tel: +82-55-290-6390, Fax: +82-55-290-6588, E-mail: jijibaeheiwon@hanmail.net ORCID: Seung Hwan Jin  (http://orcid.org/ 0000-0002-1585-1313 ); Young Sook Park  (http://orcid.org/ 0000-0003-2752-7120 ); Yun Hee Park  (http:// orcid.org/ 0000-0003-4707-2266 ); Hyun Jung Chang  (http://orcid.org/ 0000-0001-9126-4316 ); Sung Rok Kim  (http://orcid.org/ 0000-0002-8065-6629 ).",Non-OADS,/arxiv_data1/oa_pdf/2a/4b/arm-41-72.PMC5344829.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2a/4b/arm-41-72.PMC5344829.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2017 ;41(1):80-89 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/50/d3/arm-41-80.PMC5344830.pdf
"Tel: +82-2-920- 6471, Fax: +82-2-929-9951, E-mail: spinelee@gmail.com ORCID: Sung Hoon Kim  (http://orcid.org/ 0000-0001-6691-708X ); Sang-Heon Lee  (http://orcid.org/ 0000-0003-0701-0028 ); Nack Hwan Kim  (http:// orcid.org/ 0000-0002-9650-2755 ); Min Hyun Kim  (http://orcid.org/ 0000-0001-6605-8705 ); Hyeun Jun Park  (http://orcid.org/ 0000-0002-3830-7994 );  Yong Jin Jung  (http://orcid.org/ 0000-0002-5839-2268 ); Hyun-Joon Yoo  (http://orcid.org/ 0000-0002-3610-1765 ); Won Jun Meng  (http://orcid.org/ 0000- 0002-8886-7105 ); Victoria Kim  (http://orcid.org/ 0000-0002-0091-2988 ).",Non-OADS,/arxiv_data1/oa_pdf/50/d3/arm-41-80.PMC5344830.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/d3/arm-41-80.PMC5344830.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2017 ;41(1):9-15 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/9c/c4/arm-41-9.PMC5344831.pdf
"Tel: +82- 53-200-5311, Fax: +82-53-423-0389, E-mail: teeed0522@hanmail.net ORCID: Jong-Moon Hwang  (http://orcid.org/ 0000-0002-9807-8783 ); Youn-Soo Cheong  (http://orcid.org/ 0000-0001-7105-4776 ); Min-Gu Kang  (http:// orcid.org/ 0000-0002-0680-9607 ); Seong Min Chun  (http://orcid.org/ 0000-0002-2174-8742 ); Yu-Sun Min  (http://orcid.org/ 0000-0003-0373-0538 );  Yang-Soo Lee  (http://orcid.org/ 0000-0002-8855-1231 ); Tae-Du Jung  (http://orcid.org/ 0000-0002-1636-8665 ).",Non-OADS,/arxiv_data1/oa_pdf/9c/c4/arm-41-9.PMC5344831.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/c4/arm-41-9.PMC5344831.pdf
Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2017 ;41(1):90-96 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.,Non-OADS,/arxiv_data1/oa_pdf/fb/1a/arm-41-90.PMC5344832.pdf
"Tel: +82-31-961-7460, Fax: +82-31-961-7488, E-mail: bskwon@dumc.or.kr ORCID: Kyoung Hwan Lee  (http://orcid.org/ 0000-0002-8720-3315 ); Jin Woo Park  (http://orcid.org/ 0000-0003-4989-2575 ); Ho Jun Lee  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/fb/1a/arm-41-90.PMC5344832.pdf
org/ 0000-0002-1997-2593 ); Ki Yeun Nam  (http://orcid.org/ 0000-0001-6932-6541 ); Tae June Park  (http://orcid.org/ 0000-0001-7166-059X ); Hee Jae Kim   (http://orcid.org/ 0000-0001-6062-5246 ); Bum Sun Kwon  (http://orcid.org/ 0000-0001-7755-435X ).,Non-OADS,/arxiv_data1/oa_pdf/fb/1a/arm-41-90.PMC5344832.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/1a/arm-41-90.PMC5344832.pdf
"Typically,  over-expression of the chromosome results in a decrease  of the overall number of neurons in the central nervous  system, a delay of myelination, and dysregulation of cell  cycles that lead to overproduction of protein precursors  and subsequently cause neurotransmission abnormali -Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2017 ;41(1):97-103 pISSN: 2234-0645 • eISSN: 2234-0653 https://doi.org/10.5535/arm.2017.41.1.",Non-OADS,/arxiv_data1/oa_pdf/2c/95/arm-41-97.PMC5344833.pdf
"Tel: +82-31-900-0349, Fax: +82-31-900-0028, E-mail: jungdior5@gmail.com ORCID: Hyo In Kim  (http://orcid.org/ 0000-0003-0640-5597 ); Seong Woo Kim  (http://orcid.org/ 0000-0002-1548-8147 ); Jiyong Kim  (http://orcid.",Non-OADS,/arxiv_data1/oa_pdf/2c/95/arm-41-97.PMC5344833.pdf
org/ 0000-0003-4693-8400 ); Ha Ra Jeon  (http://orcid.org/ 0000-0002-4234-8086 ); Da Wa Jung  (http://orcid.org/ 0000-0002-2420-3553 ).,Non-OADS,/arxiv_data1/oa_pdf/2c/95/arm-41-97.PMC5344833.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/95/arm-41-97.PMC5344833.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2c/95/arm-41-97.PMC5344833.pdf
"Klawans and Barr 9reported four such cases in 1985; the patients had remission from tics before the age of 20 years,Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/8e/dc/tre-07-450-7522-1.PMC5344964.pdf
Tic Exacerbation in Adults Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/8e/dc/tre-07-450-7522-1.PMC5344964.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/8e/dc/tre-07-450-7522-1.PMC5344964.pdf
Tic Exacerbation in Adults Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/8e/dc/tre-07-450-7522-1.PMC5344964.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/8e/dc/tre-07-450-7522-1.PMC5344964.pdf
Tic Exacerbation in Adults Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/8e/dc/tre-07-450-7522-1.PMC5344964.pdf
Available   from: http://www.afro.who.int/en/divisions‑a‑programmes/ dsd/ health‑technologies ‑a‑laboratories.html.,Non-OADS,/arxiv_data1/oa_pdf/11/83/AJTS-11-1.PMC5345273.pdf
Available  from: http://www.who.int/bloodsafety/universalbts/en/index.,Non-OADS,/arxiv_data1/oa_pdf/11/83/AJTS-11-1.PMC5345273.pdf
Available from: http://www.afsbt.org.,Non-OADS,/arxiv_data1/oa_pdf/11/83/AJTS-11-1.PMC5345273.pdf
Available from: http://www.ispub.com/ IJOS/11/2/10204.,Non-OADS,/arxiv_data1/oa_pdf/11/83/AJTS-11-1.PMC5345273.pdf
Available  from: http://www.patientsafetyauthority.org/ADVISORIES/ AdvisoryLibrary/2010/Jun7 (2)/Pages/33.aspx.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/AJTS-11-18.PMC5345275.pdf
Available from: http://www.jointcommission.org/.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/AJTS-11-18.PMC5345275.pdf
Available  from: http://www.jointcommission.org/PatientSafety/ NationalPatientSafetyGoals.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/AJTS-11-18.PMC5345275.pdf
Available from:  http://www.fda.gov/downloads/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/ OtherRecommendationsforManufacturers/UCM062678.,Non-OADS,/arxiv_data1/oa_pdf/d7/51/AJTS-11-28.PMC5345277.pdf
Available  from: http://www.transfusionguidelines.org/red‑book/chapter‑ 11‑reagent‑ manufacture/11 ‑2‑specifications ‑performance ‑ evaluation‑and‑quality‑control‑of‑blood‑grouping‑reagents.,Non-OADS,/arxiv_data1/oa_pdf/d7/51/AJTS-11-28.PMC5345277.pdf
Available from: http://www.diamed.com/pdfs/ B004033_50870_08.13_GEFISP.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c6/34/AJTS-11-53.PMC5345282.pdf
Available  from: http://www.ihn.withtoast.co.uk/wp‑content/ uploads/2011/02/STIR‑2008‑2009.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bf/82/AJTS-11-6.PMC5345284.pdf
Available  from: http://www.ihn.withtoast.co.uk/wp‑content/Table 4: Frequency of transfusion events (type of reactions/component) Type of adverse reaction WB (%) RCC (%) Buffy coat  depleted RCC (%)Leukodepleted  RCC (%)PC/PRP (%) FFP (%) Acute hemolytic transfusion reaction 2 (0.007) 2 (0.004) 0 0 0 0 Acute nonhemolytic transfusion reaction Immune FNHTR 97 (0.345) 64 (0.143) 3 (0.017) 0 6 (0.016) 2 (0.007) Allergic reaction 59 (0.21) 46 (0.103) 12 (0.067) 2 (0.031) 5 (0.014) 6 (0.022) Anaphylactic 4 (0.014) 0 0 0 0 0 TRALI 1 (0.004) 0 0 0 0 0 Nonimmune 0 0 0 0 0 TACO 3 (0.011) 0 0 0 0 0 Brackets represent the percentage of reactions from total units of the component issued.,Non-OADS,/arxiv_data1/oa_pdf/bf/82/AJTS-11-6.PMC5345284.pdf
"Available from:  http://ec.europa.eu/health/mental_health/docs/europopp_full  _en.pdf ,  accessed on November 11, 2016.",Non-OADS,/arxiv_data1/oa_pdf/e2/cc/IJMR-144-491.PMC5345292.pdf
"Available from: http://www.worldbank.org/en/ events/2016/03/09/out-of-the-shadows-making-mental-health  -a-globalpriority , accessed on July 23, 2016.",Non-OADS,/arxiv_data1/oa_pdf/45/ba/IJMR-144-496.PMC5345293.pdf
"Available from: http://www.apps.who.int/medicinedocs/ en/m/abstract/Js17054e/ , accessed on October 9, 2015.",OADS,/arxiv_data1/oa_pdf/75/87/IJMR-144-502.PMC5345295.pdf
"WHO/EMP/MIE/2011.2.2 Available from:    http://www.who.int/medicines/areas/policy/world_medicines_ situation/WMS_ch14_wRational.pdf, accessed on October 9,  2015.",Non-OADS,/arxiv_data1/oa_pdf/75/87/IJMR-144-502.PMC5345295.pdf
"Available from:  http://www.who.int/ medicines/areas/policy/access_noncommunicable/Essential  MedicinesforNCDs.pdf , accessed on October 19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/75/87/IJMR-144-502.PMC5345295.pdf
"Available from: http://apps.who.int/medicinedocs/ en/d/Jh3011e/3.html , accessed on October 9, 2015.",OADS,/arxiv_data1/oa_pdf/75/87/IJMR-144-502.PMC5345295.pdf
"Available from: http://www.gabionline.net/Reports/Brand- name-drugs-show-huge-price-increases , accessed on October  9, 2015.",Non-OADS,/arxiv_data1/oa_pdf/75/87/IJMR-144-502.PMC5345295.pdf
"Available from: http://www.gabionline.net/ Reports/US-insurers-switch-up-to-70-of-drugs , accessed on  October 9,  2015.",Non-OADS,/arxiv_data1/oa_pdf/75/87/IJMR-144-502.PMC5345295.pdf
"Average dietary intakes of macronutrients and fatty acids – a comparison between global intakes and intakes in India Mean intakes per day RDA-India21High-income  economies33#Low-/middle -  income economies33#India (rural -  NNMB)24India (urban  women)*India -  urban34 Energy (kcal) 3400 2550 2300 2140 2325 CHO (%E) 55-70 51 67 71 61 63 Protein (%E) 8-12 12.4 10.5 10 12.5 12.5 Fat (%E) 15-30 36 22.5 19 26 24 SFA (%E) <10 12.3 13.1 4.5 8.8 7.2 LA (%E) 2.5-9 5.4 4.2 4.9 8.2 6.8 ALNA  (%E) >0.5 0.28 0.22 0.24 0.24 LC n-3 PUFA  (mg/day) 200 335 220 - 20 - *Unpublished data  (personal communication), #Data on dietary intakes categorized into different economies based on the World Bank  definitions (http://data.worldbank.org/country ).",Non-OADS,/arxiv_data1/oa_pdf/1e/53/IJMR-144-507.PMC5345296.pdf
"Available from: http://wcd.nic.in/Schemes/research/ nti1947/7.2%20dietary%20intakes%20pr%204.2.pdf , accessed  on February 7, 2016.",Non-OADS,/arxiv_data1/oa_pdf/1e/53/IJMR-144-507.PMC5345296.pdf
"Available from: http://www.fao.org/es/esa ,  accessed on February 7, 2016.",Non-OADS,/arxiv_data1/oa_pdf/1e/53/IJMR-144-507.PMC5345296.pdf
"Available from: https://health.gov/ dietaryguidelines/dgac/pdf/dgac_ration.pdf , accessed on  February 7, 2016.",Non-OADS,/arxiv_data1/oa_pdf/1e/53/IJMR-144-507.PMC5345296.pdf
"Available from: http://www.OpenEpi.com , accessed on March  29, 2015.",Non-OADS,/arxiv_data1/oa_pdf/94/1d/IJMR-144-525.PMC5345298.pdf
Available from: http://www.nlep.nic.in/data.,OADS,/arxiv_data1/oa_pdf/94/1d/IJMR-144-525.PMC5345298.pdf
"Available from: http://www.ncdc.gov.in/ writereaddata/linkimages/222.pdf , accessed on July 10, 2014.",OADS,/arxiv_data1/oa_pdf/77/c0/IJMR-144-592.PMC5345307.pdf
"[http://dx.doi.org/10.4103/0972-0707.73385 ] [PMID: 21217949 ] [4] Orchardson R, Gillam DG.",Non-OADS,/arxiv_data1/oa_pdf/36/55/TODENTJ-11-65.PMC5345329.pdf
"[http://dx.doi.org/10.14219/jada.archive.2006.0321 ] [PMID: 16803826 ] [5] Samuel  SR,  Khatri  SG,  Acharya  S.  Clinical  Evaluation  of  self  and  professionally  applied  desensitizing  agents  in  relieving  dentin hypersensitivity after a single topical application: A Randomized Controlled Trial.",Non-OADS,/arxiv_data1/oa_pdf/36/55/TODENTJ-11-65.PMC5345329.pdf
"[http://dx.doi.org/10.4317/jced.51439 ] [PMID: 25593653 ] [6] Addy M, West NX.",Non-OADS,/arxiv_data1/oa_pdf/36/55/TODENTJ-11-65.PMC5345329.pdf
"[http://dx.doi.org/10.1159/000350477 ] [PMID: 23817061 ] [7] Orchardson R, Gillam DG.",OADS,/arxiv_data1/oa_pdf/36/55/TODENTJ-11-65.PMC5345329.pdf
"[http://dx.doi.org/10.1111/j.1600-051X.2004.00581.x ] [PMID: 15367193 ] [9] Raafat Abdelaziz R, Mosallam RS, Yousry MM.",OADS,/arxiv_data1/oa_pdf/36/55/TODENTJ-11-65.PMC5345329.pdf
"[http://dx.doi.org/10.3109/00016357.2011.572290 ] [PMID: 21453220 ] [10] Azarpazhooh  A,  Limeback  H,  Lawrence  HP,  Fillery  ED.",Non-OADS,/arxiv_data1/oa_pdf/36/55/TODENTJ-11-65.PMC5345329.pdf
"[http://dx.doi.org/10.1016/j.joen.2008.10.001 ] [PMID: 19084115 ] [11] Dähnhardt JE, Gygax M, Martignoni B, Suter P, Lussi A.",OADS,/arxiv_data1/oa_pdf/36/55/TODENTJ-11-65.PMC5345329.pdf
"[http://dx.doi.org/10.1038/sj.ebd.6400732 ] [PMID: 20938468 ] [13] Baysan A, Lynch E. The use of ozone in dentistry and medicine.",Non-OADS,/arxiv_data1/oa_pdf/36/55/TODENTJ-11-65.PMC5345329.pdf
"[http://dx.doi.org/10.1308/1355761053695158 ] [PMID: 15901432 ] [14] Holland  GR,  Narhi  MN,  Addy  M,  Gangarosa  L,  Orchardson  R.  Guidelines  for  the  design  and  conduct  of  clinical  trials  on  dentine hypersensitivity.",Non-OADS,/arxiv_data1/oa_pdf/36/55/TODENTJ-11-65.PMC5345329.pdf
"[http://dx.doi.org/10.1111/j.1600-051X.1997.tb01194.x ] [PMID: 9402502 ] [15] Kienle GS, Kiene H. The powerful placebo effect: fact or fiction?",Non-OADS,/arxiv_data1/oa_pdf/36/55/TODENTJ-11-65.PMC5345329.pdf
"[http://dx.doi.org/10.1016/S0895-4356(97)00203-5 ] [PMID: 9449934 ] [16] Ozgül  BM,  Saat  S,  Sönmez  H,  Oz  FT.  Clinical  evaluation  of  desensitizing  treatment  for  incisor  teeth  affected  by  molar-incisor hypomineralization.",Non-OADS,/arxiv_data1/oa_pdf/36/55/TODENTJ-11-65.PMC5345329.pdf
[http://dx.doi.org/10.17796/jcpd.38.2.92mx26l6n482j682 ] [PMID: 24683770 ] [17] Consensus-based recommendations for the diagnosis and management of dentin hypersensitivity.,Non-OADS,/arxiv_data1/oa_pdf/36/55/TODENTJ-11-65.PMC5345329.pdf
"[http://dx.doi.org/10.1111/j.1875-595X.2005.tb00063.x ] [PMID: 16167604 ] © Lena and Marianne; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/55/TODENTJ-11-65.PMC5345329.pdf
CNV Validation and Mapping   Signal intensity and B-allele frequencies of all rare CNVs  were visualized (http://noise-free-cnv.sourceforge.net/ con- tact.php) to identify putative false-positive calls and to in- spect and map the breakpoints.,OADS,/arxiv_data1/oa_pdf/bf/3d/CG-18-206.PMC5345335.pdf
The first and the last SNPs of each CNV were mapped  onto the human genome (GRCh38) (http://www.ensembl.org  /Homo_sapiens).,OADS,/arxiv_data1/oa_pdf/bf/3d/CG-18-206.PMC5345335.pdf
Data Sources   FlyBase database 5.50 was used to retrieve chromosomal  positions of the majority of genetic features analyzed in the  study (ftp://ftp.flybase.net/genomes/Drosophila_melanogaster/ dmel_r5.50_FB2013_02/gff/dmel-all-no-analysisr5.50.gff.gz).,OADS,/arxiv_data1/oa_pdf/83/c6/CG-18-214.PMC5345337.pdf
Available from: http://www.sante.gov.bf/ SiteSante/plans/assurqualite  24.,Non-OADS,/arxiv_data1/oa_pdf/cf/bc/jphia-2012-2-e29.PMC5345389.pdf
Available from: http://www.sante.gouv.fr  34.,Non-OADS,/arxiv_data1/oa_pdf/cf/bc/jphia-2012-2-e29.PMC5345389.pdf
"27 June 2002, 19:29 GMT http://news.bbc.co.uk/2/low/africa/2070634.",Non-OADS,/arxiv_data1/oa_pdf/e9/1d/jphia-2010-1-e2.PMC5345393.pdf
http://www.unicef.org/ infobycountry/nige- ria_38450.html.,Non-OADS,/arxiv_data1/oa_pdf/e9/1d/jphia-2010-1-e2.PMC5345393.pdf
http://www.unicef.org/ infobycountry/nigeria_39432.html.,Non-OADS,/arxiv_data1/oa_pdf/e9/1d/jphia-2010-1-e2.PMC5345393.pdf
Home page address: http://www.un.org/esa/population/ 4.,Non-OADS,/arxiv_data1/oa_pdf/93/a4/jphia-2010-1-e7.PMC5345398.pdf
Available at: http://www.prb.org/Publications/Datasheet s/2010/2010wpds.aspx 5.,Non-OADS,/arxiv_data1/oa_pdf/93/a4/jphia-2010-1-e7.PMC5345398.pdf
Home page address: http://www.who.int/healthinfo/en/ 2.,Non-OADS,/arxiv_data1/oa_pdf/9a/38/jphia-2010-1-e8.PMC5345399.pdf
Home page address: http://www.who.int/ workforcealliance/en/ Journal of Public Health in Africa 2010 ; volume 1:e8 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/9a/38/jphia-2010-1-e8.PMC5345399.pdf
Home page address: http://www.who.int/3by5/ publications/documents/imai/en/ 9.,Non-OADS,/arxiv_data1/oa_pdf/9a/38/jphia-2010-1-e8.PMC5345399.pdf
Available from: http://www.unaids.org/en/media/unaids/co ntentassets/documents/epidemiology/2012 /gr2012/20121120_UNAIDS_Global_Repor t_2012_with_annexes_en.pdf  2.,Non-OADS,/arxiv_data1/oa_pdf/b8/63/jphia-2016-2-402.PMC5345400.pdf
Available from: http://www.unaids.,Non-OADS,/arxiv_data1/oa_pdf/b8/63/jphia-2016-2-402.PMC5345400.pdf
Available from: http://www.unaids.org/sites/default/files/m edia_asset/fast-track-commitments_ en.pdf 4.,OADS,/arxiv_data1/oa_pdf/b8/63/jphia-2016-2-402.PMC5345400.pdf
Available from http://aidsinfo.unaids.org/ 6.,Non-OADS,/arxiv_data1/oa_pdf/b8/63/jphia-2016-2-402.PMC5345400.pdf
2013.Available from http://apps.who.int/gho/ data/node.main.REPWOMEN39?lang=en  9.,OADS,/arxiv_data1/oa_pdf/b8/63/jphia-2016-2-402.PMC5345400.pdf
Available from: http://www.unaids.org/en/media/unaids/co ntentassets/documents/unaidspublica- tion/2011/20110609_jc2137_global-plan- elimination-hiv-children_en.pdf  10.,Non-OADS,/arxiv_data1/oa_pdf/b8/63/jphia-2016-2-402.PMC5345400.pdf
Available from: https://ntp.niehs.nih.gov/ntp/ noms/support_docs/hydroquinone_may2009.pdf 20.,Non-OADS,/arxiv_data1/oa_pdf/30/b1/jphia-2016-2-552.PMC5345401.pdf
Available from: http://www.who.int/trade/glossary/story077 /en/ 9.,Non-OADS,/arxiv_data1/oa_pdf/a9/09/jphia-2016-2-559.PMC5345404.pdf
Available from: http://www.cdc.gov/vhf/ebola/about.html.,OADS,/arxiv_data1/oa_pdf/70/a8/jphia-2016-2-570.PMC5345406.pdf
Available from: http://www.who.int/csr/disease/ebola/evd- outbreak-response-plan-westafrica- 2014.pdf/.,Non-OADS,/arxiv_data1/oa_pdf/70/a8/jphia-2016-2-570.PMC5345406.pdf
Available from: http://www.who.int/csr/resources/publica- tions/ebola/health-workers-infections/en.,Non-OADS,/arxiv_data1/oa_pdf/70/a8/jphia-2016-2-570.PMC5345406.pdf
Available from: https://pediatrics.aappubli- cations.org/content/pediatrics/118/1/404.fu ll.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/63/a1/jphia-2016-2-584.PMC5345407.pdf
Available from: https://www.ilo.org/dyn/natlex/docs/ELEC- TRONIC/99129/118193/F-746502152/CMR- 99129.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/60/01/jphia-2016-2-614.PMC5345408.pdf
Availablefrom: http://www.gfmer.ch/SRH-Course- 2011/research-methodology/pdf/WHO-pro- posal-guidelines-forms-2003.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/60/01/jphia-2016-2-614.PMC5345408.pdf
Available from: http://www.unaids.org/sites/default/ files/media_asset/UNAIDS_Global_Report _2013_en_1.pdf 23.,OADS,/arxiv_data1/oa_pdf/60/01/jphia-2016-2-614.PMC5345408.pdf
Available from: http://www.unaids.org/sites/default/files/coun- try/documents/CMR_narrative_report_2014.pdf 24.,Non-OADS,/arxiv_data1/oa_pdf/60/01/jphia-2016-2-614.PMC5345408.pdf
Materials and Methods Study design and setting A retrospective record review was conducted on routine data in the ETR.Net (http://www.etr- net.info/WhatIsETR.aspx) for all new smear positive TB patients in the Free State who received treatment between 2003 and 2009.,Non-OADS,/arxiv_data1/oa_pdf/8b/79/jphia-2014-2-324.PMC5345412.pdf
Available fr om: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/a1/42/jphia-2014-2-334.PMC5345413.pdf
Available From: http://www.who.int/mediacentre/fact- sheets/fs286/en/ Accessed: 5 Jan 2011.,Non-OADS,/arxiv_data1/oa_pdf/a1/42/jphia-2014-2-334.PMC5345413.pdf
Available from: http://www.afro.who.int/index.php?option=com_docman&task=doc_download&gid=3675 Accessed: 15 Dec 2012.,Non-OADS,/arxiv_data1/oa_pdf/a1/42/jphia-2014-2-334.PMC5345413.pdf
Available from: http://www.cdc.gov/hrqol/concept.htm Accessed: 31 Jan 2012.,OADS,/arxiv_data1/oa_pdf/55/13/jphia-2014-2-366.PMC5345416.pdf
Available from: http://www.who.int/tb/publications/global_r eport/archive/en/ Accessed: 31 Jan 2012.10.,Non-OADS,/arxiv_data1/oa_pdf/55/13/jphia-2014-2-366.PMC5345416.pdf
Availa- ble from: http://www.who.int/substance_ abuse/research_tools/whoqolbref/en/ Ac- cessed: 31 Jan 2012.,OADS,/arxiv_data1/oa_pdf/55/13/jphia-2014-2-366.PMC5345416.pdf
Available from: http://www.who.int/ mental_health/media/en/76.pdf Accessed: 31 Jan 2012.,Non-OADS,/arxiv_data1/oa_pdf/55/13/jphia-2014-2-366.PMC5345416.pdf
"Bangladesh National Garments Worker Federation, Activity Report: 1999-2004, Available from: http://www.agp.org Accessed: 14/11/2008.",Non-OADS,/arxiv_data1/oa_pdf/1a/41/jphia-2014-2-373.PMC5345417.pdf
Available from: http://www.utmem.edu/gim/smallt alks/dia- b etes_guidelines.pdf Accessed: 10/06/12.,Non-OADS,/arxiv_data1/oa_pdf/1a/41/jphia-2014-2-373.PMC5345417.pdf
Available from: http://www.who.int/mediacentre/fact- sheets/fs317/en/index.html Accessed: 09/01/13.,Non-OADS,/arxiv_data1/oa_pdf/1a/41/jphia-2014-2-373.PMC5345417.pdf
"Enhancing access to Global Alliance  for Vaccines and Immunization funds GAVI has supported Nigeria’s immunization system since 2001 to address extremely poorimmunization coverage, particularly in the northern states (http://www.gavialliance.org/ country/nigeria/).",Non-OADS,/arxiv_data1/oa_pdf/db/39/jphia-2014-2-381.PMC5345418.pdf
"healthpartners-int.co.uk/; http://www.prri nn-mnch.org/index.html) and assessment of training institutions; iii) sharing experience on planning and conducting base- line assessments, development of a monitoring and evaluation framework, and the Comprehensive Emergency Obstetric Care (CEOC) cluster model used; iv) participation in the planning of refresher training of midwives countrywide by NPHCDA-MSS; v) developing national integrated supportive supervision (ISS) tools (the ISS tools have been institution- alized and the ISS teams oriented nationwide); vi) providing in-service training to MSS mid- wives in the three states based on training needs earlier identified during an induction workshop.",Non-OADS,/arxiv_data1/oa_pdf/db/39/jphia-2014-2-381.PMC5345418.pdf
Available from: http://www.unhchr.ch/huridocda/hurido- ca.nsf/(Symbol)/A.RES.48.104.En Acces - sed: 1 April 2009.,Non-OADS,/arxiv_data1/oa_pdf/3a/b3/jphia-2013-1-e1.PMC5345419.pdf
Available from: http://www.unfpa.org/ Accessed: 1 July 2009.7.,Non-OADS,/arxiv_data1/oa_pdf/3a/b3/jphia-2013-1-e1.PMC5345419.pdf
Available from: http://www.unaids.org/en/KnowledgeCentr e/HIVData/GlobalReport/2008/ Accessed: 1 June 2009.,OADS,/arxiv_data1/oa_pdf/3a/b3/jphia-2013-1-e1.PMC5345419.pdf
Available from: http://www.unesco.,Non-OADS,/arxiv_data1/oa_pdf/3a/b3/jphia-2013-1-e1.PMC5345419.pdf
Available from: http://www.who.int/whr/2005/en/ 5.,OADS,/arxiv_data1/oa_pdf/da/fd/jphia-2013-1-e10.PMC5345420.pdf
Available from: http://www.mamaproject.org/  6.,Non-OADS,/arxiv_data1/oa_pdf/da/fd/jphia-2013-1-e10.PMC5345420.pdf
Available from: http://www.herfon.org/docs/report_on_im munization_study_tour_to_eygpt.pdf Accessed: 10 March 2012.,Non-OADS,/arxiv_data1/oa_pdf/da/fd/jphia-2013-1-e10.PMC5345420.pdf
Available from: http://moh.arahe.co/attach- ments/733□ Accessed: 1 March 2006.,Non-OADS,/arxiv_data1/oa_pdf/91/c6/jphia-2013-1-e2.PMC5345421.pdf
Available from: http://www.health.,Non-OADS,/arxiv_data1/oa_pdf/91/c6/jphia-2013-1-e2.PMC5345421.pdf
Available from: http://news.bbc.co.uk/2/hi/africa/7242421.s tm  2.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/jphia-2013-1-e5.PMC5345424.pdf
Available from: http://en.wikipedia.org/ wiki/2007–08_Kenyan_crisis  3.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/jphia-2013-1-e5.PMC5345424.pdf
Available from: http://www.trust.org/item/20111027150000 -p57gx/?source=search  5.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/jphia-2013-1-e5.PMC5345424.pdf
Available from: http://www.washington- post.com/wp-dyn/content/article/2007/09/ 08/AR2007090801194.html  16.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/jphia-2013-1-e5.PMC5345424.pdf
Available from: http://www.amnesty.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/jphia-2013-1-e5.PMC5345424.pdf
Available from: http://www.doctorswithoutborders.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/jphia-2013-1-e5.PMC5345424.pdf
Available from: http://www.guardian.co.uk/film/2008/may/0 9/women.congo  23.,Non-OADS,/arxiv_data1/oa_pdf/e7/e3/jphia-2013-1-e5.PMC5345424.pdf
Available from: http://webarchive.nation- alarchives.gov.uk/20120919132719/http://w ww.communities.gov.uk/documents/com- munities/pdf/actionplan Accessed: 25 April 2013.,Non-OADS,/arxiv_data1/oa_pdf/7e/db/jphia-2013-1-e6.PMC5345425.pdf
Available from: http://ec.europa.eu/health/archive/ph_dete rminants/life_style/mental/green_paper/m ental_gp_co118.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7e/db/jphia-2013-1-e6.PMC5345425.pdf
Available from: http://www.local.gov.uk/publications Accessed: 25 April 2013.,Non-OADS,/arxiv_data1/oa_pdf/7e/db/jphia-2013-1-e6.PMC5345425.pdf
Available from: https://www.chf.org.au/pdfs/rep/rep-guide-running-health-workshops.pdfAccessed: 25 April 2013. Review,Non-OADS,/arxiv_data1/oa_pdf/7e/db/jphia-2013-1-e6.PMC5345425.pdf
"A good example is a case study by Elliott, Golby and Williams cited by Wistmar et al.,9and more examples can be found in the HIA gateway (http://www.apho.org.uk/default.aspx?RID=44 538).",Non-OADS,/arxiv_data1/oa_pdf/b0/e0/jphia-2013-1-e7.PMC5345426.pdf
Available from: http://www3.webng.com/jer- barker/home/eia-toolkit/downloads/ grants/BitondoReport.pdf  7.,Non-OADS,/arxiv_data1/oa_pdf/b0/e0/jphia-2013-1-e7.PMC5345426.pdf
"Health impact assessment and waste managementwith particular reference to incineration - An introductory paper; 2005. http://www.publichealth.ie/files/file/Waste_ Management_and_Health_report.pdf Accessed: October 15, 2010.",Non-OADS,/arxiv_data1/oa_pdf/b0/e0/jphia-2013-1-e7.PMC5345426.pdf
"Available from: http://www.who.int/whr/2006/en/ Accessed: October 14, 2010.",OADS,/arxiv_data1/oa_pdf/b0/e0/jphia-2013-1-e7.PMC5345426.pdf
Available from: http://www.oxfordscholar- ship.com/view/10.1093/acprof:oso/97801985 26292.001.0001/acprof-9780198526292- chapter-28   22.,Non-OADS,/arxiv_data1/oa_pdf/b0/e0/jphia-2013-1-e7.PMC5345426.pdf
"Available from: http://www.who.int/gho/publica- tions/world_health_statistics/en/index.html Accessed: November 8, 2010.",Non-OADS,/arxiv_data1/oa_pdf/e6/c6/jphia-2013-1-e9.PMC5345428.pdf
"Available from: http://issuu.com/ryacat/docs/pidsdps9513 15 Peng Y, Chang W, Zhou H, et al.",OADS,/arxiv_data1/oa_pdf/e6/c6/jphia-2013-1-e9.PMC5345428.pdf
Available from: http://www.cso.,Non-OADS,/arxiv_data1/oa_pdf/d3/13/jphia-2013-2-e11.PMC5345429.pdf
Available from: http://www.caab.co.bw/caab-content.php?,Non-OADS,/arxiv_data1/oa_pdf/d3/13/jphia-2013-2-e11.PMC5345429.pdf
Available from: http://who.int/hrp/publica- tions/progress53.pdf 6.,OADS,/arxiv_data1/oa_pdf/b3/a3/jphia-2013-2-e12.PMC5345430.pdf
Available from: http://www.saga.,Non-OADS,/arxiv_data1/oa_pdf/f9/a2/jphia-2013-2-e13.PMC5345431.pdf
Available from: http://www.aidsportal.org/store/909.pdf Accessed: 8 March 2011.,Non-OADS,/arxiv_data1/oa_pdf/f9/a2/jphia-2013-2-e13.PMC5345431.pdf
Available from: http://www.cdc.gov/std/treatment/ Acces - sed: 4 June 2012.,Non-OADS,/arxiv_data1/oa_pdf/f1/2f/jphia-2013-2-e14.PMC5345432.pdf
Available from: http://en.wikipedia.org/wiki/Festival Accessed: 16 August 2013.,Non-OADS,/arxiv_data1/oa_pdf/f3/42/jphia-2013-2-e15.PMC5345433.pdf
Available from: http://www.who.int/ reproductivehealth/topics/family_plan- ning/Hormonal_contraception_and_HIV.p df Accessed: 4 June 2013.,Non-OADS,/arxiv_data1/oa_pdf/80/01/jphia-2013-2-e16.PMC5345434.pdf
Available from: http://www.thestandard.,Non-OADS,/arxiv_data1/oa_pdf/80/01/jphia-2013-2-e16.PMC5345434.pdf
Available from: http://ww1.aegis.org/conferences/iac/1998/ 13562.html Accessed: January 2013.,Non-OADS,/arxiv_data1/oa_pdf/80/01/jphia-2013-2-e16.PMC5345434.pdf
Available from: http://www.who.int/healthinfo/global_bur- den_disease/2004_report_update/en/index.,OADS,/arxiv_data1/oa_pdf/9a/c4/jphia-2013-2-e18.PMC5345436.pdf
Available from: http://www.who.int/whosis/whostat/2011/en/ index.html 5.,OADS,/arxiv_data1/oa_pdf/9a/c4/jphia-2013-2-e18.PMC5345436.pdf
Available from: http://www.fda.gov/Drugs/Science Research/ResearchAreas/Pharmacogenetic s/ucm083378.html Accessed: October 2012.,Non-OADS,/arxiv_data1/oa_pdf/9a/c4/jphia-2013-2-e18.PMC5345436.pdf
Available from: http://www.cdc.gov/ genomics/gtesting/ACCE/index.htm 36.,OADS,/arxiv_data1/oa_pdf/9a/c4/jphia-2013-2-e18.PMC5345436.pdf
Available from: http://www.unaids.org/en/resources/press- centre/featurestories/2009/march/2009033 1ungass2010/ 26.,Non-OADS,/arxiv_data1/oa_pdf/42/20/jphia-2013-2-e19.PMC5345437.pdf
Available from: http://data.unaids.org/publications/IRC- pub02/jc891-wac_framework_en.pdf Accessed: 19 September 2006.,OADS,/arxiv_data1/oa_pdf/8e/4a/jphia-2012-1-e10.PMC5345439.pdf
http://www.unaids.org Accessed: 29 November 2006.,Non-OADS,/arxiv_data1/oa_pdf/8e/4a/jphia-2012-1-e10.PMC5345439.pdf
Available from: http://data.unaids.org/pub- lications/irc-pub06/jc943-epiupdate 2003_en.pdf20.,OADS,/arxiv_data1/oa_pdf/8e/4a/jphia-2012-1-e10.PMC5345439.pdf
"Accessed at http://www.ilo.org/public/english/region/as ro/newdelhi/aids/download/socioec.pdf Accessed: 10 January, 2007.",Non-OADS,/arxiv_data1/oa_pdf/8e/4a/jphia-2012-1-e10.PMC5345439.pdf
Available from: http://nigeria.unfpa.org/pdf/snyp2009.pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/8e/4a/jphia-2012-1-e10.PMC5345439.pdf
Available from: http://www.population.,OADS,/arxiv_data1/oa_pdf/8e/4a/jphia-2012-1-e10.PMC5345439.pdf
"An earlier study3examined the effect of a proxy for SES on child survival in Malawi, a poor country with an estimated population of 13 million people and an HIV prevalence rate in 2008 of 11% (http://www.countrystat.org/ mwi/cont/pages/page/indicators/en).",Non-OADS,/arxiv_data1/oa_pdf/79/c2/jphia-2012-1-e11.PMC5345440.pdf
The census data were obtained from the archives of The African Census Analysis Project based at the University of Pennsylvania (http://www.acap.,OADS,/arxiv_data1/oa_pdf/79/c2/jphia-2012-1-e11.PMC5345440.pdf
Available from: http://www.csiss.org/ 17.,Non-OADS,/arxiv_data1/oa_pdf/cd/c1/jphia-2012-1-e12.PMC5345441.pdf
1-5. http://www.arch.,Non-OADS,/arxiv_data1/oa_pdf/73/6a/jphia-2012-1-e14.PMC5345443.pdf
[page 58] [Journal of Public Health in Africa 2012; 3:e14]Available from: http://ideas.repec.org/p/ pra/mprapa/10249.html 26.,Non-OADS,/arxiv_data1/oa_pdf/73/6a/jphia-2012-1-e14.PMC5345443.pdf
A/CONF.206.6 1-22. http://www.un-documents.net/hfa.,Non-OADS,/arxiv_data1/oa_pdf/73/6a/jphia-2012-1-e14.PMC5345443.pdf
Available from: http://info.worldbank.org/etools/docs/ library/114715/istanbul03/docs/istan- bul03/02balamir3-n%5B1%5D.pdf  29.,Non-OADS,/arxiv_data1/oa_pdf/73/6a/jphia-2012-1-e14.PMC5345443.pdf
Available from: http://www.grif.umon- treal.ca/pages/i-rec%20papers/ofori.pdf 31.,Non-OADS,/arxiv_data1/oa_pdf/73/6a/jphia-2012-1-e14.PMC5345443.pdf
2003 [Accessed 20 April 2011] Available from http://www.actionhealth- inc.org/ 8.,Non-OADS,/arxiv_data1/oa_pdf/28/83/jphia-2012-1-e4.PMC5345448.pdf
"11, 2004.Available from: http://www.bvsde.paho.org/ bvsacd/cd59/casewater.pdf 8.",OADS,/arxiv_data1/oa_pdf/31/66/jphia-2012-1-e7.PMC5345451.pdf
"http://www.un.org/News/Press/ docs/2011/sgt2789.doc.htm Accessed: November 21, 2011.",Non-OADS,/arxiv_data1/oa_pdf/09/4c/jphia-2012-1-e9.PMC5345453.pdf
Available from: http://www.healthpolicyinitiative.com/Publ ications/Documents/1058_1_Nigeria_NHI S_Report_FINAL_2_1_10_acc.pdf Letter,Non-OADS,/arxiv_data1/oa_pdf/09/4c/jphia-2012-1-e9.PMC5345453.pdf
Available from: http://www.unicef.,Non-OADS,/arxiv_data1/oa_pdf/68/ad/jphia-2014-1-277.PMC5345456.pdf
"Available from: http://www.thephss.org/ppep/resource/National_Immunization_Policy_with_frwd_and_acknwldg.pdf Accessed: July 18, 2012.",Non-OADS,/arxiv_data1/oa_pdf/ac/4b/jphia-2014-1-297.PMC5345457.pdf
"Availablefrom: http://nigeria.unfpa.org/abia.html Accessed: September 15, 2012.",Non-OADS,/arxiv_data1/oa_pdf/ac/4b/jphia-2014-1-297.PMC5345457.pdf
"Av ailable f rom: http://data.world- bank.org/indicator/SP.DYN.CBRT.IN Acces - sed: August 12, 2012.",Non-OADS,/arxiv_data1/oa_pdf/ac/4b/jphia-2014-1-297.PMC5345457.pdf
Available from: http://www.opendata.go.ke Accessed: 11/04/2012.,Non-OADS,/arxiv_data1/oa_pdf/16/3c/jphia-2014-1-313.PMC5345459.pdf
"Available from: http://www.who.int/countries/cmr/en/ Accessed: October 20, 2011.",OADS,/arxiv_data1/oa_pdf/5e/4e/jphia-2014-1-322.PMC5345461.pdf
"Available from: https://www.hsph.harvard.edu/take- mi/files/2012/10/rp141.pdf Accessed: August 4, 2013.",Non-OADS,/arxiv_data1/oa_pdf/5e/4e/jphia-2014-1-322.PMC5345461.pdf
Available from: http://www.ecoi.net/file_ upload/90_1236873017_accord-health- care-in-ghana-20090312.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/01/bb/jphia-2014-1-352.PMC5345465.pdf
Available from: http://erd.eui.,Non-OADS,/arxiv_data1/oa_pdf/01/bb/jphia-2014-1-352.PMC5345465.pdf
"Hsiao WC, Shaw RP, Fraker A, et  a l. Social health insurance for developing nations.Washington, DC: The World Bank; 2007.Available from: http://www.hsph.harvard.",Non-OADS,/arxiv_data1/oa_pdf/01/bb/jphia-2014-1-352.PMC5345465.pdf
Available from:http://www.equinetafrica.org/bibl/docs/DIS 2 7fin.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/01/bb/jphia-2014-1-352.PMC5345465.pdf
Available from: http://www.nhis.gov.gh/files/8(1).pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/01/bb/jphia-2014-1-352.PMC5345465.pdf
Available from: http://www.ch-ghana.org/documents/ Publication/Report%20on%20observa- tions%20and%20commentary%20on%20N HIS.pdf 27.,Non-OADS,/arxiv_data1/oa_pdf/01/bb/jphia-2014-1-352.PMC5345465.pdf
Available from: http://uhcforward.org/sites/ uhcforward.org/files/718940PUB0PUBL06 7869B09780821395660.pdf4.,Non-OADS,/arxiv_data1/oa_pdf/be/19/jphia-2014-1-353.PMC5345466.pdf
Available from: http://www.ch-ghana.org/documents/Publication/Report on observations and commentary on NHIS.pdf 9.,Non-OADS,/arxiv_data1/oa_pdf/be/19/jphia-2014-1-353.PMC5345466.pdf
Availablefrom: http://www.psa.ac.uk/journals /pdf/ 5 /2012/873_495.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/be/19/jphia-2014-1-353.PMC5345466.pdf
WHO global strategy for containment of antimicrobialresistance; 2001. http://www.who.int/dru- gresistance/WHO_Global_Strategy_Englis h.pdf Accessed: 1 April 2010.,OADS,/arxiv_data1/oa_pdf/17/2f/jphia-2014-1-354.PMC5345467.pdf
Home page address: http://www.nigerianstat.gov.ng/Connection  s/Pop2006.pdf  3.World Bank Nigeria: Country Brief.,Non-OADS,/arxiv_data1/oa_pdf/7a/85/jphia-2011-1-e1.PMC5345468.pdf
http://web.worldbank.org/  4.World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/7a/85/jphia-2011-1-e1.PMC5345468.pdf
http://apps.who.int/medicine - docs/en/d/Jwhozip16e/ 5.World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/7a/85/jphia-2011-1-e1.PMC5345468.pdf
Home page address: http://www.who.int/whr/2005/en/index.html 6.United Nations Development Programme.,Non-OADS,/arxiv_data1/oa_pdf/7a/85/jphia-2011-1-e1.PMC5345468.pdf
Home page  address: http://hdr.undp.org/en/media/ hdr04_complete.pdf  7.United Nations Development Programme.,Non-OADS,/arxiv_data1/oa_pdf/7a/85/jphia-2011-1-e1.PMC5345468.pdf
Available from: http://www.foreignpolicy.,Non-OADS,/arxiv_data1/oa_pdf/c3/0d/jphia-2011-1-e10.PMC5345469.pdf
Available  from: http://www.who.int/mediacentre/ factsheets/fs101/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/c3/0d/jphia-2011-1-e10.PMC5345469.pdf
Available at: http://www.freepatentson - line.com/article/Journal-Instructional-  Psychology/157946272.html,Non-OADS,/arxiv_data1/oa_pdf/2c/6c/jphia-2011-1-e11.PMC5345470.pdf
Available from: http://www.who.int/malar - ia/world_malaria_report_2009/en/index.ht  ml  2.,Non-OADS,/arxiv_data1/oa_pdf/b5/b2/jphia-2011-1-e12.PMC5345471.pdf
Available  from: http://www.undp.org/mdg/goal6.,Non-OADS,/arxiv_data1/oa_pdf/b5/b2/jphia-2011-1-e12.PMC5345471.pdf
Available from:  http://www.searo.who.int/LinkFiles/Report  s_RBM_Strategy.pdf  7.,OADS,/arxiv_data1/oa_pdf/b5/b2/jphia-2011-1-e12.PMC5345471.pdf
Available from: http://fieldresearch.msf.org  /msf/handle/10144/90416  14.,Non-OADS,/arxiv_data1/oa_pdf/b5/b2/jphia-2011-1-e12.PMC5345471.pdf
Available from:  http://www.china.org.cn/opinion/2010-  04/23/content_19895418.htm  33. WHO.,Non-OADS,/arxiv_data1/oa_pdf/b5/b2/jphia-2011-1-e12.PMC5345471.pdf
"Address: http://www.citymayors.com/statistics/large  st-cities-density-125.html Accessed Oct 1, 2010).",Non-OADS,/arxiv_data1/oa_pdf/aa/35/jphia-2011-1-e14.PMC5345473.pdf
Home page address: http://www.who.int/healthinfo/en/ 2.WHO/UNAIDS/PEPFAR.,Non-OADS,/arxiv_data1/oa_pdf/ef/1c/jphia-2011-1-e2.PMC5345477.pdf
Home page address: http://www.who.int/ workforcealliance/en/ Article  Table 1.,OADS,/arxiv_data1/oa_pdf/ef/1c/jphia-2011-1-e2.PMC5345477.pdf
"Home  page address: http://www.who.int/3by5/ publications/documents/imai/en/ 9.Selke HM, Kimaiyo S, Sidle JE, et al.",OADS,/arxiv_data1/oa_pdf/ef/1c/jphia-2011-1-e2.PMC5345477.pdf
Available at: http://www.unfoundation.org/global- issues/technology/mhealth-alliance.html  2.World Health Organisation.,Non-OADS,/arxiv_data1/oa_pdf/63/eb/jphia-2011-1-e3.PMC5345478.pdf
Available at: http://www.who.int/healthpro - motion/conferences/7gchp/en/  3.United Nations.,Non-OADS,/arxiv_data1/oa_pdf/63/eb/jphia-2011-1-e3.PMC5345478.pdf
"Available  at: http://www.un.org/millenniumgoals/ pdf/The%20Millennium%20Development%  20Goals%20Report%202008.pdf 4.Ooms G, Stuckler D, Basu S, McKee M. Financing the Millennium Development Goals for health and beyond: sustaining  the 'Big Push'.",Non-OADS,/arxiv_data1/oa_pdf/63/eb/jphia-2011-1-e3.PMC5345478.pdf
"Available at: http://www.economist.com/node/14483896  11.Anantraman V, Mikkelsen T, Khilnani R, et al.",OADS,/arxiv_data1/oa_pdf/63/eb/jphia-2011-1-e3.PMC5345478.pdf
"Available at: http://www.malecir - cumcision.org/media/documents/MC_Glob  al_Trends_Determinants.pdf  2.World Health Organization, UNAIDS.",Non-OADS,/arxiv_data1/oa_pdf/b2/46/jphia-2011-1-e4.PMC5345479.pdf
"Available at: http://www.measuredhs.com/ pubs/pdf/FR183/15Chapter15.pdf  15.Mishra V, Medley A, Hong Ret al.",Non-OADS,/arxiv_data1/oa_pdf/b2/46/jphia-2011-1-e4.PMC5345479.pdf
Available from:  http://www.popcouncil.org/pdfs/horizons/s  Article,Non-OADS,/arxiv_data1/oa_pdf/b5/61/jphia-2011-1-e6.PMC5345481.pdf
Available from:  http://www.aidsuganda.org/pdf/Pallisa_DR  I_AR_Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/61/jphia-2011-1-e6.PMC5345481.pdf
Available at:  http://www.etharc.org/arvinfo/ethARTguid  e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/61/jphia-2011-1-e6.PMC5345481.pdf
Available at:  http://data.unaids.org/Governance/PCB03/  pcb_11_01_03_1_en.pdf  18.,OADS,/arxiv_data1/oa_pdf/b7/c8/jphia-2011-1-e9.PMC5345483.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/5f/56/jphia-2011-2-e18.PMC5345491.pdf
"Available from: http://www.unicef.org/media/media_  51087.html 3.Mathers CD, Boerma T, Ma Fat D. Global and regional causes of death.",Non-OADS,/arxiv_data1/oa_pdf/5f/56/jphia-2011-2-e18.PMC5345491.pdf
"Available from: http://www.indepth-net- work.org/ 8.Joshi R, Kengne AP, Neal B. Methodological trends in studies based on  verbal autopsies before and after pub - lished guidelines.",Non-OADS,/arxiv_data1/oa_pdf/5f/56/jphia-2011-2-e18.PMC5345491.pdf
Available from: http://www.unicef.,Non-OADS,/arxiv_data1/oa_pdf/5f/56/jphia-2011-2-e18.PMC5345491.pdf
Available from: http://www.bdrghana.gov.gh/ 12.Tradig Economics.,Non-OADS,/arxiv_data1/oa_pdf/5f/56/jphia-2011-2-e18.PMC5345491.pdf
"Available from: http://www.who.int/csr/ resources/publications/surveillance/ WHO_CDS_CSR_ISR_99_4/en/ index.html 16.Adams I, Darko D, Accorsi S. Assessing  efficiency in service delivery.",OADS,/arxiv_data1/oa_pdf/5f/56/jphia-2011-2-e18.PMC5345491.pdf
"Available from:  http://www.moh- ghana.org/UploadFiles/Publications/ANNU  ALREVIEWREPORT2008090825071054.pdf 21.Black RE, Morris SS, Bryce J.",Non-OADS,/arxiv_data1/oa_pdf/5f/56/jphia-2011-2-e18.PMC5345491.pdf
Available from: http://www.who.int /tb/publications/global_report/2009/en/index.,OADS,/arxiv_data1/oa_pdf/d2/69/jphia-2011-2-e19.PMC5345492.pdf
Retrieved  from: http://www.dfid.gov.uk/Where-we- work/Africa-West--Central/Nigeria/Key-facts/ Accessed on 11th July 2010.,Non-OADS,/arxiv_data1/oa_pdf/d2/69/jphia-2011-2-e19.PMC5345492.pdf
Available from: http://www.who.int/choice/en/ 14.Central Bank of Nigeria.,Non-OADS,/arxiv_data1/oa_pdf/d2/69/jphia-2011-2-e19.PMC5345492.pdf
Retrieved from http://cenbank.org/rates/ infltates.asp?year=2008.,OADS,/arxiv_data1/oa_pdf/d2/69/jphia-2011-2-e19.PMC5345492.pdf
Available from: http://www.who.int/tb/publications/global_pl an_to_stop_tb/en/index.html 17.Central Bank of Nigeria.,Non-OADS,/arxiv_data1/oa_pdf/d2/69/jphia-2011-2-e19.PMC5345492.pdf
Retrieved from  http://cenbank.org/rates/forex.asp?year=200  8.,OADS,/arxiv_data1/oa_pdf/d2/69/jphia-2011-2-e19.PMC5345492.pdf
http://devdata.worldbank.,Non-OADS,/arxiv_data1/oa_pdf/d2/69/jphia-2011-2-e19.PMC5345492.pdf
Available  from: http://www.who.int/whosis/ whostat/ EN_WHS08_Full.pdf.,OADS,/arxiv_data1/oa_pdf/d2/69/jphia-2011-2-e19.PMC5345492.pdf
Available  from: http://www.oanda.com/currency/con - verter/ Accessed October 12th 2010.,Non-OADS,/arxiv_data1/oa_pdf/d2/69/jphia-2011-2-e19.PMC5345492.pdf
Available from: http://www.who.int/substance_abuse/publi - cations/alcohol_injury_summary.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cc/b7/jphia-2011-2-e20.PMC5345493.pdf
Available from: http://www.who.int/substance_abuse/publi - cations/global_status_report_2004_overvie  w.pdf.,OADS,/arxiv_data1/oa_pdf/cc/b7/jphia-2011-2-e20.PMC5345493.pdf
Available from: http://www.surgeongeneral.,Non-OADS,/arxiv_data1/oa_pdf/cc/b7/jphia-2011-2-e20.PMC5345493.pdf
Available from: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/cc/b7/jphia-2011-2-e20.PMC5345493.pdf
Available from:  http://moh.gov.my/speeches/.,Non-OADS,/arxiv_data1/oa_pdf/98/b8/jphia-2011-2-e23.PMC5345496.pdf
Available from:  http://www.fep.um.edu.my/images/fep/doc/  2004% 20Pdf/FEA-WP-2004-003.pdf.,Non-OADS,/arxiv_data1/oa_pdf/98/b8/jphia-2011-2-e23.PMC5345496.pdf
Available from:  http://www.epu.gov.my/web/guest/eight - malaysiaplan.,Non-OADS,/arxiv_data1/oa_pdf/98/b8/jphia-2011-2-e23.PMC5345496.pdf
Available from: http://www.nst.,Non-OADS,/arxiv_data1/oa_pdf/98/b8/jphia-2011-2-e23.PMC5345496.pdf
http://www.nst.com.my/nst/arti - cles/28credit2/Article/index_html.,Non-OADS,/arxiv_data1/oa_pdf/98/b8/jphia-2011-2-e23.PMC5345496.pdf
Available from: http://thestar.com.my/  news/story.asp?file=/2010/11/23/parlia - ment/7482825&sec=parliament.,Non-OADS,/arxiv_data1/oa_pdf/98/b8/jphia-2011-2-e23.PMC5345496.pdf
"Available from http://www.who.int/who - sis/mme_2005.pdf 2.UNFPA, EngenderHealth.",OADS,/arxiv_data1/oa_pdf/90/b6/jphia-2011-2-e26.PMC5345499.pdf
Available from http://www.unfpa.org/ fistula/docs/fistula-needs-assessment.pdf 3.AbouZahr C. Global burden of maternal death and disability.,Non-OADS,/arxiv_data1/oa_pdf/90/b6/jphia-2011-2-e26.PMC5345499.pdf
"Available from: http://www.prb.org/Publications/PolicyBrie  fs/HiddenSufferingDisabilitiesFromPregn  ancyandChildbirthinLDCs.aspx  5.Wall LL, Karshima JA, Kirschner C, Arrowsmith SD.",Non-OADS,/arxiv_data1/oa_pdf/90/b6/jphia-2011-2-e26.PMC5345499.pdf
"Available  from: http://www.unmillenni- umproject.org/goals/index/htm  8.Ramphal S, Kalane G, Fourie T, Moodley J. Obstetric urinary fistulas in KwaZulu- Natal-What is the extent of this tragedy?",Non-OADS,/arxiv_data1/oa_pdf/90/b6/jphia-2011-2-e26.PMC5345499.pdf
Available from: http://siteresources.world - bank.org/DATASTATISTICS/Resources/WD  I08supplement1216.pdf 14.WHO.,Non-OADS,/arxiv_data1/oa_pdf/90/b6/jphia-2011-2-e26.PMC5345499.pdf
"Available from: http://www.who.int/whosis/whostat/2010/e  n/index.html 15.Uganda Bureau of Statistics, Macro  International.",OADS,/arxiv_data1/oa_pdf/90/b6/jphia-2011-2-e26.PMC5345499.pdf
Available from: http://emedicine.com/med/topic3321.htm.,Non-OADS,/arxiv_data1/oa_pdf/90/b6/jphia-2011-2-e26.PMC5345499.pdf
"Available from: http://www.unicef.org/spanish/sowc08/ docs/sowc08_execsummary-sp.pdf  2.Black RE, Morris SS, Bryce J.",Non-OADS,/arxiv_data1/oa_pdf/f9/33/jphia-2011-2-e27.PMC5345500.pdf
"Available from: http://www.afro.who.int/cah/documents/tra  ining/lancet/child_survival_1.pdf  3.Ahmad OB, Lopez AD, Inoue M. The  decline in child mortality: a reappraisal.",Non-OADS,/arxiv_data1/oa_pdf/f9/33/jphia-2011-2-e27.PMC5345500.pdf
"Available from: http://www.fun - salud.org.mx/CASEsalud/caleidosco - pio/15%20DeterminantesDelGasto.pdf  16.Tafani R, Gaspio N, Maldonado R. Economía, Educación y Salud Materno  Infantil.",Non-OADS,/arxiv_data1/oa_pdf/f9/33/jphia-2011-2-e27.PMC5345500.pdf
2007:http://who.int/hiv/mediacen - tre/MCrecommendations_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1e/ae/jphia-2011-2-e28.PMC5345501.pdf
Available from: http://www.scielosp.org/ scielo.php?script=sci_arttext&pid=S0042  -96862000001000010&nrm=iso.,Non-OADS,/arxiv_data1/oa_pdf/d5/f3/jphia-2011-2-e30.PMC5345503.pdf
Available from: http://www.un.org/millenniumgoals/pdf/T  he%20Millennium%20Development%20G  oals%20Report%202008.pdf  6.UNECA.,Non-OADS,/arxiv_data1/oa_pdf/d5/f3/jphia-2011-2-e30.PMC5345503.pdf
Available from: http://www.uneca.,Non-OADS,/arxiv_data1/oa_pdf/d5/f3/jphia-2011-2-e30.PMC5345503.pdf
Available from: http://www.un.org/millenniumgoals/pdf/M  DG_Report_2009_ENG.pdf  8.Burki T. Slow progress towards sanitation  goal.,Non-OADS,/arxiv_data1/oa_pdf/d5/f3/jphia-2011-2-e30.PMC5345503.pdf
Available from: http://edis.ifas.ufl.,Non-OADS,/arxiv_data1/oa_pdf/d5/f3/jphia-2011-2-e30.PMC5345503.pdf
Available from: http://www.ghtcoalition.org/files/gfind - er_dec2009.pdf  144.,OADS,/arxiv_data1/oa_pdf/d5/f3/jphia-2011-2-e30.PMC5345503.pdf
Available from: http://www.nhis.gov.ng  /index.php?option=com_content&view=a  rticle&id=92&Itemid=77  3.,OADS,/arxiv_data1/oa_pdf/55/bb/jphia-2011-2-e31.PMC5345504.pdf
Available from:  http://www.nap.edu/openbook.php?isbn=0  309085187  7.,Non-OADS,/arxiv_data1/oa_pdf/55/bb/jphia-2011-2-e31.PMC5345504.pdf
2007 Available  from: http://www.unicef.org/health/index  maternal health.html  2.,Non-OADS,/arxiv_data1/oa_pdf/eb/c1/jphia-2011-2-e33.PMC5345506.pdf
Available from:  http://www.unfpa.org/swp/2005/presskit/fa  ctsheets/facts_rh.htm  3.,Non-OADS,/arxiv_data1/oa_pdf/eb/c1/jphia-2011-2-e33.PMC5345506.pdf
Available from:  http://www.prb.org/pdf06/06world - datasheet.pdf  6.,Non-OADS,/arxiv_data1/oa_pdf/eb/c1/jphia-2011-2-e33.PMC5345506.pdf
Available from:  http://www.who.int/making_pregnancy_sa  fer/survey/en/index.html 11.,Non-OADS,/arxiv_data1/oa_pdf/eb/c1/jphia-2011-2-e33.PMC5345506.pdf
Available from: http://www.childinfo.org/  files/maternal_mortality_finalgui.pdf  15.,Non-OADS,/arxiv_data1/oa_pdf/eb/c1/jphia-2011-2-e33.PMC5345506.pdf
"Global tuber - culosis control – Surveillance, planning, financing 2008. http://www.who.int/tb/pub - lications/global_report/2008/en/index.htm; 2008.4.Noble M, Barnes H, Wright G, Roberts B.",OADS,/arxiv_data1/oa_pdf/1c/40/jphia-2011-2-e34.PMC5345507.pdf
"6, 1294368 http://dx.doi.org/10.1080/20013078.2017.1294368 © 2017 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/ff/84/zjev-6-1294368.PMC5345580.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/84/zjev-6-1294368.PMC5345580.pdf
"6, 1284449 http://dx.doi.org/10.1080/20013078.2017.1284449 © 2017 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/3c/86/zjev-6-1284449.PMC5345581.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/86/zjev-6-1284449.PMC5345581.pdf
"6, 1286095 http://dx.doi.org/10.1080/20013078.2017.1286095 © 2017 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/83/22/zjev-6-1286095.PMC5345583.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/22/zjev-6-1286095.PMC5345583.pdf
The occurrence of each protein within a census of 1542 manually curated RBPs [ 169] was queried within the Vesiclepedia database ( http://www.microvesicles.org ; v3.1; restricted to Homo sapiens samples).,OADS,/arxiv_data1/oa_pdf/83/22/zjev-6-1286095.PMC5345583.pdf
"ORCID Emma J. K. Kowal http://orcid.org/0000-0002-8992-7608 Andrew F. Hill http://orcid.org/0000-0001-5581-2354 Jennifer C. Jones http://orcid.org/0000-0002-9488-7719 Kenneth W. Witwer http://orcid.org/0000-0003-1664- 4233 References [ 1 ]C o l o m b oM ,R a p o s oG ,T h é r yC .B i o g e n e s i s ,s e c r e t i o n , and intercellular interactions of exosomes and other extra- cellular vesicles.",OADS,/arxiv_data1/oa_pdf/83/22/zjev-6-1286095.PMC5345583.pdf
"Retrieved from http://www.nature.com/ articles/srep22519 [21] Wang K, Zhang S, Weber J, et al.",OADS,/arxiv_data1/oa_pdf/83/22/zjev-6-1286095.PMC5345583.pdf
"Retrieved from http://www.journalofex tracellularvesicles.net/index.php/jev/article/view/27031 [32] Van Deun J, Mestdagh P, Sormunen R, et al.",OADS,/arxiv_data1/oa_pdf/83/22/zjev-6-1286095.PMC5345583.pdf
Retrieved from http://www.journalofextrac ellularvesicles.net/index.,Non-OADS,/arxiv_data1/oa_pdf/83/22/zjev-6-1286095.PMC5345583.pdf
"Retrieved from http://nar.oxford journals.org/lookup/doi/10.1093/nar/gkr254 [47] Vickers KC, Palmisano BT, Shoucri BM, et al.",OADS,/arxiv_data1/oa_pdf/83/22/zjev-6-1286095.PMC5345583.pdf
"Retrieved from http://www.nature.c om/doifinder/10.1038/ ncb2210 [48] Yuana Y, Levels J, Grootemaat A, et al.",OADS,/arxiv_data1/oa_pdf/83/22/zjev-6-1286095.PMC5345583.pdf
"Retrieved from http://www.journalofextracel lularvesicles.net/index.php/jev/article/view/23430 [50] Fritz JV, Heintz-Buschart A, Ghosal A, et al.",Non-OADS,/arxiv_data1/oa_pdf/83/22/zjev-6-1286095.PMC5345583.pdf
"Retrieved from http://www.nature.com/doifinder/10.1038/ncb1930 [136] Stalder L, Heusermann W, Sokol L, et al.",OADS,/arxiv_data1/oa_pdf/83/22/zjev-6-1286095.PMC5345583.pdf
Retrieved from http://www.nature.com/doifinder/10.,Non-OADS,/arxiv_data1/oa_pdf/83/22/zjev-6-1286095.PMC5345583.pdf
Retrieved from http://linkinghub.elsevier.com/ retrieve/pii/S0962892416000428 [229] Clevers H. Modeling development and disease with organoids.,Non-OADS,/arxiv_data1/oa_pdf/83/22/zjev-6-1286095.PMC5345583.pdf
Retrieved from http://eutils.ncbi.,OADS,/arxiv_data1/oa_pdf/83/22/zjev-6-1286095.PMC5345583.pdf
"12, 1290741 http://dx.doi.org/10.1080/19932820.2017.1290741 © 2017 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/84/da/zljm-12-1290741.PMC5345584.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/da/zljm-12-1290741.PMC5345584.pdf
"12, 1289651 http://dx.doi.org/10.1080/19932820.2017.1289651 © 2017 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/8a/4b/zljm-12-1289651.PMC5345591.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/4b/zljm-12-1289651.PMC5345591.pdf
This study is in compliance with the Strobe guidelines for cohort studies ( http://www.strobe-statement.org ).,Non-OADS,/arxiv_data1/oa_pdf/8a/4b/zljm-12-1289651.PMC5345591.pdf
"ORCID Mehdi Khemiss http://orcid.org/0000-0001-7366-9934 Helmi Ben Saad http://orcid.org/0000-0002-7477-2965 References [1] Pandey P, Reddy NV, Rao VA, et al.",Non-OADS,/arxiv_data1/oa_pdf/8a/4b/zljm-12-1289651.PMC5345591.pdf
"Available from: http://apps.who.int/iris/bitstream/10665/161991/ 1/9789241508469_eng.pdf?ua=1&ua=1 [21] Morton J, Song Y, Fouad H, et al.",OADS,/arxiv_data1/oa_pdf/8a/4b/zljm-12-1289651.PMC5345591.pdf
"12, 1283162 http://dx.doi.org/10.1080/19932820.2017.1283162 © 2017 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/92/6c/zljm-12-1283162.PMC5345598.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/6c/zljm-12-1283162.PMC5345598.pdf
"The ﬁrst of these, AFLPSURV (http://www.ulb.ac.be/sciences/lagev/a ﬂp-surv.html), follows an approach for calculating Wright ’sFstoutlined by Lynch and Milligan (1994).",Non-OADS,/arxiv_data1/oa_pdf/de/3f/hdy201694a.PMC5345609.pdf
DATA ARCHIVING Data ﬁles of wing spot sizes and AFLP genotypes available from the Dryad Digital Repository: http://dx.doi.org/10.5061/dryad.j7v42.,OADS,/arxiv_data1/oa_pdf/de/3f/hdy201694a.PMC5345609.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by- nc-sa/4.0/ rThe Author(s) 2017 Supplementary Information accompanies this paper on Heredity website (http://www.nature.com/hdy)Wing spots and genetic structure of meadow brown butter ﬂies SW Baxter et al 329 Heredity",Non-OADS,/arxiv_data1/oa_pdf/de/3f/hdy201694a.PMC5345609.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0b/f4/bctt-9-111.PMC5345689.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0b/f4/bctt-9-111.PMC5345689.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 111–120Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 111 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S126557 CYP2D6 polymorphisms may predict occurrence  of adverse effects to tamoxifen: a preliminary  retrospective study Ishani Wickramage1 Kamani Hemamala  T ennekoon1 Merenchi Arachchige Yasantha Ariyaratne 2 Asanka Sudeshini Hewage1 Tharmini Sundralingam1 1Institute of Biochemistry, Molecular  Biology and Biotechnology (IBMBB),   University of Colombo, Colombo,  Sri Lanka;  2National Cancer Institute,   Maharagama, Sri LankaIntroduction and aims: Tamoxifen is an adjuvant drug effective in treating hormone  receptor –   positive breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/0b/f4/bctt-9-111.PMC5345689.pdf
"Keywords: fatty-liver, 2988G>A, CYP2D6*41, intermediate-metabolizer, SNP Introduction Breast cancer is the commonest cancer among females in Sri Lanka, accounting for  27% of all cancers in women.1 In 2010 in Sri Lanka, 2401 women were diagnosed with Correspondence: Ishani Wickramage 10/1, 2nd lane, Ratmalana, Sri LankaTel +94 07 7087 1370Fax +94 11 255 3683Email ishaniwick2011@gmail.comJournal name: Breast Cancer - Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Wickramage et alRunning head recto: CYP2D6 polymorphisms and tamoxifen adverse effectsDOI: http://dx.doi.org/10.2147/BCTT.S126557 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/0b/f4/bctt-9-111.PMC5345689.pdf
Or use: http://youtu.be/RODy-_cM-hQ,Non-OADS,/arxiv_data1/oa_pdf/0b/f4/bctt-9-111.PMC5345689.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/0b/f4/bctt-9-111.PMC5345689.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 120 Wickramage et al Limitations The biggest limitation in this study is the small sample size.,Non-OADS,/arxiv_data1/oa_pdf/0b/f4/bctt-9-111.PMC5345689.pdf
Avialbale from: http://www.ncbi.nlm.nih.gov/books/NBK247013.,Non-OADS,/arxiv_data1/oa_pdf/0b/f4/bctt-9-111.PMC5345689.pdf
Available from: http://livertox.nih.gov/Tamoxifen.htm.,Non-OADS,/arxiv_data1/oa_pdf/0b/f4/bctt-9-111.PMC5345689.pdf
Available from: http://www.cypalleles.ki.se/cyp2d6.htm.,Non-OADS,/arxiv_data1/oa_pdf/0b/f4/bctt-9-111.PMC5345689.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/22/37/amep-8-195.PMC5345690.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/22/37/amep-8-195.PMC5345690.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 195–203Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 195 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S126046 Care pathways in thrombosis management: the  INNOVATE peer-to-peer educational initiative Raj K Patel King’s College Hospital, London, UKContext: Anticoagulant options for the management of venous thromboembolism (VTE)  now include the non-vitamin K antagonist oral anticoagulants (NOACs).",Non-OADS,/arxiv_data1/oa_pdf/22/37/amep-8-195.PMC5345690.pdf
"This practice has been recognized by industry guidelines and health care service providers as important for educating health care professionals on new drugs, with the stipulation that comprehensive, balanced, and unbiased information must be Correspondence: Raj K Patel Department of Haematological Medicine, King’s Thrombosis Centre, 4th Floor Hambleden Wing West, King’s College Hospital, Denmark Hill, London,  SE5 9RS, UKTel +44 20 3299 4152Fax +44 20 8181 4711Email rajpatel@nhs.netJournal name: Advances in Medical Education and Practice Article Designation: REVIEWY ear: 2017V olume: 8Running head verso: PatelRunning head recto: The INNOV ATE educational initiativeDOI: http://dx.doi.org/10.2147/AMEP .S126046",Non-OADS,/arxiv_data1/oa_pdf/22/37/amep-8-195.PMC5345690.pdf
Available from: http://www.guidelinesinpractice.co.uk/GinP .co.uk/mar_10_anderson_jw_mar10.,Non-OADS,/arxiv_data1/oa_pdf/22/37/amep-8-195.PMC5345690.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/22/37/amep-8-195.PMC5345690.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 203 The INNOVATE educational initiative Figure S2 INNOVATE program: global reach to date.,Non-OADS,/arxiv_data1/oa_pdf/22/37/amep-8-195.PMC5345690.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e7/c5/bctt-9-121.PMC5345691.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e7/c5/bctt-9-121.PMC5345691.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 121–126Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 121 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S113025 Intensity modulated radiation therapy for  breast cancer: current perspectives Milly Buwenge1 Silvia Cammelli1 Ilario Ammendolia1 Giorgio T olento1  Alice Zamagni1  Alessandra Arcelli2  Gabriella Macchia3 Francesco Deodato3  Savino Cilla4 Alessio G Morganti1 1Department of Experimental,   Diagnostic and Specialty Medicine –  DIMES, Radiation Oncology Center,  University of Bologna, S.Orsola-Malpighi Hospital,  2Radiation  Oncology Unit, Bellaria Hospital,  Bologna,  3Radiation Oncology Unit,   4Medical Physics Unit, Research and  Care Foundation ‘Giovanni Paolo II,’ Catholic University of Sacred Heart,  Campobasso, ItalyBackground: Owing to highly conformed dose distribution, intensity modulated radiation  therapy (IMRT) has the potential to improve treatment results of radiotherapy (RT).",Non-OADS,/arxiv_data1/oa_pdf/e7/c5/bctt-9-121.PMC5345691.pdf
"4–6 Furthermore, several phase II or retrospective studies on IMRT in BC showed  decreased acute radiation-induced toxicity and reduced chronic breast edema with simi-lar results in terms of local control and secondary malignancies compared with standard Correspondence: Milly Buwenge  Department of Experimental, Diagnostic and Specialty Medicine – DIMES, Radiation Oncology Center, University of Bologna, S.Orsola-Malpighi Hospital, via Giuseppe Massarenti 9, 40138, Bologna, Italy Tel +39 051 6363 136 Fax +39 051 6364 336 Email mbuwenge@gmail.com Journal name: Breast Cancer - Targets and Therapy Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Buwenge et alRunning head recto: IMRT in breast cancerDOI: http://dx.doi.org/10.2147/BCTT.S113025",Non-OADS,/arxiv_data1/oa_pdf/e7/c5/bctt-9-121.PMC5345691.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/e7/c5/bctt-9-121.PMC5345691.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 126 Buwenge et al Conclusion In conclusion, on the basis of randomized trials, IMRT seems  able to reduce toxicity in selected patients treated with post-operative RT for BC, particularly in combination with partial breast irradiation and prone patients positioning.",Non-OADS,/arxiv_data1/oa_pdf/e7/c5/bctt-9-121.PMC5345691.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.NEUROGENESIS 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"1, e1285383 (9 pages)http://dx.doi.org/10.1080/23262133.2017.1285383",Non-OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Nature neuroscience 2002; 5(4):308-315; PMID:11896398; http://dx.doi.org/10.1038/nn828 [2] Masserdotti G, Gascon S, Gotz M. Direct neuronal reprog- ramming: learning from and for development.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Development 2016; 143(14):2494-2510; PMID: 27436039; http://dx.doi.org/10.1242/dev.092163 [3] Jang S, Cho HH, Cho YB, Park JS, Jeong HS.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"BMC cell biology 2010; 11:25;PMID: 20398362; http://dx.doi.org/10.1186/1471-2121-11-25 [4] Liu Y, Jiang X, Yu MK, Dong J, Zhang X, Tsang LL, Chung YW, Li T, Chan HC.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Cell biol-ogy international 2010; 34(11):1075-1083; PMID:20939829; http://dx.doi.org/10.1042/CBI20100516 [ 5 ] O n o r a t iM ,C a m n a s i oS ,B i n e t t iM ,J u n gC B ,M o r e t t i A, Cattaneo E. Neuropotent self-renewing neural stem(NS) cells derived from mouse induced pluripotent stem (iPS) cells.",Non-OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Molecular and cellular neurosciences 2010; 43(3):287-295; PMID: 20026276; http://dx.doi.org/10.1016/j.mcn.2009.12.002 [6] Liu ML, Zang T, Zou Y, Chang JC, Gibson JR, Huber KM, Zhang CL.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Cell stem cell 2015; 17(2):204-212;PMID:26253202;http://dx.doi.org/10.1016/j.stem.2015.07.006 [ 8 ] L iX ,Z u oX ,J i n gJ ,M aY ,W a n gJ ,L i uD ,Z h uJ ,D uX ,X i o n g L, Du Y et al.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Cell stem cell 2015; 17(6):735-747; PMID:26481520; http://dx.doi.org/10.1016/j.stem.2015.09.012 [10] Gascon S, Murenu E, Masserdotti G, Ortega F, Russo GL, Petrik D, Deshpande A, Heinrich C, Karow M, Robertson SP, et al.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Nature 1987; 328(6126):175-178; PMID: 2885756;http://dx.doi.org/10.1038/328175a0 [12] Yin JC, Wallach JS, Del V ecchio M, Wilder EL, Zhou H, Quinn WG, Tully T. Induction of a dominant negativeCREB transgene speci ﬁcally blocks long-term memory in Drosophila.",Non-OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Cell 1994; 79(1):49-58; PMID: 7923376; http://dx.doi.org/10.1016/0092-8674(94)90399-9 [13] Balschun D, Wolfer DP, Gass P, Mantamadiotis T, Welzl H, Schutz G, Frey JU, Lipp HP.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"(25):7966-7977; PMID: 19553437; http://dx.doi.org/ 10.1523/JNEUROSCI.1054-09.2009 [15] Rudiger R, Binder E, Tsarovina K, Schmidt M, Reiff T, Stubbusch J, Rohrer H. In vivo role for CREB sig-naling in the noradrenergic differentiation of sympa-thetic neurons.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
Molecular and cellular neurosciences2009; 42(2):142-151; PMID: 19545628; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"The Journal of neuroscience : the of ﬁcial journal of the Society for Neu- roscience 2005; 25(44):10105-10118; PMID: 16267218;http://dx.doi.org/10.1523/JNEUROSCI.3512-05.2005 [19] Shan ZY, Shen JL, Li QM, Wang Y, Huang XY, Guo T Y ,L i uH W ,L e iL ,J i nL H .p C R E Bi si n v o l v e di nn e u r a linduction of mouse embryonic stem cells by RA.",Non-OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Ana-tomical record 2008; 291(5):519-526; http://dx.doi.org/ 10.1002/ar.20686 [20] Fusco S, Leone L, Barbati SA, Samengo D, Piacentini R, Maulucci G, Toietta G, Spinelli M, McBurney M, Pani G,et al.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Cell reports2016; 14(5):1195-1205; PMID: 26804914; http://dx.doi.org/10.1016/j.celrep.2015.12.092 [21] Lonze BE, Riccio A, Cohen S, Ginty DD.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Neuron 2002; 34(3):371-385;PMID: 11988169; http://dx.doi.org/10.1016/S0896-6273(02)00686-4 [22] Mantamadiotis T, Lemberger T, Bleckmann SC, Kern H, Kretz O, Martin Villalba A, Tronche F, Kellendonk C,Gau D, Kapfhammer J, et al.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Nature genetics 2002; 31(1):47-54; PMID: 11967539; http://dx.doi.org/ 10.1038/ng882 [23] Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Ca2 Cinﬂux regulates BDNF transcription by a CREB family transcription factor-dependent mechanism.Neuron 1998; 20(4):709-726; PMID: 9581763; http://dx.doi.org/10.1016/S0896-6273(00)81010-7 [24] Wilson BE, Mochon E, Boxer LM.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Molecular andcellular biology 1996; 16(10):5546-5556; PMID: 8816467; http://dx.doi.org/10.1128/MCB.16.10.5546 [25] Tullai JW, Schaffer ME, Mullenbrock S, Sholder G, Kasif S, Cooper GM.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
The Journal of biological chemistry 2007;282(33):23981-23995; PMID: 17575275; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Science1999; 286(5448):2358-2361; PMID: 10600750; http://dx.doi.org/10.1126/science.286.5448.2358 [27] Mioduszewska B, Jaworski J, Kaczmarek L. Inducible cAMP early repressor (ICER) in the nervous system –a transcriptional regulator of neuronal plasticity and programmed cell death.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Journal of neurochemistry2003; 87(6):1313-1320; PMID: 14713288; http://dx.doi.org/10.1046/j.1471- 4159.2003.02116.x [28] Gur TL, Conti AC, Holden J, Bechtholt AJ, Hill TE, Lucki I, Malberg JE, Blendy JA.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"The Journal of neuroscience: the of ﬁcial journal of the Society for Neuroscience 2007; 27(29):7860-7868; PMID: 17634380;http://dx.doi.org/10.1523/JNEUROSCI.2051-07.2007 [29] Conkright MD, Guzman E, Flechner L, Su AI, Hogenesch JB, Montminy M. Genome-wide analysis of CREB target genesreveals a core promoter requirement for cAMP responsive-ness.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Molecular cell 2003; 11(4):1101-1108; PMID: 12718894;http://dx.doi.org/10.1016/S1097-2765(03)00134-5 [30] Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava D. Direct reprogram-ming of ﬁbroblasts into functional cardiomyocytes by deﬁned factors.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Cell 2010; 142(3):375-386; PMID: 20691899; http://dx.doi.org/10.1016/j.cell.2010.07.002 [31] Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Nature 2008; 455(7213):627-632; PMID: 18754011; http://dx.doi.org/10.1038/nature07314 [32] Caiazzo M, Giannelli S, Valente P, Lignani G, Carissimo A, Sessa A, Colasante G, Bartolomeo R, Massimino L,Ferroni S, et al.",Non-OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Stem cell reports 2015; 4(1):25-36; PMID: 25556566; http://dx.doi.org/10.1016/j.stemcr.2014.12.002 [33] Heinrich C, Gascon S, Masserdotti G, Lepier A, Sanchez R, Simon-Ebert T, Schroeder T, G €otz M, Berninger B.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"Generation of subtype-speci ﬁcn e u r o n s from postnatal astroglia of the mouse cerebral cortex.Nature protocols 2011; 6(2):214-228; PMID:21293461; http://dx.doi.org/10.1038/nprot.2010.188 [34] Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M. Direct conversion of ﬁ bro- blasts to functional neurons by de ﬁned factors.",OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
Nature 2010; 463(7284):1035-1041; PMID: 20107439; http://dx.doi.org/10.1038/nature08797NEUROGENESIS e1285383-9,Non-OADS,/arxiv_data1/oa_pdf/b1/ce/kngs-04-01-1285383.PMC5345748.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.NEUROGENESIS 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"1, e1288510 (12 pages)http://dx.doi.org/10.1080/23262133.2017.1288510",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"ORCID Jenna M. Ramaker http://orcid.org/0000-0001-9190-9620 Philip F. Copenhaver http://orcid.org/0000-0003-0918- 3264PhD References [1] Hardy J, Selkoe DJ.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"The amyloid hypothesis of Alzheimer ’s disease: progress and problems on the road to therapeutics.Science 2002; 297(5580):353-6; PMID:12130773; http://dx.doi.org/10.1126/science.1072994 [2] Nicolas M, Hassan BA.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Devt 2014; 141(13):2543-8; http://dx.doi.org/10.1242/dev.108712 [3] van der Kant R, Goldstein LS.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Dev Cell 2015; 32(4):502-15; PMID:25710536; http://dx.doi.org/10.1016/j.devcel.2015.01.022 [4] Zhang H, Ma Q, Zhang YW, Xu H. Proteolytic process- ing of Alzheimer ’sb-amyloid precursor protein.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"J Neurochem 2016; 139 Suppl 2:237-52:1-16; PMID:27255958; http:// dx.doi.org/10.1111/jnc.13632 [6] Gauthier S, Albert M, Fox N, Goedert M, Kivipelto M, Mestre-Ferrandiz J, Middleton LT. Why has therapydevelopment for dementia failed in the last two decades?Alzheimer ’s Dement 2016; 12(1):60-4; http://dx.doi.org/ 10.1016/j.jalz.2015.12.003 [7] Deyts C, Thinakaran G, Parent AT.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Trends Pharmacol Sci 2016; 37 (5):390-411; PMID:26837733; http://dx.doi.org/10.1016/j.tips.2016.01.005 [8] Kogel D, Deller T, Behl C. Roles of amyloid precursor protein family members in neuroprotection, stress signal-ing and aging.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"2012; 217(3-4):471-9;http://dx.doi.org/10.1007/s00221-011-2932-4 [9] Young-Pearse TL, Bai J, Chang R, Zheng JB, LoTurco JJ, Selkoe DJ.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"J Neurosci 2007; 27(52):14459-69; PMID:18160654; http://dx.doi.org/10.1523/JNEUROSCI.4701-07.2007 [10] Herms J, Anliker B, Heber S, Ring S, Fuhrmann M, Kretzschmar H, Sisodia S, Muller U. Cortical dysplasiaresembling human type 2 lissencephaly in mice lacking all three APP family members.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"(20):4106-15; PMID:15385965; http://dx.doi.org/10.1038/ sj.emboj.7600390 [11] Klevanski M, Saar M, Baumkotter F, Weyer SW, Kins S, Muller UC.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Mol CellNeurosci 2014; 61:201-10; PMID:24998676; http://dx.doi.org/10.1016/j.mcn.2014.06.004 [12] Zou C, Crux S, Marinesco S, Montagna E, Sgobio C, Shi Y, Shi S, Zhu K, Dorostkar MM, Muller UC, et al.Amyloid precursor protein maintains constitutive andadaptive plasticity of dendritic spines in adult brainby regulating D-serine homeostasis.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"EMBO J 2016; 35(20):2213-22; PMID:27572463; http://dx.doi.org/10.15252/embj.201694085 [13] Corrigan F, Vink R, Blumbergs PC, Masters CL, Cappai R, van den Heuvel C. Characterisation of the effect of knockout of the amyloid precursor protein on outcomefollowing mild traumatic brain injury.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Brain Res 2012;1451:87-99; PMID:22424792; http://dx.doi.org/10.1016/j.brainres.2012.02.045 [14] Plummer S, Van den Heuvel C, Thornton E, Corrigan F, Cappai R. The neuroprotective properties of the amyloidprecursor protein following traumatic brain injury.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
Aging Dis 2016; 7(2):163-79; PMID:27114849; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Prog Neurobiol 2016;143:36-60; PMID:27327400; http://dx.doi.org/10.1016/j.pneurobio.2016.06.004 [17] Shariati SA, De Strooper B. Redundancy and divergence in the amyloid precursor protein family.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"FEBS Lett 2013;587(13):2036-45; PMID:23707420; http://dx.doi.org/10.1016/j.febslet.2013.05.026 [18] Olsen O, Kallop DY, McLaughlin T, Huntwork-Rodri- guez S, Wu Z, Duggan CD, Simon DJ, Lu Y, Easley-Neal C, Takeda K, et al.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"J Neurosci 2014; 34 (19):6438-47; PMID:24806670; http://dx.doi.org/10.1523/JNEUROSCI.3522-13.2014 [19] Torroja L, Packard M, Gorczyca M, White K, Budnik V. The Drosophila b-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscularjunction.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
EMBO J 2005; 24(23):3996- 4006; PMID:16252002; http://dx.doi.org/10.1038/sj.,OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Biochem Bio-phys Res Commun 2006; 341(1):1-5; PMID:16406235;http://dx.doi.org/10.1016/j.bbrc.2005.12.150 [22] Shariati SA, Lau P, Hassan BA, Muller U, Dotti CG, De Strooper B, Gartner A. APLP2 regulates neuronal stemcell differentiation during cortical development.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
J Cell Sci 2013; 126(Pt 5):1268-77; PMID:23345401; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"J Biol Chem 1995; 270(9):4205-8; PMID:7876177; http://dx.doi.org/10.1074/jbc.270.9.4205 [25] Brouillet E, Trembleau A, Galanaud D, Volovitch M, Bouillot C, Valenza C, Prochiantz A, Allinquant B.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
J Neurosci 2013; 33(24):10165-81; PMID:23761911; http://dx.doi.org/ 10.1523/JNEUROSCI.1146-13.2013 [27] Patel T B.,Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Single transmembrane spanning heterotrimeric G protein-coupled receptors and their signaling cascades.Pharmacol Rev 2004; 56(3):371-85; PMID:15317909;http://dx.doi.org/10.1124/pr.56.3.4 [28] Nishimoto I, Okamoto T, Matsuura Y, Takahashi S, Oka- moto T, Murayama Y, Ogata E. Alzheimer amyloid pro- tein precursor complexes with brain GTP-binding protein G(o).",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Nature 1993; 362(6415):75-9;PMID:8446172; http://dx.doi.org/10.1038/362075a0 [29] Jiang M, Bajpayee NS.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Neurosignals 2009; 17(1):23-41; PMID:19212138;http://dx.doi.org/10.1159/000186688 [30] Bromberg KD, Iyengar R, He JC.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Front Biosci 2008; 13:4544-57; PMID:18508528; http://dx.doi.org/ 10.2741/3022 [31] Sudo H, Hashimoto Y, Niikura T, Shao Z, Yasukawa T, Ito Y, Yamada M, Hata M, Hiraki T, Kawasumi M, et al.Secreted A bdoes not mediate neurotoxicity by antibody- stimulated amyloid precursor protein.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Biochem BiophysRes Commun 2001; 282(2):548-56; PMID:11401495;http://dx.doi.org/10.1006/bbrc.2001.4604 [32] Hashimoto Y, Niikura T, Chiba T, Tsukamoto E, Kadowaki H, Nishitoh H, Yamagishi Y, Ishizaka M,e1288510-10 J. M. RAMAKER AND P. F. COPENHAVER",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"J Pharmacol Exp Ther 2003; 306(3):889-902; PMID:12829723; http://dx.doi.org/10.1124/jpet.103.051383 [33] Rohn TT, Ivins KJ, Bahr BA, Cotman CW, Cribbs DH.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"J Neurochem 2000; 74(6):2331-42; PMID:10820193; http://dx.doi.org/10.1046/j.1471-4159.2000.0742331.x [34] Niikura T, Yamada M, Chiba T, Aiso S, Matsuoka M, Nishimoto I.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"J Neurosci Res 2004; 77(1):54-62; PMID:15197738; http://dx.doi.org/ 10.1002/jnr.20139 [35] Sola Vigo F, Kedikian G, Heredia L, Heredia F, Anel A D ,R o s aA L ,L o r e n z oA .A m y l o i d - b e t ap r e c u r s o rprotein mediates neuronal toxicity of amyloid b through Go protein activation.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Neurobiol Aging 2009;30(9):1379-92; PMID:18187234; http://dx.doi.org/10.1016/j.neurobiolaging.2007.11.017 [36] Shaked GM, Chauv S, Ubhi K, Hansen LA, Masliah E. Interactions between the amyloid precursor protein C-terminal domain and G proteins mediate calcium dysre-gulation and amyloid btoxicity in Alzheimer ’s disease.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"FEBS J 2009; 276(10):2736-51; PMID:19368557; http://dx.doi.org/10.1111/j.1742-4658.2009.06997.x [37] Giambarella U, Murayama Y, Ikezu T, Fujita T, Nishi- moto I.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"FEBS Lett 1997; 412(1):97-101;PMID:9257698; http://dx.doi.org/10.1016/S0014-5793(97)00753-9 [38] Deyts C, Vetrivel KS, Das S, Shepherd YM, Dupre DJ, Thinakaran G, Parent AT.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"J Neurosci 2012; 32 (5):1714-29; PMID:22302812; http://dx.doi.org/10.1523/ JNEUROSCI.5433-11.2012 [39] Deyts C, Clutter M, Herrera S, Jovanovic N, Goddi A, Parent AT.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Elife 2016; 5:1-24;http://dx.doi.org/10.7554/eLife.15645 [40] Gralle M, Botelho MG, Wouters FS.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"J Biol Chem 2009; 284 (22):15016-25; PMID:19336403; http://dx.doi.org/10.1074/jbc.M808755200 [41] Milosch N, Tanriover G, Kundu A, Rami A, Fran- c o i sJ C ,B a u m k o t t e rF ,W e y e rS W ,S a m a n t aA ,Jaschke A, Brod F, et al.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Cell Death Dis 2014; 5:e1391(1324 pp); http://dx.doi.org/ 10.1038/cddis.2014.352[42] Cassar M, Kretzschmar D. Analysis of amyloid precursor protein function in Drosophila melanogaster.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Frontiers Mol Neurosci 2016; 9:61; PMID:27507933; http://dx.doi.org/10.3389/fnmol.2016.00061 [43] Carmine-Simmen K, Proctor T, Tschape J, Poeck B, Triphan T, Strauss R, Kretzschmar D. Neurotoxiceffects induced by the Drosophila amyloid- bpeptide suggest a conserved toxic function.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Neurobiol Dis 2009; 33(2):274-81; PMID: 19049874; http://dx.doi.org/ 10.1016/j.nbd.2008.10.014 [44] Luo L, Tully T, White K. Human amyloid precursor pro- tein ameliorates behavioral de ﬁcit of ﬂies deleted for Appl gene.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Neuron 1992; 9(4):595-605; PMID:1389179;http://dx.doi.org/10.1016/0896-6273(92)90024-8 [45] Luo LQ, Martin-Morris LE, White K. Identi ﬁcation, secretion, and neural expression of APPL, a Drosophila protein similar to human amyloid protein precursor.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
Dev Biol 2005; 288(1):160-78; PMID:16229831; http://dx.doi.org/10.1016/j.ydbio.2005.09.029 [47] Copenhaver PF.,OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Dev Dyn 2007; 236(7):1841-64;PMID:17420985; http://dx.doi.org/10.1002/dvdy.21138 [48] Horgan AM, Copenhaver PF.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"J Neurosci 2016; 36(33):8757-75; PMID:2753592 0; http://dx.doi.org/ 10.1523/JNEUROSCI.0729-16.2016 [50] Shimoda Y, Watanabe K. Contactins: emerging key roles in the development and function of the nervous system.Cell Adhesion Migration 2009; 3(1):64-70; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Devt 2008; 135(6):1189-99; http://dx.doi.org/10.1242/dev.007401 [52] Ma QH, Futagawa T, Yang WL, Jiang XD, Zeng L, Takeda Y, Xu RX, Bagnard D, Schachner M, Furley AJ,et al.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Nat Cell Biol 2008; 10 (3):283-94; PMID:18278038; http://dx.doi.org/10.1038/ncb1690 [53] Tachi N, Hashimoto Y, Nawa M, Matsuoka M. TAG-1 is an inhibitor of TGFbeta2-induced neuronal death viaamyloid bprecursor protein.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Biochem Biophys Res Com- mun 2010; 394(1):119-25; PMID:20184861; http://dx.doi.org/10.1016/j.bbrc.2010.02.127 [54] Banerjee S, Pillai AM, Paik R, Li J, Bhat MA.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"J Neurosci 2006; 26(12):3319-29; PMID:16554482; http://dx.doi.org/10.1523/JNEUROSCI.5383-05.2006 [55] Kaech S, Huang CF, Banker G. Long-term time-lapse imaging of developing hippocampal neurons in culture.Cold Spring Harbor Protocols 2012; 2012(3):335-9;PMID:22383652 [56] Horgan AM, Lagrange MT, Copenhaver PF.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Dev Biol1995; 172(2):640-53; PMID:8612978; http://dx.doi.org/10.1006/dbio.1995.8042 [57] Soderling SH, Guire ES, Kaech S, White J, Zhang F, Schutz K, Langeberg LK, Banker G, Raber J, Scott JD.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"J Neurosci 2007; 27(2):355-65; PMID:17215396; http://dx.doi.org/10.1523/JNEUROSCI.3209-06.2006 [58] Dent EW, Gupton SL, Gertler FB.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Cold SpringHarbor Perspectives Biol 2011; 3(3):1-39; http://dx.doi.org/10.1101/cshperspect.a001800 [59] Wayman GA, Kaech S, Grant WF, Davare M, Impey S, Tokumitsu H, Nozaki N, Banker G, Soderling TR.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Regu- lation of axonal extension and growth cone motility bycalmodulin-dependent protein kinase I. J Neurosci 2004;24(15):3786-94; PMID:15084659; http://dx.doi.org/10.1523/JNEUROSCI.3294-03.2004 [60] Lin MY, Lin YM, Kao TC, Chuang HH, Chen RH.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"J Cell Biol 2011; 193(6):985-94; PMID:21670212; http://dx.doi.org/ 10.1083/jcb.201103015[61] Thambi NC, Quan F, Wolfgang WJ, Spiegel A, Forte M. Immunological and molecular characterization of Go a- like proteins in the Drosophila central nervous system.",Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Science 1984; 226(4676):860-2; PMID:6436980; http://dx.doi.org/10.1126/science.6436980 [63] Sudo H, Jiang H, Yasukawa T, Hashimoto Y, Niikura T, Kawasumi M, Matsuda S, Takeuchi Y, Aiso S, MatsuokaM, et al.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Mol Cell Neurosci 2000; 16(6):708-23; PMID:11124892; http://dx.doi.org/10.1006/mcne.2000.0910 [64] Lefort R, Pozueta J, Shelanski M. Cross-linking of cell surface amyloid precursor protein leads to increased b-amyloid peptide production in hippocampal neurons: implications for Alzheimer ’s disease.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"J Neurosci 2012; 32 (31):10674-85; PMID:22855816; http://dx.doi.org/10.1523/JNEUROSCI.6473-11.2012 [65] Osterhout JA, Stafford BK, Nguyen PL, Yoshihara Y, Huberman AD.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"Neuron 2015; 86(4):985-99; PMID:25959733; http://dx.doi.org/10.1016/j.neuron.2015.04.005 [66] Dawkins E, Small DH.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"J Neurochem 2014; 129(5):756-69; PMID:24517464; http://dx.doi.org/10.1111/jnc.12675 [67] Muller UC, Zheng H. Physiological functions of APP family proteins.",OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
Cold Spring Harbor Perspectives Med 2012; 2(2):a006288; PMID:22355794; http://dx.doi.org/ 10.1101/cshperspect.a006288e1288510-12 J. M. RAMAKER AND P. F. COPENHAVER,Non-OADS,/arxiv_data1/oa_pdf/fb/14/kngs-04-01-1288510.PMC5345750.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.NEUROGENESIS 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"1, e1262934 (10 pages)http://dx.doi.org/10.1080/23262133.2016.1262934",Non-OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
ORCID Carlos P. Fitzsimons http://orcid.org/0000-0002-1556-2650e1262934-6 P. BIELEFELD ET AL.,Non-OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Biochem Soc Trans 2004; 32:1090-1092;PMID:15506974; http://dx.doi.org/10.1042/BST0321090 [2] Dolmetsch RE, Lewis RS, Goodnow CC, Healy JI.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Nature 1997; 386:855-858; PMID:9126747; http://dx.doi.org/10.1038/386855a0 [3] Hoffmann A, Levchenko A, Scott ML, Baltimore D. The IkappaB-NF-kappaB signaling module: temporal controland selective gene activation.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Science 2002; 298:1241-1245; PMID:12424381; http://dx.doi.org/10.1126/science.1071914 [4] Lahav G, Rosenfeld N, Sigal A, Geva-Zatorsky N, Levine AJ, Elowitz MB, Alon U. Dynamics of the p53-Mdm2 feed-back loop in individual cells.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Nat Genet 2004; 36:147-150; PMID:14730303; http://dx.doi.org/10.1038/ng1293 [5] Nelson DE, Ihekwaba AE, Elliott M, Johnson JR, Gibney CA, Foreman BE, Nelson G, See V, Horton CA, SpillerDG, et al.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Science 2004; 306:704-708; PMID:15499023; http://dx.doi.org/10.1126/science.1099962 [6] Wang HY, Huang YX, Zheng LH, Bao YL, Sun LG, Wu Y, Yu CL, Song ZB, Sun Y, Wang GN, et al.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Curr Opin Genet Dev2010; 20:656-664; PMID:20934871; http://dx.doi.org/10.1016/j.gde.2010.08.008 [9] Wee KB, Yio WK, Surana U, Chiam KH.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"PLoS One 2011; 6:e15766; PMID:21267416; http://dx.doi.org/10.1371/journal.pone.0015766 [11] Tiana G, Krishna S, Pigolotti S, Jensen MH, Sneppen K. Oscillations and temporal signalling in cells.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
Phys Biol 2007; 4:R1-17; PMID:17664651; http://dx.doi.org/10.1088/1478-3975/4/2/R01 [12] Lei J. Time-delayed negative feedback.,Non-OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Nat Cell Biol 2009; 11:1093-1102;PMID:19684579; http://dx.doi.org/10.1038/ncb1922 [14] Zhang Y, Liu J, Yao S, Li F, Xin L, Lai M, Bracchi-Ricard V, Xu H, Yen W, Meng W, et al.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Stem Cells 2012; 30:510-524; PMID:22134901;http://dx.doi.org/10.1002/stem.1006 [15] Grilli M, Memo M. Possible role of NF-kappaB and p53 in the glutamate-induced pro-apoptotic neuronal path-way.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Cell Death Differ 1999; 6:22-27; PMID:10200544;http://dx.doi.org/10.1038/sj.cdd.4400463 [16] Li J, Tang Y, Cai D. IKKbeta/NF-kappaB disrupts adult hypothalamic neural stem cells to mediate a neurodegen-erative mechanism of dietary obesity and pre-diabetes.Nat Cell Biol 2012; 14:999-1012; PMID:22940906; http://dx.doi.org/10.1038/ncb2562 [17] Ashall L, Horton CA, Nelson DE, Paszek P, Harper CV, Sillitoe K, Ryan S, Spiller DG, Unitt JF, Broomhead DS,et al.",Non-OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Sci- ence 2009; 324:242-246; PMID:19359585; http://dx.doi.org/10.1126/science.1164860 [18] Fatt MP, Cancino GI, Miller FD, Kaplan DR. p63 and p73 coordinate p53 function to determine the balancebetween survival, cell death, and senescence in adult neu-ral precursor cells.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Cell Death Differ 2014; 21:1546-1559;PMID:24809925; http://dx.doi.org/10.1038/cdd.2014.61 [19] Meletis K, Wirta V, Hede SM, Nist /C19er M, Lundeberg J, Fris/C19en J. p53 suppresses the self-renewal of adult neural stem cells.",Non-OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Development 2006; 133:363-369;PMID:16368933; http://dx.doi.org/10.1242/dev.02208 [20] Hunziker A, Jensen MH, Krishna S. Stress-speci ﬁc response of the p53-Mdm2 feedback loop.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"BMC Syst Biol2010; 4:94; PMID:20624280; http://dx.doi.org/10.1186/1752-0509-4-94 [21] Batchelor E, Loewer A, Lahav G. The ups and downs of p53: understanding protein dynamics in single cells.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"NatRev Cancer 2009; 9:371-377; PMID:19360021; http://dx.doi.org/10.1038/nrc2604 [22] MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases.",Non-OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"DevCell 2009; 17:9-26; PMID:19619488; http://dx.doi.org/10.1016/j.devcel.2009.06.016 [23] Rao TP, Kuhl M. An updated overview on Wnt signaling pathways: a prelude for more.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Circ Res 2010; 106:1798-1806; PMID:20576942; http://dx.doi.org/10.1161/CIRCRESAHA.110.219840 [24] Cadigan KM, Nusse R. Wnt signaling: a common theme in animal development.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Genes Dev 1997; 11:3286-3305(); PMID:9407023; http://dx.doi.org/10.1101/gad.11.24.3286 [25] Goldbeter A, Pourquie O.",Non-OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"J Theor Biol 2008; 252:574-585; PMID:18308339; http://dx.doi.org/10.1016/j.jtbi.2008.01.006 [26] Dunty WC, Jr, Biris KK, Chalamalasetty RB, Taketo MM, Lewandoski M, Yamaguchi TP.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
Develop- ment 2008; 135:85-94; PMID:18045842; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Curr Opin Cell Biol2008; 20:632-637; PMID:18845254; http://dx.doi.org/10.1016/j.ceb.2008.09.002 [28] Karalay O, Doberauer K, Vadodaria KC, Knobloch M, Berti L, Miquelajauregui A, Schwark M, Jagasia R, Taketo MM, Tarabykin V, et al.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Nat Neurosci 2009; 12:1097- 1105; PMID:19701198; http://dx.doi.org/10.1038/nn.2360 [30] Lie DC, Colamarino SA, Song HJ, D /C19esir/C19e L, Mira H, Consiglio A, Lein ES, Jessberger S, Lansford H, DearieAR, et al.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Nature 2005; 437:1370-1375;PMID:16251967; http://dx.doi.org/10.1038/nature04108 [31] Ables JL, Decarolis NA, Johnson MA, Rivera PD, Gao Z, Cooper DC, Radtke F, Hsieh J, Eisch AJ.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"J Neurosci 2010; 30:10484-10492;PMID:20685991; http://dx.doi.org/10.1523/JNEUROSCI.4721-09.2010 [32] Giachino C, Taylor V. Notching up neural stem cell homogeneity in homeostasis and disease.",Non-OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Front Neurosci2014; 8:32; PMID:24611040; http://dx.doi.org/10.3389/ fnins.2014.00032 [33] Basak O, Giachino C, Fiorini E, Macdonald HR, Taylor V. Neurogenic subventricular zone stem/progenitor cellsare Notch1-dependent in their active but not quiescentstate.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"J Neurosci 2012; 32:5654-5666; PMID:22514327;http://dx.doi.org/10.1523/JNEUROSCI.0455-12.2012 [34] Lieber T, Kidd S, Alcamo E, Corbin V, Young MW.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Genes Dev1993; 7:1949-1965 (); PMID:8406001; http://dx.doi.org/ 10.1101/gad.7.10.1949 [35] Mumm JS, Kopan R. Notch signaling: from the outside in.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Dev Biol 2000; 228:151-165; PMID:11112321; http://dx.doi.org/10.1006/dbio.2000.9960 [36] Imayoshi I, Isomura A, Harima Y, Kawaguchi K, Kori H, Miyachi H, Fujiwara T, Ishidate F, Kageyama R. Oscillatory control of factors determining multipotencyand fate in mouse neural progenitors.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Science 2013; 342:1203-1208; PMID:24179156; http://dx.doi.org/10.1126/science.1242366 [37] Baek JH, Hatakeyama J, Sakamoto S, Ohtsuka T, Kageyama R. Persistent and high levels of Hes1expression regulate bounda ry formation in the devel- oping central nervous system.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
Development 2006; 133:2467-2476; PMID:16728479; http://dx.doi.org/ 10.1242/dev.02403 [38] Pfeuty B.,OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Development 2015; 142:477-485; PMID:25605780; http://dx.doi.org/10.1242/dev.112649 [39] Harima Y, Imayoshi I, Shimojo H, Kobayashi T, Kageyama R. The roles and mechanism of ultradian oscillatory expression of the mouse Hes genes.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"SeminCell Dev Biol 2014; 34:85-90; PMID:24865153; http://dx.doi.org/10.1016/j.semcdb.2014.04.038 [40] Hirata H, Yoshiura S, Ohtsuka T, Bessho Y, Harada T, Yoshikawa K, Kageyama R. Oscillatory expression of thebHLH factor Hes1 regulated by a negative feedback loop.Science 2002; 298:840-843; PMID:12399594; http://dx.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Nat Commun 2014; 5:3399; PMID:24595054;http://dx.doi.org/10.1038/ncomms4399 [43] Jing B, Yuan J, Yin Z, Lv C, Lu S, Xiong H, Tang H, Ye G, Shi F. Dynamic properties of the segmentation clockmediated by microRNA.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Nat Struct Mol Biol2009; 16:365-371; PMID:19330006; http://dx.doi.org/10.1038/nsmb.1576 [45] Eendebak RJ, Lucassen PJ, Fitzsimons CP.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
FEBS Lett 2011; 585:717-722; PMID:21295033; http://dx.doi.org/10.1016/j.febslet.,OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
Neuroscience 1994; 61:203-209 (); PMID:7969902; http://dx.doi.org/ 10.1016/0306-4522(94)90224-0e1262934-8 P. BIELEFELD ET AL.,OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"J Neurosci 2006; 26:5402-5410;PMID:16707792; http://dx.doi.org/10.1523/JNEUROSCI.4906-05.2006 [49] Oomen CA, Mayer JL, de Kloet ER, Joels M, Lucassen PJ.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Eur J Neurosci 2007;26:3395-3401; PMID:18052970; http://dx.doi.org/10.1111/j.1460-9568.2007.05972.x [50] Bose R, Moors M, To ﬁghi R, Cascante A, Hermanson O, Ceccatelli S. Glucocorticoids induce long-lasting effectsin neural stem cells resulting in senescence-related alterations.",Non-OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Cell Death Dis 2010; 1:e92; PMID:21368868; http://dx.doi.org/10.1038/cddis.2010.60 [51] Wong EY, Herbert J.",Non-OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Eur J Neurosci 2004; 20:2491-2498;PMID:15548194; http://dx.doi.org/10.1111/j.1460-9568.2004.03717.x [52] Fitzsimons CP, van Hooijdonk LW, Schouten M, Zalachoras I, Brinks V, Zheng T, Schouten TG, Saaltink DJ, Dijkmans T, Steindler DA, et al.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Mol Psychiatry 2013; 18:993-1005;PMID:22925833; http://dx.doi.org/10.1038/mp.2012.123 [53] Chetty S, Friedman AR, Taravosh-Lahn K, Kirby ED, Mirescu C, Guo F, Krupik D, Nicholas A, Geraghty AC, Krishnamurthy A, et al.",Non-OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"MolPsychiatry 2014; 19:1275-1283; PMID:24514565; http://dx.doi.org/10.1038/mp.2013.190 [54] Fitzsimons CP, Herbert J, Schouten M, Meijer OC, Lucassen PJ, Lightman S. Circadian and ultradianglucocorticoid rhythmicity: Implications for the effects ofglucocorticoids on neural stem cells and adult hippocampal neurogenesis.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Front Neuroendocrinol 2016; 41:44-58; PMID:27234350; http://dx.doi.org/10.1016/j.yfrne.2016.05.001 [55] de Kloet ER, Fitzsimons CP, Datson NA, Meijer OC, Vreugdenhil E. Glucocorticoid signaling and stress-related limbic susceptibility pathway: about receptors,transcription machinery and microRNA.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Brain Res 2009;1293:129-141; PMID:19332027; http://dx.doi.org/ 10.1016/j.brainres.2009.03.039 [56] Picard M, Juster RP, McEwen BS.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Nat Rev Endocrinol 2014; 10:303-310; PMID:24663223;http://dx.doi.org/10.1038/nrendo.2014.22 [57] Weitzman ED, Fukushima D, Nogeire C, Roffwarg H, Gallagher TF, Hellman L. Twenty-four hour pattern ofthe episodic secretion of cortisol in normal subjects.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"J Clin Endocrinol Metab 1971; 33:14-22; PMID:4326799; http://dx.doi.org/10.1210/jcem-33-1-14[58] Dallman MF, Engeland WC, Rose JC, Wilkinson CW, Shinsako J, Siedenburg F. Nycthemeral rhythm in adrenalresponsiveness to ACTH.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Origin of ultradian pulsatility in the hypothalamic-pituitary-adrenal axis.Proc Biol Sci 2010; 277:1627-1633; PMID:20129987; http://dx.doi.org/10.1098/rspb.2009.2148 [60] Conway-Campbell BL, Sarabdjitsingh RA, McKenna MA, Pooley JR, Kershaw YM, Meijer OC, De Kloet ER,Lightman SL.",Non-OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"J Neuroendocrinol 2010; 22:1093-1100;PMID:20649850; http://dx.doi.org/10.1111/j.1365-2826.2010.02051.x [61] Sarabdjitsingh RA, Isenia S, Polman A, Mijalkovic J, Lachize S, Datson N, de Kloet ER, Meijer OC.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Endocrinology2010; 151:1177-1186; PMID:20080870; http://dx.doi.org/10.1210/en.2009-1119 [62] Qian X, Droste SK, Lightman SL, Reul JM, Linthorst AC.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Endocrinology 2012;153:4346-4353; PMID:22822164; http://dx.doi.org/10.1210/en.2012-1484 [63] Fitzsimons CP, Ahmed S, Wittevrongel CF, Schouten TG, Dijkmans TF, Scheenen WJ, Schaaf MJ, de Kloet ER,Vreugdenhil E. The microtubule-associated proteindoublecortin-like regulates the transport of the glucocor- ticoid receptor in neuronal progenitor cells.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Mol Endocri- nol 2008; 22:248-262; PMID:17975023; http://dx.doi.org/10.1210/me.2007-0233 [64] Stavreva DA, Coulon A, Baek S, Sung MH, John S, Tesikova M, Hakim O, Miranda T, Hawkins M, et al.Dynamics of chromatin accessibility and long-rangeinteractions in response to glucocorticoid pulsing.Genome Res 2015; 25:845-857; PMID:25677181; http:// dx.doi.org/10.1101/gr.184168.114 [65] Vreugdenhil E, Verissimo CS, Mariman R, Kamphorst JT, Barbosa JS, Zweers T, Champagne DL, Schouten T,Meijer OC, de Kloet ER, et al.",OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Endocri-nology 2009; 150:2220-2228; PMID:19131573; http://dx.doi.org/10.1210/en.2008-1335 [66] Smith SS, Dole NS, Franceschetti T, Hrdlicka HC, Delany AM.",Non-OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
Transl Psychiatry 2015; 5:e682; PMID:26575223; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"LancetDiabetes Endocrinol 2014; 2:593-599; PMID:24731665; http://dx.doi.org/10.1016/S2213-8587(13)70182-7 [71] Koyanagi S, Okazawa S, Kuramoto Y, Ushijima K, Shimeno H, Soeda S, Okamura H, Ohdo S. Chronictreatment with prednisolon e represses the circadian oscillation of clock gene expression in mouse periph-eral tissues.",Non-OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
"Mol Endocrinol 2006; 20:573-583; PMID:16269518; http://dx.doi.org/10.1210/me.2005- 0165 [72] Spulber S, Conti M, DuPont C, Raciti M, Bose R, Onishchenko N, Ceccatelli S. Alterations in circadianentrainment precede the onset of depression-like behav-ior that does not respond to ﬂuoxetine.",Non-OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
Transl Psychiatry 2015; 5:e603; PMID:26171984; http://dx.doi.org/10.1038/tp.2015.94e1262934-10 P. BIELEFELD ET AL.,Non-OADS,/arxiv_data1/oa_pdf/4a/bc/kngs-04-01-1262934.PMC5345753.pdf
(2012) and implemented in code provided by that group using version 112 (http://people.oregonstate.edu/~housemae/software/).,OADS,/arxiv_data1/oa_pdf/4d/5c/nnr-66-115.PMC5345885.pdf
"RESULTS Detailed statistical results are available (see Figures, Supple- mental Digital Content 1, http://links.lww.com/NRES/A236).Nursing Research March/April 2017 Volume 66 No.",Non-OADS,/arxiv_data1/oa_pdf/4d/5c/nnr-66-115.PMC5345885.pdf
"The regression analysis revealed the dynamics of cell type proportions in cord blood (as estimated by DNAm in cell typespecific CpGs) when examined across a range of gestational age groups (Table 1; Figure 1C and D; also see Figures, Supple- mental Digital Content 2, http://links.lww.com/NRES/A237).",OADS,/arxiv_data1/oa_pdf/4d/5c/nnr-66-115.PMC5345885.pdf
To submit a Letter to the Editor you should login to Editorial Manager here: http://www.editorialmanager.com/nres/default.aspx and choose article type ‘Letter to the Editor.,Non-OADS,/arxiv_data1/oa_pdf/4d/5c/nnr-66-115.PMC5345885.pdf
Previous Letters published can be found on the publisher ’s website: http://journals.lww.com/nursingresearchonline/ Pages/LetterstotheEditor.aspx.122 Cord Blood DNA Methylation Differences www.nursingresearchonline.com,Non-OADS,/arxiv_data1/oa_pdf/4d/5c/nnr-66-115.PMC5345885.pdf
Plasma sample days are listed in Supplemental Digital Content 7 (http://links.lww.com/QAD/B40).,Non-OADS,/arxiv_data1/oa_pdf/88/92/aids-31-771.PMC5345886.pdf
See Supplemental Digital Content 1 (http://links.lww.com/QAD/B40) for primers and PCR conditions.,Non-OADS,/arxiv_data1/oa_pdf/88/92/aids-31-771.PMC5345886.pdf
See Supplemental Digital Content 1 (http://links.lww.com/QAD/B40) for primers and PCR conditions.,Non-OADS,/arxiv_data1/oa_pdf/88/92/aids-31-771.PMC5345886.pdf
Defective viruses were characterized using the Los Alamos HIV-1 Database Hypermut tool (http://www.hiv.lanl.gov) to screen for sequences con- taining G-A hypermutations and by screening the amino acid sequences for premature stop codons.,Non-OADS,/arxiv_data1/oa_pdf/88/92/aids-31-771.PMC5345886.pdf
"Phylogenetic analysis of the sequences from all six participants formed individual clades with no inter-participant mixing (see ﬁgure, Supplemental Digital Content 3, http://links.lww.com/ QAD/B40).",OADS,/arxiv_data1/oa_pdf/88/92/aids-31-771.PMC5345886.pdf
"2 and 3, and ﬁgures, Supplemental Digital Content 5 and 6, http://links.lww.com/QAD/B40).",Non-OADS,/arxiv_data1/oa_pdf/88/92/aids-31-771.PMC5345886.pdf
"As shown in table (Supplemental Digital Content 7, http://links.lww.- com/QAD/B40), HIV-1 RNA values ranged from 3 to 70 copies/ml.",OADS,/arxiv_data1/oa_pdf/88/92/aids-31-771.PMC5345886.pdf
"For participant 7, we also obtained ﬁve p24- RT plasma HIV-1 RNA sequences that were above 99.7%, similar to each other (Supplemental Digital Content 6C, http://links.lww.com/QAD/B40), which supports the ﬁnding from the env region, indicating that the env and p24-RT sequences likely represent the same single cluster of identical plasma HIV-1 RNA sequences.",OADS,/arxiv_data1/oa_pdf/88/92/aids-31-771.PMC5345886.pdf
"Participant 7 had two p24-RT plasma HIV-1 RNA sequences that were identical to two HIV-1 DNA sequences (see ﬁgure, Supplemental Digital Content 6c, http://links.lww.com/QAD/B40).",Non-OADS,/arxiv_data1/oa_pdf/88/92/aids-31-771.PMC5345886.pdf
"Eighty-two articles were finally included in this meta-analysis (see Table S1, Supplemental Digital Content 1, http://links.lww.com /NRES/A215, Characteristics of Studies —Studies Included in the Meta-analysis).",Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"The most investigated racial-ethnic groups for MTHFR and breast cancer were White (28 studies), followed by Asian (25 studies for East Asian and 8 studies for South Asian), Middle Eastern (6 studies), U.S. mixed (8 studies), Brazil mixed (4 studies), Mexico (1 study), Ecuador (1 study), and Morocco (1 study; see Table S1, Supplemental Digital Con- tent 1, http://links.lww.com/NRES/A215, Characteristics ofStudies).",Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"The control and case groups in the studies were aggregatedper country to visualize the bigger picture of genotype percent distribution (see Figure S1, Supplemental Digital Content 2, http://links.lww.com/NRES/A216, MTHFR 677, % Mutations; see Figure S2, Supplemental Digital Content 3, http://links.",Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"Using the control group as the reference for the general healthy population, the rank order of subgroups with the MTHFR 677 TT (homozygous) mutation was Middle East (13.57%) followed by U.S. mixed (12.63%), East Asian (12.22%), Caucasian ( 11.28%), Brazil mixed (10.69%), and South Asian (2.97%; for specific percent mutations per control and case groups, see Figure S1, Supplemental Digital Content 2, http://links.lww.com/NRES/A216, MTHFR 677).",Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"GIS maps enhanced the visualization of geographic re- gional patterns of MTHFR 677 polymorphisms-mutations and breast cancer risks in countries worldwide (see Figure S3, Sup-plemental Digital Content 4, http://links.lww.com/NRES/ A218, Combined MTHFR 677 TT and CT Polymorphism-Mutation Genotypes).",OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"lww.com/NRES/A219, for MTHFR 677 TT homozygous mu- tation genotype; see Figure S5, Supplemental Digital Con- tent 6, http://links.lww.com/NRES/A220, for CT heterozygousTABLE 1.",Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"Further use of global visualization showed that the highest polymorphism-mutation rates on MTHFR 677 TT were found in the Middle East (Iran and Saudi Arabia), Europe (Cyprus, Spain, Germany, Slovenia, and United Kingdom), Asia (Japan and China), and North America (Canada and United States) for the control group (see Figure S4, Supplemental Digital Content 5, http://links.lww.com/NRES/ A219).",Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"As noted in the map for risk of breast cancer from MTHFR 677 TT mutations (see Figure S4, Supplemental Digital Content 5, http://links.lww.com/NRES/A219, the third map), the darkest color (red) depicted the highest breast cancer risks in Australia, South Korea, China, Pakistan, Turkey, Syria, Italy, Cyprus, Greece, Croatia, Poland, Canada, Mexico, and Ecuador.",Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"As projected, RRs presented more con- servative results than ORs (see Table S2a, Supplemental Dig- ital Content 8, http://links.lww.com/NRES/A222).",Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"Using the control group as a reference for the general healthy population, the rank order of MTHFR 1298 CC (homozygous) mutation was Cauc asian (14.58%) followed by Middle East (10.59%), U.S. mixed (8.38%), East Asian (5.57%), South Asian (5.32%), and Brazi l mixed (5.10%; for specificpercent mutations per case and control groups, see Figure S2, Supplemental Digital Content 3, http://links.lww.com/NRES/ A217, MTHFR 1298).",Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"For visual examination, GIS maps were also generated (see Figure S7, Supplemental Digital Content 9,http://links.lww.co m/NRES/A223, Combined MTHFR 1298 CC and AC Polymorphism-Mutation Genotypes; see Figure S8, Supple- mental Digital Content 10, http://links.lww.com/NRES/A224, TABLE 2.",OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"MTHFR 1298 CC Homozygous Mutation Genotype; see Figure S9, Supplemental Digital Content 11, http://links.lww.com/ NRES/A225, AC Heterozygous Mutation Genotype).",Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"For the control group, the highest mutation rates on MTHFR 1298 CCwere located in Europe (Cyprus, United Kingdom, Finland, Germany, Poland, Greece, Sweden, and Russia) and the Middle East (Iran, Syria, and Jordan; se e Figure S8, Supplemental Digital Content 10, http://links.lww.com/NRES/A224).",Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"On the maps for breast cancer risk from MTHFR 1298 CC mutations (see Figure S8, Supplemental Digital Content 10, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"Additional subgroup analyses based on risk groups were more revealing for MTHFR 1298 (see Figure S10, Supplemental Digital Content 12, http://links.lww.com/NRES/A226, Figure S11, Supplemental Digital Content 13, http://links.lww.com/ NRES/A227, and Figure S12, Supplemental Digital Content 14,http://links.lww.com/NRES/A228, Forest Plots).",Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"Countries or regions with MTHFR 1298 CC mutation as a risk genotype were North and South Europe (Sweden, Poland, Turkey, Cyprus, Greece, Slovenia, Italy, and Spain), Ecuador, Southeast Asia (Thailand and India), and the Middle East (Kazakhstan, Pakistan, Syria, and Jordan; see Figure S10, Supplemental Digital Content 12, http://links.lww.com/NRES/A226).",Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"Air Pollution, MTHFR Mutations, and Breast Cancer Risks On the metapredictive analysis, although all potential risk factors including quality score, source of controls, and types of breast cancer were explored, the level of APD was the only significant contributing factor for the polymorphism- mutations and breast cancer risks (e.g., see Figure S13, Sup- plemental Digital Content 15, http://links.lww.com/NRES/ A229).",Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"The partition tree and Tukey's test did not render any statistically signifi- cant differences among the tested associations (see Table S3, Supplemental Digital Content 16 , http://links.lww.com/NRES/ A230, 677 TT and CT M).",OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"We further explored the nonlinear fit between our po- tential contributing factor —levels of APD —and percent MTHFR 677 TT homozygous mutation per control and breast can- cer case groups (see Figure S14a, Supplemental Digital Con- tent 17, http://links.lww.com/NRES/A231).",Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"We noted a similar trend in MTHFR 1298 CC (homo- zygous) mutation genotype rate although the curve wasnoticeably flatter (see Figure S14b, Supplemental Digital Content 17, http://links.lww.com/NRES/A231).",Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"On percent MTHFR 677 TT by levels of APD, data density with red blocks depicted higher concentra- tion of 677 TT with air pollution Level 4 (see Figure S15, Sup- plemental Digital Content 18, http://links.lww.com/NRES/ A232, MTHFR 677 TT Genotype).",OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"For percent MTHFR 1298 CC, red blocks with high data concentration dropped as airpollution progressed from Level 3 to Level 4 for both case and control groups (see Figure S15, Supplemental Digital Content 18, http://links.lww.com/NRES/A232, MTHFR 1298 CC Genotype).DISCUSSION Compared to previous meta-analy ses, this metaprediction study presents the most comprehensive report on MTHFR and breast cancer in that this study employ ed triangulation techniques be- yond the conventional pooled and subgroup analyses.",Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
Retrieved from http://www.who.int/heli/risks/urban/en/uapmap.1.pdf?ua=1World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"Retrieved from http://aqicn.org/ faq/2015-05-16/world-health-org anization-2014-air-pollution- ranking/ W u ,Y .- L .",OADS,/arxiv_data1/oa_pdf/de/d2/nnr-66-152.PMC5345887.pdf
"Complera (FTC/RPV/TFV) Gilead Nonclinical Sum- mary, 2010. http://www.pmda.go.jp/drugs/2014/P2014001 48/800155000_22600AMX01325_H100_1.pdf [Accessed 11 October 2016].Long-acting HIV drug combo boosts host cell exposure Kraft et al.",OADS,/arxiv_data1/oa_pdf/06/14/aids-31-765.PMC5345888.pdf
https://dailymed.nlm.,Non-OADS,/arxiv_data1/oa_pdf/06/14/aids-31-765.PMC5345888.pdf
Direct URL citations  appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal).,Non-OADS,/arxiv_data1/oa_pdf/ad/19/ccm-45-567.PMC5345889.pdf
"Additional information about calibra-tion and commutability are provided in Supplemental T able  1 (Supplemental Digital Content 1, http://links.lww.com/ CCM/C303).",Non-OADS,/arxiv_data1/oa_pdf/ad/19/ccm-45-567.PMC5345889.pdf
"Copyright © 2017 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.Feature Articles Critical Care Medicine www.ccmjournal.org  571Monte Carlo simulation contour plots of clinical risk in critical  care adult patients to the BGMS trial data in critical care adult  patients are presented as supplemental data (Supplemental  Digital Content 1, http://links.lww.com/CCM/C303).",Non-OADS,/arxiv_data1/oa_pdf/ad/19/ccm-45-567.PMC5345889.pdf
"Detailed information about the breakdown of  patient age and glucose ranges, medication classes, and range of confounding physiological and biochemical parameters are pro- vided in Supplemental T ables 2–4 (Supplemental Digital Content 1, http://links.lww.com/CCM/C303).",Non-OADS,/arxiv_data1/oa_pdf/ad/19/ccm-45-567.PMC5345889.pdf
Available at: http://www.iso.org/iso/catalogue.,Non-OADS,/arxiv_data1/oa_pdf/ad/19/ccm-45-567.PMC5345889.pdf
Available at: http://www.iso.org/iso/catalogue.,Non-OADS,/arxiv_data1/oa_pdf/ad/19/ccm-45-567.PMC5345889.pdf
Available at: http://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guid-ancedocuments/ucm380325.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ad/19/ccm-45-567.PMC5345889.pdf
Avail-able at: http://shop.clsi.org/point-of-care-documents/POCT12.html.,Non-OADS,/arxiv_data1/oa_pdf/ad/19/ccm-45-567.PMC5345889.pdf
Available at: http://www.usp.org/reference-standards/reference-st andards-catalog.,Non-OADS,/arxiv_data1/oa_pdf/ad/19/ccm-45-567.PMC5345889.pdf
Available at: http://www.fda.gov/   MedicalDevices/DeviceRegulationandGuidance/PostmarketRequirements/   ReportingAdverseEvents/ucm127891.htm.,Non-OADS,/arxiv_data1/oa_pdf/ad/19/ccm-45-567.PMC5345889.pdf
Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm416144.htm.,Non-OADS,/arxiv_data1/oa_pdf/ad/19/ccm-45-567.PMC5345889.pdf
Available at: https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/Survey   CertificationGenInfo/Downloads/Survey-and-Cert-Letter-15-11.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ad/19/ccm-45-567.PMC5345889.pdf
Available at: http://www.wadsworth.org/labcert/clep/files/Glucose_meters_off_label_use_1_13_14.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ad/19/ccm-45-567.PMC5345889.pdf
Available at: http://www.ecfr.gov/cgi-bin/text-idx?SID=1248e3189da5e5f936e55315402bc38b&node=pt42.5.493&rgn=div5.,OADS,/arxiv_data1/oa_pdf/ad/19/ccm-45-567.PMC5345889.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/41/87/ndt-13-715.PMC5345900.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 715–720Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  715Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S12760 5 Prevalence of dementia in egypt: a systematic  review Mohamed H elshahidi1 Muhammad A elhadidi2 Ahmed A Sharaqi1 Ahmed Mostafa3 Mohamed A elzhery1 1Faculty of Medicine, Mansoura  University, Mansoura, 2Faculty of  Medicine, Zagazig University, Zagazig,   3Faculty of Medicine, Sohag University,   Sohag, egyptBackground:  With the growing prevalence of dementia worldwide, two-third of the people  with dementia are projected to be from the developing countries by 2050.",Non-OADS,/arxiv_data1/oa_pdf/41/87/ndt-13-715.PMC5345900.pdf
edu.e g Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2017 Volume: 13 Running head verso: Elshahidi et al Running head recto: Dementia in Egypt DOI: http://dx.doi.org/10.2147/NDT.S127605 Point your SmartPhone at the code above.,Non-OADS,/arxiv_data1/oa_pdf/41/87/ndt-13-715.PMC5345900.pdf
Or use: http://youtu.be/HUtMM4yZWQ Mvideo abstract,Non-OADS,/arxiv_data1/oa_pdf/41/87/ndt-13-715.PMC5345900.pdf
Available from: http://www.who.int/mental_health/neurology/demen - tia/thematic_briefs_dementia/en /.,Non-OADS,/arxiv_data1/oa_pdf/41/87/ndt-13-715.PMC5345900.pdf
Available from: http://www.crd.york.ac.uk/ PROSPERO /display_record.asp?ID =CRD4201603969 5  12.,Non-OADS,/arxiv_data1/oa_pdf/41/87/ndt-13-715.PMC5345900.pdf
"Available  from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.as p.  Accessed September 6, 2016.",Non-OADS,/arxiv_data1/oa_pdf/41/87/ndt-13-715.PMC5345900.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/41/87/ndt-13-715.PMC5345900.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/87/ndt-13-715.PMC5345900.pdf
Available from: http://www.who.int/mental_health/pub - lications/dementia_report_2012/en /.,Non-OADS,/arxiv_data1/oa_pdf/41/87/ndt-13-715.PMC5345900.pdf
Available from: http://www.msrintranet.capmas.,Non-OADS,/arxiv_data1/oa_pdf/41/87/ndt-13-715.PMC5345900.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5f/86/ndt-13-707.PMC5345901.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 707–713Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  707OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12842 9 New opinion on the subtypes of poststroke  depression in chinese stroke survivors Yingying Yue1,2 rui liu3 Yin cao4 Yanfeng Wu5 shining Zhang6 huajie li7 Jijun Zhu8 Wenhao Jiang1,2 aiqin Wu9 Y onggui Yuan1,2 1Department of Psychosomatics  and Psychiatry, ZhongDa hospital,   school of Medicine, southeast  University, Nanjing, 2institute of  Psychosomatics, Medical school  of southeast university, Nanjing,   3school of information science and  engineering, southeast University,   Nanjing, 4Department of Neurology,   changzhou second People’s hospital  affiliated to Nanjing  Medical  University, changzhou, 5Department  of Neurology, The second  affiliated hospital of Nanjing  Medical University, 6Department of  Psychiatry, Nanjing Brain hospital  of Nanjing Medical University,   Nanjing, 7Department of Neurology,   changzhou First People’s hospital,   changzhou, 8Department of  Neurology, Yancheng Third People’s  hospital, Yancheng, 9Department of  Psychosomatics, The affiliated First  hospital of suzhou University, suzhou,   People’s republic of chinaAim:  Poststroke depression (PSD) is the most common complication of stroke.",Non-OADS,/arxiv_data1/oa_pdf/5f/86/ndt-13-707.PMC5345901.pdf
"correspondence: Yonggui Yuan Department of Psychosomatics and  Psychiatry, ZhongDa hospital, school of  Medicine, southeast University, No 87  Dingjiaqiao road, Nanjing 210009,  People’s republic of china Tel +86 025 8328 5124 email yygylh2000@sina.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Yue et al Running head recto: The diagnosis of PSD DOI: http://dx.doi.org/10.2147/NDT.S128429",Non-OADS,/arxiv_data1/oa_pdf/5f/86/ndt-13-707.PMC5345901.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/5f/86/ndt-13-707.PMC5345901.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/86/ndt-13-707.PMC5345901.pdf
"https://doi.org/10.1177/1177932217694837Bioinformatics and Biology Insights Volume 11: 1–7 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1177932217694837 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Melanoma remains the leading cause of skin cancer–related  deaths, and an estimated 76 380 individuals will be diagnosed in the United States in 2016.",Non-OADS,/arxiv_data1/oa_pdf/6c/c4/10.1177_1177932217694837.PMC5345922.pdf
"https://doi.org/10.1177/1177390117690152Analytical Chemistry Insights  1–6 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1177390117690152 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Medroxyprogesterone acetate also known as 17α-hydroxy-6α- methylprogesterone acetate is a synthetic analogue of the ster-oid hormone progesterone 1,2 (Figure 1).",Non-OADS,/arxiv_data1/oa_pdf/59/3e/10.1177_1177390117690152.PMC5345923.pdf
1999;36. http://dx.doi.org/10.1590/S1413-   95961999000500002.,Non-OADS,/arxiv_data1/oa_pdf/59/3e/10.1177_1177390117690152.PMC5345923.pdf
9. http://www.drugs.com/vet/veramix-sponges-can.html.,Non-OADS,/arxiv_data1/oa_pdf/59/3e/10.1177_1177390117690152.PMC5345923.pdf
SUPPLEMETARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602076/DC1section S1.,Non-OADS,/arxiv_data1/oa_pdf/4b/03/1602076.PMC5345924.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1601552/DC1 section S1.,Non-OADS,/arxiv_data1/oa_pdf/b2/f6/1601552.PMC5345925.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1601958/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/50/ac/1601958.PMC5345926.pdf
"The tran- scripts common to a pair wise comparison with putative functions in all the six RNAiAFL transgenic to nontransgenic null comparisonswere determined (http://de.iplantcollaborative.org/dl/d/24DC6B1C- EF2C-4A00-9EBF-85B43234E88C/Pairwise_Sig_Transcripts_with_ Function.xlsx), and the matrix intersections of the comparisons areshown in Fig.",OADS,/arxiv_data1/oa_pdf/10/cf/1602382.PMC5345927.pdf
Transgenic maize production Maize ( Zea mays Hi II hybrid A188 and B73 background) was trans- formed with the pRNAiAFL construct via A. tumefaciens –mediated transformation ( 35) by the Iowa State Universi ty Plant Transformation Facility (http://agron-www.agron.iastate.edu/ptf/).,Non-OADS,/arxiv_data1/oa_pdf/10/cf/1602382.PMC5345927.pdf
Intersections of transcript comparisons were determined using the interactive web browser UpSet (http://vcg.github.io/upset/) ( 46).,OADS,/arxiv_data1/oa_pdf/10/cf/1602382.PMC5345927.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602382/DC1table S1.,Non-OADS,/arxiv_data1/oa_pdf/10/cf/1602382.PMC5345927.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1601545/DC1 Supplementary Materials and Methods fig.,Non-OADS,/arxiv_data1/oa_pdf/cf/d5/1601545.PMC5345929.pdf
"Argo data were collectedand made freely available by the International Argo Program and the national programs that contribute to it (www.argo.ucsd.edu, http://argo.jcommops.org).",OADS,/arxiv_data1/oa_pdf/cf/d5/1601545.PMC5345929.pdf
"https://doi.org/10.1177/1179064417695255Cancer Growth and Metastasis Volume 10: 1–11 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1179064417695255 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Cancer metastasis contributes to more than 90% of cancer  mortality due to its systemic nature and resistance to the exist-ing treatments.",Non-OADS,/arxiv_data1/oa_pdf/5b/aa/10.1177_1179064417695255.PMC5345945.pdf
"https://doi.org/10.1177/1178222617692538Biomedical Informatics Insights  1–10 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178222617692538 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Underuse of immunization for vaccine-preventable diseases is  a significant public health concern in the United States.1 The  Advisory Committee on Immunization Practices (ACIP) recommends routine provision of several vaccines for adoles-cents and adults to reduce and control the burden of vaccine-preventable diseases in the United States.",Non-OADS,/arxiv_data1/oa_pdf/1a/8b/10.1177_1178222617692538.PMC5345946.pdf
"Final state-level influenza vaccination coverage estimates for the 2010–11 season–United States, National Immunization  Survey and Behavioral Risk Factor Surveillance System, August 2010 through  May 2011. http://www.cdc.gov/flu/fluvaxview/coverage_1011estimates.htm.",Non-OADS,/arxiv_data1/oa_pdf/1a/8b/10.1177_1178222617692538.PMC5345946.pdf
http://flushot.healthmap.org/ Published 2012.,Non-OADS,/arxiv_data1/oa_pdf/1a/8b/10.1177_1178222617692538.PMC5345946.pdf
"https://doi.org/10.1177/1177271916684823Biomarker Insights  1–6 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1177271916684823 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction   and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages    (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Patients react to an inflammatory stimulus with a variety of  proinflammatory mediators.",Non-OADS,/arxiv_data1/oa_pdf/91/f5/10.1177_1177271916684823.PMC5345948.pdf
"https://doi.org/10.1177/1178222616688893Biomedical Informatics Insights  1–8 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178222616688893 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Immunization Information Systems The vision for management of immunization information   is availability of real-time consolidated data and services   for all ages, to clinical, public health, and other stakeholders.",Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
http://www.cdc.gov/vaccines/programs/iis/index.html.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
http://www.cdc.gov/vaccines/programs/iis/annual-re - port-IISAR/index.html.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
http://www.cdc.gov/vaccines/schedules/hcp/index.html.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
http://www.health.state.mn.us/divs/idepc/immunize/registry/index.html.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
http://www.immregistries.org/ resources/iis-meetings/michael_flynn_aira_2012_conf_deip.pdf.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
http://www.health.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
http://www.health.state.mn.us/divs/idepc/immunize/registry/infographic.pdf.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
https://www.revi - sor.mn.gov/statutes/?id=144.3351.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
http://www.health.state.mn.us/divs/idepc/immunize/ registry/hp/asr.html.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
http://www.health.state.mn.us/divs/idepc/immunize/registry/hp/traincfu.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
http://www.health.state.mn.us/divs/idepc/immunize/regis - try/afix.html.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
http://www.health.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
http://www.health.state.mn.us/e-health/hitimp/index.html.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
http://www.health.state.mn.us/divs/idepc/immunize/registry/hp/data.html.,OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
http://www.immregistries.org/resources/iis-meetings/Using_IIS_and_Vital_Statistics_Data_to_Measure_Racial/Ethnic_Immunization_Coverage_Disparities_in_MN.pdf.,OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
http://www.health.state.mn.us/ divs/idepc/diseases/flu/vaccine/vaxhcw/flusafe/flusafe.html.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
http://www.immregistries.org/resources/iis-meetings/ Leveraging_an_IIS_to_assist_child_care_centers_with_their_annual_ Immunization_report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
https://cdc.confex.com/cdc/nic2012/webprogram/Paper30309.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
https://apps.health.state.mn.us/mndata/.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
MIIC Strategic  Plan: 2013-2017. http://www.health.state.mn.us/divs/idepc/immunize/registry/ plan.pdf.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
http://www.immregistries.org/about-aira/vision-mission.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/10.1177_1178222616688893.PMC5345950.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.02.0112211-3355/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/a5/c6/main.PMC5345953.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/c6/main.PMC5345953.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/a5/c6/main.PMC5345953.pdf
https://www.bls.gov/emp/ep_chart_001.htm .,Non-OADS,/arxiv_data1/oa_pdf/a5/c6/main.PMC5345953.pdf
https://www.lasvegasnevada.gov/cs/groups/public/documents/document/dhn0/ mday/~edisp/tst002706.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a5/c6/main.PMC5345953.pdf
https://www.R-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/a5/c6/main.PMC5345953.pdf
http://www.saferoutesinfo.org/about-us/newsroom/studyreveals-more- k-8-children-are-walking-to-school .,Non-OADS,/arxiv_data1/oa_pdf/a5/c6/main.PMC5345953.pdf
https://www.gov.uk/ government/uploads/system/uploads/attachment_data/ ﬁle/476635/travel-to-school.,Non-OADS,/arxiv_data1/oa_pdf/a5/c6/main.PMC5345953.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/82/main.PMC5345954.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/82/main.PMC5345954.pdf
http://dx.doi.org/10.1016/j.eucr.2017.02.010Urology Case Reports 12 (2017) 31 e33,Non-OADS,/arxiv_data1/oa_pdf/aa/82/main.PMC5345954.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.02.009 2211-3355/© 2017 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/98/31/main.PMC5345957.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/31/main.PMC5345957.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/98/31/main.PMC5345957.pdf
Methods This study was conducted using a 14-item questionnaire hosted on the survey website http://www.surveygizmo.com (Supplementary Ap- pendix 1).,OADS,/arxiv_data1/oa_pdf/98/31/main.PMC5345957.pdf
http://www.thebody.com/cgi- bin/bbs/ubbthreads.php (21\05\).,Non-OADS,/arxiv_data1/oa_pdf/98/31/main.PMC5345957.pdf
http://www.facebook.com/ TheRedRibbonArmy?v=wall&ref=ts .,Non-OADS,/arxiv_data1/oa_pdf/98/31/main.PMC5345957.pdf
http://data.worldbank.,Non-OADS,/arxiv_data1/oa_pdf/98/31/main.PMC5345957.pdf
http://www.who.int/hiv/data/ en/(01\02\).,OADS,/arxiv_data1/oa_pdf/98/31/main.PMC5345957.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/f8/main.PMC5345958.pdf
An  esophagogastroduedenoscopy  (GF)  and http://dx.doi.org/10.1016/j.ijscr.2017.02.039 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/bb/f8/main.PMC5345958.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/bd/main.PMC5345959.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2017.03.001 2213-2244/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/bd/main.PMC5345959.pdf
http://www.ehp.qld.gov.au/wildlife/caring-for- wildlife/marine-strandings-data.html (Accessed 24 August 2016).,Non-OADS,/arxiv_data1/oa_pdf/4d/bd/main.PMC5345959.pdf
Marine strandings Update 2015. https://www.ehp.qld.gov.au/wildlife/caring-for- wildlife/marine-strandings-update.html (Accessed 5 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/4d/bd/main.PMC5345959.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2017.01.004,OADS,/arxiv_data1/oa_pdf/84/2f/main.PMC5345960.pdf
The extracellular solution was composed of the following (in mM):Na-gluconate 140; K-gluconate 5; Mg-Gluconate 2; Ca-gluconate 2;HEPES 10; glucose 5; TEA-Cl 5 (pH adjusted to 7.4 with NaOH).The intrapipette solution was composed of the following (in mM):Cs-gluconate 145; Na-gluconate 8; EGTA 10; Mg-gluconate orMgATP (as indicated); HEPES 10 (pH adjusted to 7.2 with CsOH).Free [Mg 2+]iwas estimated using the program WEBMAXC STANDARD ( http://www.stanford.edu/~cpatton/webmaxcS.htm ).,Non-OADS,/arxiv_data1/oa_pdf/84/2f/main.PMC5345960.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/e8/main.PMC5345961.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2017.01.007,OADS,/arxiv_data1/oa_pdf/8b/e8/main.PMC5345961.pdf
http://dx.doi.org/10.1038/oncsis.2013.35 .,Non-OADS,/arxiv_data1/oa_pdf/8b/e8/main.PMC5345961.pdf
http://dx.doi.org/10.1186/1471-2407-15-2 .,Non-OADS,/arxiv_data1/oa_pdf/8b/e8/main.PMC5345961.pdf
http://dx.doi.org/10.1101/gad.190678.112 .,Non-OADS,/arxiv_data1/oa_pdf/8b/e8/main.PMC5345961.pdf
"https://doi.org/10.1177/1178630217694149Environmental Health Insights Volume 11: 1–4 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178630217694149 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Organophosphate poisoning is a major public health problem  in developing countries, resulting in significant morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/36/bb/10.1177_1178630217694149.PMC5345965.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.02.024 2211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/d3/main.PMC5345966.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ca/d3/main.PMC5345966.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/ca/d3/main.PMC5345966.pdf
http://dx.doi.org/ 10.1016/j.ijsu.2014.08.353 .,OADS,/arxiv_data1/oa_pdf/ca/d3/main.PMC5345966.pdf
http://www.healthdata.org/sites/default/ ﬁles/ﬁles/GBD_2013_ Protocol.pdf (Date of access 23 December 2015).,OADS,/arxiv_data1/oa_pdf/ca/d3/main.PMC5345966.pdf
http://dx.doi.org/10.1016/j.afjem.2017.01.006 .,OADS,/arxiv_data1/oa_pdf/ca/d3/main.PMC5345966.pdf
"The World Bank Available: http://data.worldbank.org (Date of access 23 December 2015) United Nations, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ca/d3/main.PMC5345966.pdf
https://esa.un.org/unpd/ wpp/ (Date of access 15 December 2015).,Non-OADS,/arxiv_data1/oa_pdf/ca/d3/main.PMC5345966.pdf
"World Bank, Washington, DC http://dx.doi.org/10.1596/978-1-4648-0958-3 .120 M. Sengoelge et al.",Non-OADS,/arxiv_data1/oa_pdf/ca/d3/main.PMC5345966.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.02.0192211-3355/© 2017 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/af/83/main.PMC5345967.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/83/main.PMC5345967.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/af/83/main.PMC5345967.pdf
"Full details of the DEAL study rationale and methods can be found else- where ( Harding et al., 2011; Maynard et al., 2009 );http://dash.sphsu.",Non-OADS,/arxiv_data1/oa_pdf/af/83/main.PMC5345967.pdf
:CD001871 http://dx.doi.org/10.1002/14651858.CD001871.pub3 .,Non-OADS,/arxiv_data1/oa_pdf/af/83/main.PMC5345967.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/8f/main.PMC5345968.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.03.004 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/14/8f/main.PMC5345968.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 195 e197,Non-OADS,/arxiv_data1/oa_pdf/14/8f/main.PMC5345968.pdf
"2015 (2015) 5, http://dx.doi.org/10.1155/2015/421201 .",Non-OADS,/arxiv_data1/oa_pdf/14/8f/main.PMC5345968.pdf
"2 (2009) 6963, http://dx.doi.org/10.4076/ 1757-1626-2-6963 .",Non-OADS,/arxiv_data1/oa_pdf/14/8f/main.PMC5345968.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/88/main.PMC5345969.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.02.011 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/88/main.PMC5345969.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 201 e204,Non-OADS,/arxiv_data1/oa_pdf/e6/88/main.PMC5345969.pdf
"No one asked the questions, whether 16 h of daily physical work in the ﬁelds was a healthy endeavour or if moving from central Asia to Europe, on foot, could jeopardize life with the intensive production of http://dx.doi.org/10.1016/j.redox.2017.02.015 Received 29 December 2016; Received in revised form 16 February 2017; Accepted 21 February 2017⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
5 (2006)165– 178. http://dx.doi.org/10.1016/j.arr.2006.03.003.,OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.1111/sms.12605 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
"Bassil, R. Gougeon, Muscle protein anabolism in type 2 diabetes Current opinion in clinical nutrition and metabolic care, 2013 16:83 –88〈http://dx.doi.org/ 10.1097/MCO.0b013e32835a88ee 〉.",Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.1074/jbc.C112.364620 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
"Lieberman, Endurance running and the evolution of Homo, Nature 432 (2004) 345– 352. http://dx.doi.org/10.1038/nature03052 .",Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/ 10.1111/jgs.12400 .,OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
"Calabrese, L.A. Baldwin, U-shaped dose-responses in biology, toxicology, and public health Annual review of public health, 2001 22:15 –33〈http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
32 (2007) 954– 966. http://dx.doi.org/10.1139/h07- 085.,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
35 (2017) 812– 819. http://dx.doi.org/10.1080/ 02640414.2016.1192670 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
Rep. (2015) 3. http://dx.doi.org/ 10.14814/phy2.12462 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
92 (2013) 523– 532. http://dx.doi.org/10.1097/PHM.0b013e31828cd254 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
567 (2005) 113– 120. http://dx.doi.org/10.1113/ jphysiol.2004.080564 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2015.04.006 .,OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
74 (2012) 896– 903. http://dx.doi.org/10.1097/ PSY.0b013e31827457f4 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2493- 16.2016 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.3390/ ijms160921008 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
1254 (2012) 1 –6.http://dx.doi.org/10.1111/j.1749-6632.2012.06495.x .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
40 (2015) 990– 996. http://dx.doi.org/ 10.1139/apnm-2014-0538 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.1556/oh.2013.29616 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.1111/ jsm.12977 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
370 (2015) 20140064. http://dx.doi.org/10.1098/rstb.2014.0064 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.1161/circulationa- ha.112.000880 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.1093/carcin/bgl057 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
405 (2015) 223– 232. http://dx.doi.org/ 10.1007/s11010-015-2413-3 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
89 (2015) 852– 862. http://dx.doi.org/10.1016/j.freeradbiomed.2015.10.412 .,OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.1074/ jbc.M116.751453 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.1113/jphysiol.2013.267419.,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
64 (2013) 43 –49.http://dx.doi.org/10.2478/10004-1254-64-2013-2260 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
40 (2015) 343– 352. http://dx.doi.org/10.1139/apnm-2014-0302.,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.1152/physrev.00031.2007 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
49 (2010) 587– 596. http://dx.doi.org/10.1016/j.freeradbiomed.2010.05.008 .,OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
"Chung, S. Goto, Exercise and hormesis: oxidative stress-related adaptation for successful aging, Biogerontology 6 (2005) 71 –75.http://dx.doi.org/ 10.1007/s10522-004-7386-7 .",OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
44 (2008) 153– 159. http://dx.doi.org/ 10.1016/j.freeradbiomed.2007.01.029 .,OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
20 (2010) 777– 783. http://dx.doi.org/10.3233/JAD-2010-091531 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
58 (2013) 87 –97.http://dx.doi.org/10.1016/j.freerad- biomed.2013.01.004 .,OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.1016/j.mam.2011.10.010 .,OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/ 10.1073/pnas.0903485106 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.1016/j.diabres.2007.01.039 .Z.,OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.1113/JP272491 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
1281 (2013) 141– 159. http://dx.doi.org/10.1111/j.1749-6632.2012.06785.x .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
"(Bethesda, Md:1985) 111 (2011) 573– 586. http://dx.doi.org/10.1152/japplphysiol.00373.2011.",Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.3945/ajcn.110.009266 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/ 10.1371/journal.pone.0114075 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.1371/jour- nal.pone.0113667 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.3109/10715762.2014.937341 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/ 10.1093/emph/eow026 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
110 (2011) 264– 274. http://dx.doi.org/10.1152/japplphy- siol.00993.2010 .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/ 10.1249/MSS.0b013e3181cd76be .,Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
"[65] Y. Yilmaz, Y. Colak, R. Kurt, E. Senates, F. Eren, Linking nonalcoholic fatty liver disease to hepatocellular carcinoma: from bedside to bench and back, Tumori 99(2013) 10 –16.http://dx.doi.org/10.1700/1248.13781 .",Non-OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
http://dx.doi.org/10.1016/j.jstrokecer- ebrovasdis.2016.07.033 .Z.,OADS,/arxiv_data1/oa_pdf/3c/1b/main.PMC5345970.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Subthreshold depressionOnset-age effect Voxel-based morphometry Globus pallidusThalamus 1.,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1016/j.nicl.2017.02.022 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
22 (1):1 –16.http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1006/nimg.2000.0582 .,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1006/nimg.2001.0961 .,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1017/s0033291711001668 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1016/S0006-3223(01)01280-X .,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
"http://dx.doi.org/10.1016/j.jad.2006.01.014 .Caracciolo, B., Giaquinto, S., 2002.",OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1016/j.neuropsychologia.2016.07.001 .,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
University of Tennessee http://trace.tennessee.edu/utk_ graddiss/1172 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/ 10.1038/tp.2016.209 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.3758/s13415-015-0366-3 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1007/s00429-008-0189-x .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1101/lm.48402 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1016/j.ijdevneu.2015.07.007 .,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1038/tp.2015.148 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1038/sj.mp.,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1016/j.jad.2012.10.023 .,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1016/j.jpsychires.2016.,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
9:243. http://dx.doi.org/10.3389/fnbeh.2015.00243 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1001/archgenpsychiatry.2011.60 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1016/j.jad.2012.01.042 .,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
222 (1 –2):29 –36.http://dx.doi.org/10.1016/ j.pscychresns.2014.02.013 .,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1017/S0033291713001815 .550 J. Li et al.,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1162/089892903321662994 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1093/cercor/10.3.206 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.3349/ymj.2014.55.6.1712 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1176/appi.ajp.2014.14010076 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1146/annurev- clinpsy-050212-185606 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1038/npp.2009.104 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1177/ 014662167700100306 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1037/pag0000027 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1016/ j.neuroimage.2010.04.244 .,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1093/scan/nst115 .,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1016/j.nicl.2016.,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1002/brb3.350 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
University of Illinois at Urbana-Cham-paign https://www.ideals.illinois.edu/handle/2142/26407 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1176/jnp.16.2.127 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
"http://dx.doi.org/10.1016/j.jad.2014.07.018 .Takahashi, K., Oshima, A., Ida, I., Kumano, H., Yuuki, N., Fukuda, M., ... Mikuni, M., 2008.",OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1016/ j.pscychresns.2013.09.003 .,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1177/1087054712446172 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/ 10.1016/j.jaac.2015.07.006 .,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1016/j.nicl.2016.07.011 .,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1038/tp.2016.18 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1176/appi.ajp.161.7.1270 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1016/j.jad.,OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
http://dx.doi.org/10.1017/ S0033291714000518 .,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
BMC Psychiatry 16:219. http://dx.doi.org/10.1186/s12888-016- 0928-0 .551 J. Li et al.,Non-OADS,/arxiv_data1/oa_pdf/2e/46/main.PMC5345971.pdf
"However, no previous study has tested the possibility that increased nitrate concentrations usually found in plasma and in http://dx.doi.org/10.1016/j.redox.2017.03.003 Received 14 December 2016; Received in revised form 27 February 2017; Accepted 3 March 2017⁎Correspondence to: Department of Pharmacology Ribeirao Preto Medical School, University of Sao Paulo, Av.",Non-OADS,/arxiv_data1/oa_pdf/84/67/main.PMC5345972.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/84/67/main.PMC5345972.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Anxiety Panic disorder MEGVentromedial prefrontal cortexDorsolateral prefrontal cortex 1.,Non-OADS,/arxiv_data1/oa_pdf/0f/ad/main.PMC5345973.pdf
http://dx.doi.org/10.1016/j.nicl.2017.02.013 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/ad/main.PMC5345973.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/ad/main.PMC5345973.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/c8/main.PMC5345974.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.03.003 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/c8/main.PMC5345974.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 198 e200,Non-OADS,/arxiv_data1/oa_pdf/e6/c8/main.PMC5345974.pdf
"New York City, http://www.cdc.gov/ tb/publications/factsheets/general/mbovis.pdf .",Non-OADS,/arxiv_data1/oa_pdf/e6/c8/main.PMC5345974.pdf
"7 (4) (2013) e2177, http://dx.doi.org/10.1371/journal.pntd.0002177 , 2013 Apr 25.",Non-OADS,/arxiv_data1/oa_pdf/e6/c8/main.PMC5345974.pdf
http://www.ncbi.nlm.nih.gov/pubmed/15455603?,Non-OADS,/arxiv_data1/oa_pdf/e6/c8/main.PMC5345974.pdf
Retrieved from: http://www.uptodate.com/contents/mycobacterium-bovis .,Non-OADS,/arxiv_data1/oa_pdf/e6/c8/main.PMC5345974.pdf
Accessed: http://www.bbc.co.uk/news/health-26766006 [6/4/2015].,Non-OADS,/arxiv_data1/oa_pdf/e6/c8/main.PMC5345974.pdf
"17 (3) (2011), http://dx.doi.org/10.3201/eid1703.101111 .",Non-OADS,/arxiv_data1/oa_pdf/e6/c8/main.PMC5345974.pdf
Retrieved from: http://www.uptodate.com/ contents/tuberculous-pleural-effusions-in-hiv-uninfected-patients .,Non-OADS,/arxiv_data1/oa_pdf/e6/c8/main.PMC5345974.pdf
https://www.ncbi.nlm.nih.gov/pubmed/ 22863812 .,Non-OADS,/arxiv_data1/oa_pdf/e6/c8/main.PMC5345974.pdf
"June, https://www.ncbi.nlm.nih.gov/pubmed/26150911 .",Non-OADS,/arxiv_data1/oa_pdf/e6/c8/main.PMC5345974.pdf
"July, https://www.ncbi.nlm.nih.gov/pubmed/ 20473171 .",Non-OADS,/arxiv_data1/oa_pdf/e6/c8/main.PMC5345974.pdf
"Sept- Oct, https://www.ncbi.nlm.nih.gov/pubmed/19672657 .",OADS,/arxiv_data1/oa_pdf/e6/c8/main.PMC5345974.pdf
"June, https://www.ncbi.nlm.nih.gov/pubmed/26150919 .",Non-OADS,/arxiv_data1/oa_pdf/e6/c8/main.PMC5345974.pdf
Accessed:http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5211a1.htm .,OADS,/arxiv_data1/oa_pdf/e6/c8/main.PMC5345974.pdf
"Once activated, however, I κB is phosphorylated by I κB kinase (IKK) and is rapidly degraded, which subsequently dissociates from NF- κB, en- abling NF- κB dimers to enter the nucleus and regulate various inﬂammatory mediators, including tumor necrosis factor- α(TNF- α), http://dx.doi.org/10.1016/j.redox.2017.03.001 Received 27 January 2017; Received in revised form 10 February 2017; Accepted 1 March 2017⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/99/6a/main.PMC5345976.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/99/6a/main.PMC5345976.pdf
PCB-153 reduced HNF1b http://dx.doi.org/10.1016/j.redox.2017.02.026 Received 7 February 2017; Received in revised form 25 February 2017; Accepted 28 February 2017⁎Corresponding authors.,OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
92 –93 (2016) 416– 421. http://dx.doi.org/ 10.1016/j.envint.2016.03.028 .,OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
"(Barking, Essex: 1987) 215 (2016) 135– 140. http://dx.doi.org/10.1016/j.envpol.2016.05.007 .",Non-OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
40 (2012) 170– 178. http://dx.doi.org/ 10.1016/j.envint.2011.07.010 .,OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
http://dx.doi.org/10.1289/ehp.0901480 .,Non-OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
146 (2016) 207– 217. http://dx.doi.org/10.1016/j.envres.2016.01.005 .,OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
238 (2016)69–89.http://dx.doi.org/10.1007/398_2015_5001.,Non-OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
http://dx.doi.org/10.2337/dc10-2116 .,Non-OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
138 (2015) 217– 223. http://dx.doi.org/ 10.1016/j.envres.2015.02.018 .,Non-OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
Health Part A 76 (2013) 701– 715. http://dx.doi.org/ 10.1080/15287394.2013.796503 .,Non-OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
116 (2008) 761– 768. http://dx.doi.org/10.1289/ehp.10554 .,Non-OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
120 (2012) 727– 732. http://dx.doi.org/10.1289/ehp.1104247 .,Non-OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
http://dx.doi.org/10.1016/j.jnutbio.2013.01.009 .,OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
150 (2016) 282– 288. http://dx.doi.org/10.1016/j.envres.2016.06.023 .,OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
"Song, et al., Endocrine-disrupting chemicals, risk of type 2 diabetes, and diabetes-related metabolic traits: a systematic review and meta-analysis, J. Diabetes 8 (2016) 516– 532. http://dx.doi.org/10.1111/1753-0407.12325 .",Non-OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
http://dx.doi.org/10.1016/j.lpm.2015.08.008 .,OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
496 (2014) 624– 634. http://dx.doi.org/ 10.1016/j.scitotenv.2014.06.113 .,Non-OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
http://dx.doi.org/10.1210/jc.2014-1683 .,Non-OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
http://dx.doi.org/10.1016/ j.taap.2015.10.015 .,OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
81 (2004) 35 –42.http://dx.doi.org/10.1093/toxsci/kfh193 .,Non-OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
http://dx.doi.org/10.1016/j.freerad- biomed.2015.07.012 .,OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
http://dx.doi.org/10.1016/j.ecoenv.2014.09.012 .,OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
http://dx.doi.org/10.1016/j.jnutbio.2013.10.003 .,OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
"Surh, A formulated red ginseng extract rescues PC12 cells from PCB-induced oxidative cell death through Nrf2- mediated upregulation of heme oxygenase-1 and glutamate cysteine ligase,Toxicology 278 (2010) 131– 139. http://dx.doi.org/10.1016/j.tox.2010.04.003 .",Non-OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
10 (2008) 179– 206. http://dx.doi.org/10.1089/ars.2007.1672 .,Non-OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
http://dx.doi.org/10.1136/jmg.2005.032854.,OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
http://dx.doi.org/10.1111/j.1523-1755.2005.00625.x .,Non-OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
54 (2015) 35 –49.http://dx.doi.org/10.1002/mc.22072.,Non-OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
http://dx.doi.org/10.3390/ijms150813317 .,Non-OADS,/arxiv_data1/oa_pdf/67/44/main.PMC5345977.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/42/04/clep-9-151.PMC5345979.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/42/04/clep-9-151.PMC5345979.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2017:9 151–156Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 151 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S124091 The completeness of chest X-ray procedure  codes in the Danish National Patient Registry Peter Hjertholm1 Kaare Rud Flarup1 Louise Mahncke  Guldbrandt1 Peter Vedsted1,2 1Research Center for Cancer  Diagnosis in Primary Care,   Department of Public Health,   2University Clinic for Innovative  Health Care Delivery, Diagnostic Centre, Silkeborg Hospital,  Department of Clinical Medicine,  Aarhus University, Aarhus, DenmarkObjective: The aim of this validation study was to assess the completeness of the registrations  of chest X-rays (CXR) in two different versions of the Danish National Patient Registry (DNPR).",Non-OADS,/arxiv_data1/oa_pdf/42/04/clep-9-151.PMC5345979.pdf
"Studies using registry data are vulnerable (eg, to missing data and selection bias), often with no possibility to discover such problems.Correspondence: Peter Hjertholm Research Center for Cancer Diganosis in Primary Care, Department of Public Health, Aarhus University, Bartholins Alle 2, 8000 Aarhus, DenmarkTel +45 4041 4454Email hjertholm@ph.au.dk Journal name: Clinical Epidemiology Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Hjertholm et alRunning head recto: The completeness of chest X-ray procedure codesDOI: http://dx.doi.org/10.2147/CLEP .S124091",Non-OADS,/arxiv_data1/oa_pdf/42/04/clep-9-151.PMC5345979.pdf
"Clinical Epidemiology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/42/04/clep-9-151.PMC5345979.pdf
[The Danish National  Patient Registery] http://www.esundhed.dk/sundhedsregistre/LPR/.,Non-OADS,/arxiv_data1/oa_pdf/42/04/clep-9-151.PMC5345979.pdf
[The Classification System of the Danish Health Services] http://sundhedsdatastyrelsen.dk/da/rammer-og-retningslinjer/om-klassifi-kationer/sks-klassifikationer.,Non-OADS,/arxiv_data1/oa_pdf/42/04/clep-9-151.PMC5345979.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0d/85/ppa-11-479.PMC5345980.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 479–486Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  479OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12180 0 Factors driving customers to seek health care  from pharmacies for acute respiratory illness and  treatment recommendations from drug sellers in  Dhaka city, Bangladesh Fahmida chowdhury1 Katharine sturm-ramirez1,2 Abdullah Al Mamun1 A Danielle iuliano2 Mejbah Uddin Bhuiyan1 Mohammod Jobayer chisti1 Makhdum Ahmed1 sabbir haider3 Mahmudur rahman3 eduardo Azziz- Baumgartner2 1infectious Diseases Division,   international centre for Diarrhoeal  Disease research, Bangladesh, Dhaka,   Bangladesh; 2influenza Division,   centers for Disease control and  Prevention, Atlanta, gA, UsA;   3institute of epidemiology, Disease  control and research, Dhaka,   BangladeshBackground:  Pharmacies in Bangladesh serve as an important source of health service.",Non-OADS,/arxiv_data1/oa_pdf/0d/85/ppa-11-479.PMC5345980.pdf
"Keywords:  drug sellers, pharmacy, acute respiratory illness, dispensing practice, health care  seeking, customers Introduction Acute respiratory infection (ARI) is a leading cause of death and accounted for 16% of  the 5.9 million global deaths among children aged .5 years during 2000–2015.1 ARI  causes substantial morbidity and mortality among adults and children, with 97% of the  world’s new pneumonia cases occurring in low-income countries.2–4 In Bangladesh,  a lower middle-income country with scarcity of health care providers,5 ARI is the  major cause of mortality in children aged ,5 years, accounting for an estimated 28% correspondence: Fahmida chowdhury respiratory Viruses Working group,  Programme on emerging infections,  infectious Diseases Division, international  centre for Diarrhoeal Disease research,  68 shaheed Tajuddin Ahmed sarani,  Mohakhali, Dhaka 1212, Bangladesh Tel +88 018 1705 4481 email fahmida_chow@icddrb.or g Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Chowdhury et al Running head recto: Factors driving customers to seek health care from pharmacies for ARI DOI: http://dx.doi.org/10.2147/PPA.S121800",Non-OADS,/arxiv_data1/oa_pdf/0d/85/ppa-11-479.PMC5345980.pdf
"The poster’s abstract was  published in “International Conference on Emerging Infec - tious Diseases 2015 Poster and Oral Presentation Abstracts”,  http://www.iceid.or g. Disclosure The authors report no conflicts of interest in this work.",Non-OADS,/arxiv_data1/oa_pdf/0d/85/ppa-11-479.PMC5345980.pdf
Available from: https://www.unicef.org/publications/ files/APR_2015_Key_Findings_8_Sep_15.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/85/ppa-11-479.PMC5345980.pdf
Available from: http://www.dghs.gov.bd/licts_file/images/ BDHS/BDHS_2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/85/ppa-11-479.PMC5345980.pdf
Available from: http://dspace.icddrb.org:8080/jspui/ bitstream/123456789/6421/1/FHS_book_Health_for_Rural_Masses.,Non-OADS,/arxiv_data1/oa_pdf/0d/85/ppa-11-479.PMC5345980.pdf
Available from: http://www.searo.who.,Non-OADS,/arxiv_data1/oa_pdf/0d/85/ppa-11-479.PMC5345980.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/0d/85/ppa-11-479.PMC5345980.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e2/5c/dddt-11-659.PMC5345981.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 659–668Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  659Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12732 8 Paclitaxel-loaded star-shaped copolymer  nanoparticles for enhanced malignant melanoma  chemotherapy against multidrug resistance Y ongsheng su1 Jian hu1 Zhibin huang1 Yubin huang1 Bingsheng Peng1 ni Xie2 hui liu1 1Department of Burn and Plastic  surgery, The People’s hospital of  Baoan shenzhen affiliated to southern  Medical University, 2core laboratory,   shenzhen second People’s hospital,   First affiliated hospital of shenzhen  University, shenzhen, People’s  republic of chinaAbstract:  Malignant melanoma (MM) is the most dangerous type of skin cancer with annually  increasing incidence and death rates.",Non-OADS,/arxiv_data1/oa_pdf/e2/5c/dddt-11-659.PMC5345981.pdf
").4 In order correspondence: hui liu Department of Burn and Plastic  surgery, The People’s hospital of  Baoan Shenzhen Affiliated to Southern  Medical University, shenzhen 518101,  People’s republic of china Tel/fax +86 755 2778 8311 email huiliu22@163.co m  ni Xie core laboratory, shenzhen second  People’s Hospital, First Affiliated Hospital  of shenzhen University, shenzhen  518035 , People’s republic of china Tel/fax +86 755 8300 3435 email kejiaoke100@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Su et al Running head recto: PTX-loaded copolymer nanoparticles for melanoma chemotherapy DOI: http://dx.doi.org/10.2147/DDDT.S127328",Non-OADS,/arxiv_data1/oa_pdf/e2/5c/dddt-11-659.PMC5345981.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/e2/5c/dddt-11-659.PMC5345981.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/5c/dddt-11-659.PMC5345981.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/18/ee/ijgm-10-061.PMC5345982.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/18/ee/ijgm-10-061.PMC5345982.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2017:10 61–68International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 61 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S125806How French general practitioners manage and  prevent recurrent respiratory tract infections in  children: the SOURIRRE survey Bruno Chicoulaa1 Hervé Haas2 Jérôme Viala3 Maryline Salvetat4 Jean-Pierre Olives5 1Faculty of Medicine, T oulouse  Rangueil, T oulouse, 2Paediatric  Emergency and Infectious Disease  Departments, Lenval University Hospital, Nice,  3Gastroenterology  Department, Robert-Debré Hospital, Paris,  4Sports and General  Medicine Practice, Labruguière,   5Gastroenterology and Nutrition  Department, Children’s Hospital,  University Hospital, T oulouse, FranceBackground: Recurrent respiratory tract infections (RRTIs) are the most common reason for  children’ s visits to primary care physicians in France; however, little is known about general  practitioners’ (GPs) opinions and expectations concerning the management and prevention of  these common and recurrent pathologies.",Non-OADS,/arxiv_data1/oa_pdf/18/ee/ijgm-10-061.PMC5345982.pdf
"4  The treatment of acute episodes is thoroughly described in clinical guidelines.3,5,6 Correspondence: Bruno Chicoulaa Faculté de Médecine de Toulouse Rangueil, 133 route de Narbonne, 31063 Toulouse Cedex, FranceTel +33 5 6121 9878Fax +33 5 6113 3377Email bruno1.chicoulaa1@dumg-toulouse.frJournal name: International Journal of General Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Chicoulaa et alRunning head recto: Prevention of recurrent respiratory tract infections in FranceDOI: http://dx.doi.org/10.2147/IJGM.S125806",Non-OADS,/arxiv_data1/oa_pdf/18/ee/ijgm-10-061.PMC5345982.pdf
Available from: http://www.drees.sante.gouv.fr/IMG/pdf/er588.pdf.,Non-OADS,/arxiv_data1/oa_pdf/18/ee/ijgm-10-061.PMC5345982.pdf
Available from: http://www.infectiologie.com/UserFiles/File/medias/Recos/2011-infections-respir-hautes-argumentaire.pdf.,Non-OADS,/arxiv_data1/oa_pdf/18/ee/ijgm-10-061.PMC5345982.pdf
Avialable from: http://www.invs.sante.fr/beh/2009/01/.,Non-OADS,/arxiv_data1/oa_pdf/18/ee/ijgm-10-061.PMC5345982.pdf
Available from: http://www.invs.sante.fr/beh/2009/01/.,Non-OADS,/arxiv_data1/oa_pdf/18/ee/ijgm-10-061.PMC5345982.pdf
Available from: http://www.voixmedicales.fr/wp-content/uploads/2013/12/Th%C3%A8se-Alexandre-Saunier-VF .pdf.,Non-OADS,/arxiv_data1/oa_pdf/18/ee/ijgm-10-061.PMC5345982.pdf
"International Journal of General Medicine 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/18/ee/ijgm-10-061.PMC5345982.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 68 Chicoulaa et al  15.,Non-OADS,/arxiv_data1/oa_pdf/18/ee/ijgm-10-061.PMC5345982.pdf
Available from: https://www.conseil-national.medecin.fr/sites/default/files/atlas_national_de_la_demographie_medicale_2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/18/ee/ijgm-10-061.PMC5345982.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a8/0d/ceor-9-181.PMC5345983.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a8/0d/ceor-9-181.PMC5345983.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2017:9 181–188ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  181 ORiginal REsEaRCh open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S126975T opical medication utilization and health resources  consumption in adult patients affected by psoriasis:  findings from the analysis of administrative  databases of local health units Valentina Perrone Diego Sangiorgi stefano Buda Luca Degli Esposti Clicon s.r.l.",Non-OADS,/arxiv_data1/oa_pdf/a8/0d/ceor-9-181.PMC5345983.pdf
"health, Economics &  Outcomes Research, Via salara 36, 48100 Ravenna, italyTel +39 544 38393Fax +39 544 212 699Email luca.degliesposti@clicon.itJournal name: ClinicoEconomics and Outcomes Research Article Designation: Original ResearchY ear: 2017V olume: 9Running head verso: Perrone et alRunning head recto: Topical medication utilization in psoriasis patientsDOI: http://dx.doi.org/10.2147/CEOR.S126975",Non-OADS,/arxiv_data1/oa_pdf/a8/0d/ceor-9-181.PMC5345983.pdf
Available from: http://www.snlg-iss.it/cms/files/LG_Psoriasi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a8/0d/ceor-9-181.PMC5345983.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK247829/.,Non-OADS,/arxiv_data1/oa_pdf/a8/0d/ceor-9-181.PMC5345983.pdf
Avail-able from: https://www.agenziafarmaco.gov.it/ricclin/sites/default/files/files_ wysiwyg/files/CIRCULARS/Circular%2031st%20May%202010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a8/0d/ceor-9-181.PMC5345983.pdf
"ClinicoEconomics and Outcomes Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/a8/0d/ceor-9-181.PMC5345983.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 188 Perrone et al 34.,Non-OADS,/arxiv_data1/oa_pdf/a8/0d/ceor-9-181.PMC5345983.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7b/ae/copd-12-793.PMC5345984.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 793–801International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  793OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12556 4 Inhaled treatment of COPD: a Delphi consensus  statement Vincent ninane1 Jean-louis Corhay2 Paul germonpré3 Wim Janssens4 guy F Joos5 giuseppe liistro6 Walter Vincken7 sandra gurdain8 evelyne Vanvlasselaer8 an lehouck8 1Department of respiratory Medicine,   saint-Pierre hospital, Université libre  de Bruxelles, Brussels, 2Department  of respiratory Medicine, ChU,   liege, 3Department of respiratory  Medicine, aZ Maria Middelares,   ghent, 4Department of respiratory  Medicine, Katholieke Universiteit,   leuven, 5Department of respiratory  Medicine, ghent University hospital,   ghent, 6Department of respiratory  Medicine, University hospitals  saint-luc, Brussels, 7Department of  respiratory Medicine, University  hospital Brussels, Brussels, 8Medical  Department, novartis Pharma,   Vilvoorde, BelgiumBackground:  Global Initiative for Chronic Obstructive Lung Disease (GOLD) global strategy  (2015) provides guidance for the treatment of chronic obstructive pulmonary disease (COPD)  with different first-choice options per GOLD category without specification.",Non-OADS,/arxiv_data1/oa_pdf/7b/ae/copd-12-793.PMC5345984.pdf
"In the 2011 update of the GOLD global strategy, severity of symptoms  (according to Modified Medical Research Council [mMRC] or COPD Assessment  Test scores) and frequency of exacerbations were added next to lung function (forced  expiratory volume in 1 second [FEV1]), as important parameters to take into account  when recommending treatment.2 The main role of the new A–D classification is to Correspondence: Vincent ninane Department of respiratory Medicine,  Centre hospitalier Universitaire  saint-Pierre service de Pneumologie,  rue haute, 322, Brussels 1000, Belgium email vincent_ninane@stpierre-bru.b e Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Ninane et al Running head recto: Inhaled treatment of COPD DOI: http://dx.doi.org/10.2147/COPD.S125564",Non-OADS,/arxiv_data1/oa_pdf/7b/ae/copd-12-793.PMC5345984.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/7b/ae/copd-12-793.PMC5345984.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/ae/copd-12-793.PMC5345984.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/96/98/cia-12-487.PMC5345985.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 487–497Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  487RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12702 3 The effect of visual biofeedback on balance in  elderly population: a systematic review Hammad Alhasan1 victoria Hood2 Frederick Mainwaring2 1Physiotherapy Department, Faculty  of Applied Medical Science, Umm  al-Qura University, Mecca, Kingdom  of Saudi Arabia; 2School of Health  Science, University of Nottingham,   Nottingham, Nottinghamshire, UKBackground:  Balance is commonly affected by multiple factors, especially among the elderly  population.",Non-OADS,/arxiv_data1/oa_pdf/96/98/cia-12-487.PMC5345985.pdf
"Keywords:  visual feedback, exergames, older adult, postural balance Introduction Balance impairments in older adults are one of the most experienced and reported  problems to physicians,1 and balance and gait disorders are the second leading causes  of falls.2 Literature has suggested that between 20% and 33% of adults aged 65 years  experience problems with their balance.3 In adults aged 60 years, there is a 30%  chance of falling at least one time a year, and this chance increases up to 45% in those  aged 70 years.4 It is estimated that falls cost the United Kingdom’s National Health  Service approximately £2.3 billion every year.5 The human balance system is a complicated one, which involves integration  and coordination of sensory, motor, and biomechanical activities in such a way as Correspondence: Hammad Alhasan PO Box 9195, Alrabiah District, Mecca  21955, Makkah, Saudi Arabia Tel +966 55 551 6226 email hshasan@uqu.edu.s a Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Alhasan et al Running head recto: Effect of biofeedback on balance among elderly DOI: http://dx.doi.org/10.2147/CIA.S127023",Non-OADS,/arxiv_data1/oa_pdf/96/98/cia-12-487.PMC5345985.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/96/98/cia-12-487.PMC5345985.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/96/98/cia-12-487.PMC5345985.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/96/98/cia-12-487.PMC5345985.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/08/0b/dddt-11-643.PMC5345986.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 643–657Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  643Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S10346 8 New developments in the management of  partial-onset epilepsy: role of brivaracetam Giangennaro Coppola1 Giulia iapadre2 Francesca Felicia Operto1 Alberto verrotti2 1Unit of Child and Adolescent  Neuropsychiatry, Department of  Medicine and Surgery, University  of Salerno, Salerno, 2Department of  Pediatrics, University of L’Aquila,   L’Aquila, italyAbstract:  Currently, a number of novel anticonvulsant drugs, the so-called third generation,  are in various stages of development.",Non-OADS,/arxiv_data1/oa_pdf/08/0b/dddt-11-643.PMC5345986.pdf
"More recently, in the International League Against Epilepsy (ILAE) 2010 report,  Berg et al2 confirmed to remove the distinction between complex partial and simple par - tial, however, recognizing that impairment of consciousness/awareness or dyscognitive Correspondence: Giangennaro Coppola Unit of Child and Adolescent  Neuropsychiatry, Department of  Medicine and Surgery, S Giovanni di  Dio and Ruggi d’Aragona Hospital,  University of Salerno, Largo d’ippocrate,  Salerno 84100, italy Tel +39 089 672 578 email gcoppola@unisa.i t Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Coppola et al Running head recto: Brivaracetam for partial-onset epilepsy DOI: http://dx.doi.org/10.2147/DDDT.S103468",Non-OADS,/arxiv_data1/oa_pdf/08/0b/dddt-11-643.PMC5345986.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/08/0b/dddt-11-643.PMC5345986.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/0b/dddt-11-643.PMC5345986.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5b/8f/vhrm-13-081.PMC5345987.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5b/8f/vhrm-13-081.PMC5345987.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management  2017:13 81–90Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress  81 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S89213Novel stroke risk reduction in atrial fibrillation:  left atrial appendage occlusion with a focus on the  Watchman closure device Arash Alipour Lisette I S Wintgens Martin J Swaans Jippe C BaltBenno J W M RensingLucas V A Boersma Department of Cardiology, St.   Antonius Hospital, Nieuwegein, the NetherlandsAbstract:  Atrial fibrillation (AF) remains an important clinical problem with severe complica- tions such as stroke, which especially harms those with risk factors as calculated by the CHADS2  or CHA2DS2-V ASc.",Non-OADS,/arxiv_data1/oa_pdf/5b/8f/vhrm-13-081.PMC5345987.pdf
"The most striking of these is ischemic stroke, which accounts for Correspondence: Arash Alipour Department of Cardiology, St. Antonius Hospital, Koekoekslaan 1, 3435 Nieuwegein, the NetherlandsTel +31 30 609 9111Fax +31 30 609 2274Email a.alipour@antoniusziekenhuis.nlJournal name: Vascular Health and Risk Management  Article Designation: REVIEWY ear: 2017V olume: 13Running head verso: Alipour et alRunning head recto: Left atrial appendage occlusion in AFDOI: http://dx.doi.org/10.2147/VHRM.S89213",Non-OADS,/arxiv_data1/oa_pdf/5b/8f/vhrm-13-081.PMC5345987.pdf
"Vascular Health and Risk Management  2017:13submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular-health-and-risk-management-journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/5b/8f/vhrm-13-081.PMC5345987.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 90 Alipour et al  68.,Non-OADS,/arxiv_data1/oa_pdf/5b/8f/vhrm-13-081.PMC5345987.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8a/35/imcrj-10-073.PMC5345988.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8a/35/imcrj-10-073.PMC5345988.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2017:10 73–75International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 73 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S120422T oxicant-associated steatohepatitis: à propos a  case of benzene exposure Daniel Benharroch1  Boris Talalay2 1Department of Pathology,   2Department of Family Medicine,   Soroka University Medical Center  and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, IsraelAbstract:  An attempted interpretation of recurrent episodes of hepatitis in a girl at ages 6 and  13 years, which were followed by an interval of 35 years of apparent good health, is reported.",Non-OADS,/arxiv_data1/oa_pdf/8a/35/imcrj-10-073.PMC5345988.pdf
"Correspondence: Daniel Benharroch   Department of Pathology, Soroka  University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, 1, Itshak Rager Boulevard, PO Box 151, Beer-Sheva 84101, Israel   Tel +972 5 0757 9140   Email dbenharroch@yahoo.comJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2017V olume: 10Running head verso: Benharroch and TalalayRunning head recto: Benzene-induced steatohepatitisDOI: http://dx.doi.org/10.2147/IMCRJ.S120422",Non-OADS,/arxiv_data1/oa_pdf/8a/35/imcrj-10-073.PMC5345988.pdf
"International Medical Case Reports Journal 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/8a/35/imcrj-10-073.PMC5345988.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 75 Benzene-induced steatohepatitis zene poisoning.,Non-OADS,/arxiv_data1/oa_pdf/8a/35/imcrj-10-073.PMC5345988.pdf
Available from: http://www.balloonmagic.com/bmthemag.php.,Non-OADS,/arxiv_data1/oa_pdf/8a/35/imcrj-10-073.PMC5345988.pdf
Available from: http://lasecuritedesjouets.blogspot.co.il/2008/11/pate-ballons-retrait-du-march-en.html.,Non-OADS,/arxiv_data1/oa_pdf/8a/35/imcrj-10-073.PMC5345988.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/88/ec/cmar-9-065.PMC5345989.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/88/ec/cmar-9-065.PMC5345989.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Cancer Management and Research 2017:9 65–72Cancer Management and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  65 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S124475Glucocorticoid receptor expression in 20 solid  tumor types using immunohistochemistry assay Thaddeus S Block1,2  Tiffany I Murphy3 Pamela N Munster4 Dat P Nguyen1 Frank J Lynch3 1Corcept Therapeutics, Inc, Menlo  Park, CA, 2Department of Psychiatry  and Behavioral Sciences, Stanford  University, Stanford, CA, 3QualT ek  Molecular Laboratories, Newtown, PA,   4Department of Medicine, University  of California, San Francisco, San Francisco, CA, USABackground: Glucocorticoid receptor (GR) activity plays a role in many aspects of human  physiology and may play a crucial role in chemotherapy resistance in a wide variety of solid  tumors.",Non-OADS,/arxiv_data1/oa_pdf/88/ec/cmar-9-065.PMC5345989.pdf
"2,6  Investigators have identified the role of GR in the development of chemotherapy resistance in experimental models involving tumors of epithelial origin, especially Correspondence: Thaddeus S Block Corcept Therapeutics, Inc,   149 Commonwealth Drive, Menlo Park,   CA 94025, USATel +1 650 688 8816Fax +1 650 327 3218Email tblock@corcept.comJournal name: Cancer Management and Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Block et alRunning head recto: Glucocorticoid receptor expression in solid tumorsDOI: http://dx.doi.org/10.2147/CMAR.S124475",Non-OADS,/arxiv_data1/oa_pdf/88/ec/cmar-9-065.PMC5345989.pdf
Available from: https://clinicaltri-als.gov/.,Non-OADS,/arxiv_data1/oa_pdf/88/ec/cmar-9-065.PMC5345989.pdf
"Cancer Management and Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Cancer Management and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/cancer-management-and-research-journalCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/88/ec/cmar-9-065.PMC5345989.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 72 Block et al,Non-OADS,/arxiv_data1/oa_pdf/88/ec/cmar-9-065.PMC5345989.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b6/aa/jbm-8-029.PMC5345990.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b6/aa/jbm-8-029.PMC5345990.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Blood Medicine 2017:8 29–34Journal of Blood Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  29 Original research open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S129516The risk of renal disease is increased in lambda  myeloma with bone marrow amyloid deposits Piotr Kozlowski1 scott Montgomery2–4 rahel Befekadu5 Victoria hahn-strömberg6 1Department of Medicine, school  of Medical sciences, Örebro  University, Örebro, sweden; 2clinical  epidemiology and Biostatistics,   school of Medical sciences, Örebro  University, Örebro, sweden; 3clinical  epidemiology Unit, Karolinska University hospital, Karolinska  institutet, stockholm, sweden;   4Department of epidemiology and  Public health, University college  london, london, UK; 5Department  of Transfusion Medicine, school of  Medical sciences, Örebro University,   Örebro, sweden; 6Department  of Medical cell Biology, Uppsala  University, Uppsala, swedenBackground: Light chain amyloidosis (AL) is a rare deposition disease and is present in  10–15% of patients with myeloma (MM).",Non-OADS,/arxiv_data1/oa_pdf/b6/aa/jbm-8-029.PMC5345990.pdf
"The former has no impact on survival and no  connection correspondence: Piotr Kozlowski Department of Medicine, Örebro University hospital, södra grev rosengatan, Örebro 701 85, swedenTel +46 19 602 1533Fax +46 19 602 4580email piotr.kozlowski@regionorebrolan.seJournal name: Journal of Blood Medicine Article Designation: Original ResearchY ear: 2017V olume: 8Running head verso: Kozlowski et alRunning head recto: Renal disease risk in MM with bone marrow amyloid depositsDOI: http://dx.doi.org/10.2147/JBM.S129516",Non-OADS,/arxiv_data1/oa_pdf/b6/aa/jbm-8-029.PMC5345990.pdf
"Journal of Blood Medicine 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Blood Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/journal-of-blood-medicine-journalThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects   of all aspect pertaining to blood based medicine including but not limited to:   Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,   and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of blood related medicine; Legal aspects of blood medicine; Historical perspec-tives.",Non-OADS,/arxiv_data1/oa_pdf/b6/aa/jbm-8-029.PMC5345990.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dovepress 34 Kozlowski et al 16.,Non-OADS,/arxiv_data1/oa_pdf/b6/aa/jbm-8-029.PMC5345990.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4d/9d/dddt-11-669.PMC5345991.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 669–676Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  669Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12584 3 Protective influence of hyaluronic acid on focal  adhesion kinase activity in human skin fibroblasts  exposed to ethanol Magdalena Donejko1 edyta rysiak2 Elżbieta Galicka1 Robert T erlikowski3 Edyta Katarzyna Głażewska1 andrzej Przylipiak1 1Department of Esthetic Medicine,   2Department of Medicinal Chemistry,   Faculty of Pharmacy, 3Department  of Health Restoration, Medical  University of Białystok,   Białystok, PolandAim:  The aim of this study was to evaluate the effect of ethanol and hyaluronic acid (HA) on  cell survival and apoptosis in cultured human skin fibroblasts.",Non-OADS,/arxiv_data1/oa_pdf/4d/9d/dddt-11-669.PMC5345991.pdf
"The raised reactive oxygen correspondence: Magdalena Donejko Department of Esthetic Medicine, Faculty  of Pharmacy, Medical University of  Białystok, 3 Akademicka Street,   15-267 Białystok, Poland email donejko@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Donejko et al Running head recto: Protective influence of hyaluronic acid on FAK DOI: http://dx.doi.org/10.2147/DDDT.S125843",Non-OADS,/arxiv_data1/oa_pdf/4d/9d/dddt-11-669.PMC5345991.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4d/9d/dddt-11-669.PMC5345991.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/9d/dddt-11-669.PMC5345991.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f4/19/ov-6-021.PMC5345992.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f4/19/ov-6-021.PMC5345992.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Oncolytic Virotherapy 2017:6 21–30Oncolytic Virotherapy Dovepress submit your manuscript | www.dovepress.com Dovepress  21 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OV.S123292Proinflammatory response induced by Newcastle  disease virus in tumor and normal cells T eridah Ernala Ginting   Jeremiah Suryatenggara   Salomo Christian   George Mathew Division of Immunology, Mochtar  Riady Institute for Nanotechnology and Medical Science Group, University of Pelita Harapan, Tangerang, IndonesiaPurpose: To investigate the specific role of immune responses induced by lentogenic Newcastle  disease virus (NDV) for its antitumor effect.",Non-OADS,/arxiv_data1/oa_pdf/f4/19/ov-6-021.PMC5345992.pdf
"14–18 NDV causes a disease that predominantly affects poultry, although  infection in humans has been reported to cause conjunctivitis19,20 and/or mild flu-like  symptoms.13–17,21 Based on their virulence on birds, NDV strains can be divided into Correspondence: Teridah Ernala Ginting   Mochtar Riady Institute for  Nanotechnology and Medical Science Group, University of Pelita Harapan, Jalan Boulevard Jenderal Sudirman 1688, Lippo Karawaci, Tangerang, Banten 15811, Indonesia   Tel +62 21 5421 0123   Fax +62 21 5421 0110Email tginting@mrinstitute.orgJournal name: Oncolytic Virotherapy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 6Running head verso: Ginting et alRunning head recto: IFNs and NDV: tumor-specific cytotoxicityDOI: http://dx.doi.org/10.2147/OV .S123292",Non-OADS,/arxiv_data1/oa_pdf/f4/19/ov-6-021.PMC5345992.pdf
"Oncolytic Virotherapy 2017:6submit your manuscript | www.dovepress.com Dovepress Dovepress Oncolytic Virotherapy Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/oncolytic-virotherapy-journalOncolytic Virotherapy is an international, peer-reviewed, open access online journal  publishing original research, study protocols, reviews, editorials and commentaries   on all aspects of oncolytic virology, namely the application of oncolytic viruses for   the treatment of cancer.",Non-OADS,/arxiv_data1/oa_pdf/f4/19/ov-6-021.PMC5345992.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 30 Ginting et al,Non-OADS,/arxiv_data1/oa_pdf/f4/19/ov-6-021.PMC5345992.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/83/20/ijgm-10-069.PMC5345993.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/83/20/ijgm-10-069.PMC5345993.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2017:10 69–77International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 69 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S128047The use status of anticoagulation drugs for  inpatients with nonvalvular atrial fibrillation in  Southwest China Huan Jie Zheng Shu Kun Ouyang Yue Zhao Kai LuSu Xin LuoHua Xiao Department of Cardiology, The First  Affiliated Hospital of Chongqing Medical University, Chongqing,  People’s Republic of ChinaBackground: Oral anticoagulants (OACs) are effective for the prophylaxis of stroke in patients  with atrial fibrillation (AF).",Non-OADS,/arxiv_data1/oa_pdf/83/20/ijgm-10-069.PMC5345993.pdf
"During the latest 10 years, the anticoagulant use rate has grown by 28.7%; however, the rate is  Correspondence: Hua Xiao Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong, Chongqing 400016, People’s Republic of ChinaTel +86 23 8901 1565Fax +86 23 8901 1565Email xiaoheart1974@163.comJournal name: International Journal of General Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Zheng et alRunning head recto: Anticoagulation therapy in atrial fibrillationDOI: http://dx.doi.org/10.2147/IJGM.S128047",Non-OADS,/arxiv_data1/oa_pdf/83/20/ijgm-10-069.PMC5345993.pdf
"International Journal of General Medicine 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/83/20/ijgm-10-069.PMC5345993.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 77 Anticoagulation therapy in atrial fibrillation 17.,Non-OADS,/arxiv_data1/oa_pdf/83/20/ijgm-10-069.PMC5345993.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b0/f7/ijn-12-1803.PMC5345996.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1803–1813International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1803OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11336 6 Nh4hcO3 gas-generating liposomal nanoparticle  for photoacoustic imaging in breast cancer Jizhu Xia gang Feng Xiaorong Xia lan hao Zhigang Wang chongqing Key laboratory of  Ultrasound Molecular Imaging,   Department of Ultrasound, The  second affiliated hospital of  chongqing Medical University,   chongqing, People’s republic of chinaAbstract:  In this study, we have developed a biodegradable nanomaterial for photoacoustic  imaging (PAI).",Non-OADS,/arxiv_data1/oa_pdf/b0/f7/ijn-12-1803.PMC5345996.pdf
"Gold is also very correspondence: lan hao;   Zhigang Wang chongqing Key laboratory of Ultrasound  Molecular Imaging, The Second Affiliated  hospital of chongqing Medical University,  linjiang road 76, chongqing, 400010,  People’s republic of china Tel +86 23 6848 6153 email lanhao5@163.co m;  wzg62942443@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Xia et al Running head recto: NH4HCO3 gas-generating liposomal nanoparticle DOI: http://dx.doi.org/10.2147/IJN.S113366",Non-OADS,/arxiv_data1/oa_pdf/b0/f7/ijn-12-1803.PMC5345996.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b0/f7/ijn-12-1803.PMC5345996.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/f7/ijn-12-1803.PMC5345996.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c1/6a/dddt-11-553.PMC5345997.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 553–562Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  553Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11328 9 adenosine a2a receptor agonist prevents cardiac  remodeling and dysfunction in spontaneously  hypertensive male rats after myocardial infarction Jaqueline s da silva1 Daniele gabriel-costa1 roberto T sudo1 hao Wang2 leanne groban2 emanuele B Ferraz3 José hamilton M  nascimento3 carlos alberto M Fraga1 eliezer J Barreiro1 gisele Zapata-sudo1 1research Program Development  of Drugs, institute of Biomedical  sciences, Universidade Federal do  rio de Janeiro, rio de Janeiro, Brazil;   2Department of anesthesiology,   Wake Forest school of Medicine,   Winston-salem, nc, Usa; 3institute  of Biophysics carlos chagas Filho,   Universidade Federal do rio  de Janeiro, rio de Janeiro, BrazilBackground:  This work evaluated the hypothesis that 3,4-methylenedioxybenzoyl-2-   thienylhydrazone (LASSBio-294), an agonist of adenosine A2A receptor, could be beneficial for  preventing cardiac dysfunction due to hypertension associated with myocardial infarction (MI).",Non-OADS,/arxiv_data1/oa_pdf/c1/6a/dddt-11-553.PMC5345997.pdf
"This cardiovascular disease is often preceded by myocardial infarction (MI) and  hypertension.1,2 HF presents with a complex constellation of symptoms, including  dyspnea and exercise intolerance.3–5 The primary underlying defect in HF is an inability  of the left ventricle (LV) to maintain an adequate forward stroke volume to meet the  metabolic demands of the body, either because of impaired LV contractile function  or insufficient LV filling.6 The dynamic cellular and molecular processes that lead to permanent alterations in  the geometry and function of the ventricles after an MI or due to chronic hypertension correspondence: gisele Zapata-sudo Universidade Federal do rio de Janeiro,  centro de ciências da saúde, instituto  de ciências Biomédicas, Bloco J, sala 14,  rio de Janeiro, rJ 21941-590, Brazil Tel/fax +55 21 3938 6478 email gzsudo@oi.com.b rJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: da Silva et al Running head recto: Cardioprotection of LASSBio-294 in infarcted SHR DOI: http://dx.doi.org/10.2147/DDDT.S113289",Non-OADS,/arxiv_data1/oa_pdf/c1/6a/dddt-11-553.PMC5345997.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c1/6a/dddt-11-553.PMC5345997.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/6a/dddt-11-553.PMC5345997.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/c2/f8/40261_2016_Article_489.PMC5346111.pdf
Available from: http://med.uofg.edu.sd/ Objectives.aspx.,Non-OADS,/arxiv_data1/oa_pdf/19/fb/JAMP-5-60.PMC5346169.pdf
Available from: http://med.uofg.edu.sd/ program.aspx.,Non-OADS,/arxiv_data1/oa_pdf/19/fb/JAMP-5-60.PMC5346169.pdf
Available from: http://med.uofg.edu.sd/ fmug.aspx.,Non-OADS,/arxiv_data1/oa_pdf/19/fb/JAMP-5-60.PMC5346169.pdf
Available from: https://tomprof.stanford.,Non-OADS,/arxiv_data1/oa_pdf/df/2c/JAMP-5-67.PMC5346170.pdf
"E-mail: scpark@sookmyung.ac.kr https://doi.org/10.5483/BMBRep.2016.49.12.186Received 31 October 2016Keywords: Anks1a, Breast tumor, ErbB2 (HER2, neu), PTB adaptor Abbreviations:  COPII, coat protein complex II; EGF , epidermal  growth factor; ER, endoplasmic reticulum; ERES, ER exit site; PMTC, primary mammary tumor cell; PTB, phosphotyrosine bind-ing; RTK, receptor tyrosine kinase Perspective to:  Haeryung Lee et al (2016), Anks1a regulates  COPII-mediated anterograde transport of receptor tyrosine kinases critical for tumorigenesis.",Non-OADS,/arxiv_data1/oa_pdf/9b/1b/bmb-49-651.PMC5346308.pdf
The role of Anks1a in the export of RTKs from the ER Soochul Park 652 BMB Reports http://bmbreports.org Fig.,OADS,/arxiv_data1/oa_pdf/9b/1b/bmb-49-651.PMC5346308.pdf
"E-mail: kimchan@macrogen.com https://doi.org/10.5483/BMBRep.2016.49.12.195Received 22 November 2016Keywords: AK1, De novo assembly, Haplotype phasing, Linked  Reads, Long reads, NGM, Reference genome Abbreviations:  A K 1 ,  A l t a i c  K o r e a n  O n e ;  B A C ,  B a c t e r i a l  Artificial  Chromosome; NGM, Next-Generation Map; NIST, National Insti-tute of Standards and Technologies; PacBio, Pacific Biosciences;SMRT , Single Molecule Real Time Perspective to:  Seo, J-S et al., 2016, De novo assembly and phasing  of a Korean human genome.",Non-OADS,/arxiv_data1/oa_pdf/c2/7f/bmb-49-653.PMC5346309.pdf
"Nature; 538:243 http://dx.doi.org /  10.1038/nature20098 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Birth of an ‘ Asian cool’ reference genome: AK1 Changhoon Kim * Bioinformatics Institute, Macrogen Inc., Seoul 08511, Korea The human reference genome, maintained by the Genome  Reference Consortium, is conceivably the most complete genome assembly ever, since its first construction.",Non-OADS,/arxiv_data1/oa_pdf/c2/7f/bmb-49-653.PMC5346309.pdf
AK1 de novo assembly Changhoon Kim 654 BMB Reports http://bmbreports.orgthe finding as to their being commonly found in the Asian  population) were discovered.,OADS,/arxiv_data1/oa_pdf/c2/7f/bmb-49-653.PMC5346309.pdf
"Tel: +82-42-629-8938; Fax: +82-42-629-  8811; E-mail: jongjin9@hnu.kr https://doi.org/10.5483/BMBRep.2016.49.12.166Received 28 September 2016Keywords: Cell behaviors, Grafting-to/-from approach, Polymer  brush, Stem cell engineering, Tissue formation ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Polymer brush: a promising grafting approach to scaffolds for  tissue engineering Woonjung Kim & Jongjin Jung * Department of Chemistry, Hannam University, Daejeon 34054, Korea Polymer brush is a soft material unit tethered covalently on the  surface of scaffolds.",Non-OADS,/arxiv_data1/oa_pdf/72/70/bmb-49-655.PMC5346310.pdf
Polymer brush for tissue engineering Woonjung Kim and Jongjin Jung 656 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/72/70/bmb-49-655.PMC5346310.pdf
"Polymer brush for tissue engineering Woonjung Kim and Jongjin Jung 657 http://bmbreports.org BMB ReportsPolymer brush SAM (self-assembled monolayer) Grafting-to Grafting-from Grafting molecule Almost all types of polymers Mainly alkanethiol & alkyl silnae Micro-architecture Various and complex polymeric structures Well assembled molecular monolayer Scaffold materials Glass, titanium, gold, silver, silicon, etc Gold thin film, oxide-formed substrateThickness High tenability by adjusting polymer chain length Thin: one molecular layerCoating defects Presence: short polymer chain Self-healing of defects: long polymer chainPresence of defects and pinhole In vivo stability High stability Low stability Coating density Loosely packed Densely packed Densely packedFabrication approach Various chemical coupling  between polymer and surfaceVarious polymerization  on the surfaceThiol-gold bond & silane linkageTable 1.",Non-OADS,/arxiv_data1/oa_pdf/72/70/bmb-49-655.PMC5346310.pdf
"Polymer brush for tissue engineering Woonjung Kim and Jongjin Jung 658 BMB Reports http://bmbreports.orgPOLYMER BRUSH FOR TISSUE ENGINEERING  Polymer brush has been widely used for protein adsorption,  biosensing, anti-fouling, cell culture, and regulation of cell  behavior in the field of biomedicine.",Non-OADS,/arxiv_data1/oa_pdf/72/70/bmb-49-655.PMC5346310.pdf
Polymer brush for tissue engineering Woonjung Kim and Jongjin Jung 659 http://bmbreports.org BMB Reportsof the thickness and density of a polymer brush is also an  important factor that can affect cell behaviors due to resulting changes in its micro-architectures and physico-chemical  characteristics.,Non-OADS,/arxiv_data1/oa_pdf/72/70/bmb-49-655.PMC5346310.pdf
Polymer brush for tissue engineering Woonjung Kim and Jongjin Jung 660 BMB Reports http://bmbreports.orgmetals as a form of nanotechnology.,OADS,/arxiv_data1/oa_pdf/72/70/bmb-49-655.PMC5346310.pdf
Polymer brush for tissue engineering Woonjung Kim and Jongjin Jung 661 http://bmbreports.org BMB Reportscell-invasion characteristics.,Non-OADS,/arxiv_data1/oa_pdf/72/70/bmb-49-655.PMC5346310.pdf
"Jae-Hyung Lee, Tel: +82-2-961-9290; Fax:  +82-2-962-0598; E-mail: jaehlee@khu.ac.kr, Ji-Hoi Moon, Tel: +82-2-961-0795; Fax: +82-2-962-0598; E-mail: prudence75@khu.ac.kr https://doi.org/10.5483/BMBRep.2016.49.12.164Received 23 September 2016Keywords: Bioinformatics, Diversity, Human Microbiome Project  (HMP), Next-generation Sequencing (NGS), Oral microbiome ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Probing the diversity of healthy oral microbiome with  bioinformatics approaches Ji-Hoi Moon * & Jae-Hyung Lee * Department of Maxillofacial Biomedical Engineering, School of De ntistry, and Department of Life  and Nanopharmaceutical Sciences ,  Kyung Hee University, Seoul 02447, Korea The human oral cavity contains a highly personalized  microbiome essential to maintaining health, but capable of causing oral and systemic diseases.",Non-OADS,/arxiv_data1/oa_pdf/f1/1f/bmb-49-662.PMC5346311.pdf
Analysis of oral microbiome Ji-Hoi Moon and Jae-Hyung Lee 663 http://bmbreports.org BMB ReportsName 16S rRNA coverage Database URL (reference) CORE Human Oral Bacteria http://microbiome.osu.edu/ (32) RDP Archaea and Bacteria https://rdp.cme.msu.edu/ (33) Human Oral Microbiolome Database Human Oral Bacteria http://www.homd.org/index.,OADS,/arxiv_data1/oa_pdf/f1/1f/bmb-49-662.PMC5346311.pdf
php (65) EzTaxon-e Archaea and Bacteria http://www.ezbiocl oud.net/eztaxon (95) SILVA Archaea and Bacteria https://www.arb-silva.de/ (96) Greengenes Archaea and Bacteria http://greengenes.secondgenome.com/ (97)Table 1.,Non-OADS,/arxiv_data1/oa_pdf/f1/1f/bmb-49-662.PMC5346311.pdf
A number of computational tools have been used for the preprocessing: FastQC (http://www.bioinformatics.,Non-OADS,/arxiv_data1/oa_pdf/f1/1f/bmb-49-662.PMC5346311.pdf
; FASTX- toolkit  (http://hannonlab.cshl.edu/fastx_toolkit/) allows detecting and trimming the low quality region of the individual read  (especially 3’-end of the reads); DUST is used to remove  low-complexity regions in the sequencing read (24).,Non-OADS,/arxiv_data1/oa_pdf/f1/1f/bmb-49-662.PMC5346311.pdf
"Analysis of oral microbiome Ji-Hoi Moon and Jae-Hyung Lee 664 BMB Reports http://bmbreports.orgBody SiteV1-V3 V3-V5  Patients OTUs Estimated richnessaPatients OTUs Estimated richnessa Buccal mucosa 114 2,025 6,635 198 898 4,650 Hard palate 112 1,741 3,793 190 912 3,125 Keratinized gingiva 117 1,545 4,387 206 857 3,352Palatine Tonsils 119 3,683 10,023 204 1,633 9,020 Saliva 99 2,341 6,546 181 1,399 6,801 Subgingival plaque 119 4,216 14,410 204 1,672 11,501Supragingival plaque 121 3,851 11,154 205 1,587 8,254 Throat 110 2,343 5,601 192 1,136 4,154 Tongue dorsum 119 3,651 7,910 205 1,503 7,947Posterior fornix b59 428 1,151 95 400 1,466 Stoolb118 6,050 23,665 209 5,391 33,627 aUpper and lower confidence limits are not included in this table.",Non-OADS,/arxiv_data1/oa_pdf/f1/1f/bmb-49-662.PMC5346311.pdf
"Analysis of oral microbiome Ji-Hoi Moon and Jae-Hyung Lee 665 http://bmbreports.org BMB ReportsMetagenomic WGS data analysis Although the 16S rRNA profiling is a powerful, effective and  straightforward technique to study microbial communities, it only provides the taxonomic composition.",Non-OADS,/arxiv_data1/oa_pdf/f1/1f/bmb-49-662.PMC5346311.pdf
"Recently, several metagenomic analysis pipeline  software have been developed, such as MG-RAST (62) and  IMG/MER (https://img.jgi.doe.gov/cgi-bin/mer/main.cgi).",OADS,/arxiv_data1/oa_pdf/f1/1f/bmb-49-662.PMC5346311.pdf
"Analysis of oral microbiome Ji-Hoi Moon and Jae-Hyung Lee 666 BMB Reports http://bmbreports.orghabitats, the oral habitats have the highest alpha diversity  showing the highest OTU level richness, after the stool samples (Table 2), while the skin and vaginal microbiota show  lower alpha diversity (11, 13).",Non-OADS,/arxiv_data1/oa_pdf/f1/1f/bmb-49-662.PMC5346311.pdf
"Analysis of oral microbiome Ji-Hoi Moon and Jae-Hyung Lee 667 http://bmbreports.org BMB Reportsinnate immune responses to infectious agents, but also tooth  morphologies, vary according to ethnic affiliation (75-78).",Non-OADS,/arxiv_data1/oa_pdf/f1/1f/bmb-49-662.PMC5346311.pdf
"Analysis of oral microbiome Ji-Hoi Moon and Jae-Hyung Lee 668 BMB Reports http://bmbreports.orgACKNOWLEDGEMENTS This work was supported by the Ministry of Science, ICT &  Future Planning (NRF-2015R1C1A2A01054588) and the  National Honor Scientist Program (NRF-2012R1A3A1050385).",OADS,/arxiv_data1/oa_pdf/f1/1f/bmb-49-662.PMC5346311.pdf
Analysis of oral microbiome Ji-Hoi Moon and Jae-Hyung Lee 669 http://bmbreports.org BMB Reportsdata.,OADS,/arxiv_data1/oa_pdf/f1/1f/bmb-49-662.PMC5346311.pdf
"Analysis of oral microbiome Ji-Hoi Moon and Jae-Hyung Lee 670 BMB Reports http://bmbreports.organalysis of the human saliva microbiome from different  climate zones: Alaska, Germany, and Africa.",OADS,/arxiv_data1/oa_pdf/f1/1f/bmb-49-662.PMC5346311.pdf
"ac.kr https://doi.org/10.5483/BMBRep.2016.49.12.184Received 27 October 2016, Revised 15 November 2016,  Accepted 15 November 2016 Keywords: Epigenetics, Learning and memory, Neurodegenerative diseases ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Age-related epigenetic regulation in the brain and its role in  neuronal diseases Jeongsil Kim-Ha1 & Young-Joon Kim2,3,* 1Department of Integrative Bioscience and Biotechnology, College of Life Sciences, Sejong University, Seoul 05006, 2Department of  Integrated Omics for Biomedical Science, Graduate School, Yonsei University, 3Department of Biochemistry, College of Life Science and  Technology, Yonsei University, Seoul 03722, Korea Accumulating evidence indicates many brain functions are  mediated by epigenetic regulation of neural genes, and their dysregulations result in neuronal disorders.",Non-OADS,/arxiv_data1/oa_pdf/95/97/bmb-49-671.PMC5346312.pdf
Age-related epigenetic regulation in the brain Jeongsil Kim-Ha and Young-Joon Kim 672 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/95/97/bmb-49-671.PMC5346312.pdf
"Age-related epigenetic regulation in the brain Jeongsil Kim-Ha and Young-Joon Kim 673 http://bmbreports.org BMB Reportsspecific genes vulnerable to aging (25, 26).",Non-OADS,/arxiv_data1/oa_pdf/95/97/bmb-49-671.PMC5346312.pdf
"Age-related epigenetic regulation in the brain Jeongsil Kim-Ha and Young-Joon Kim 674 BMB Reports http://bmbreports.orgdifferent regions of the genome in AD patients, involving  global as well as local dysregulation of DNA methylation (43).",OADS,/arxiv_data1/oa_pdf/95/97/bmb-49-671.PMC5346312.pdf
Age-related epigenetic regulation in the brain Jeongsil Kim-Ha and Young-Joon Kim 675 http://bmbreports.org BMB Reportsobserved in PD model mice and patients (62).,OADS,/arxiv_data1/oa_pdf/95/97/bmb-49-671.PMC5346312.pdf
Age-related epigenetic regulation in the brain Jeongsil Kim-Ha and Young-Joon Kim 676 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/95/97/bmb-49-671.PMC5346312.pdf
Age-related epigenetic regulation in the brain Jeongsil Kim-Ha and Young-Joon Kim 677 http://bmbreports.org BMB Reportsand are secreted in the cerebrospinal fluid or blood (87); they  would therefore reflect the microRNA profile inside the brain.,OADS,/arxiv_data1/oa_pdf/95/97/bmb-49-671.PMC5346312.pdf
Age-related epigenetic regulation in the brain Jeongsil Kim-Ha and Young-Joon Kim 678 BMB Reports http://bmbreports.org603-649  11.,Non-OADS,/arxiv_data1/oa_pdf/95/97/bmb-49-671.PMC5346312.pdf
Age-related epigenetic regulation in the brain Jeongsil Kim-Ha and Young-Joon Kim 679 http://bmbreports.org BMB ReportsAlzheimer's disease patient.,Non-OADS,/arxiv_data1/oa_pdf/95/97/bmb-49-671.PMC5346312.pdf
Age-related epigenetic regulation in the brain Jeongsil Kim-Ha and Young-Joon Kim 680 BMB Reports http://bmbreports.orgHuntington disease activity in man and mouse.,Non-OADS,/arxiv_data1/oa_pdf/95/97/bmb-49-671.PMC5346312.pdf
"https://doi.org/10.5483/BMBRep.2016.49.12.132Received 4 August 2016, Revised 30 August 2016,  Accepted 10 October 2016 Keywords: Class II fructose 1,6-bisphosphate aldolase, Inorganic  cofactor, Metal ion, X-ray crystallography ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Crystallographic snapshots of active site metal shift in E. coli  fructose 1,6-bisphosphate aldolase Huyen-Thi Tran1,2,#, Seon-Hwa Lee3,#, Thien-Hoang Ho1, Seung-Hye Hong3, Kim-Hung Huynh1, Yeh-Jin Ahn4,  Deok-Kun Oh3,* & Lin-Woo Kang1,* 1Department of Biological Sciences, Konkuk University, Seoul 05029, Korea, 2Department of Biotechnology and Food Technology,  Industrial University of Ho Chi Minh City, 12 Nguyen Van Bao Street, Ward 4, Go Vap District, Ho Chi Minh City, Vietnam, 3Department  of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Korea, 4Department of Life Science, Sangmyung University, Seoul  03016, Korea Fructose 1,6-bisphosphate aldolase (FBA) is important for both  glycolysis and gluconeogenesis in life.",Non-OADS,/arxiv_data1/oa_pdf/e3/da/bmb-49-681.PMC5346313.pdf
682 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/e3/da/bmb-49-681.PMC5346313.pdf
683 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/e3/da/bmb-49-681.PMC5346313.pdf
684 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/e3/da/bmb-49-681.PMC5346313.pdf
685 http://bmbreports.org BMB Reports5'-ATAATGCGGCCGC TTACAGAACGTCGATCGCGTT-3'.,OADS,/arxiv_data1/oa_pdf/e3/da/bmb-49-681.PMC5346313.pdf
686 BMB Reports http://bmbreports.orgREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e3/da/bmb-49-681.PMC5346313.pdf
"https://doi.org/10.5483/BMBRep.2016.49.12.169Received 6 October 2016, Revised 17 October 2016,  Accepted 19 October 2016 Keywords: Hypoxia, Microglia, Oxidative stress, 3-(Naphthalen-2-  yl(propoxy)methyl)azetidine hydrochloride ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Protective effect of 3-(naphthalen-2-yl(propoxy)methyl)azetidine  hydrochloride on hypoxia-induced toxicity by suppressing microglial activation in BV-2 cells Jiae Kim1,#, Su-Min Kim2,#, Jung-Min Na1, Hoh-Gyu Hahn3, Sung-Woo Cho1,* & Seung-Ju Yang2,* 1Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine, Seoul 05505, 2Department of Biomedical  Laboratory Science, Konyang University, Daejeon 35365, 3Chemical Kinomics Research Center, Korea Institute of Science and Technology,  Seoul 02456, Korea We recently reported the anti-inflammatory effects of  3-(naphthalen-2-yl(propoxy)me thyl)azetidine hydrochloride  (KHG26792) on the ATP-induced activation of the NFAT and  MAPK pathways through the P2X7 receptor in microglia.",Non-OADS,/arxiv_data1/oa_pdf/7d/0c/bmb-49-687.PMC5346314.pdf
688 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/7d/0c/bmb-49-687.PMC5346314.pdf
689 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/7d/0c/bmb-49-687.PMC5346314.pdf
690 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/7d/0c/bmb-49-687.PMC5346314.pdf
691 http://bmbreports.org BMB Reportscompound.,Non-OADS,/arxiv_data1/oa_pdf/7d/0c/bmb-49-687.PMC5346314.pdf
"692 BMB Reports http://bmbreports.orgANOVA, followed by Student’s t-test, and a threshold of P ＜  0.01 was used to define statistical significance.",OADS,/arxiv_data1/oa_pdf/7d/0c/bmb-49-687.PMC5346314.pdf
"Tel: +82-62-230-6655; Fax: +82-62-230-  6650; E-mail: sangkeesong@chosun.ac.kr https://doi.org/10.5483/BMBRep.2016.49.12.180Received 24 October 2016, Revised 28 October 2016,  Accepted 2 November 2016 Keywords: Arabidopsis thaliana , EDS1-dependent defense-related gene expression, EDS1-independent defense-related gene expres-sion, Stunted growth, Toll/Interleuin-1 receptor domain protein ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Misexpression of AtTX12 encoding a Toll/interleukin-1  receptor domain induces growth defects and expression of defense-related genes partially independently of EDS1 in Arabidopsis Sang-Kee Song * Department of Biology, Chosun University, Gwangju 61452, Korea In this study, a tissue-specific GAL4/UAS activation tagging  system was used for the characterization of genes which could induce lethality when ubiquitously expressed.",Non-OADS,/arxiv_data1/oa_pdf/97/1f/bmb-49-693.PMC5346315.pdf
AtTX12 functions partially independently of EDS1 Sang-Kee Song 694 BMB Reports http://bmbreports.org Fig.,OADS,/arxiv_data1/oa_pdf/97/1f/bmb-49-693.PMC5346315.pdf
AtTX12 functions partially independently of EDS1 Sang-Kee Song 695 http://bmbreports.org BMB Reports Fig.,OADS,/arxiv_data1/oa_pdf/97/1f/bmb-49-693.PMC5346315.pdf
AtTX12 functions partially independently of EDS1 Sang-Kee Song 696 BMB Reports http://bmbreports.org Fig.,OADS,/arxiv_data1/oa_pdf/97/1f/bmb-49-693.PMC5346315.pdf
AtTX12 functions partially independently of EDS1 Sang-Kee Song 697 http://bmbreports.org BMB Reportsabsence of any functional EDS1 thereby withstood the  increased expression of AtTX12 and remained healthy (Fig.,Non-OADS,/arxiv_data1/oa_pdf/97/1f/bmb-49-693.PMC5346315.pdf
AtTX12 functions partially independently of EDS1 Sang-Kee Song 698 BMB Reports http://bmbreports.orgACKNOWLEDGEMENTS This work was supported by the National Research Foundation  of Korea (grant no.,OADS,/arxiv_data1/oa_pdf/97/1f/bmb-49-693.PMC5346315.pdf
"E-mail: cchoi@kaist.ac.kr https://doi.org/10.5483/BMBRep.2016.49.11.174Received 10 October 2016Keywords: Drug delivery, Exosome, Extracellular vesicles, Light-in- duced protein-protein interaction, Protein drug Abbreviations:  CIB1, CRY-interacting basic-helix-loop-helix 1; CIBN, a truncated version of CIB1; CRY2, cryptochrome 2; EV , Extracel-lular vesicles; EXPLOR, Exosomes for protein loading via optically reversible protein-protein interaction; MVB, Multivesicular bodies Perspective to:  Nambin Yim et al (2016) Exosome engineering for  efficient intracellular delivery of soluble proteins using optically re-versible protein-protein interaction module.",Non-OADS,/arxiv_data1/oa_pdf/02/96/bmb-49-585.PMC5346316.pdf
Extracellular vesicles as novel carriers for therapeutic molecules Nambin Yim and Chulhee Choi 586 BMB Reports http://bmbreports.org Fig.,OADS,/arxiv_data1/oa_pdf/02/96/bmb-49-585.PMC5346316.pdf
"E-mail: ekim@ajou.ac.kr https://doi.org/10.5483/BMBRep.2016.49.11.178Received 17 October 2016Keywords: Circadian rhythm, CLOCK, Drosophila , PERIOD, TTFL Abbreviations:  DN, dorsal neuron; LN V, ventral lateral neuron;  SCN, suprachiasmatic nucleus; TTFL, Transcriptional/TranslationalFeedback Loop Perspective to:  Euna Lee, 2016, Pacemaker-neuron-dependent dis- turbance of the molecular clockwork by a Drosophila CLOCK mu- tant homologous to the mouse Clock mutation.",Non-OADS,/arxiv_data1/oa_pdf/12/12/bmb-49-587.PMC5346317.pdf
588 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/12/12/bmb-49-587.PMC5346317.pdf
589 http://bmbreports.org BMB Reportsin LN vs vs. DNs.,Non-OADS,/arxiv_data1/oa_pdf/12/12/bmb-49-587.PMC5346317.pdf
"Tel: +82-43-840-3903; Fax: +82-43-852-  3616; E-mail: bahk12@empal.com, byoung1@kku.ac.kr https://doi.org/10.5483/BMBRep.2016.49.11.109Received 4 July 2016Keywords: Cholangiocarcinoma, Clonorchiasis, Clonorchis sinensis ,  Liver cancer, Liver flukes ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Clonorchis sinensis , an oriental liver fluke, as a human biological  agent of cholangiocarcinoma: a brief review Tong-Soo Kim1, Jhang Ho Pak2, Jong-Bo Kim3 & Young Yil Bahk3,* 1Department of Parasitology and Tropical Medicine, School of Medicine, Inha University, Incheon 22212, 2Department of Convergence  Medicine, College of Medicine, University of Ulsan, Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, 3Department of  Biotechnology, Konkuk University, Chungju 27478, Korea  Parasitic diseases remain an unarguable public health  problem worldwide.",Non-OADS,/arxiv_data1/oa_pdf/c7/d4/bmb-49-590.PMC5346318.pdf
"591 http://bmbreports.org BMB ReportsLIFE CYCLE OF C. sinensis , SYMPTOMS, DIAGNOSIS  AND EPIDEMIOLOGY C. sinensis  is a leaf-shaped slender digenetic trematode,  measuring 15-20 mm in length and 3-4 mm in width belonging to class Trematoda, phylum Platyhelminthes.",OADS,/arxiv_data1/oa_pdf/c7/d4/bmb-49-590.PMC5346318.pdf
592 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/c7/d4/bmb-49-590.PMC5346318.pdf
593 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/c7/d4/bmb-49-590.PMC5346318.pdf
"594 BMB Reports http://bmbreports.org(LO), cyclooxygenase (COX) and iNOS (59).",OADS,/arxiv_data1/oa_pdf/c7/d4/bmb-49-590.PMC5346318.pdf
595 http://bmbreports.org BMB Reportsinduces cholangiocarcinoma.,Non-OADS,/arxiv_data1/oa_pdf/c7/d4/bmb-49-590.PMC5346318.pdf
596 BMB Reports http://bmbreports.orgclinical features of infection.,Non-OADS,/arxiv_data1/oa_pdf/c7/d4/bmb-49-590.PMC5346318.pdf
"597 http://bmbreports.org BMB Reportsoxidative stress in the genesis and perpetuation of cancer:  Role of lipid peroxidation, DNA damage and Repair.",Non-OADS,/arxiv_data1/oa_pdf/c7/d4/bmb-49-590.PMC5346318.pdf
"Tel: +82-2-2123-5695; Fax: +82-2-362-  9897; E-mail: jso678@yonsei.ac.kr https://doi.org/10.5483/BMBRep.2016.49.11.120Received 21 July 2016Keywords: ARF , ARF knockout mice, Cancer, Posttranslational reg- ulation, Senescence, Tumorigenesis, Ubiquitination ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/a9/bmb-49-598.PMC5346319.pdf
599 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/9a/a9/bmb-49-598.PMC5346319.pdf
600 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/9a/a9/bmb-49-598.PMC5346319.pdf
"601 http://bmbreports.org BMB Reportsof melanoma in a genetically engineered mouse model, while  senescence is induced in p53- but not in ARF-deficient primary melanocytes (32).",Non-OADS,/arxiv_data1/oa_pdf/9a/a9/bmb-49-598.PMC5346319.pdf
602 BMB Reports http://bmbreports.orgStrain Targeting site Treatment Type of tumor formation Latency Ref  ARF-/- 129svj X  C57BL6 Exon1 None Sarcoma (43%)  Lymphoid malignancies (29%) Carcinoma (17%)  /Squamous cell carcinoma /Pulmonary adenocarcinoma  /Poorly differentiated carcinoma in pancreas /Salivary gland carcinoma  Tumors of the nervous system (11%)  /Spinal cord neural sheath tumor/Glioma ∼38 weeks 56  DMBA Squamous cell carcinoma  /+Lymphoma /+Sarcoma and adnexal tumor  /+Sarcoma and lymphomax  /+sarcoma ∼24 weeks  X-ray Sarcomas  Lymphoma Meningeal tumor  ARF-/- FVB Exon1  None Small lymphoma (33%)  Malig.,Non-OADS,/arxiv_data1/oa_pdf/9a/a9/bmb-49-598.PMC5346319.pdf
"603 http://bmbreports.org BMB ReportsTissue  typeARF status Frequency  (%) Ref Breast Low mRNA 77 70  Promoter methylation 50  HD 11.5  LOH 27 High mRNA  17  No alteration 88  Promoter methylation 24 71  Bladder Promoter methylation 56 72  LOH 22 68 HD 14 Mutation 2  Colon Promoter methylation 33 73  Promoter methylation 50.8 74 Promoter methylation 28.2 80  Promoter methylation 32 75  Liver Promoter methylation 25 76 HD 4  LOH 16  Promoter methylation 12 77 HD 2.3 67 Mutation 4.6  High mRNA 93.2  Gastric Promoter methylation (diffuse type) 45.5 78  Promoter methylation (intestinal) 25  Lung Promoter methylation 30 69  LOH 26  Promoter methylation 8 79  Oral Promoter methylation 18 66  HD 12  Promoter methylation 43.8 64  HD 26.5  Prostate Promoter methylation 6.25 65  HD 6.25  Kidney HD 23.5 81 Brain Promoter methylation 22 79  HD: Homologus Deletion, LOH: Loss Of Heterozygosity.Table 2.",Non-OADS,/arxiv_data1/oa_pdf/9a/a9/bmb-49-598.PMC5346319.pdf
604 BMB Reports http://bmbreports.orgREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9a/a9/bmb-49-598.PMC5346319.pdf
605 http://bmbreports.org BMB ReportsMatsuoka M (2002) p53-independent apoptosis is induced  by the p19ARF tumor suppressor.,Non-OADS,/arxiv_data1/oa_pdf/9a/a9/bmb-49-598.PMC5346319.pdf
606 BMB Reports http://bmbreports.org420 67.,Non-OADS,/arxiv_data1/oa_pdf/9a/a9/bmb-49-598.PMC5346319.pdf
"Tel: +1-713-834-6151; Fax: +1-713-563-  4235; E-mail: jlee@mdanderson.org https://doi.org/10.5483/BMBRep.2016.49.11.145Received 16 August 2016Keywords: Clinical significance, Genomics, Methylation, Proteo- mics, The cancer genome atlas ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Exploring cancer genomic data from the cancer genome atlas  project Ju-Seog Lee * Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA  The Cancer Genome Atlas (TCGA) has compiled genomic,  epigenomic, and proteomic data from more than 10,000 samples derived from 33 types of cancer, aiming to improve  our understanding of the molecular basis of cancer development.",Non-OADS,/arxiv_data1/oa_pdf/d9/d3/bmb-49-607.PMC5346320.pdf
Analysis of TCGA data Ju-Seog Lee 608 BMB Reports http://bmbreports.orgin use of the data.,OADS,/arxiv_data1/oa_pdf/d9/d3/bmb-49-607.PMC5346320.pdf
Analysis of TCGA data Ju-Seog Lee 609 http://bmbreports.org BMB Reports Fig.,OADS,/arxiv_data1/oa_pdf/d9/d3/bmb-49-607.PMC5346320.pdf
"However,  as of July 15th, 2016, the TCGA Data Portal is no longer  operational and all TCGA data now resides at the Genomic  Data Commons (GDC, https://gdc-portal.nci.nih.gov/).",OADS,/arxiv_data1/oa_pdf/d9/d3/bmb-49-607.PMC5346320.pdf
Access to controlled data is  typically granted by program-specific Data Access Committees  (https://gdc.nci.nih.gov/access-data/obtaining-access-controlled- data).,OADS,/arxiv_data1/oa_pdf/d9/d3/bmb-49-607.PMC5346320.pdf
Public availability of the data is ruled by the NIH Genomic  Data Sharing Policy (https://gds.nih.gov/).,OADS,/arxiv_data1/oa_pdf/d9/d3/bmb-49-607.PMC5346320.pdf
Processed high level data are also available from UCSC  Cancer Genomics Browser (https://genome-cancer.ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/d9/d3/bmb-49-607.PMC5346320.pdf
"In addition to genomic,  proteomic, and clinical data, TCGA also offers radiological  imaging data from TCGA patients through The Cancer Imaging Archive, TCIA (http://www.cancerimagingarchive.net) in order  to stimulate imaging phenotype-genotype study (16).",OADS,/arxiv_data1/oa_pdf/d9/d3/bmb-49-607.PMC5346320.pdf
Analysis of TCGA data Ju-Seog Lee 610 BMB Reports http://bmbreports.org Fig.,OADS,/arxiv_data1/oa_pdf/d9/d3/bmb-49-607.PMC5346320.pdf
"The Broad GDAC Firehose (http://gdac.broadinstitute.org/) is a  web portal site that has been developed by the Broad Institute, aiming to deliver automated analyses of the TCGA data to  general users.",OADS,/arxiv_data1/oa_pdf/d9/d3/bmb-49-607.PMC5346320.pdf
Expression of  genes of interest across all cancer types can be also easily  assessed in firebrowse (http://firebrowse.org/).,Non-OADS,/arxiv_data1/oa_pdf/d9/d3/bmb-49-607.PMC5346320.pdf
PROGgeneV2 (http://watson.compbio.iupui.edu/chirayu/proggene/  database/) provide survival analysis of patients from multiple cohorts in database (18).,OADS,/arxiv_data1/oa_pdf/d9/d3/bmb-49-607.PMC5346320.pdf
"Mexpress (http://mexpress.be/) prov ides easy-to-use data  visualization tool of the TCGA data including mRNA ex- pression, DNA methylation, and clinical data (19).",OADS,/arxiv_data1/oa_pdf/d9/d3/bmb-49-607.PMC5346320.pdf
Analysis of TCGA data Ju-Seog Lee 611 http://bmbreports.org BMB ReportsREFERENCES 1.,OADS,/arxiv_data1/oa_pdf/d9/d3/bmb-49-607.PMC5346320.pdf
"Haihong Shen, Tel: +82-62-715-2507; Fax: +82-62-715-2484; E-mail: haihongshen@gist.ac.kr, Xuexiu Zheng,  Tel: +82-62-715-2520; Fax: +82-62-715-2484; E-mail: xuexiuzheng@ gist.ac.kr https://doi.org/10.5483/BMBRep.2016.49.11.118Received 21 July 2016, Revised 22 July 2016,  Accepted 16 August 2016 Keywords: CD44, Pre-mRNA splicing, SR protein, V 6 exon ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.SR proteins regulate V 6 exon splicing of CD44 pre-mRNA Tiing Jen Loh1, Heegyum Moon1, Ha Na Jang1, Yongchao Liu1, Namjeong Choi1, Shengfu Shen2, Darren Reece Williams1,  Da-Woon Jung1, Xuexiu Zheng1,* & Haihong Shen1,* 1School of life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Korea, 2Willston Northampton School,  Easthampton, MA 01027, USA CD44 pre-mRNA includes 20 exons, of which exons 1-5  (C1-C5) and exons 16-20 (C 6-C10) are constant exons, whereas  exons 6-15 (V 1-V10) are variant exons.",Non-OADS,/arxiv_data1/oa_pdf/bd/f6/bmb-49-612.PMC5346321.pdf
613 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/bd/f6/bmb-49-612.PMC5346321.pdf
614 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/bd/f6/bmb-49-612.PMC5346321.pdf
615 http://bmbreports.org BMB Reportsanalyzed the SR proteins function by reducing their expression  levels through shRNA treatment.,Non-OADS,/arxiv_data1/oa_pdf/bd/f6/bmb-49-612.PMC5346321.pdf
616 BMB Reports http://bmbreports.orgrestricted tissue expression in transcripts encoding the  mouse pgp-1 (cd44) homing receptor.,Non-OADS,/arxiv_data1/oa_pdf/bd/f6/bmb-49-612.PMC5346321.pdf
"Present Address of Christine Seok Young Chung: Amherst College,  Amherst, MA 01002, USA https://doi.org/10.5483/BMBRep.2016.49.11.117Received 21 July 2016, Revised 4 August 2016,  Accepted 24 August 2016 Keywords: Akt/MAPK, Ischemia, Oxidative stress, Protein therapy,  Tat-NQO1 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Protective effects of Tat-NQO1 against oxidative  stress-induced HT-22 cell damage, and ischemic injury in animals Hyo Sang Jo1,#, Duk-Soo Kim2,#, Eun Hee Ahn1,#, Dae Won Kim3, Min Jea Shin1, Su Bin Cho1, Jung Hwan Park1,  Chi Hern Lee1, Eun Ji Yeo1, Yeon Joo Choi1, Hyeon Ji Yeo1, Christine Seok Young Chung1, Sung-Woo Cho4,  Kyu Hyung Han1, Jinseu Park1, Won Sik Eum1,* & Soo Young Choi1,* 1Department of Biomedical Science and Research Institute of Bi oscience and Biotechnology, Hallym University, Chuncheon 24252,   2Department of Anatomy, College of Medici ne, Soonchunhyang University, Cheonan 31538, 3Department of Biochemistry and Molecular  Biology, Research Institute of Oral Sciences, College of Dentistry, Gangneung-Wonju National University, Gangneung 25457, 4Department  of Biochemistry and Molecular Biology, University of Ulsan College of Medicine, Seoul 05505, Korea Oxidative stress is closely associated with various diseases and  is considered to be a major factor in ischemia.",Non-OADS,/arxiv_data1/oa_pdf/04/7e/bmb-49-617.PMC5346322.pdf
618 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/04/7e/bmb-49-617.PMC5346322.pdf
619 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/04/7e/bmb-49-617.PMC5346322.pdf
620 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/04/7e/bmb-49-617.PMC5346322.pdf
621 http://bmbreports.org BMB ReportsREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/04/7e/bmb-49-617.PMC5346322.pdf
622 BMB Reports http://bmbreports.orgCelastrol ameliorates cytokine toxicity and pro-inflammatory  immune responses by suppressing NF- B activation in  RINm5F beta cells.,Non-OADS,/arxiv_data1/oa_pdf/04/7e/bmb-49-617.PMC5346322.pdf
"Tel: +86-0898-68642221; Fax: +86-898-  68642222; E-mail: drligao117@163.com https://doi.org/10.5483/BMBRep.2016.49.11.133Received 4 August 2016, Revised 25 August 2016,  Accepted 23 September 2016 Keywords: GPR78, Lung cancer, Metastasis, Rho GTPase ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.GPR78 promotes lung cancer cell  migration and metastasis by  activation of G q-Rho GTPase pathway Dan-Dan Dong1, Hui Zhou2 & Gao Li3,* 1Department of Pathology, Sichuan Academy of Medical Sciences , Sichuan Provincial People’s Hospital, Chengdu 610072, Sichuan,  2Department of Thoracic Medicine, The Affiliated Cancer Hospital  of Xiangya School of Medicine, Central South University, Changs ha  410013, Hunan, 3Thoracic Surgery , Hainan General Hospital, Haikou 570311, Hainan, PR China GPR78 is an orphan G-protein coupled receptor (GPCR) that is  predominantly expressed in human brain tissues.",Non-OADS,/arxiv_data1/oa_pdf/16/0c/bmb-49-623.PMC5346323.pdf
624 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/16/0c/bmb-49-623.PMC5346323.pdf
625 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/16/0c/bmb-49-623.PMC5346323.pdf
626 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/16/0c/bmb-49-623.PMC5346323.pdf
627 http://bmbreports.org BMB ReportsImmortalized HBEC3 and HBEC4 cells were cultured in  Keratinocyte Serum Free media (KSFM) (Gibco) at 37oC and  5% CO 2.,OADS,/arxiv_data1/oa_pdf/16/0c/bmb-49-623.PMC5346323.pdf
628 BMB Reports http://bmbreports.orgcoupled receptors at a glance.,OADS,/arxiv_data1/oa_pdf/16/0c/bmb-49-623.PMC5346323.pdf
"Tel: +82-33-248-2635; Fax: +82-33-241-  3640; E-mail: hjookwon@hallym.ac.kr https://doi.org/10.5483/BMBRep.2016.49.11.151Received 29 August 2016, Revised 17 September 2016,  Accepted 27 September 2016 Keywords: Domains, Localization, Tissue expression, TMCC3,  14-3-3 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Expression and characterization of transmembrane and  coiled-coil domain family 3 Wern-Joo Sohn1, Jae-Young Kim1, Dongbum Kim2, Jeong-A Park3, Younghee Lee3 & Hyung-Joo Kwon2,4,* 1Department of Biochemistry, School of Dentistry,  IHBR, Kyungpook National University, Daegu 41940, 2Center for Medical Science  Research, College of Medicine, Hallym University, Chuncheon 24252, 3Department of Biochemistry, College of Natural Sciences,  Chungbuk National University, Cheongju 28644, 4Department of Microbiology, College of Medicine, Hallym University, Chuncheon  24252, Korea Transmembrane and coiled-coil domain family 3 (TMCC3) has  been reported to be expressed in the human brain; however, its function is still unknown.",Non-OADS,/arxiv_data1/oa_pdf/57/5f/bmb-49-629.PMC5346324.pdf
630 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/57/5f/bmb-49-629.PMC5346324.pdf
631 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/57/5f/bmb-49-629.PMC5346324.pdf
"According to the accumulated information  regarding the TMCC3 gene in the human genome database  GeneCards (http://www.genecards.org), TMCC3 RNA is ex-pressed widely with subtle difference depending on the  analysis methods used (e.g., microarray, RNAseq or serial  analysis of gene expression: SAGE).",OADS,/arxiv_data1/oa_pdf/57/5f/bmb-49-629.PMC5346324.pdf
632 BMB Reports http://bmbreports.orgbe involved in protein-protein interactions and oligomeri- zation.,OADS,/arxiv_data1/oa_pdf/57/5f/bmb-49-629.PMC5346324.pdf
"633 http://bmbreports.org BMB Reportsthe human embryonic kidney cell line, HEK 293, from the  American Type Culture Collection (ATCC, Manassas, VA, USA).",Non-OADS,/arxiv_data1/oa_pdf/57/5f/bmb-49-629.PMC5346324.pdf
"The amino acid  sequences of the resulting peptides were analyzed using the database from the National Center for Biotechnology  Information (NCBI, http://www.ncbi.nlm.nih.gov).",OADS,/arxiv_data1/oa_pdf/57/5f/bmb-49-629.PMC5346324.pdf
634 BMB Reports http://bmbreports.orgIdentification of novel genes regulated in the developing  human ventral mesencephalon.,Non-OADS,/arxiv_data1/oa_pdf/57/5f/bmb-49-629.PMC5346324.pdf
"Tel: +82-2-2030-5345; Fax: +82-2-2030-  7899; E-mail: leej@kuh.ac.kr https://doi.org/10.5483/BMBRep.2016.49.11.172Received 9 October 2016, Revised 14 October 2016,  Accepted 17 October 2016 Keywords: Eph/ephrin expression, Reactive astrocytes, Stroke, Stroke recovery, Task-specific training ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Effect of task-specific training on Eph/ephrin expression after  stroke Dong-Hee Choi1,3, Jin-Hee Ahn1, In-Ae Choi1, Ji-Hye Kim3, Bo-Ram Kim2 & Jongmin Lee2,3,* Departments of 1Medical Science, 2Rehabilitation Medicine, Konkuk University School of Medicine, 3Center for Neuroscience Research,  Institute of Biomedical Science and Techno logy, Konkuk University, Seoul 05029, Korea Recent evidence indicates that the ephrin receptors and ephrin  ligands (Eph/ephrin) expression modulate axonal reorganiza-tion and synaptic plasticity in stroke recovery.",Non-OADS,/arxiv_data1/oa_pdf/e6/12/bmb-49-635.PMC5346325.pdf
636 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/e6/12/bmb-49-635.PMC5346325.pdf
637 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/e6/12/bmb-49-635.PMC5346325.pdf
638 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/e6/12/bmb-49-635.PMC5346325.pdf
639 http://bmbreports.org BMB Reports(Permit Number: KU13123).,Non-OADS,/arxiv_data1/oa_pdf/e6/12/bmb-49-635.PMC5346325.pdf
"640 BMB Reports http://bmbreports.orggrant to JL), a grant from the Korea Health Technology R&D  Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare,  Republic of Korea (grant number: HI14C2339), and the  National Research Foundation of Korea (NRF) grant funded by the Korea government (NRF-2016R1A5A2012284).",Non-OADS,/arxiv_data1/oa_pdf/e6/12/bmb-49-635.PMC5346325.pdf
"Available at http://www.pop- data.bc.ca/data Bertakis, K. D., R. Azari, L. J. Helms, E. J. Callahan, and J.",Non-OADS,/arxiv_data1/oa_pdf/a0/46/HESR-52-697.PMC5346502.pdf
"Available at http://www2.gov.bc.ca/gov/content/health/health-drug-coverage/pharmacare-for-bc-residents/pharmanet Hanley, G., and S. Morgan.",Non-OADS,/arxiv_data1/oa_pdf/a0/46/HESR-52-697.PMC5346502.pdf
"Available at http://www.oecd.org/els/health-systems/ oecd-health-statistics-2014-frequently-requested-data.htm Øymoen, A., A. Potteg ård, and A.",OADS,/arxiv_data1/oa_pdf/a0/46/HESR-52-697.PMC5346502.pdf
Avail- able at http://apps.who.int/medicinedocs/en/d/Js20039en/ WHO Collaborating Centre for Drug Statistics Methodology.,OADS,/arxiv_data1/oa_pdf/a0/46/HESR-52-697.PMC5346502.pdf
"Available at http://www.whocc.no/atcddd/ Woodward, M. C. 2003.",OADS,/arxiv_data1/oa_pdf/a0/46/HESR-52-697.PMC5346502.pdf
"31 https://doi.org/10.3345/kjp.2017.60.2.31Korean J Pediatr 2017;60(2):31-37 Management issues of congenital adrenal  hyperplasia during the transition from pediatric to adult care Jin-Ho Choi, MD, PhD, Han-Wook Yoo, MD, PhD  Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Steroid 21-hydroxylase deficiency is the most prevalent form of congenital adrenal hyperplasia (CAH),  accounting for approximately 95% of cases.",Non-OADS,/arxiv_data1/oa_pdf/1f/c4/kjped-60-31.PMC5346506.pdf
"Successful transition from pediatric to adult  care requires regular follow-up of patients by a multidisciplinary team including pediatric Corresponding author: Jin-Ho Choi, MD, PhD Department of Pediatrics, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, KoreaTel: +82-2-3010-3991Fax: +82-2-473-3725E-mail: jhc@amc.seoul.kr Received: 20 November, 2015 Revised: 21 January, 2016Accepted: 13 February, 2016 Copyright © 2017 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2017;60(2):31-37 https://doi.org/10.3345/kjp.2017.60.2.31pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/1f/c4/kjped-60-31.PMC5346506.pdf
"https://doi.org/10.3345/kjp.2017.60.2.31Choi JH and Yoo HW • Management of adults with congenital adrenal hyperplasia 32endocrinologists, urologists, gynecologists, psychiatrists, and  adult endocrinologists.",Non-OADS,/arxiv_data1/oa_pdf/1f/c4/kjped-60-31.PMC5346506.pdf
33 https://doi.org/10.3345/kjp.2017.60.2.31Korean J Pediatr 2017;60(2):31-37 potential metabolic consequences of obesity2).,Non-OADS,/arxiv_data1/oa_pdf/1f/c4/kjped-60-31.PMC5346506.pdf
"https://doi.org/10.3345/kjp.2017.60.2.31Choi JH and Yoo HW • Management of adults with congenital adrenal hyperplasia 34The need for mineralocorticoids decreases with age, because  levels of serum aldosterone are high and renal mineralocorticoid  receptor mRNA are low at birth36).",Non-OADS,/arxiv_data1/oa_pdf/1f/c4/kjped-60-31.PMC5346506.pdf
"35 https://doi.org/10.3345/kjp.2017.60.2.31Korean J Pediatr 2017;60(2):31-37 abscesses, cysts, or scar tissue35).",Non-OADS,/arxiv_data1/oa_pdf/1f/c4/kjped-60-31.PMC5346506.pdf
https://doi.org/10.3345/kjp.2017.60.2.31Choi JH and Yoo HW • Management of adults with congenital adrenal hyperplasia 36Pescovitz OH.,Non-OADS,/arxiv_data1/oa_pdf/1f/c4/kjped-60-31.PMC5346506.pdf
37 https://doi.org/10.3345/kjp.2017.60.2.31Korean J Pediatr 2017;60(2):31-37 Am 2001;30:207-29.,Non-OADS,/arxiv_data1/oa_pdf/1f/c4/kjped-60-31.PMC5346506.pdf
"https://doi.org/10.3345/kjp.2017.60.2.38Park S, et al.",OADS,/arxiv_data1/oa_pdf/1d/a7/kjped-60-38.PMC5346507.pdf
"Meanwhile, after Laxer and Petty7) reported the existence of hyponatremia in patients  with KD in 1982, several studies reported about the relevance between serum sodium level Corresponding author: Lucy Youngmin Eun, MD,  PhDDivision of Pediatric Cardiology, Department of Pediatrics, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, KoreaTel: +82-2-2019-3350Fax: +82-2-3461-9473E-mail: lucyeun@yuhs.ac  Received: 8 September, 2016 Revised: 14 October, 2016Accepted: 18 October, 2016 Copyright © 2017 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2017;60(2):38-44 https://doi.org/10.3345/kjp.2017.60.2.38pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/1d/a7/kjped-60-38.PMC5346507.pdf
39 https://doi.org/10.3345/kjp.2017.60.2.38Korean J Pediatr 2017;60(2):38-44 and inflammation status of disease.,Non-OADS,/arxiv_data1/oa_pdf/1d/a7/kjped-60-38.PMC5346507.pdf
"https://doi.org/10.3345/kjp.2017.60.2.38Park S, et al.",OADS,/arxiv_data1/oa_pdf/1d/a7/kjped-60-38.PMC5346507.pdf
41 https://doi.org/10.3345/kjp.2017.60.2.38Korean J Pediatr 2017;60(2):38-44 (P=0.055).,Non-OADS,/arxiv_data1/oa_pdf/1d/a7/kjped-60-38.PMC5346507.pdf
"https://doi.org/10.3345/kjp.2017.60.2.38Park S, et al.",OADS,/arxiv_data1/oa_pdf/1d/a7/kjped-60-38.PMC5346507.pdf
43 https://doi.org/10.3345/kjp.2017.60.2.38Korean J Pediatr 2017;60(2):38-44 opathy.,Non-OADS,/arxiv_data1/oa_pdf/1d/a7/kjped-60-38.PMC5346507.pdf
"https://doi.org/10.3345/kjp.2017.60.2.38Park S, et al.",OADS,/arxiv_data1/oa_pdf/1d/a7/kjped-60-38.PMC5346507.pdf
"45 https://doi.org/10.3345/kjp.2017.60.2.45Korean J Pediatr 2017;60(2):45-49 The serum level of 25-hydroxyvitamin D for  maximal suppression of parathyroid hormone in children: the relationship between 25- hydroxyvitamin D and parathyroid hormone Jung In Kang, MD1, Yoon Suk Lee, MD1, Ye Jin Han, MD1, Kyoung Ae Kong, MD2, Hae Soon Kim, MD1 1Department of Pediatrics, Ewha Womans University School of Medicine, Seoul, 2Clinical Trial Center, Ewha Womans University Medical Center, Seoul, Korea Purpose: Serum level of 25-hydroxyvitamin D (25-OHD) is considered as the most appropriate marker  of vitamin D status.",Non-OADS,/arxiv_data1/oa_pdf/d4/21/kjped-60-45.PMC5346508.pdf
"Subsequently, secondary hyperparathyroidism leads to osteomalacia, irreversible bone loss, Corresponding author: Hae Soon Kim, MD Department of Pediatrics, Ewha Womans Univer - sity School of Medicine, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul 07985, KoreaTel: +82-2-2650-5569Fax: +82-2-2650-3718E-mail: hyesk@ewha.ac.kr Received: 16 July, 2016 Revised: 18 October, 2016Accepted: 25 October, 2016 Copyright © 2017 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2017;60(2):45-49 https://doi.org/10.3345/kjp.2017.60.2.45pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/d4/21/kjped-60-45.PMC5346508.pdf
"https://doi.org/10.3345/kjp.2017.60.2.45Kang JI, et al.",OADS,/arxiv_data1/oa_pdf/d4/21/kjped-60-45.PMC5346508.pdf
47 https://doi.org/10.3345/kjp.2017.60.2.45Korean J Pediatr 2017;60(2):45-49 the 2 groups according to the serum 25-OHD level at the inflec - tion point (18.0 ng/mL) (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/d4/21/kjped-60-45.PMC5346508.pdf
"https://doi.org/10.3345/kjp.2017.60.2.45Kang JI, et al.",OADS,/arxiv_data1/oa_pdf/d4/21/kjped-60-45.PMC5346508.pdf
"49 https://doi.org/10.3345/kjp.2017.60.2.45Korean J Pediatr 2017;60(2):45-49 of PTH, which is compatible with other criteria regarding vitamin  D deficiency.",Non-OADS,/arxiv_data1/oa_pdf/d4/21/kjped-60-45.PMC5346508.pdf
"https://doi.org/10.3345/kjp.2017.60.2.50Shin JW, et al.",OADS,/arxiv_data1/oa_pdf/8e/42/kjped-60-50.PMC5346509.pdf
"This study analyzes the  safety and pharmacokinetics of using LEV in neonates with seizures and develops a  population pharmacokinetics (PPK) model of LEV in Korean neonates.Corresponding author: Soon Min Lee, MD, PhD Department of Pediatrics, Yonsei University Col-lege of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, KoreaTel: +82-2-2019-3350Fax: +82-2-3461-9473E-mail: smlee@yuhs.ac  Received: 19 August, 2016 Revised: 20 October, 2016Accepted: 25 October, 2016 Copyright © 2017 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2017;60(2):50­54 https://doi.org/10.3345/kjp.2017.60.2.50pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/8e/42/kjped-60-50.PMC5346509.pdf
51 https://doi.org/10.3345/kjp.2017.60.2.50Korean J Pediatr 2017;60(2):50-54 Materials and methods 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/kjped-60-50.PMC5346509.pdf
The plots were created using R (http://www.r-project.org).,OADS,/arxiv_data1/oa_pdf/8e/42/kjped-60-50.PMC5346509.pdf
"https://doi.org/10.3345/kjp.2017.60.2.50Shin JW, et al.",OADS,/arxiv_data1/oa_pdf/8e/42/kjped-60-50.PMC5346509.pdf
53 https://doi.org/10.3345/kjp.2017.60.2.50Korean J Pediatr 2017;60(2):50-54 dent kinetics.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/kjped-60-50.PMC5346509.pdf
"https://doi.org/10.3345/kjp.2017.60.2.50Shin JW, et al.",OADS,/arxiv_data1/oa_pdf/8e/42/kjped-60-50.PMC5346509.pdf
"J Contemp Brachytherapy 2017; 9, 1: 30–35   DOI: https://doi.org/10.5114/jcb.2017.65147 Key words: brachytherapy, chemoradiotherapy, esophageal cancer, intraluminal, quality of life.",Non-OADS,/arxiv_data1/oa_pdf/1c/28/JCB-9-29106.PMC5346601.pdf
"J Contemp Brachytherapy 2017; 9, 1: 66–70   DOI: https://doi.org/10.5114/jcb.2017.65163 Key words: edema, HDR, target coverage, tongue cancer.",Non-OADS,/arxiv_data1/oa_pdf/6b/fc/JCB-9-29108.PMC5346602.pdf
"J Contemp Brachytherapy 2017; 9, 1: 59–65   DOI: https://doi.org/10.5114/jcb.2017.65290 Key words: brachytherapy, catheter reconstruction, gynecology, interstitial implants, clinical dosimetry.",Non-OADS,/arxiv_data1/oa_pdf/18/ed/JCB-9-29174.PMC5346603.pdf
"A 3D mod - el of each needle was created with FreeCAD (version  0.14, http://www.freecadweb.org/) and open para- metric modeler software.",OADS,/arxiv_data1/oa_pdf/18/ed/JCB-9-29174.PMC5346603.pdf
"J Contemp Brachytherapy 2017; 9, 1: 14–19  DOI: https://doi.org/10.5114/jcb.2017.65476 Key words: electronic brachytherapy, skin cancer, ultrasound.",Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB-9-29247.PMC5346604.pdf
Available at: http://www.xoft-inc.com/treating_derma.html (accessed 24 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/86/1b/JCB-9-29247.PMC5346604.pdf
"J Contemp Brachytherapy 2017; 9, 1: 71–76  DOI: https://doi.org/10.5114/jcb.2017.65640 Key words: cervix cancer, cervical cancer, pulsed-dose-rate, uterus didelphys.",Non-OADS,/arxiv_data1/oa_pdf/e0/e0/JCB-9-29339.PMC5346605.pdf
"J Contemp Brachytherapy 2017; 9, 1: 20–29   DOI: https://doi.org/10.5114/jcb.2017.65641 Key words: brachytherapy, cost, sarcoma, staged reconstruction, wound-vac.",Non-OADS,/arxiv_data1/oa_pdf/bd/15/JCB-9-29340.PMC5346606.pdf
"J Contemp Brachytherapy 2017; 9, 1: 36–43   DOI: https://doi.org/10.5114/jcb.2017.65839 Key words: californium-252, elderly patients, esophageal squamous cell cancer, neutron brachytherapy, late com - plication.",Non-OADS,/arxiv_data1/oa_pdf/4b/3d/JCB-9-29468.PMC5346607.pdf
"Common Terminology Criteria for Adverse Events VA, 2006: Available at: http://ctep.cancer.gov/protocolDevelopment/ electronic_applications/docs/ctcaev3.pdf.",Non-OADS,/arxiv_data1/oa_pdf/4b/3d/JCB-9-29468.PMC5346607.pdf
"J Contemp Brachytherapy 2017; 9, 1: 79–88   DOI: https://doi.org/10.5114/jcb.2017.65849 Key words: dose calculation, MBDCA, Monte Carlo, TG-43.",Non-OADS,/arxiv_data1/oa_pdf/25/c9/JCB-9-29470.PMC5346608.pdf
"Presented at Joint Brachytherapy Meeting of GEC/ESTRO/ABS, 2004. http://www.xoftinc.com/treating_physics.html.",Non-OADS,/arxiv_data1/oa_pdf/25/c9/JCB-9-29470.PMC5346608.pdf
"White paper,   Elekta Brachytherapy, 2014. http://blog.elekta.com/blog/   2015/04/new-elekta-brachytherapy-white-papers/ Accessed   7 June 2016.",Non-OADS,/arxiv_data1/oa_pdf/25/c9/JCB-9-29470.PMC5346608.pdf
"White paper, GMV SA, 2015. http://www.gmv.com/export/sites/gmv/DocumentosPDF/radiance/radi- ance-white-paper-en_2015.pdf.",Non-OADS,/arxiv_data1/oa_pdf/25/c9/JCB-9-29470.PMC5346608.pdf
http://www.aapm.org/org/structure/default.asp?committee_code=WGDCAB.,Non-OADS,/arxiv_data1/oa_pdf/25/c9/JCB-9-29470.PMC5346608.pdf
Agenda at https://www.americanbrachy-   therapy.org/meetings/annual2016/agenda/.,Non-OADS,/arxiv_data1/oa_pdf/25/c9/JCB-9-29470.PMC5346608.pdf
"J Contemp Brachytherapy 2017; 9, 1: 7–13  DOI: https://doi.org/10.5114/jcb.2017.66043 Key words: breast carcinoma, LAD, pulsed-dose-rate brachytherapy.",Non-OADS,/arxiv_data1/oa_pdf/6e/4f/JCB-9-29506.PMC5346609.pdf
"J Contemp Brachytherapy 2017; 9, 1: 1–6   DOI: https://doi.org/10.5114/jcb.2017.66072 Key words: LDR brachytherapy, high-risk, prostate cancer, seeds.",Non-OADS,/arxiv_data1/oa_pdf/75/81/JCB-9-29511.PMC5346610.pdf
The high-risk patients in the present study included both high-risk and very high-risk  prostate cancer as classified in the current National Can- cer Network Criteria (http://www.nccn.org).,Non-OADS,/arxiv_data1/oa_pdf/75/81/JCB-9-29511.PMC5346610.pdf
"J Contemp Brachytherapy 2017; 9, 1: 44–51   DOI: https://doi.org/10.5114/jcb.2017.66082 Key words: biological dose, EQD2 software, LQL model.",Non-OADS,/arxiv_data1/oa_pdf/40/3a/JCB-9-29512.PMC5346611.pdf
"J Contemp Brachytherapy 2017; 9, 1: 52–58   DOI: https://doi.org/10.5114/jcb.2017.66110  Key words: brachytherapy, cervical cancer, intra-fraction, HDR.",Non-OADS,/arxiv_data1/oa_pdf/eb/41/JCB-9-29516.PMC5346612.pdf
"J Contemp Brachytherapy 2017; 9, 1: 89–98   DOI: https://doi.org/10.5114/jcb.2017.66111 Key words: APBI, breast cancer, interstitial, multicatheter, treatment planning, dosimetry.",Non-OADS,/arxiv_data1/oa_pdf/ad/b1/JCB-9-29517.PMC5346613.pdf
"Study Protocol, European Brachytherapy Breast Can-cer GEC-ESTRO Working Group, 2004; available at: http://www.apbi.uni-erlangen.de/outline/outline.html, Accessed 16 December, 2016.",Non-OADS,/arxiv_data1/oa_pdf/ad/b1/JCB-9-29517.PMC5346613.pdf
"National Surgical Adjuvant Breast and Bowel Project/ Radiation Therapy On-cology Group, Pittsburgh/Philadelphia, 2004; available at: http://atc.wustl.edu/protocols/nsabp/b-39/0413.pdf, Ac-cessed 16 December, 2016.",Non-OADS,/arxiv_data1/oa_pdf/ad/b1/JCB-9-29517.PMC5346613.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/59/67/2186-3326-79-0001.PMC5346614.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/e8/16/2186-3326-79-0017.PMC5346616.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/d5/3b/2186-3326-79-0027.PMC5346617.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/55/81/2186-3326-79-0037.PMC5346618.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/88/61/2186-3326-79-0043.PMC5346619.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ed/51/2186-3326-79-0047.PMC5346620.pdf
"All tumor samples  were independently reviewed by two experienced pathologists and the samples were graded histologically using published criteria.1 4) SNP Selection and Genotyping The Tag-SNPs were selected based on the following criteria: firstly based on the genes in  AKT pathway with the most common somatic copy number aberrations reported previously.7)  Based on that, SNPs of five genes (IRS2, PTEN AKT3, PIK3C2B and PIK3C2G) were selected  and the pathogenic polymorphisms being associated with cancer or other diseases were screened out according to studies reported previously (http://www.ncbi.nlm.nih.gov/SNP).",Non-OADS,/arxiv_data1/oa_pdf/ed/51/2186-3326-79-0047.PMC5346620.pdf
15-19) We finally  pooled 11 tag-SNP derived from the International HapMap Project Database (http://www.hapmap.org).,OADS,/arxiv_data1/oa_pdf/ed/51/2186-3326-79-0047.PMC5346620.pdf
Genotypic was performed using the Sequenom MassARRAY iPLEXTM Platform (http://www.sequenom.com/seq.genotyping.,OADS,/arxiv_data1/oa_pdf/ed/51/2186-3326-79-0047.PMC5346620.pdf
"Statistical Methods For each polymorphism, deviation of the observed genotype frequencies from those expected  under Hardy-Weinberg equilibrium (HWE) was evaluated in the Chi-square test in the SHEsis  analysis platform (http://analysis.bio-x.cn/myAnalysis.php).",OADS,/arxiv_data1/oa_pdf/ed/51/2186-3326-79-0047.PMC5346620.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/81/ca/2186-3326-79-0055.PMC5346621.pdf
"Declaration of Alma-Ata International Conference on Primary Health Care, Alma-Ata, USSR, 6–12  September 1978. http://www.who.int/publications/almaata_declaration_en.pdf (accessed on November.",Non-OADS,/arxiv_data1/oa_pdf/81/ca/2186-3326-79-0055.PMC5346621.pdf
"WHO Traditional Medicine Strategy 2014–2023, http://www.who.int/medicines/publications/traditional/ trm_strategy14_23/en/ (accessed on November.",Non-OADS,/arxiv_data1/oa_pdf/81/ca/2186-3326-79-0055.PMC5346621.pdf
"WHO Traditional Medicine Strategy 2002–2005, http://apps.who.int/medicinedocs/en/d/Js2297e/4.2.html (accessed on November.",Non-OADS,/arxiv_data1/oa_pdf/81/ca/2186-3326-79-0055.PMC5346621.pdf
(http://www.mhlw.go.jp/english/wp/wp-hw8/index.html) (accessed on November.,Non-OADS,/arxiv_data1/oa_pdf/81/ca/2186-3326-79-0055.PMC5346621.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/8b/e8/2186-3326-79-0065.PMC5346622.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/81/62/2186-3326-79-0075.PMC5346623.pdf
"Available at: http://www.nanbyou.or.jp/entry/1356 [accessed 2016/1/19]  8) Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL.",Non-OADS,/arxiv_data1/oa_pdf/81/62/2186-3326-79-0075.PMC5346623.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/d6/8d/2186-3326-79-0085.PMC5346624.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/3a/ce/2186-3326-79-0091.PMC5346625.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/9f/1d/2186-3326-79-0097.PMC5346626.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ae/58/2186-3326-79-0103.PMC5346627.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/cf/f8/2186-3326-79-0109.PMC5346628.pdf
"To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/61/8d/2186-3326-79-0115.PMC5346629.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercialuse, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.",Non-OADS,/arxiv_data1/oa_pdf/04/67/hgtb.2016.151.PMC5346630.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 1Efforts to Find Targets Involving Angiogenesis: Step to  Improve the Efficacy of Target Therapy in the Era of  Colorectal Cancer Treatment   In Ja Park Department of Colon and Rectal Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaEditorial Ann Coloproctol 2017;33(1):1-2 https://doi.org/10.3393/ac.2017.33.1.1 Continuous efforts have been made to find an effective treatment  to improve oncologic outcomes for patients with colorectal can - cer.",Non-OADS,/arxiv_data1/oa_pdf/a3/fd/ac-33-1.PMC5346775.pdf
"Department of Colon and Rectal Surgery, Asan Medical Center, University of  Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505,  Korea Tel: +82-2-3010-3937, Fax: +82-2-474-9027 E-mail: ipark@amc.seoul.kr © 2017 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/fd/ac-33-1.PMC5346775.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 16Single Center Experience With Hyperthermic  Intraperitoneal Chemotherapy  Woo Ram Kim, Hyuk Hur1, Byung Soh Min1, Seung Hyuk Baik2, Kang Y oung Lee1, Nam Kyu Kim1 Department of Surgery, CHA Bundang Medical Center, CHA University, Seongnam; 1Department of Surgery, Y onsei University College of  Medicine, Seoul; 2Department of Surgery, Gangnam Severance Hospital, Seoul, KoreaOriginal Article Ann Coloproctol 2017;33(1):16-22 https://doi.org/10.3393/ac.2017.33.1.16 Purpose:  Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been proposed for  controlling peritoneal seeding metastasis in some kinds of cancers, including those of colorectal origin, but their safety  and oncological benefits are subjects of debate.",Non-OADS,/arxiv_data1/oa_pdf/b6/04/ac-33-16.PMC5346776.pdf
"Department of Surgery, Yonsei University College of Medicine, Yonsei  University Health System, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722,  Korea Tel: +82-2-2228-2117, Fax +82-2-313-8289, E-mail: namkyuk@yuhs.ac © 2017 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/04/ac-33-16.PMC5346776.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 23Transanal Endoscopic Microsurgery for Patients With Rectal  Tumors: A Single Institution’s Experience Audrius Dulskas, Alfredas Kilius, Kestutis Petrulis, Narimantas E. Samalavicius1 Centre of Oncosurgery, National Cancer Institute, Vilnius; 1Centre of Oncosurgery, National Cancer Institute, Clinic of Internal, Family  Medicine and Oncology, Faculty of Medicine, Vilnius, LithuaniaOriginal Article Ann Coloproctol 2017;33(1):23-27 https://doi.org/10.3393/ac.2017.33.1.23 Purpose:  The purpose of this study was to look at our complication rates and recurrence rates, as well as the need for fur - ther radical surgery, in treating patients with benign and early malignant rectal tumors by using transanal endoscopic mi - crosurgery (TEM).",Non-OADS,/arxiv_data1/oa_pdf/25/ac/ac-33-23.PMC5346777.pdf
"Center of Oncosurgery, National Cancer Institute, 1 Santariskiu Street,  Vilnius LT – 08406, Lithuania Tel: +37067520094, Fax: +3702720164   E-mail: audrius.dulskas@gmail.com © 2017 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/ac/ac-33-23.PMC5346777.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 28Early Experience With a Partial Stapled Hemorrhoidopexy  for Treating Patients With Grades III–IV Prolapsing  Hemorrhoids Hyeonseok Jeong, Sunghwan Hwang, Kil O Ryu, Jiyong Lim, Hyun Tae Kim, Hye Mi Yu, Jihoon Y oon,   Ju-Y oung Lee, Hyoung Rae Kim, Y oung Gil Choi Department of Surgery, Busan Hang-Un Hospital, Busan, KoreaOriginal Article Ann Coloproctol 2017;33(1):28-34 https://doi.org/10.3393/ac.2017.33.1.28 Purpose:  Circular stapled hemorrhoidopexy (CSH) is widely used to treat patients with grades III–IV hemorrhoids be - cause of less pain and short hospital stay.",Non-OADS,/arxiv_data1/oa_pdf/38/be/ac-33-28.PMC5346778.pdf
"Department of Surgery, Busan Hang-Un Hospital, 1 Chungnyeol-daero  348beon-gil, Dongnae-gu, Busan 47889, Korea Tel: +82-51-580-2824, Fax: +82-51-580-2753 E-mail: hwangcin@hanmail.net © 2017 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/be/ac-33-28.PMC5346778.pdf
Available from:  http://www.nhis.or.kr/bbs7/boards/B0079/16017.,Non-OADS,/arxiv_data1/oa_pdf/38/be/ac-33-28.PMC5346778.pdf
"Dong-Guk Park Department of Surgery, Dankook University College of Medicine, Cheonan, KoreaEditorial Ann Coloproctol 2017;33(1):3-4 https://doi.org/10.3393/ac.2017.33.1.3 Multimodality therapy, such as a combination of cytoreductive  surgery (CRS) and hyperthermic intraperitoneal chemotherapy  (HIPEC), is associated with improved survival for selected pa - tients with peritoneal metastasis of various cancer types.",Non-OADS,/arxiv_data1/oa_pdf/05/00/ac-33-3.PMC5346779.pdf
"Department of Surgery, Dankook University College of Medicine,   119 Dandae-ro, Dongnam-gu, Cheonan 31116, Korea Tel: +82-41-550-3931, Fax: +82-41-565-6167 E-mail: dkpark@dankook.ac.kr © 2017 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/00/ac-33-3.PMC5346779.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 35Mucosa-Associated Lymphoid-Tissue Lymphoma of the  Cecum and Rectum: A Case Report Myung Jin Nam, Byung Chang Kim, Sung Chan Park, Chang Won Hong, Kyung Su Han, Dae Kyung Sohn,  Weon Seo Park1, Hee Jin Chang, Jae Hwan Oh Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang; 1Center for Prostate Cancer, Research  Institute and Hospital, National Cancer Center, Goyang, KoreaCase Report Ann Coloproctol 2017;33(1):35-38 https://doi.org/10.3393/ac.2017.33.1.35 A colonic mucosa-associated lymphoid-tissue (MALT) lymphoma is relatively rare compared to lymphomas of the stom - ach or small intestine.",Non-OADS,/arxiv_data1/oa_pdf/0f/f4/ac-33-35.PMC5346780.pdf
"Center for Colorectal Cancer, Research Institute and Hospital, National  Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea Tel: +82-31-920-1649, Fax: +82-31-920-0002 E-mail: mdzara@ncc.re.kr © 2017 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/f4/ac-33-35.PMC5346780.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 39High-Grade Mixed Adenoneuroendocrine Carcinoma in  the Cecum: A Case Report Sang Ho Shin, Sae Hee Kim, Sung Hee Jung, Ji Woong Jang, Min Seok Kang, Sang Il Kim, Ji Hye Kim,   Jun Ho Lee Department of Internal Medicine, Eulji University Hospital, Eulji University College of Medicine, Daejeon, KoreaCase Report Ann Coloproctol 2017;33(1):39-42 https://doi.org/10.3393/ac.2017.33.1.39 Gastrointestinal neoplasms with an exocrine and a neuroendocrine component are rare.",Non-OADS,/arxiv_data1/oa_pdf/e5/66/ac-33-39.PMC5346781.pdf
"Department of Internal Medicine, Eulji University Hospital, Eulji University  College of Medicine, 95 Dunsanseo-ro, Seo-gu, Daejeon 35233, Korea Tel: +82-42-611-3000, Fax: +82-42-611-3261, E-mail: cozy129@eulji.ac.kr © 2017 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/66/ac-33-39.PMC5346781.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 5Transanal Endoscopic Microsurgery   Byung Chun Kim Department of Surgery, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, KoreaEditorial Ann Coloproctol 2017;33(1):5-6 https://doi.org/10.3393/ac.2017.33.1.5 The use of a local excision to treat patients with early rectal cancer  is increasing these days [1].",Non-OADS,/arxiv_data1/oa_pdf/76/40/ac-33-5.PMC5346782.pdf
"Department of Surgery, Hallym University Kangnam Sacred Heart Hospital,  Hallym University College of Medicine, 1 Singil-ro, Yeongdeungpo-gu, Seoul  07441, Korea Tel: +82-2-829-5130, Fax: +82-2-849-4469, E-mail: bckimgs@hallym.or.kr © 2017 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/40/ac-33-5.PMC5346782.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 7Partial Stapled Hemorrhoidopexy Versus Circular Stapled  Hemorrhoidopexy    Jin Sub Kim Good Morning Coloproctology Clinic, Seoul, KoreaEditorial Ann Coloproctol 2017;33(1):7-8 https://doi.org/10.3393/ac.2017.33.1.7 A stapled hemorrhoidopexy (SH) is a recently rising therapy and  is widely performed.",Non-OADS,/arxiv_data1/oa_pdf/a0/04/ac-33-7.PMC5346783.pdf
"Good Morning Coloproctology Clinic, 204 Bongeunsa-ro, Gangnam-gu,  Seoul 06135, Korea Tel: +82-2-558-6625, Fax: +82-2-558-6635, E-mail: joseph-dr@hanmail.net © 2017 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/04/ac-33-7.PMC5346783.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 9Expressions and Clinical Significances of Angiopoietin-1,  Angiopoietin-2, and Tie-2 Receptor in Patients With  Colorectal Cancer Sunghoon Hong, Hae Il Jung, Tae Sung Ahn, Han-Jo Kim1, Kyu-Taek Lee1, Moo-Jun Baek, Sang-Byung Bae1 Department of Surgery, Soonchunhyang University Cheonan Hospital, Cheonan; 1Division of Hematology and Oncology, Department of  Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, KoreaOriginal Article Ann Coloproctol 2017;33(1):9-15 https://doi.org/10.3393/ac.2017.33.1.9 Purpose:  Angiopoietin-1 (Ang-1) plays a crucial role in vascular and hematopoietic development, mainly through its cog - nate receptor, Tie-2.",Non-OADS,/arxiv_data1/oa_pdf/8f/07/ac-33-9.PMC5346784.pdf
"Division of Hematology and Oncology, Department of Internal Medicine,  Soonchunhyang University Cheonan Hospital, 31 Suncheonhyang 6-gil,  Dongnam-gu, Cheonan 31151, Korea Tel: +82-41-570-3667, Fax: +82-41-574-5762 E-mail: baesan@schmc.ac.kr © 2017 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/07/ac-33-9.PMC5346784.pdf
The Empowerproject (29) (http://stt-consulting.com/index.php ) is a new promising and energetic newcomer in the field.,Non-OADS,/arxiv_data1/oa_pdf/b3/bc/jomb-35-103.PMC5346785.pdf
Available from: http://www.contesolutions.com/Western_Electric_SQC_Handbook.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b3/bc/jomb-35-103.PMC5346785.pdf
Available from:http://wwwn.cdc.gov/clia/pdf/PHSA_353.pdf.,OADS,/arxiv_data1/oa_pdf/b3/bc/jomb-35-103.PMC5346785.pdf
"http://www.bipm.org/utils/common/documents/jcgm/JCGM_100_2008_E.pdf: Joint Committee for Guides inMetrology; 2008.112 Theodorsson: Q uality assurance in clinical chemistry  Received: February 15, 2016 Accepted: February 23, 2016",Non-OADS,/arxiv_data1/oa_pdf/b3/bc/jomb-35-103.PMC5346785.pdf
Global Strategy for Asthma Management and Prevention (revised 2006): Global Initiative for Asthma (GINA).Available at: http://www.gi nasthma.org/local/uploads/ files/GINA_Report_2010_1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7c/f1/jomb-35-055.PMC5346802.pdf
The Journal Of The International Federation OfClinical Chemistry And Laboratory Medicine 2010;http://www.ifcc.org/ifccfiles/docs/publications/eJIFCC/vol21/02/eJIFCC_v21_02_05.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d5/05/jomb-35-069.PMC5346804.pdf
Available at: http://www.pharmacy.bg.ac.rs/studije/inte-grisane-akademske/farmacija-medicinska-biohemija.,Non-OADS,/arxiv_data1/oa_pdf/d5/05/jomb-35-069.PMC5346804.pdf
Available at: http://www.pharmacy.bg.ac.rs/dokumenti/pravilnici/Pravilnik_o_studiranju_na_Farmaceutskom_fakultetu.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d5/05/jomb-35-069.PMC5346804.pdf
Available at: http://www.dmbj.org.,Non-OADS,/arxiv_data1/oa_pdf/d5/05/jomb-35-069.PMC5346804.pdf
Available at: http://www.komorabiohemsr-bije.org.rs/index.php?option=com_content&view=arti-cle&id=52&Itemid=64.,Non-OADS,/arxiv_data1/oa_pdf/d5/05/jomb-35-069.PMC5346804.pdf
Available at: http://www.farmacija.org/default.aspx?ID=Sections&LN=SRL.,Non-OADS,/arxiv_data1/oa_pdf/d5/05/jomb-35-069.PMC5346804.pdf
"R Foundation for Statistical Computing,Vienna, Austria 2014; URL http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/d3/2f/jomb-35-312.PMC5346809.pdf
Available from: http://tree.bio.ed.ac.,OADS,/arxiv_data1/oa_pdf/fb/fa/jomb-35-337.PMC5346813.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits anynoncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.Health Security Volume 15, Number 1, 2017 Mary Ann Liebert, Inc. DOI: 10.1089/hs.2016.0044 81",Non-OADS,/arxiv_data1/oa_pdf/59/c4/hs.2016.0044.PMC5346815.pdf
"Richland, WA: Paciﬁc Northwest National Laboratory; 2015. http://biodetectionresource.pnnl.gov.",Non-OADS,/arxiv_data1/oa_pdf/59/c4/hs.2016.0044.PMC5346815.pdf
"Tables of Links TARGETS Enzymes CyclooxygenaseLIGANDS Aspirin Ibuprofen IL-6 Paracetamol These Tables list key protein targets and ligands in this article that are hyperlinked to corresponding entries in http://www.guidetopharmacology .org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY [1], and are permanently archived in the Concise Guide to PHARMACOLOGY 2015/16 [2].",OADS,/arxiv_data1/oa_pdf/b7/1b/BCP-83-742.PMC5346867.pdf
"Tables of Links TARGETS Tumour necrosis factorLIGANDS Etanercept These Tables list key protein targets and ligands in this article that are hyperlinked to corresponding entries in http://www.guidetopharmacology .org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY [1], and are permanently archived in the Concise Guide to PHARMACOLOGY 2015/16 [2].",OADS,/arxiv_data1/oa_pdf/61/93/BCP-83-732.PMC5346872.pdf
Competing Interests All authors have completed the Uni ﬁed Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (availableon request from the corresponding author).,Non-OADS,/arxiv_data1/oa_pdf/61/93/BCP-83-732.PMC5346872.pdf
Available at http://pi.amgen.com/united_state s/enbrel/derm/enbrel_pi.pdf (last accessed 16 March 2016).,Non-OADS,/arxiv_data1/oa_pdf/61/93/BCP-83-732.PMC5346872.pdf
Available at http://www.fda.gov/downloads/drugs/ guidancecomplianceregulatoryinformation/guidances/ucm397017.pdf.,Non-OADS,/arxiv_data1/oa_pdf/61/93/BCP-83-732.PMC5346872.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Non- commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source arecredited.",Non-OADS,/arxiv_data1/oa_pdf/36/d7/wound.2016.0706.PMC5346906.pdf
"http://onlinelibrary.wiley .com/doi/10.1002/0471440264.pst256.pub2/abstract;jsessionid=D851C72B9A16B85582D64CD42DEAC CE3.f02t01 (last accessed November 1, 2016).",OADS,/arxiv_data1/oa_pdf/36/d7/wound.2016.0706.PMC5346906.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.STEM CELLS AND DEVELOPMENT Volume 26, Number 6, 2017 Mary Ann Liebert, Inc. DOI: 10.1089/scd.2016.0196 391",Non-OADS,/arxiv_data1/oa_pdf/1e/28/scd.2016.0196.PMC5346911.pdf
"   Case Rep Neurol 2017;9:12 –16  DOI: 10.1159/000455942   Published online: February 6, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/63/c3/crn-0009-0012.PMC5346915.pdf
"   Case Rep Ophthalmol 2017;8:81 –86  DOI: 10.1159/000456028   Published online: February 2, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/92/49/cop-0008-0081.PMC5346916.pdf
"   Case Rep Dermatol 2017;9:45 –50  DOI: 10.1159/000457898   Published online: February 21, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/ef/76/cde-0009-0045.PMC5346917.pdf
"At 12 months, this group was more likely to be depressed (OR 6.75, 95% CI 2.78–16.4), anxious (OR 3.31, 95% CI 1.54–7.09), dis - abled (OR 3.60, 95% CI 2.07–6.25), and not have returned to work, compared to those without Received: September 30, 2016 Accepted after revision: December 5, 2016 Published online: Fe bruary 3, 2017EX TR A Prof. Nick Glozier Brain and Mind Centre, The University of Sydney 94 Mallett Street, Camperdown, NSW 2050 (Australia) E-Mail nick.glozier  @  sydney.edu.auwww.karger.com/cee This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/a4/f7/cee-0007-0009.PMC5346918.pdf
"   Case Rep Ophthalmol 2017;8:104 –107  DOI: 10.1159/000458516   Published online: February 17, 2017  © 2017 The Author(s)Publ ished by S.  Karger AG, Basel   www.karger.com/cop   This article is licensed  under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/40/25/cop-0008-0104.PMC5346919.pdf
"   Case Rep Oncol 2017;10:161 –168  DOI: 10.1159/000456029   Published online: February 15, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/4d/93/cro-0010-0161.PMC5346920.pdf
"   Case Rep Oncol 2017;10:199 –204  DOI: 10.1159/000457117   Published online: February 15, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/98/71/cro-0010-0199.PMC5346921.pdf
"For Germany, the prevalence of dementia  in individuals aged ≥65 years is estimated at about 7%, corresponding to about 1.3 million Published online: Fe bruary 10, 2017EX TR A Larissa Schwarzkopf Helmholtz Zentrum München, German Research Center for Environmental Health  (GmbH), Institute of Health Economics and Health Care Management Ingolstaedter Landstrasse 1, DE–85764 Neuherberg (Germany)E-Mail l.schwarzkopf  @  helmholtz-muenchen.dewww.karger.com/dee This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/ad/94/dee-0007-0041.PMC5346922.pdf
"   Case Rep Oncol 2017;10:156 –160  DOI: 10.1159/000452146   Published online: February 15, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/5c/7b/cro-0010-0156.PMC5346923.pdf
"Predictors Received: July 14, 2016 Accepted after Revision: January 10, 2017 Published online: Fe bruary 16, 2017EX TR A Dr. Heather L. Flowers Department of Rehabilitation Sciences, University of Ottawa 451 Smyth Road Ottawa, ON K1H 8M5 (Canada)E-Mail heather.flowers  @  uottawa.cawww.karger.com/cee This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna-   tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/72/be/cee-0007-0021.PMC5346925.pdf
"   Case Rep Oncol 2017;10:182 –191  DOI: 10.1159/000457791   Published online: February 15, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/0c/87/cro-0010-0182.PMC5346926.pdf
"   Case Rep Oncol 2017;10:143 –150  DOI: 10.1159/000456611   Published online: February 2, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/06/b0/cro-0010-0143.PMC5346927.pdf
"   Case Rep Ophthalmol 2017;8:108 –115  DOI: 10.1159/000458518   Published online: February 20, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cop   This article is licensed  under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/bf/2f/cop-0008-0108.PMC5346928.pdf
"© 2017 The Author(s) Published by S. Karger AG, BaselReceived: September 30, 2016 Accepted: November 17, 2016Published online: Fe bruary 9, 2017EX TR A Dr. Sanjeet RoyDepartment of General Pathology, Christian Medical Hospital Asha Building, 4th floor Vellore, Tamil Nadu 632004 (India)E-Mail sanjeetroy06  @  gmail.comwww.karger.com/nne This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/bb/7a/nne-0007-0001.PMC5346929.pdf
"© 2017 The Author(s) Published by S. Karger AG, BaselReceived: September 12, 2016 Accepted: November 17, 2016 Published online: Fe bruary 9, 2017EX TR A Catherine Weber, MD, FRCPC Division of Nephrology, McGill University Health Centre 1650 Cedar Avenue, L4-505 Montreal, QC H3G 1A4 (Canada)E-Mail catherine.weber  @  mcgill.cawww.karger.com/nne This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/93/8a/nne-0007-0010.PMC5346930.pdf
"About 70,000 people Published online: Fe bruary 9, 2017EX TR A Anne Sverdrup Efjestad, MSc Baerum Hospital Pharmacy, Hospital Pharmacy Enterprises, South Eastern Norway Sogneprest Munthe-Kaasvei 100 NO–1346 Gjettum (Norway)E-Mail anne.efjestad  @  sykehusapotekene.nowww.karger.com/dee This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/e3/dd/dee-0007-0030.PMC5346931.pdf
"http://www.who.int/healthinfo/survey/ageingdefnolder/en/ (accessed August 25, 2016).",OADS,/arxiv_data1/oa_pdf/e3/dd/dee-0007-0030.PMC5346931.pdf
"https://www.nice.org.uk/guidance/CG42 (accessed August 25, 2016).",Non-OADS,/arxiv_data1/oa_pdf/e3/dd/dee-0007-0030.PMC5346931.pdf
"http://www.lovdata.no (accessed August 25, 2016).",Non-OADS,/arxiv_data1/oa_pdf/e3/dd/dee-0007-0030.PMC5346931.pdf
"http://www.whocc.no/atc_ddd_index/ (accessed August 25, 2016).",OADS,/arxiv_data1/oa_pdf/e3/dd/dee-0007-0030.PMC5346931.pdf
"http://www.who.int/healthinfo/survey/ageingde - fnolder/en/ (accessed August 25, 2016).",OADS,/arxiv_data1/oa_pdf/e3/dd/dee-0007-0030.PMC5346931.pdf
"http://urn.nb.no/URN:NBN:no-31107 (accessed August 25, 2016).",Non-OADS,/arxiv_data1/oa_pdf/e3/dd/dee-0007-0030.PMC5346931.pdf
"http://www.R-project.org/ (accessed August 25, 2016).",Non-OADS,/arxiv_data1/oa_pdf/e3/dd/dee-0007-0030.PMC5346931.pdf
"   Case Rep Ophthalmol 2017;8:99 –103  DOI: 10.1159/000458519   Published online: February 10, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/93/5a/cop-0008-0099.PMC5346933.pdf
"   Case Rep Ophthalmol 2017;8:91 –98  DOI: 10.1159/000456708   Published online: February 2, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/cf/e4/cop-0008-0091.PMC5346935.pdf
"   Case Rep Oncol 2017;10:205 –211  DOI: 10.1159/000458436   Published online: February 17, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/00/fe/cro-0010-0205.PMC5346936.pdf
"   Case Rep Oncol 2017;10:192 –198  DOI: 10.1159/000457949   Published online: February 15, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/ae/21/cro-0010-0192.PMC5346937.pdf
"   Case Rep Neurol 2017;9:22 –30  DOI: 10.1159/000458435   Published online: February 20, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/27/3a/crn-0009-0022.PMC5346938.pdf
"American Cancer Society, 7 July 2007.  http://cancerguide.org/r cc_staging.html (accessed July 19, 2016).",Non-OADS,/arxiv_data1/oa_pdf/27/3a/crn-0009-0022.PMC5346938.pdf
"February 10, 2016.  https://www.cancer.org/cancer/kidney -cancer/about/what -is-kidney -cancer.html (accessed June 10,  2016).",Non-OADS,/arxiv_data1/oa_pdf/27/3a/crn-0009-0022.PMC5346938.pdf
"© 2017 The Author(s)   Published by S. Karger AG, BaselPublished online: Fe bruary 2, 2017EX TR A Tzeyu L. Michaud, PhD Center for Reducing Health Disparities 984340 Nebraska Medical Center Omaha, NE 68198 (USA)E-Mail tzeyu.michaud  @  unmc.eduwww.karger.com/dee This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/4f/2d/dee-0007-0015.PMC5346939.pdf
"https://www.alz.washington.edu/WEB/study_pop.html (accessed September 27, 2016).",Non-OADS,/arxiv_data1/oa_pdf/4f/2d/dee-0007-0015.PMC5346939.pdf
"   Case Rep Dermatol 2017;9:30 –37  DOI: 10.1159/000456652   Published online: February 10, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/c4/2d/cde-0009-0030.PMC5346941.pdf
"   Case Rep Neurol 2017;9:17 –21  DOI: 10.1159/000456610   Published online: February 14, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/29/07/crn-0009-0017.PMC5346942.pdf
"   Case Rep Ophthalmol 2017;8:87 –90  DOI: 10.1159/000456535   Published online: February 2, 2017  © 2017 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/13/64/cop-0008-0087.PMC5346944.pdf
"   Case Rep Oncol 2017;10:169 –174  DOI: 10.1159/000457116   Published online: February 15, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/d4/d6/cro-0010-0169.PMC5346945.pdf
"   Case Rep Dermatol 2017;9:38 –44  DOI: 10.1159/000452828   Published online: February 10, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/fa/17/cde-0009-0038.PMC5346946.pdf
"   Case Rep Oncol 2017;10:1 75–181  DOI: 10.1159/000457831   Published online: February 15, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/32/a0/cro-0010-0175.PMC5346947.pdf
"   Case Rep Dermatol 2017;9:25 –29  DOI: 10.1159/000456000   Published online: February 8, 2017  © 2017 The Author(s)Published by S.  Karger AG, Ba sel  www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/e6/db/cde-0009-0025.PMC5346948.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution,and reproduction in any medium, provided the original author(s) and the source are credited.",Non-OADS,/arxiv_data1/oa_pdf/36/b6/wound.2016.0711.PMC5346954.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.SOFT ROBOTICS Volume 4, Number 1, 2017 Mary Ann Liebert, Inc.DOI: 10.1089/soro.2016.0032 33",Non-OADS,/arxiv_data1/oa_pdf/f8/e1/soro.2016.0032.PMC5346955.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY Volume 6, Number 1, 2017Mary Ann Liebert, Inc.DOI: 10.1089/jayao.2016.0049 53",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/jayao.2016.0049.PMC5346961.pdf
"© 2017 The Author(s) Published by S. Karger AG, BaselPublished online: Fe bruary 2, 2017EX TR A Erik Hessen Department of Neurology, Akershus University Hospital Sykehusveien 25  NO–1474 Nordbyhagen (Norway)E-Mail erik.hessen  @  nevropsykologi.nowww.karger.com/dee This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/ed/36/dee-0007-0001.PMC5346963.pdf
"3 695–708 https://doi.org/10.1083/jcb.201511044Introduction Recessive mutations in phosphatase and tensin homologue– induced kinase (PINK1) cause early-onset Parkinson’s dis- ease (PD), an incurable neurodegenerative movement disorder  (Valente et al., 2004).",Non-OADS,/arxiv_data1/oa_pdf/c6/41/JCB_201511044.PMC5346965.pdf
"3 815–834 https://doi.org/10.1083/jcb.201604065Introduction Mitochondria are key contributors to the etiology of a wide  array of diseases with neuromuscular defects or neurodegen- eration (DiMauro and Schon, 2008; Nunnari and Suomalainen,  2012).",Non-OADS,/arxiv_data1/oa_pdf/a5/40/JCB_201604065.PMC5346966.pdf
3 793–814 https://doi.org/10.1083/jcb.201604117Introduction Cytoskeletal dynamics plays a pivotal role in the establishment  of neuronal connections during development and in plasticity  in adults.,Non-OADS,/arxiv_data1/oa_pdf/b1/ca/JCB_201604117.PMC5346967.pdf
"   Case Rep Ophthalmol 2017;8:116 –119  DOI: 10.1159/000457830   Published online: February 20, 2017  © 2017 The Author(s)Published by S.  Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/96/a3/cop-0008-0116.PMC5346971.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 8(3) 1–3 DOI: 10.1177/2054270416681432",Non-OADS,/arxiv_data1/oa_pdf/8a/8b/10.1177_2054270416681432.PMC5347261.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/7a/2b/10.1177_2058460117694216.PMC5347262.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 8(3) 1–3 DOI: 10.1177/2054270416669303",Non-OADS,/arxiv_data1/oa_pdf/e6/cd/10.1177_2054270416669303.PMC5347263.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/fa/32/10.1177_2058460117695855.PMC5347267.pdf
2016;14(2):1-7. https://www.ncb i.nlm.nih.gov/pm c/articles/ PMC4826954/.,Non-OADS,/arxiv_data1/oa_pdf/8e/7c/10.1177_1559325817693167.PMC5347268.pdf
http://www.ucdmc.ucdavis.edu/ radiology/radiationdose.html.,Non-OADS,/arxiv_data1/oa_pdf/8e/7c/10.1177_1559325817693167.PMC5347268.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 8(3) 1–5 DOI: 10.1177/2054270416675083",Non-OADS,/arxiv_data1/oa_pdf/3c/c1/10.1177_2054270416675083.PMC5347269.pdf
"Hip fracture in the older person, http://learntech.uwe.ac.uk/Data/Sites/ 26/docs/Journey-Through-Trauma-Orthopaedic-Pathways/Hip-Fracture-Management on: (2007, accessed 2 September 2015).",Non-OADS,/arxiv_data1/oa_pdf/3c/c1/10.1177_2054270416675083.PMC5347269.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 8(3) 1–11 DOI: 10.1177/2054270416681434",Non-OADS,/arxiv_data1/oa_pdf/4a/0a/10.1177_2054270416681434.PMC5347270.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 8(3) 1–7 DOI: 10.1177/2054270416681747",Non-OADS,/arxiv_data1/oa_pdf/3f/a5/10.1177_2054270416681747.PMC5347273.pdf
2003;22(6):290-306. http://www.belleonline.com/newsletters/ volume11/vol11-2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0c/35/10.1177_1559325817692903.PMC5347275.pdf
2010;29(4):263-270. http://het.sagepub.com/con- tent/29/4/263.full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0c/35/10.1177_1559325817692903.PMC5347275.pdf
2016;14(4):1-10. http://dos.sage- pub.com/content/14/4/1559325816680539.full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0c/35/10.1177_1559325817692903.PMC5347275.pdf
2003;229(1):14-15. http://pubs.rsna.org/doi/full/10.1148/radiol.2291030291.,Non-OADS,/arxiv_data1/oa_pdf/0c/35/10.1177_1559325817692903.PMC5347275.pdf
http://www.iaea.org/inis/collection/NCLCollection- Store/_Public/20/071/20071717.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0c/35/10.1177_1559325817692903.PMC5347275.pdf
2015;13(1): 1-8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674170/.,Non-OADS,/arxiv_data1/oa_pdf/0c/35/10.1177_1559325817692903.PMC5347275.pdf
http://www.iaea.org/ inis/collection/NCLCollectio nStore/_Public/20/029/20029409.,Non-OADS,/arxiv_data1/oa_pdf/0c/35/10.1177_1559325817692903.PMC5347275.pdf
2012;10(4):644-663. http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3526333/.,Non-OADS,/arxiv_data1/oa_pdf/0c/35/10.1177_1559325817692903.PMC5347275.pdf
2000;19(1):41-75. http://www.radi ation-hormesis.com/wp-con tent/uploads/2014/03/Hormesis-H istorical-Investigations-Hum- Exp-Toxicol-2000-Calabrese-41 -75.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0c/35/10.1177_1559325817692903.PMC5347275.pdf
2016;44(11):23-24. http://hps.org/hpspublications/ newsletter_vol44no11.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0c/35/10.1177_1559325817692903.PMC5347275.pdf
2015;13(4):1-4. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679206/.6 Dose-Response: An International Journal,Non-OADS,/arxiv_data1/oa_pdf/0c/35/10.1177_1559325817692903.PMC5347275.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/9b/29/10.1177_2058460117693463.PMC5347276.pdf
"British Social Attitudes: the 30th report, 2013, http://www.dyingmatters.org/sites/default/files/BSA30_Full_Report.pdf?Graph 2.",Non-OADS,/arxiv_data1/oa_pdf/3d/15/10.1177_0269216316655747.PMC5347351.pdf
"Deaths from renal diseases  in England, 2001 to 2008, 2010, http://www.endoflifecare-intelligence.org.uk/resources/publications/deaths_from_ renal_diseases  7.",Non-OADS,/arxiv_data1/oa_pdf/3d/15/10.1177_0269216316655747.PMC5347351.pdf
"National survey of patient activity data for specialist pallia- tive care services: MDS full report for the year 2011-2012,  2013, http://www.ncpc.org.uk/sites/default/files/MDS%20 Full%20Report%202012.pdf  10.",Non-OADS,/arxiv_data1/oa_pdf/3d/15/10.1177_0269216316655747.PMC5347351.pdf
"Retrieved from http://livingisforeveryone.com.au/Uploads/docs/Rural%20and%20Remote%20Suicides.pdf Kondo, N., van Dam, R. M., Sembajwe, G., Subramanian, S.  V., Kawachi, I., & Yamagata, Z.",Non-OADS,/arxiv_data1/oa_pdf/06/c2/10.1177_1049732315625195.PMC5347352.pdf
Retrieved from http://www.who.int/mental_health/suicide-preven-tion/en/ World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/06/c2/10.1177_1049732315625195.PMC5347352.pdf
"Retrieved from http://apps.who.int/iris/bitstream/10665/112738/1/   9789240692671_eng.pdf?ua=1Author Biographies Jessica Collins, Dr (Clin Psych), works in organisational psy- chology in a telecommunications company in Australia.",Non-OADS,/arxiv_data1/oa_pdf/06/c2/10.1177_1049732315625195.PMC5347352.pdf
"Population projections for Canada, provinces and territories, 2009 to 2036, http://www.stat-can.gc.ca/pub/91-520-x/91-520-x2010001-eng.pdf (2010,  accessed 9 April 2015).",OADS,/arxiv_data1/oa_pdf/8f/9f/10.1177_0269216316653524.PMC5347353.pdf
"2014 annual  report, http://www.auditor.on.ca/en/content/annualreports/ arbyyear/ar2014.html (2014, accessed 7 June 2016).",OADS,/arxiv_data1/oa_pdf/8f/9f/10.1177_0269216316653524.PMC5347353.pdf
"Palliative care—moving towards com- munity-integrated care for Canadians, http://www.hc-sc.gc.ca/ahc-asc/media/nr-cp/_2012/2012-94fs-eng.php  (2012, accessed 7 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/8f/9f/10.1177_0269216316653524.PMC5347353.pdf
"Fact sheet:  hospice palliative care in Canada, http://www.chpca.net/ media/7622/fact_sheet_hpc_in_canada_march_2013_final.pdf (2013, accessed 7 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/8f/9f/10.1177_0269216316653524.PMC5347353.pdf
"OMA’s end-of-life care strategy, https://www.oma.org/Resources/Documents/AdvancedCarePlanning.pdf (2014, accessed 7 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/8f/9f/10.1177_0269216316653524.PMC5347353.pdf
"Fact sheet:  hospice palliative care in Canada, http://www.chpca.net/ media/7622/fact_sheet_hpc_in_canada_may_2012_final.",Non-OADS,/arxiv_data1/oa_pdf/8f/9f/10.1177_0269216316653524.PMC5347353.pdf
"20 February 2016, http://www.who.int/cancer/pallia-tive/definition/en/ 32.",Non-OADS,/arxiv_data1/oa_pdf/8f/9f/10.1177_0269216316653524.PMC5347353.pdf
"Table 102-0540-Deaths, by cause, Chapter  XX: external causes of morbidity and mortality (V01 to Y89),  age group and sex, Canada, CANSIM (database), http://www5.statcan.gc.ca/cansim/a26?lang=eng&id=1020540 (2014, accessed 6 April 2015).",OADS,/arxiv_data1/oa_pdf/8f/9f/10.1177_0269216316653524.PMC5347353.pdf
"Predicting death:  estimating the proportion of deaths that are “unex- pected.” National End of Life Care Intelligence Network,  http://www.endoflifecare-intelligence.org.uk/resources/publications/predicting_death (2011, accessed 9 April  2015).",Non-OADS,/arxiv_data1/oa_pdf/8f/9f/10.1177_0269216316653524.PMC5347353.pdf
"IHPA, 2014, https://www.ihpa.gov.au/publications/teaching-training-Segal et al.",Non-OADS,/arxiv_data1/oa_pdf/2f/69/10.1177_1355819616668202.PMC5347354.pdf
http://www.aihw.gov.au/deaths/life-expectancy/(accessed September 2016).23.,Non-OADS,/arxiv_data1/oa_pdf/2f/69/10.1177_1355819616668202.PMC5347354.pdf
"http://rer.aera.net 309 Synthesizing Results From Empirical   Research on Computer-Based Scaffolding in  STEM Education: A Meta-Analysis Brian R. Belland, Andrew E. Walker, Nam Ju Kim,   and Mason Lefler Utah State University Computer-based scaffolding assists students as they generate solutions to  complex problems, goals, or tasks, helping increase and integrate their higher order skills in the process.",Non-OADS,/arxiv_data1/oa_pdf/da/6b/10.3102_0034654316670999.PMC5347356.pdf
Effect sizes were calculated for each outcome using a free online tool (ESFREE: http://esfree.usu.edu/).,OADS,/arxiv_data1/oa_pdf/da/6b/10.3102_0034654316670999.PMC5347356.pdf
Retrieved from http://eric.ed.,Non-OADS,/arxiv_data1/oa_pdf/da/6b/10.3102_0034654316670999.PMC5347356.pdf
"Retrieved from http://www.nextgen- science.org/next-generation-science-standards Niu, L., Behar-Horenstein, L. S., & Garvan, C. W. (2013).",OADS,/arxiv_data1/oa_pdf/da/6b/10.3102_0034654316670999.PMC5347356.pdf
"Rockville, MD: Agency for Healthcare Researchand Quality, 2014, Available at: http://www.hcup-us .ahrq.gov/reports/statbriefs/sb178-Preventable- Hospitalizations-by-Region.pdf.",Non-OADS,/arxiv_data1/oa_pdf/1e/c5/10.1177_1355819616679198.PMC5347357.pdf
Available at: http://hmf.sagepub.,Non-OADS,/arxiv_data1/oa_pdf/8a/da/10.1177_0840470416679413.PMC5347358.pdf
Avail- able at: http://publications.cpa -apc.org/cjp/2014/supplement/ index.html#/20/.,Non-OADS,/arxiv_data1/oa_pdf/8a/da/10.1177_0840470416679413.PMC5347358.pdf
Available at: http://www.mentalhealthcommis sion.ca/English/document/72756/guidelines-recovery-oriented- practice.,Non-OADS,/arxiv_data1/oa_pdf/8a/da/10.1177_0840470416679413.PMC5347358.pdf
Available at: http://www.mental healthcommission.ca/E nglish/initiatives/118 74/opening-minds.,Non-OADS,/arxiv_data1/oa_pdf/8a/da/10.1177_0840470416679413.PMC5347358.pdf
Available at: http://www.mentalhealthcommi ssion.ca/English/initiatives/ 11874/opening-minds.,Non-OADS,/arxiv_data1/oa_pdf/8a/da/10.1177_0840470416679413.PMC5347358.pdf
Available at: http://anp.sagepub.com/con tent/early/2015/04/28/0004867415584643.full 59.,Non-OADS,/arxiv_data1/oa_pdf/8a/da/10.1177_0840470416679413.PMC5347358.pdf
Available at: http://www.mentalhealthcommis sion.ca/English/node/5186.,Non-OADS,/arxiv_data1/oa_pdf/8a/da/10.1177_0840470416679413.PMC5347358.pdf
Avail- able at: http://www.forces.gc.ca/ en/caf-community-health-ser vices-r2mr/index.page.,Non-OADS,/arxiv_data1/oa_pdf/8a/da/10.1177_0840470416679413.PMC5347358.pdf
Available at: http://shop.csa.ca/en/canada/occupa tional-health-and-safety-man agement/cancsa-z1003-13bnq- 9700-8032013/invt/z10032013?utm_source ¼redirect&utm_ medium ¼vanity&utm_content ¼folder&utm_campaign ¼z1003# Download.,Non-OADS,/arxiv_data1/oa_pdf/8a/da/10.1177_0840470416679413.PMC5347358.pdf
"CLINICAL REHABILITATION https://doi.org/10.1177/0269215516644311Clinical Rehabilitation 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/00/17/10.1177_0269215516644311.PMC5347360.pdf
Available at: http://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CCEQFjAA&url=http%3A%2F%2Fglasgowspcmh.org.uk%2FdownloadBookletPrint%3Fbooklet%3D1&ei=YXpEVbalMYfhaqTCgNgB&usg=AFQjCNFk4-JOtkRwr7IQA2Z3svyOQS-U3Q.,Non-OADS,/arxiv_data1/oa_pdf/00/17/10.1177_0269215516644311.PMC5347360.pdf
23 The review protocol was registered on  the PROSPERO website (http://www.crd.york.ac.uk/PROSPERO) before screening and data extraction (regis-tration no.,Non-OADS,/arxiv_data1/oa_pdf/02/d4/10.1177_0269216316655736.PMC5347362.pdf
"Child Bereavement Network, 2015, http://childhood-bereavementnetwork.org.uk/research/key-statistics.aspx (accessed 12 December 2015).",Non-OADS,/arxiv_data1/oa_pdf/02/d4/10.1177_0269216316655736.PMC5347362.pdf
"Improving supportive and palliative care for adults with can-cer, 2004, https://www.nice.org.uk/guidance/csg4 (accessed 2 December 2015).",Non-OADS,/arxiv_data1/oa_pdf/02/d4/10.1177_0269216316655736.PMC5347362.pdf
"Retrieved  from https://www.cardiosmart.org/heart-conditions/atrial-fibrillation Ball, J., Carrington, M. J., McMurray, J. J., & Stewart, S. (2013).",Non-OADS,/arxiv_data1/oa_pdf/87/c2/10.1177_0193945916656609.PMC5347363.pdf
"Retrieved from https://www.healthy- people.gov/2020/about/foundation-health-measures/Disparities Virtanen, R., Kryssi, V., Vasankari, T., Salminen, M., Kivela, S., & Airaksinen, J.",Non-OADS,/arxiv_data1/oa_pdf/87/c2/10.1177_0193945916656609.PMC5347363.pdf
"A modifiable version  of this GROW Worksheet and a completed example are also available at http://www.safetynetmedicalhome.org/change-concepts/organized-evidence-based-care/behavioral-health.HIT, health information technology.",Non-OADS,/arxiv_data1/oa_pdf/16/38/10.1177_1062860615618783.PMC5347364.pdf
"For a complete list, refer to: http://www.safetynetmedicalhome.org/sites/default/files/Implementation-Guide-Behavioral- Health-Integration.pdf (pages 39-40).",Non-OADS,/arxiv_data1/oa_pdf/16/38/10.1177_1062860615618783.PMC5347364.pdf
"The Behavioral Health Integration Implementation  Guide and companion resources (including the GROW Pathway Planning Tool, Case Examples, and other resources) can be accessed at: http://www.safetynetmedic- alhome.org/change-concepts/organized-evidence-based- care/behavioral-health.",OADS,/arxiv_data1/oa_pdf/16/38/10.1177_1062860615618783.PMC5347364.pdf
http://www.aafp.org/ dam/AAFP/documents/practice_management/pcmh/initia-tives/PCMHJoint.pdf.,Non-OADS,/arxiv_data1/oa_pdf/16/38/10.1177_1062860615618783.PMC5347364.pdf
http://www.ncqa.org/Programs/Recognition/Practices/ PatientCenteredMedicalHomePCMH.aspx.,Non-OADS,/arxiv_data1/oa_pdf/16/38/10.1177_1062860615618783.PMC5347364.pdf
http://www.aafp.org/about/policies/all/mental-services.html.,Non-OADS,/arxiv_data1/oa_pdf/16/38/10.1177_1062860615618783.PMC5347364.pdf
http://www.integration.samhsa.gov/integrated-care-models/behavioral-health-in-primary-care#integrated models of BH in PC.,Non-OADS,/arxiv_data1/oa_pdf/16/38/10.1177_1062860615618783.PMC5347364.pdf
"Seattle, WA: Qualis Health, MacColl Center for Health Care Innovation at the Group Health Research Institute, and the University of  Washington’s AIMS Center; 2014. http://www.safetynet- medicalhome.org/change-concepts/organized-evidence-based-care/behavioral-health  15.",Non-OADS,/arxiv_data1/oa_pdf/16/38/10.1177_1062860615618783.PMC5347364.pdf
Available at: http://www.crcpd.org/Pubs/QAC/DAP.pdf.,Non-OADS,/arxiv_data1/oa_pdf/75/c5/10.1177_0284185116658682.PMC5347367.pdf
"https://doi.org/10.1177/2333794X17693110Global Pediatric Health Volume 4: 1 –3  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X17693110 journals.sagepub.com/home/gph Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Brief Report Introduction Hemophilia A is an X-linked hereditary condition caused  by decreased factor VIII activity, which predominately occurs in males.",Non-OADS,/arxiv_data1/oa_pdf/0a/bc/10.1177_2333794X17693110.PMC5347409.pdf
"https://doi.org/10.1177/2054358117695792Canadian Journal of Kidney Health  and Disease  Volume 4 : 1 –6 © The Author(s) 2017Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/2054358117695792 journals.sagepub.com/home/cjkResearch Case Report695792 CJKXXX10.1177/2054358117695792Canadian Journal of Kidney Health and DiseaseAmbaraghassi et al research-article 2017 First Canadian Case Report of Kidney  Transplantation From an HIV-Positive Donor to an HIV-Positive Recipient Georges Ambaraghassi1, Héloïse Cardinal2,   Daniel Corsilli3, Claude Fortin4, Marie-Chantal Fortin2,   Valérie Martel-Laferrière5, Jacques Malaise6,   Michel R. Pâquet2, and Danielle Rouleau4 Abstract Rationale: Kidney transplantation has become standard of care for carefully selected patients living with human  immunodeficiency virus (HIV) and end-stage renal disease (ESRD) in the highly active antiretroviral therapy (HAART) era.",Non-OADS,/arxiv_data1/oa_pdf/11/03/10.1177_2054358117695792.PMC5347410.pdf
https://www.govtrack.,Non-OADS,/arxiv_data1/oa_pdf/11/03/10.1177_2054358117695792.PMC5347410.pdf
"https://doi.org/10.1177/2050313X17695998 SAGE Open Medical Case Reports Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –3 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17695998 journals.sagepub.com/home/sco Introduction Sepsis is more likely to manifest with jaundice in infants and  children than in adults.",Non-OADS,/arxiv_data1/oa_pdf/44/a1/10.1177_2050313X17695998.PMC5347411.pdf
"https://doi.org/10.1177/2050313X17695719 SAGE Open Medical Case Reports Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –3 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17695719 journals.sagepub.com/home/sco Introduction Congenital anomalous origin of the left coronary artery from  the pulmonary artery (ALCAPA) is a rare (1/300,000) con-genital defect with a high infancy mortality rate (85%).",Non-OADS,/arxiv_data1/oa_pdf/7c/18/10.1177_2050313X17695719.PMC5347413.pdf
https://doi.org/10.1177/2054358117695784Canadian Journal of Kidney Health  and Disease  Volume 4: 1 –12 © The Author(s) 2017Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/2054358117695784 journals.sagepub.com/home/cjkOriginal Research Article Why is this review important This consensus review was done to develop evidence-informed  recommendations for Canadian nephrologists to guide optimal management of adult patients with ADPKD.What are the key messages 1.,Non-OADS,/arxiv_data1/oa_pdf/2f/12/10.1177_2054358117695784.PMC5347414.pdf
"13  According to the PKD Foundation of Canada, there are cur - rently 2323 known mutations in the PKD1 gene and 278 known mutations in the PKD2 gene (Autosomal Dominant Polycystic Kidney Disease Mutation Database [PKDB], http://pkdb.mayo.edu/).",Non-OADS,/arxiv_data1/oa_pdf/2f/12/10.1177_2054358117695784.PMC5347414.pdf
"33 Before interpreting TKV measurements, patients should  be categorized according to the recently published Mayo Clinic Classification (Figure 1) 29 (http://www.mayo.edu/ research/documents/pkd-center-adpkd-classification/doc-20094754).",Non-OADS,/arxiv_data1/oa_pdf/2f/12/10.1177_2054358117695784.PMC5347414.pdf
https://health-products.canada.ca/noc-ac/info.do?no=16640   &lang=en.,Non-OADS,/arxiv_data1/oa_pdf/2f/12/10.1177_2054358117695784.PMC5347414.pdf
https://www.cadth.ca/tolvaptan-7.,Non-OADS,/arxiv_data1/oa_pdf/2f/12/10.1177_2054358117695784.PMC5347414.pdf
Available online at: https://www.cadth.ca/sites/default/files/cdr/complete/SR0435_complete_Jinarc-Feb_26_16_e.pdf.,OADS,/arxiv_data1/oa_pdf/2f/12/10.1177_2054358117695784.PMC5347414.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/21/02/10.1177_2048004017695006.PMC5347415.pdf
"https://doi.org/10.1177/2050313X17695997 SAGE Open Medical Case Reports Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –4 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17695997 journals.sagepub.com/home/sco Introduction A 22-year-old female student was referred by her general  practitioner (GP) to rheumatology with a 3-week history of widespread symmetrical joint pain, swelling and stiffness involving the small and large joints (hands, wrist, shoulders, knees and feet).",Non-OADS,/arxiv_data1/oa_pdf/09/c8/10.1177_2050313X17695997.PMC5347416.pdf
"https://doi.org/10.1177/2054358117693355Canadian Journal of Kidney Health  and Disease  Volume 4: 1 –6 © The Author(s) 2017Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/2054358117693355 journals.sagepub.com/home/cjkNarrative Review693355 CJKXXX10.1177/2054358117693355Canadian Journal of Kidney Health and DiseaseT angri et al research-article 2017 Total Kidney Volume as a Biomarker  of Disease Progression in Autosomal Dominant Polycystic Kidney Disease Navdeep Tangri1,2, Ingrid Hougen1, Ahsan Alam3,   Ronald Perrone4, Phil McFarlane5, and York Pei6 Abstract Purpose of review: Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disorder characterized by the formation of kidney cysts and kidney enlargement, which progresses to kidney failure by the fifth to seventh decade of life in a majority of patients.",Non-OADS,/arxiv_data1/oa_pdf/b5/ce/10.1177_2054358117693355.PMC5347417.pdf
https://www.niddkre-pository.org/studies/crisp/.,Non-OADS,/arxiv_data1/oa_pdf/b5/ce/10.1177_2054358117693355.PMC5347417.pdf
http://www.mayo.edu/research/ documents/pkd-center-adpkd-classification/doc-20094754.,Non-OADS,/arxiv_data1/oa_pdf/b5/ce/10.1177_2054358117693355.PMC5347417.pdf
"https://doi.org/10.1177/2054358117692559Canadian Journal of Kidney Health  and Disease  Volume 4: 1 –14 © The Author(s) 2017Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/2054358117692559 journals.sagepub.com/home/cjkReview692559 CJKXXX10.1177/2054358117692559Canadian Journal of Kidney Health and DiseaseLaurin et al research-article 2017 Calcineurin Inhibitors in the  Treatment of Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis of the Literature Louis-Philippe Laurin1,2, Patrick H. Nachman3,   and Bethany J. Foster2,4,5 Abstract Purpose of review: Primary focal segmental glomerulosclerosis (FSGS) is the most common cause of nephrotic syndrome in adults.",Non-OADS,/arxiv_data1/oa_pdf/4d/d3/10.1177_2054358117692559.PMC5347418.pdf
http://www.ohri.ca/programs/clinical_ epidemiology/oxford.htm.,Non-OADS,/arxiv_data1/oa_pdf/4d/d3/10.1177_2054358117692559.PMC5347418.pdf
"https://doi.org/10.1177/2333794X16689639Global Pediatric Health Volume 4: 1 –6  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X16689639 journals.sagepub.com/home/gph Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Original Article Introduction Replacement immunoglobulin is the treatment of choice  for patients with humoral immunodeficiencies (eg, com-mon variable immunodeficiency, agammaglobinemia, hypogammaglobinemia, combined immunodeficien-cies, and specific antibody deficiency), yet a handful of patients continue to develop sinopulmonary infections while on therapy.",Non-OADS,/arxiv_data1/oa_pdf/2e/43/10.1177_2333794X16689639.PMC5347419.pdf
http://www.the-rheumatologist.org/article/the-mystery-of-ivig/.,Non-OADS,/arxiv_data1/oa_pdf/2e/43/10.1177_2333794X16689639.PMC5347419.pdf
http://www.primaryimmune.,Non-OADS,/arxiv_data1/oa_pdf/2e/43/10.1177_2333794X16689639.PMC5347419.pdf
"https://doi.org/10.1177/2054358117695793Canadian Journal of Kidney Health  and Disease  Volume 4: 1 –7 © The Author(s) 2017Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/2054358117695793 journals.sagepub.com/home/cjkStudy Protocol695793 CJKXXX10.1177/2054358117695793Canadian Journal of Kidney Health and DiseaseThangarasa et al research-article 2017 Physical Activity in Patients Treated With  Peritoneal Dialysis: A Protocol  for a Systematic Review Tharshika Thangarasa1, Rameez Imtiaz1, Swapnil Hiremath1,2,  and Deborah Zimmerman1,2 Abstract Background: Patients with chronic diseases are known to benefit from exercise.",Non-OADS,/arxiv_data1/oa_pdf/ab/68/10.1177_2054358117695793.PMC5347420.pdf
CIHI: annual report 2014-15. http://www.cihiconferences.ca/annualreport2015/index_en.,Non-OADS,/arxiv_data1/oa_pdf/ab/68/10.1177_2054358117695793.PMC5347420.pdf
https://www.usrds.,Non-OADS,/arxiv_data1/oa_pdf/ab/68/10.1177_2054358117695793.PMC5347420.pdf
http://www.ohri.ca/ programs/clinical_epidemiology/oxford.asp.,Non-OADS,/arxiv_data1/oa_pdf/ab/68/10.1177_2054358117695793.PMC5347420.pdf
"https://doi.org/10.1177/2333794X17691436Global Pediatric Health Volume 4: 1 –3  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X17691436 journals.sagepub.com/home/gph Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Brief Report Case Presentation A 14-year-old previously healthy adolescent female was  referred to the emergency department for complaints of fatigue and weakness.",Non-OADS,/arxiv_data1/oa_pdf/e7/95/10.1177_2333794X17691436.PMC5347421.pdf
"https://doi.org/10.1177/2054358117695570Canadian Journal of Kidney Health  and Disease  Volume 4 : 1 –9 © The Author(s) 2017DOI: 10.1177/2054358117695570 Reprints and permission: sagepub.com/journalsPermissions.nav journals.sagepub.com/home/cjkGuidelines and guideline commentaries695570 CJKXXX10.1177/2054358117695570Canadian Journal of Kidney Health and DiseaseChan et al research-article 2017 Choosing Wisely: The Canadian   Society of Nephrology’s List of 5 Items Physicians and Patients Should Question Emilie Chan1, Brenda Hemmelgarn2, Scott Klarenbach3,  Braden Manns2, Reem Mustafa4, Gihad Nesrallah5,   and Rory McQuillan1 Abstract Purpose of review: The purpose of this review is to contribute to the Choosing Wisely Canada campaign and develop a list of 5 items for nephrology health care professionals and patients to re-evaluate based on evidence that they are overused or misused.Sources of information: A working group was formed from the Canadian Society of Nephrology (CSN) Clinical Practice Guidelines Committee.",Non-OADS,/arxiv_data1/oa_pdf/fe/82/10.1177_2054358117695570.PMC5347422.pdf
https://www.cihi.ca/en/spending-and-health-workforce/spending/canadas-health-care-spending- growth-slows.,Non-OADS,/arxiv_data1/oa_pdf/fe/82/10.1177_2054358117695570.PMC5347422.pdf
http://www.choosingwisely.org.,Non-OADS,/arxiv_data1/oa_pdf/fe/82/10.1177_2054358117695570.PMC5347422.pdf
http://www.sign.ac.uk/pdf/SIGN147.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fe/82/10.1177_2054358117695570.PMC5347422.pdf
https://www.nhlbi.nih.gov/files/docs/guidelines/ jnc7full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fe/82/10.1177_2054358117695570.PMC5347422.pdf
"https://doi.org/10.1177/2054358117692560Canadian Journal of Kidney Health  and Disease  Volume 4: 1 –6 © The Author(s) 2017Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/2054358117692560 journals.sagepub.com/home/cjkOriginal Research Article692560 CJKXXX10.1177/2054358117692560Canadian Journal of Kidney Health and DiseaseAlobaidi et al research-article 2017 Associations Between Fluid Balance and  Outcomes in Critically Ill Children: A Protocol for a Systematic Review and Meta-analysis Rashid Alobaidi1, Catherine Morgan2, Rajit K. Basu3,4,   Erin Stenson3, Robin Featherstone5, Sumit R. Majumdar6,   and Sean M. Bagshaw7 Abstract Background: Fluid therapy is a mainstay during the resuscitation of critically ill children.",Non-OADS,/arxiv_data1/oa_pdf/c1/71/10.1177_2054358117692560.PMC5347423.pdf
http://handbook.cochrane.org/.,OADS,/arxiv_data1/oa_pdf/c1/71/10.1177_2054358117692560.PMC5347423.pdf
"https://doi.org/10.1177/2054358117693353Canadian Journal of Kidney Health  and Disease  Volume 4: 1 –8 © The Author(s) 2017Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/2054358117693353 journals.sagepub.com/home/cjkOriginal Research Article693353 CJKXXX10.1177/2054358117693353Canadian Journal of Kidney Health and DiseaseLee et al research-article 2017 Creatinine Assay Attainment of  Analytical Performance Goals Following Implementation of IDMS Standardization: Further Improvements Required Elizabeth Sunmin Lee1, Christine P. Collier2,   and Christine A. White1 Abstract Background: The international initiative to standardize creatinine (Cr) assays by tracing reference materials to Isotope  Dilution Mass Spectrometry (IDMS) assigned values was implemented to reduce interlaboratory variability and improve assay accuracy.Objective: The aims of this study were to examine whether IDMS standardization has improved Cr assay accuracy (bias),  interlaboratory variability (precision), total error (TE), and attainment of recommended analytical performance goals.Methods: External Quality Assessment (EQA) data (n = 66 challenge vials) from Ontario, Canada, were analyzed.",Non-OADS,/arxiv_data1/oa_pdf/4d/54/10.1177_2054358117693353.PMC5347424.pdf
"Availability of Data and Materials The data that support the findings of this study are available from Institute for Quality Management in Healthcare (http://iqmh.org), but restrictions apply to the availability of these data, which were  used with permission for the current study, and so are not publicly  available.",Non-OADS,/arxiv_data1/oa_pdf/4d/54/10.1177_2054358117693353.PMC5347424.pdf
http://iqmh.org.,Non-OADS,/arxiv_data1/oa_pdf/4d/54/10.1177_2054358117693353.PMC5347424.pdf
http://www.rcpaqap.com.au/docs/2014/chemp-ath/ALP.pdf.,OADS,/arxiv_data1/oa_pdf/4d/54/10.1177_2054358117693353.PMC5347424.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/49/93/10.1177_2325967117691941.PMC5347429.pdf
METHODS A retrospective cohort analysis was performed by search- ing the ESPN archive for NFL RBs (http://espn.go.com/nfl/ statistics) during the 2004 through 2014 regular seasons.,Non-OADS,/arxiv_data1/oa_pdf/49/93/10.1177_2325967117691941.PMC5347429.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/2a/48/10.1177_2325967117697677.PMC5347430.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/f5/7a/10.1177_2325967117693614.PMC5347431.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/eb/a0/10.1177_2325967117692513.PMC5347432.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/11/84/10.1177_2325967117693591.PMC5347433.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/bc/5f/10.1177_2325967117691480.PMC5347434.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/fc/23/10.1177_2325967116689387.PMC5347435.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/5c/0e/10.1177_2325967117690846.PMC5347436.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/00/21/10.1177_2325967117692507.PMC5347437.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/53/7a/10.1177_2325967116688866.PMC5347438.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/93/aa/10.1177_2325967117690131.PMC5347439.pdf
2009;50:307-314. http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/93/aa/10.1177_2325967117690131.PMC5347439.pdf
Available at: https://report.nih.gov/nihfactsheets/ ViewFactSheet.aspx?csid=112.,OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
Available at: http://www.who.int/mediacentre/factsheets/fs110/en/.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
Available at: http://www.who.int/hiv/strat-egy2016-2021/Online_Consultation_Report_16092015.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.7326/M14-1981.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/ 10.1097/QCO.0b013e3282f3d999.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.1016/j.jcma.2011.08.012.,OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.1097/QCO.0000000000000270.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
PLoS Med 2013; 10:e1001545.http://doi.org/10.1371/journal.pmed.1001545.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.1093/cid/cir699.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
Available at: http://apps.who.int/ iris/bitstream/10665/183117/1/9789241508841_eng.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.1371/journal.pone.0149568.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.1097/ QCO.0b013e32835c21b0.Point-of-care.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
Available at: http://doi.org/10.1111/jmwh.12094.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
"Available at: http://apps.who.int/iris/ bitstream/10665/112922/1/9789241507400_eng.pdf?ua=1.Cristillo et al 216 Sexually Transmitted Diseases Volume 44, Number 4, April 2017",Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
Avail- able at: http://doi.org/10.1016/S0968-8080(12)40660-7.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
Available at: http://www.who.int/whr/2004/en/re-port04_en.pdf?ua=1.,OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.1016/j.drup.2011.02.002.,OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
Infect Dis Obstet Gynecol 2016:4386127. http://doi.org/10.1155/2016/4386127.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.1128/JCM.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
BMC Res Notes 2014; 7:746. http://doi.org/10.1186/1756-0500-7-746.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.1016/j.ijgo.,OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.1136/sextrans-2015-052326.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
BMC Infect Dis 2016;16:302. http://doi.org/10.1186/s12879-016-1574-3.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.1128/JCM.02763-14.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.1016/S1473- 3099(04)01061-8.43.,OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.1097/01.aids.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.1086/315209.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.1016/j.bios.2012.12.053.,OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
http://doi.org/10.1007/s10404-013- 1305-7.,Non-OADS,/arxiv_data1/oa_pdf/69/10/olq-44-211.PMC5347466.pdf
"https://doi.org/10.1177/2050313X17695717 SAGE Open Medical Case Reports Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –4 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17695717 journals.sagepub.com/home/sco Introduction There is an assumption that the intake of large amount of  cola-based drinks may result in severe symptomatic hypoka-lemia.",Non-OADS,/arxiv_data1/oa_pdf/37/09/10.1177_2050313X17695717.PMC5347489.pdf
"https://doi.org/10.1177/2050313X17695473 SAGE Open Medical Case Reports Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –3 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17695473 journals.sagepub.com/home/sco Introduction Alveolar soft-part sarcoma (ASPS) is rare soft tissue sar - coma that often occurs primarily in the lower extremities  and trunk.",Non-OADS,/arxiv_data1/oa_pdf/99/c0/10.1177_2050313X17695473.PMC5347490.pdf
"https://doi.org/10.1177/2050313X17695472 SAGE Open Medical Case Reports Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –4 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17695472 journals.sagepub.com/home/sco Introduction Metallic mercury is liquid at room temperature and easily  transforms to vapour.",Non-OADS,/arxiv_data1/oa_pdf/d9/c7/10.1177_2050313X17695472.PMC5347491.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e4/93/main.PMC5347493.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.01.004 103,OADS,/arxiv_data1/oa_pdf/e4/93/main.PMC5347493.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/4b/main.PMC5347494.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.01.010 106,OADS,/arxiv_data1/oa_pdf/0b/4b/main.PMC5347494.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/94/d1/main.PMC5347515.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.01.012 110,OADS,/arxiv_data1/oa_pdf/94/d1/main.PMC5347515.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2017) 8, 279 –288 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2017.02.001 2090-1232 /C2112017 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/29/24/main.PMC5347516.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/24/main.PMC5347516.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/29/24/main.PMC5347516.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2017) 8, 271–278 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2017.02.003 2090-1232 /C2112017 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/e3/c0/main.PMC5347517.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/c0/main.PMC5347517.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e3/c0/main.PMC5347517.pdf
Available from: http://www.esim.eg.,Non-OADS,/arxiv_data1/oa_pdf/e3/c0/main.PMC5347517.pdf
"In this study, they   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Correspondence to: Sang Kil Lee Division of Gastroenterology, Department of Internal Medicine, Severance Hospital, Institute of Gastroenterology, Yonsei University College of  Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea  Tel: +82-2-2228-1996, Fax: +82-2-393-6884, E-mail: sklee@yuhs.ac  pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16608Do We Need to Retest of Helicobacter pylori  Infection after Gastric Cancer  Surgery?",Non-OADS,/arxiv_data1/oa_pdf/f9/a1/gnl-11-169.PMC5347639.pdf
"However, in the previous studies evaluating  factors affecting clinical and endoscopic efficacies, GMA was  revealed to be more effective in steroid-naïve patients, patients  on the low cumulative steroid dose, patients with short interval  between relapse and the first GMA session, or patients without   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Correspondence to: Seong Ran Jeon Digestive Disease Center, Institute for Digestive Research, Soonchunhyang University College of Medicine, 59 Daesagwan-ro, Yongsan-gu, Seoul  04401, Korea Tel: +82-2-709-9202, Fax: +82-2-709-9696, E-mail: 94jsr@hanmail.net pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl17028Is Adsorptive Granulocyte and Monocyte Apheresis Effective as an  Alternative Treatment Option in Patients with Ulcerative Colitis?",Non-OADS,/arxiv_data1/oa_pdf/1a/a2/gnl-11-171.PMC5347640.pdf
"Among the most impor-  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Pathophysiology and Management of Alcoholic Liver Disease: Update 2016 Felix Stickel1, Christian Datz2, Jochen Hampe3, and Ramon Bataller4 1Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland, 2Department of Internal Medicine, Hospital  Oberndorf, Teaching Hospital of the Paracelsus Private University of Salzburg, Oberndorf, Austria, 3Medical Department 1, University Hospital  Dresden, TU Dresden, Dresden, Germany, and 4Division of Gastroenterology and Hepatology, Department of Medicine and Nutrition, University  of North Carolina at Chapel Hill, Chapel Hill, NC, USA  Correspondence to: Felix Stickel Department of Gastroenterology and Hepatology, University Hospital Zurich, Rämistrasse 100, CH-8091 Zürich, Switzerland  Tel: +41-31-338-7817, Fax: +41-31-335-3519, E-mail: Felix.stickel@uzh.ch Received on September 23, 2016.",Non-OADS,/arxiv_data1/oa_pdf/fc/b9/gnl-11-173.PMC5347641.pdf
"Published online February 21, 2017pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16477",Non-OADS,/arxiv_data1/oa_pdf/fc/b9/gnl-11-173.PMC5347641.pdf
Epub 2016 May 26.  https://doi.org/10.1016/j.jbspin.2016.02.024.,OADS,/arxiv_data1/oa_pdf/fc/b9/gnl-11-173.PMC5347641.pdf
"3,6  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Management of Antiviral Resistance in Chronic Hepatitis B Young-Suk Lim Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea  Correspondence to: Young-Suk Lim Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505,  Korea Tel: +82-2-3010-5933, Fax: +82-2-485-5782, E-mail: limys@amc.seoul.kr Received on November 2, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d5/b8/gnl-11-189.PMC5347642.pdf
"Published online February 13, 2017pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl15562Lamivudine100 80 60 40 20Cumulativeincidence(%) 0 Adefovir TelbivudineEntecavir Tenofovir 0 1.2Low genetic barrier drugs High genetic barrier drugs 2438496770 3111829 417Year1 Year2 Year3 Year4Y ear5  Year6 Fig.",Non-OADS,/arxiv_data1/oa_pdf/d5/b8/gnl-11-189.PMC5347642.pdf
"15 The number of  bacteria increases from stomach (101 to 103 bacteria/g) to the  colon (1011 to 1012 bacteria/g).13 The small intestine comprises  mainly of Gram positive and aerobic bacteria and the large in- testine contains predominantly Gram negative and anaerobic  bacteria.16 Majority of bacteria residing in the colon are strictly   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome:   A Bridge between Functional Organic Dichotomy Uday C. Ghoshal, Ratnakar Shukla, and Ujjala Ghoshal Department of Gastroenterology and Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India  Correspondence to: Uday C. Ghoshal Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow 226014, India  Tel: +91-522-249-4405, Fax: +91-522-266-8017, E-mail: udayghoshal@gmail.com  Received on March 14, 2016.",Non-OADS,/arxiv_data1/oa_pdf/22/46/gnl-11-196.PMC5347643.pdf
"Accepted on July 11, 2016.pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16126",Non-OADS,/arxiv_data1/oa_pdf/22/46/gnl-11-196.PMC5347643.pdf
Epub 2016 Jun 5. https://doi.org/10.1111/jgh.13465.,Non-OADS,/arxiv_data1/oa_pdf/22/46/gnl-11-196.PMC5347643.pdf
"From this background, the aim of the present study was to   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Dynamic Changes in Helicobacter pylori  Status Following Gastric Cancer  Surgery Kichul Yoon1,2, Nayoung Kim1,3, Jaeyeon Kim3, Jung Won Lee3, Hye Seung Lee4, Jong-Chan Lee1, Hyuk Yoon1, Cheol Min  Shin1, Young Soo Park1, Sang-Hoon Ahn5, Do Joong Park5, Hyung Ho Kim5, Yoon Jin Lee6, Kyoung-Ho Lee6, Young-Hoon  Kim6, and Dong Ho Lee1,3 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, 2Department of Internal Medicine, Seoul Adventist  Hospital, Seoul, 3Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul,  Departments of  4Pathology, 5Surgery, and 6Radiology, Seoul National University Bundang Hospital, Seongnam, Korea  Correspondence to: Nayoung Kim Department of Internal Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro, 173beon-gil, Bundang-gu, Seongnam 13620, Korea  Tel: +82-31-787-7008, Fax: +82-31-787-4051, E-mail: nayoungkim49@empas.com Received on May 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/39/26/gnl-11-209.PMC5347644.pdf
"Published online November 14, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16224See editorial on page 169.",Non-OADS,/arxiv_data1/oa_pdf/39/26/gnl-11-209.PMC5347644.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Adsorptive Granulocyte and Monocyte Apheresis in the Treatment of  Ulcerative Colitis: The First Multicenter Study in China Ya-Min Lai1, Wei-Yan Yao2, Yao He3, Xuan Jiang4, Yu-Bei Gu2, Min-Hu Chen3, Yu-Lan Liu4, Yao-Zong Yuan2, and Jia-Ming  Qian1 1Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing, 2Ruijin Hospital,  Shanghai Jiaotong University School of Medicine, Shanghai, 3The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, and  4Department of Gastroenterology, Peking University People's Hospital, Beijing, China  Correspondence to: Jia-Ming Qian Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, No.",Non-OADS,/arxiv_data1/oa_pdf/24/b5/gnl-11-216.PMC5347645.pdf
"Published online November 16, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl15408See editorial on page 171.",Non-OADS,/arxiv_data1/oa_pdf/24/b5/gnl-11-216.PMC5347645.pdf
"6 The main  reason for this decreasing efficacy is assumed to be the increase   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of  Helicobacter pylori  in Peptic Ulcer Disease Joo Hyun Lim1,2, Sang Gyun Kim2, Ji Hyun Song1, Jae Jin Hwang3, Dong Ho Lee3, Jae Pil Han4, Su Jin Hong4, Ji Hyun Kim5,  Seong Woo Jeon6, Gwang Ha Kim7, Ki-Nam Shim8, Woon Geon Shin9, Tae Ho Kim10, Sun Moon Kim11, Il-Kwon Chung12,  Hyun-Soo Kim13, Heung Up Kim14, Joongyub Lee15, and Jae Gyu Kim16 1Department of Internal Medicine, Seoul National University Hospital, Healthcare System Gangnam Center, Healthcare Research Institute,  2Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, 3Department of Internal  Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 4Department of Internal  Medicine, Soonchunhyang University College of Medicine, Bucheon, 5Department of Internal Medicine, Inje University College of Medicine,  Busan, 6Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, 7Department of Internal Medicine,  Pusan National University School of Medicine, Busan, 8Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul,  9Department of Internal Medicine, Hallym University College of Medicine, Seoul, 10Department of Internal Medicine, The Catholic University  of Korea College of Medicine, Bucheon, 11Department of Internal Medicine, Konyang University College of Medicine, Daejeon, 12Department  of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, 13Department  of Internal Medicine, Chonnam National University Medical School, Gwangju, 14Department of Internal Medicine, Jeju National University  School of Medicine, Jeju, 15Medical Research Collaborating Center, Seoul National University Hospital and Seoul National University College of  Medicine, Seoul, and 16Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea  Correspondence to: Sang Gyun Kim Division of Gastroenterology, Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, 101  Daehak-ro, Jongno-gu, Seoul 03080, Korea Tel: +82-2-740-8112, Fax: +82-2-743-6701, E-mail: harley1333@hanmail.net Received on February 25, 2016.",Non-OADS,/arxiv_data1/oa_pdf/2c/41/gnl-11-226.PMC5347646.pdf
"Published online September 9, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16099",Non-OADS,/arxiv_data1/oa_pdf/2c/41/gnl-11-226.PMC5347646.pdf
"The reasons  for performing 24-hour esophageal pH monitoring varied, but  most patients had symptoms of gastroesophageal reflux such as  recurrent aspiration pneumonia, grunting after meals, frequent regurgitation, and unexplained food refusal or food-related   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Gastroesophageal Reflux in Neurologically Impaired Children: What Are the  Risk Factors?",Non-OADS,/arxiv_data1/oa_pdf/b3/e7/gnl-11-232.PMC5347647.pdf
"Published online November 14, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16150",Non-OADS,/arxiv_data1/oa_pdf/b3/e7/gnl-11-232.PMC5347647.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Positive Glucose Breath Tests in Patients with Hysterectomy, Gastrectomy,  and Cholecystectomy Dae Bum Kim1, Chang-Nyol Paik1, Yeon Ji Kim1, Ji Min Lee1, Kyong-Hwa Jun2, Woo Chul Chung1, Kang-Moon Lee1, Jin-Mo  Yang1, and Myung-Gyu Choi3  Departments of 1Internal Medicine, 2Surgery, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine, Suwon, and  3Department of Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea   Correspondence to: Chang-Nyol Paik Division of Gastroenterology, Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine, 93  Jungbu-daero (Ji-dong), Paldal-gu, Suwon 16247, Korea Tel: +82-31-249-7137, Fax: +82-31-253-8898, E-mail: cmcu@catholic.ac.kr Received on March 14, 2016.",Non-OADS,/arxiv_data1/oa_pdf/ef/29/gnl-11-237.PMC5347648.pdf
"Published online December 16, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16132",Non-OADS,/arxiv_data1/oa_pdf/ef/29/gnl-11-237.PMC5347648.pdf
"However,  their long-term administration results in gastrointestinal side  effects; therefore, alternative therapeutic approaches are needed  to manage or prevent inflammation-associated CRC.12 In this re- gard, fruits and vegetables containing various compounds with  antioxidant and anti-inflammatory properties have been con-  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Açaí Berries Inhibit Colon Tumorigenesis in Azoxymethane/Dextran Sulfate  Sodium-Treated Mice  Yoon Jin Choi1, Yoon Jeong Choi1, Nayoung Kim1,2, Ryoung Hee Nam1, Seonmin Lee1, Hye Seung Lee3, Ha-Na Lee4,   Young-Joon Surh4, and Dong Ho Lee1,2 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, 2Department of Internal Medicine and Liver  Research Institute, Seoul National University College of Medicine, Seoul, 3Department of Pathology, Seoul National University Bundang  Hospital, Seongnam, and 4Tumor Microenvironment Global Core Research Center, Seoul National University College of Pharmacy, Seoul, Korea   Correspondence to: Nayoung Kim Department of Internal Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620, Korea  Tel: +82-31-787-7008, Fax: +82-31-787-4051, E-mail: nayoungkim49@empas.com  Received on February 3, 2016.",Non-OADS,/arxiv_data1/oa_pdf/64/62/gnl-11-243.PMC5347649.pdf
"Published online December 16, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16068Yoon Jin Choi and Yoon Jeong Choi contributed equally to this work as first authors.",Non-OADS,/arxiv_data1/oa_pdf/64/62/gnl-11-243.PMC5347649.pdf
"3 Most studies by VCE have been  focused on obscure GI bleeding and abdominal pain.4-7 In the   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Diagnostic Yield and Clinical Impact of Video Capsule Endoscopy in Patients  with Chronic Diarrhea: A Korean Multicenter CAPENTRY Study Hyun Joo Song1, Jeong Seop Moon2, Seong Ran Jeon3, Jin-Oh Kim3, Jinsu Kim4, Dae Young Cheung4, Myung-Gyu Choi4,  Yun Jeong Lim5, Ki-Nam Shim6, Byong Duk Ye7, Jae Hee Cheon8, Cheol Hee Park9, Hyun-Soo Kim10, Ji Hyun Kim11, Dong  Kyung Chang12, Jae Hyuk Do13, Kyeong Ok Kim14, Byung Ik Jang14, and Sung-Jae Shin15; The Korean Gut Image Study  Group 1Department of Internal Medicine, Jeju National University School of Medicine, Jeju, 2Department of Internal Medicine, Inje University  College of Medicine, 3Department of Internal Medicine, Soonchunhyang University College of Medicine, 4Department of Internal Medicine,  The Catholic University of Korea College of Medicine, Seoul, 5Department of Internal Medicine, Dongguk University College of Medicine,  Goyang, 6Department of Internal Medicine, Ewha Womans University School of Medicine, 7Department of Gastroenterology, University of  Ulsan College of Medicine, 8Department of Internal Medicine, Yonsei University College of Medicine, Seoul, 9Department of Internal Medicine,  Hallym University College of Medicine, Anyang, 10Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju,  11Department of Internal Medicine, Inje University College of Medicine, Busan, 12Department of Internal Medicine, Sungkyunkwan University  School of Medicine, 13Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, 14Department of Internal Medicine,  Yeungnam University College of Medicine, Daegu, and 15Department of Internal Medicine, Ajou University School of Medicine, Suwon, Korea  Correspondence to: Jeong Seop Moon Department of Internal Medicine, Inje University Seoul Paik Hospital, Inje University College of Medicine, 9 Mareunnae-ro, Jung-gu, Seoul 04551,  Korea Tel: +82-2-2270-0012, Fax: +82-2-2270-0312, E-mail: moonjs2@unitel.co.kr Received on May 6, 2016.",Non-OADS,/arxiv_data1/oa_pdf/27/1b/gnl-11-253.PMC5347650.pdf
"Published online November 14, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16231",Non-OADS,/arxiv_data1/oa_pdf/27/1b/gnl-11-253.PMC5347650.pdf
"Over the past several decades, remarkable progress has been  done in the verification of molecular mechanisms of pluripotent  differentiation as a result of intensive investigations into pluri-  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Establishment of Hepatocellular Cancer Induced Pluripotent Stem Cells  Using a Reprogramming Technique Han Joon Kim1, Jaemin Jeong1, Sunhoo Park2, Young-Woo Jin2, Seung-Sook Lee2, Seung Bum Lee2, and Dongho Choi1 1Department of Surgery, Hanyang University College of Medicine, and 2Laboratory of Radiation Exposure & Therapeutics, National Radiation  Emergency Medical Center, Korea Institute of Radiological & Medical Science (KIRAMS), Seoul, Korea  Correspondence to: Dongho Choia and Seung Bum Leeb aDepartment of Surgery, Hanyang University College of Medicine, 222 Wangsimni-ro, Seongdong-gu, Seoul 04763, Korea  Tel: +82-2-2290-8449, Fax: +82-2-2281-0224, E-mail: crane87@hanyang.ac.kr bLaboratory of Radiation Exposure & Therapeutics, National Radiation Emergency Medical Center, Korea Institute of Radiological & Medical Sci- ence (KIRAMS), 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea Tel: +82-2-970-1439, Fax: +82-2-970-1952, E-mail: sblee@kirams.re.kr Received on August 11, 2015.",Non-OADS,/arxiv_data1/oa_pdf/85/b1/gnl-11-261.PMC5347651.pdf
"Published online October 13, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl15389Han Joon Kim and Jaemin Jeong contributed equally to this work as first authors.",Non-OADS,/arxiv_data1/oa_pdf/85/b1/gnl-11-261.PMC5347651.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical Characteristics and Treatment Outcome of Peginterferon Plus  Ribavirin in Patients Infected with Genotype 6 Hepatitis C Virus in Korea:  A Multicenter Study Su Rin Shin1,2, Young Seok Kim3, Young-Seok Lim4, June Sung Lee5, Jin Woo Lee6, Sun Myung Kim7, Sook-Hyang Jeong8,  Joo Hyun Sohn9, Myung Seok Lee10, and Sang Hoon Park10 1Health Care Center, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, 2Department of Internal  Medicine, Kangwon National University College of Medicine, Chuncheon, 3Department of Internal Medicine, Soonchunhyang University College  of Medicine, Bucheon, 4Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 5Department  of Internal Medicine, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, 6Department of Internal Medicine, Inha  University School of Medicine, Incheon, 7Department of Internal Medicine, Gimpo Woori Hospital, Gimpo, 8Department of Internal Medicine,  Seoul National University Bundang Hospital, Seongnam, 9Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang  University College of Medicine, Guri, and 10Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea  Correspondence to: Sang Hoon Park Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, 1 Singil-ro,  Yeongdeungpo-gu, Seoul 07441, Korea Tel: +82-2-829-5121, Fax: +82-2-846-4669, E-mail: sanghoon@hallym.or.kr Received on March 24, 2016.",Non-OADS,/arxiv_data1/oa_pdf/86/ad/gnl-11-270.PMC5347652.pdf
"Published online October 13, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16163",Non-OADS,/arxiv_data1/oa_pdf/86/ad/gnl-11-270.PMC5347652.pdf
"3  This study aimed to investigate the effectiveness of GDF-15   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Growth Differentiation Factor 15 Predicts Chronic Liver Disease Severity Eaum Seok Lee1, Seok Hyun Kim1, Hyun Jin Kim1, Kyung Hee Kim2, Byung Seok Lee1, and Bon Jeong Ku1 Departments of 1Internal Medicine and 2Pathology, Chungnam National University School of Medicine, Daejeon, Korea  Correspondence to: Byung Seok Leea and Bon Jeong Kub aDivision of Gastroenterology & Hepatology, Department of Internal Medicine, Chungnam National University School of Medicine, 266 Munhwa- ro, Jung-gu, Daejeon 35015, Korea  Tel: +82-10-9344-9763, Fax: +82-42-255-4553, E-mail: gieoo1@cnuh.co.kr bDivision of Endocrinology & Metabolism, Department of Internal Medicine, Chungnam National University School of Medicine, 266 Munhwa-ro,  Jung-gu, Daejeon 35015, KoreaTel: +82-10-8810-6031, Fax: +82-42-280-7995, E-mail: bonjeong@cnu.ac.kr Received on January 25, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b8/41/gnl-11-276.PMC5347653.pdf
"Published online October 13, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16049Byung Seok Lee and Bon Jeong Ku equally supervised this work.",Non-OADS,/arxiv_data1/oa_pdf/b8/41/gnl-11-276.PMC5347653.pdf
"Pathologic reports of resected cystic lesions   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.The Combination of Cyst Fluid Carcinoembryonic Antigen, Cytology and  Viscosity Increases the Diagnostic Accuracy of Mucinous Pancreatic Cysts  Se Hun Oh1, Jong Kyun Lee1, Kyu Taek Lee1, Kwang Hyuck Lee1, Young Sik Woo2, and Dong Hyo Noh1 1Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, and  2Division of Gastroenterology, Department of Internal Medicine, Wonkwang University Sanbon Hospital, Wonkwang University College of  Medicine, Gunpo, Korea  Correspondence to: Jong Kyun Lee Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro,  Gangnam-gu, Seoul 06351, Korea Tel: +82-2-3410-3409, Fax: +82-2-3410-6983, E-mail: jongk.lee@samsung.com Received on December 26, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c6/a6/gnl-11-283.PMC5347654.pdf
"Published online September 9, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl15650",Non-OADS,/arxiv_data1/oa_pdf/c6/a6/gnl-11-283.PMC5347654.pdf
"4 In practice, the  majority of patients with choledocholithiasis visit the emergen- cy room, and so computed tomography (CT) is often the first- line diagnostic modality, due to its convenience and its use in  the differential diagnosis of acute abdomen (e.g., perforation).1,2   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Diagnostic Value of Endoscopic Ultrasonography in Symptomatic Patients  with High and Intermediate Probabilities of Common Bile Duct Stones and a Negative Computed Tomography Scan Tae Joo Jeon1,2, Jae Hee Cho3, Yeon Suk Kim3, Si Young Song2,4, and Ji Young Park1 1Division of Gastroenterology, Department of Internal Medicine, Inje University Sanggye Paik Hospital, Inje University College of Medicine,  2Department of Internal Medicine, The Graduate School, Yonsei University College of Medicine, Seoul, 3Division of Gastroenterology, Department  of Internal Medicine, Gachon University Gil Medical Center, Incheon, and 4Brain Korea 21 Project for Medical Science, Yonsei University College  of Medicine, Seoul, Korea  Correspondence to: Ji Young Parka and Jae Hee Chob aDivision of Gastroenterology, Department of Internal Medicine, Inje University Sanggye Paik Hospital, Inje University College of Medicine, 1342  Dongil-ro, Nowon-gu, Seoul 01757, Korea  Tel: +82-2-950-1340, Fax: +82-2-950-1955, E-mail: human@paik.ac.kr bDivision of Gastroenterology, Department of Internal Medicine, Gachon University Gil Medical Center, 21 Namdong-daero, 774beon-gil, Namdong- gu, Incheon 21565, KoreaTel: +82-32-460-3213, Fax: +82-32-461-3214, E-mail: jhcho9328@gilhospital.com Received on January 26, 2016.",Non-OADS,/arxiv_data1/oa_pdf/29/ed/gnl-11-290.PMC5347655.pdf
"Published online December 16, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16052",Non-OADS,/arxiv_data1/oa_pdf/29/ed/gnl-11-290.PMC5347655.pdf
"Several phase II studies investigated the effi-  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for  Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy Kwang Hyun Chung, Ji Kon Ryu, Jun Hyuk Son, Jae Woo Lee, Dong Kee Jang, Sang Hyub Lee, and Yong-Tae Kim Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea  Correspondence to: Ji Kon Ryu Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine,  101 Daehak-ro, Jongno-gu, Seoul 03080, Korea Tel: +82-2-2072-1962, Fax: +82-2-762-9662, E-mail: jkryu@snu.ac.kr Received on June 20, 2016.",Non-OADS,/arxiv_data1/oa_pdf/c0/ae/gnl-11-298.PMC5347656.pdf
"Published online December 16, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16307",Non-OADS,/arxiv_data1/oa_pdf/c0/ae/gnl-11-298.PMC5347656.pdf
"Herein, we report three pa- tients in whom this new scope contributed to efficient technique   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Impact of a Newly Developed Short Double-Balloon Enteroscope on Stent  Placement in Patients with Surgically Altered Anatomies Koichiro Tsutsumi, Hironari Kato, and Hiroyuki Okada Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences,  Okayama, Japan  Correspondence to: Koichiro Tsutsumi Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1  Shikata-cho, Kita-ku, Okayama 700-8558, Japan Tel: +81-86-235-7219, Fax: +81-86-225-5991, E-mail: tsutsumi@cc.okayama-u.ac.jp Received on September 5, 2016.",Non-OADS,/arxiv_data1/oa_pdf/53/88/gnl-11-306.PMC5347657.pdf
"Published online February 17, 2017pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl16441Fig.",Non-OADS,/arxiv_data1/oa_pdf/53/88/gnl-11-306.PMC5347657.pdf
"Published online January 19, 2016pISSN 1976-2283  eISSN 2005-1212  https://doi.org/10.5009/gnl15316To the Editor, Gastric cancer is the third most common cause of cancer- related deaths in both sexes worldwide.",Non-OADS,/arxiv_data1/oa_pdf/c8/5f/gnl-11-312.PMC5347658.pdf
"Yoon SB, Park JM, Lim CH, Cho YK, Choi MG. Effect of Helico-  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/5f/gnl-11-312.PMC5347658.pdf
"After measurement in the review software, images wereexported at a resolution of 1525 31016 pixels and imported to ImageJ (Wayne Rasband, National Institutes of Health, Bethesda, MD; available at http://rsb.info.nih.gov/ij/index.html ).",OADS,/arxiv_data1/oa_pdf/93/92/i2164-2591-6-2-1.PMC5347660.pdf
TOVA was created using Ruby (available in the public domain at http://www.ruby-lang.org ).,OADS,/arxiv_data1/oa_pdf/1a/ad/i2164-2591-6-2-2.PMC5347661.pdf
All analyses were performed using Ruby (available inthe public domain at http://www.ruby-lang.org ) and R(http://www.r-project.org ).,OADS,/arxiv_data1/oa_pdf/1a/ad/i2164-2591-6-2-2.PMC5347661.pdf
http://www.aaai.org/ocs/index.php/ICWSM/ICWSM10/paper/download/1529/1904/.,Non-OADS,/arxiv_data1/oa_pdf/1a/ad/i2164-2591-6-2-2.PMC5347661.pdf
"[5]Despite the great efforts that have been made to address this issue, successful asymmet-ric Passerini reactions are still limited to just a few examples of [a]Department of Chemistry and Pharmaceutical Sciences, and Amsterdam Institute for Molecules Medicines and Systems (AIMMS), Vrije UniversiteitAmsterdam,De Boelelaan 1108, 1081 HZ Amsterdam, The NetherlandsE-mail: e.ruijter@vu.nl; r.v.a.orru@vu.nlhttp://syborch.com/ [b]Faculty of Applied Engineering, University of Antwerp, Groenenborgerlaan 171, 2020 Antwerpen, Belgium [c]Department of Chemistry, University of Graz, Heinrichstrasse 28, 8010 Graz, Austria Supporting information and ORCID(s) from the author(s) for this article areavailable on the WWW under http://dx.doi.org/10.1002/ejoc.201601432.",Non-OADS,/arxiv_data1/oa_pdf/57/b8/EJOC-2017-1262.PMC5347843.pdf
The research leading to these results receivedfunding from the Innovative Medicines Initiative Joint Under-taking project CHEM21 (http://www.chem21.eu) under grantagreement No.,Non-OADS,/arxiv_data1/oa_pdf/57/b8/EJOC-2017-1262.PMC5347843.pdf
"Retrieved from: http://www.ncbi.nlm.nih.gov/pubmed/ 11706808 Jarrold, C., & Baddeley, A.D. (2002).",OADS,/arxiv_data1/oa_pdf/4a/92/DESC-20-na.PMC5347847.pdf
"Retrieved from: http://www.ncbi.nlm.nih.gov/pubmed/ 22709400 Ypsilanti, A., & Grouios, G. (2008).",OADS,/arxiv_data1/oa_pdf/4a/92/DESC-20-na.PMC5347847.pdf
Available from: http://www.who.int/vaccine_ research/diseases/influenza/WHO_manual_on_animal-diag nosis_and_surveillance_2002_5.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0b/ac/MEC-26-1420.PMC5347849.pdf
"Detailed site description and data collection methods have been described previously (Meyers & Hollinger, 2004).The Ameriﬂux (http://public.ornl.gov/ameriﬂux/) L4 gap- ﬁlled weather data were used for this simulation.",OADS,/arxiv_data1/oa_pdf/f5/9a/GCB-23-1626.PMC5347850.pdf
Supportin ginforma tion andtheORCID identifica tion number(s) for theauthor(s) ofthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2016095 41.,Non-OADS,/arxiv_data1/oa_pdf/43/53/ANIE-56-2312.PMC5347859.pdf
"Author contributions All authors have agreed on the ﬁnal version and meet at least one of the following criteria [recommended by theICMJE (http://www.icmje.org/recommendations/)]: substantial contributions to conception and design,acquisition of data, or analysis and interpretation of data; drafting the article or revising it critically for importantintellectual content.",Non-OADS,/arxiv_data1/oa_pdf/3d/f0/JAN-73-966.PMC5347866.pdf
Retrieved from http://onlinelibrary.wiley.com/doi/10 /C11002/14651858.CD002084.pub2/full on 30/08/2015.,Non-OADS,/arxiv_data1/oa_pdf/3d/f0/JAN-73-966.PMC5347866.pdf
Fast and easy online submission: online submission at http://mc.manuscriptcentral.com/jan.,Non-OADS,/arxiv_data1/oa_pdf/3d/f0/JAN-73-966.PMC5347866.pdf
Available at: http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bc/34/CXO-100-144.PMC5347867.pdf
Available at: http://www.aqol.com.[au/index.php/scoring-algorithms?id=138.,Non-OADS,/arxiv_data1/oa_pdf/bc/34/CXO-100-144.PMC5347867.pdf
"Mad ison, WI53726 (USA ) E-mail :fachua nglu@w isc.edu jralp h@wisc.ed u [c]Prof. R.Sun Beijin gKeyLaboratory ofLignocellu losic Chem istry Beijin gForestry Univer sity 35Qinghua East Rd Haidian District, Beijin g,100083 (P.R.China) Supp orting Infor mati onand theORCID identificati onnumber (s)forthe autho r(s)ofthisarticle canbefoundunde rhttp://dx.doi.org/ 10.1002 / cssc.2 01700101.",Non-OADS,/arxiv_data1/oa_pdf/e7/fa/CSSC-10-830.PMC5347868.pdf
The P AXgene tubes were shipped to the Rutgers University Cell and DNA Reposi- tory (http://www.rucdr.org).,OADS,/arxiv_data1/oa_pdf/96/1e/ADB-22-550.PMC5347870.pdf
KEGG path- ways were downloaded from http://www.broadinstitute.,OADS,/arxiv_data1/oa_pdf/96/1e/ADB-22-550.PMC5347870.pdf
"VCAlphaMed Press 1066-5099/2016/$30.00/0 http://dx.doi.org/ 10.1002/stem.2514 This is an open access article under the terms ofthe Creative Commons Attribution-NonCommercial- NoDerivs License, whichpermits use and distributionin any medium, provided the original work is properly cited, the use is non-commercial and no modifications oradaptations are made.",Non-OADS,/arxiv_data1/oa_pdf/10/47/STEM-35-694.PMC5347872.pdf
Available from: http://www.g-i-n.net/document-store/working-groups-documents/adapta- tion/adapte-manual-for-guideline.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/24/bc/JEP-23-121.PMC5347874.pdf
Available from:http://www.agreetrust.org/wp-content/uploads/2013/10/AGREE-II- Users-Manual-and-23-item-Instrument_2009_UPDATE_2013.pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/24/bc/JEP-23-121.PMC5347874.pdf
"Since the discovery [a]Van 't Hoff Institute for Molecular Sciences, University of Amsterdam Science Park 904, 1098 XH Amsterdam, The NetherlandsE-mail: b.debruin@uva.nlhttp://www.homkat.nl/People/Scientific%20Staff/Bas%20de%20Bruin/Bas%20de%20Bruin.htm [‡] The manuscript was written through contributions of both authors.",Non-OADS,/arxiv_data1/oa_pdf/27/2b/EJOC-2017-1152.PMC5347896.pdf
ORCID(s) from the author(s) for this article is/are available on the WWW under http://dx.doi.org/10.1002/ejoc.201601390.,Non-OADS,/arxiv_data1/oa_pdf/27/2b/EJOC-2017-1152.PMC5347896.pdf
Using these co-ordinates we cre- ated spherical ROIs with a radius of 8 mm and extracted raw volumes at both time points using the marsbar tool(http://marsbar.sourceforge.net/).,OADS,/arxiv_data1/oa_pdf/14/91/HBM-38-631.PMC5347905.pdf
Available at: https://www.usenix.org/legacy/events/evt07/.,Non-OADS,/arxiv_data1/oa_pdf/1e/72/ACER-41-626.PMC5347908.pdf
https://doi.org/10.1002/dmrr.2858wileyonlinelibrary.com/journal/dmrr 1o f1 0,Non-OADS,/arxiv_data1/oa_pdf/d6/f1/DMRR-33-na.PMC5347910.pdf
http://www.nice.org.uk/guidance/cg87/resources/ guidance ‐type ‐2‐diabetes ‐pdf.,Non-OADS,/arxiv_data1/oa_pdf/d6/f1/DMRR-33-na.PMC5347910.pdf
Available at: http://www.ihra.net/ ﬁles/2010/06/29/GlobalState2010_Web.,Non-OADS,/arxiv_data1/oa_pdf/ad/de/ADD-111-1616.PMC5347913.pdf
2012. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/ 022200Orig1s000MedR.pdf.,OADS,/arxiv_data1/oa_pdf/84/c3/DOM-19-394.PMC5347923.pdf
2011. http://www.accessdata.fda.gov/drugsatfda_docs/nda/ 2011/201280Orig1s000MedR.pdf.,OADS,/arxiv_data1/oa_pdf/84/c3/DOM-19-394.PMC5347923.pdf
http://www.ngsp.org/ifcc.asp.,Non-OADS,/arxiv_data1/oa_pdf/b7/22/DOM-19-375.PMC5347924.pdf
2009. http://www.fda.gov/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ucm188703.htm.,Non-OADS,/arxiv_data1/oa_pdf/b7/22/DOM-19-375.PMC5347924.pdf
2014. http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm427913.htm.,Non-OADS,/arxiv_data1/oa_pdf/b7/22/DOM-19-375.PMC5347924.pdf
http://products.sanofi.,Non-OADS,/arxiv_data1/oa_pdf/b7/22/DOM-19-375.PMC5347924.pdf
https://www.lantus.,Non-OADS,/arxiv_data1/oa_pdf/b7/22/DOM-19-375.PMC5347924.pdf
Available at: http://eur-lex.europa.eu/Le xUriServ/LexUriServ.do?uri=CONSLEG:1993L0042:20071011:en:PDF (accessedon 20 November 2016).,Non-OADS,/arxiv_data1/oa_pdf/4b/de/APT-45-631.PMC5347926.pdf
Available at: http://crc.marionegri.it/sf36/sf36v1ita.,Non-OADS,/arxiv_data1/oa_pdf/4b/de/APT-45-631.PMC5347926.pdf
"A total of12,037 unique publications were examined and 537 wereincluded in the analyses based on the Preferred Reporting Items for Systematic reviews and Meta-Analyses Statement (PRISMA; http://www.prisma-statement.org/).",OADS,/arxiv_data1/oa_pdf/0b/6b/HBM-38-1846.PMC5347927.pdf
"Coordinates were trans-formed to MNI, if reported in Talairach space, using the “tal2icbm_fsl” transform (http://www.brainmap.org/ icbm2tal/).",OADS,/arxiv_data1/oa_pdf/0b/6b/HBM-38-1846.PMC5347927.pdf
"Oxford cortical and subcortical atlases [Desikan et al., 2006; Frazier et al., 2005] (http://www.cma.mgh.harvard.",Non-OADS,/arxiv_data1/oa_pdf/0b/6b/HBM-38-1846.PMC5347927.pdf
"edu/fsl_atlas.html; http://fsl.fmrib.ox.ac.uk/fsl/), with a probability threshold of 10% for each region.",Non-OADS,/arxiv_data1/oa_pdf/0b/6b/HBM-38-1846.PMC5347927.pdf
Available from URL: http://www.abs.gov.au/ausstats/abs@.nsf/mf/2039.0.55.001 3 Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat.,Non-OADS,/arxiv_data1/oa_pdf/83/5d/AJR-25-34.PMC5347938.pdf
[Cited 25 Oct 2014].Available from URL: http://www.un.org/esa/population/ publications/wup2003/WUP2003Report.pdf 4 CFF.,OADS,/arxiv_data1/oa_pdf/83/5d/AJR-25-34.PMC5347938.pdf
"Available from URL: http://www.un.org/esa/ population/publications/wup2003/WUP2003Report.pdf 5 Bell SC, Robinson PJ, eds.",Non-OADS,/arxiv_data1/oa_pdf/83/5d/AJR-25-34.PMC5347938.pdf
Available from URL: http://www.abs.gov.au/ausstats/abs@.nsf/mf/1216.0 21 Australian Bureau of Statistics.,OADS,/arxiv_data1/oa_pdf/83/5d/AJR-25-34.PMC5347938.pdf
"Available from URL: http://www.abs.gov.au/ausstats/ abs@.nsf/mf/2039.0.55.001 22 Stephenson A, Hux J, Tullis E, Austin PC, Corey M, Ray J. Socioeconomic status and risk of hospitalization among individuals with cystic ﬁbrosis in Ontario,Canada.",Non-OADS,/arxiv_data1/oa_pdf/83/5d/AJR-25-34.PMC5347938.pdf
Preferred Reporting Items for Systematic Reviews and Meta-Analyses.Available at: http://www.prisma-statement.org/ (accessed 04 augustus 2015).,OADS,/arxiv_data1/oa_pdf/a5/93/JCPE-44-225.PMC5347939.pdf
"To investigate the effect of the CNR1 gene we selected possibly functional single nucleotide polymorphisms (SNPs) from previous lit-erature and haplotype tag SNPs (htSNPs) to cover the whole gene.Genetic data were extracted from the International HapMap project(http://hapmap.ncbi.nlm.nih.gov/, Phase I. June 2005, CEPH popu-lation and AFD_EUR_18-MAY-2004 panel).",OADS,/arxiv_data1/oa_pdf/b2/21/GBB-16-384.PMC5347942.pdf
"Statistical analysis To calculate Hardy-Weinberg equilibrium Pvalues, to run logistic regression analysis with additive genetic models, and to computehaplotypes PLINK v1 .07 (http://pngu.mgh.harvard.edu/~purcell/plink/)analysis programme was used.",Non-OADS,/arxiv_data1/oa_pdf/b2/21/GBB-16-384.PMC5347942.pdf
"To adjust Pvalues for the multiple testing false discovery rate q values were calculated and were accepted at level of 5% (Q value, http://www.bioconductor.org/packages/release/bioc/html/qvalue.html).",OADS,/arxiv_data1/oa_pdf/b2/21/GBB-16-384.PMC5347942.pdf
Quanto 1 .2 version (http://biostats.usc.edu/Quanto.html/) was employed to calculate the power of the recruited populations.Assuming a case–control design (3 controls/case) and an additivegenetic model with a minor allele frequency between 10% and 50%in our study ( n=2426) we have 45–84% power to detect genetic main effects and 65–95% power to detect a gene ×environment interaction ( P=0.05 two-tailed) that is associated with 1 .2 odds ratio for a disease.,OADS,/arxiv_data1/oa_pdf/b2/21/GBB-16-384.PMC5347942.pdf
Available at:http://www.cancer.org/cancer/prostateca ncer/detailedguide/prostate-cancer-survi val-rates (accessed 6/11/2015).,Non-OADS,/arxiv_data1/oa_pdf/fa/b2/ECC-26-na.PMC5347946.pdf
79.Available at: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=6012 9545133 (accessed 3/11/2015).,OADS,/arxiv_data1/oa_pdf/fa/b2/ECC-26-na.PMC5347946.pdf
Available at: http://www.cancerresearchuk.org/health-professional/canc er-statistics/statistics-by-cancer-type/pro state-cancer#heading-Two (accessed 3/11/2015).,Non-OADS,/arxiv_data1/oa_pdf/fa/b2/ECC-26-na.PMC5347946.pdf
Available at:http://globocan.iarc.fr (accessed 14/11/ 2015).,Non-OADS,/arxiv_data1/oa_pdf/fa/b2/ECC-26-na.PMC5347946.pdf
"MDS is increasingly available for clinical use, and its performance characteristics are being evaluated in an ongoing prospective, multicenter study (http://www.ciapm.org/project/precision- diagnosis-acute -infectious- diseases).",Non-OADS,/arxiv_data1/oa_pdf/4a/74/AJT-17-803.PMC5347949.pdf
Available at: https://www.imshealth.com/ ﬁles/web/IMSH%20Insti- tute/NSP_Data_Brief-.pdf [7 October 2016].,Non-OADS,/arxiv_data1/oa_pdf/b2/87/PDS-26-353.PMC5347952.pdf
Available at:https://www.regulations.gov/document?D=FDA-2009-N-0138-0236 [17 October2016].,Non-OADS,/arxiv_data1/oa_pdf/b2/87/PDS-26-353.PMC5347952.pdf
Available at: https://www.safekids.org/sites/default/ ﬁles/3-17-16-skw_medicine_ safety_study_for_web.pdf [7 October 2016].,Non-OADS,/arxiv_data1/oa_pdf/b2/87/PDS-26-353.PMC5347952.pdf
"A weighted, Bonferroni-based, sequentially rejective, closed multiple-testing proc edure was used to maintain strong control of Type I error for the 24-week primary and major second-ary end points (see Supplementary Figure 1, available on theArthritis & Rheumatology web site at http://onlinelibrary.wiley.com/ doi/10.1002/art.39953/abstract) ( 18,19).",Non-OADS,/arxiv_data1/oa_pdf/d3/cc/ART-69-506.PMC5347954.pdf
"Compared to MTX monothera py, statistically signifi- cant improvements were observ ed for baricitinib monother- apy and baricitinib plus MTX in the 24-week major secondary measures of superiority of the ACR20 response, improvement in the DAS28-CRP, improvement in HAQDI scores, and SDAI remission (Figure 2) (see Supplemen- tary Figures 2F and 3A, http://onlinelibrary.wiley.com/doi/ 10.1002/art.39953/abstract).",Non-OADS,/arxiv_data1/oa_pdf/d3/cc/ART-69-506.PMC5347954.pdf
"1002/art.39953/abstract) and their components (see Sup- plementary Figure 2, http://onlinelibrary.wiley.com/doi/ 10.1002/art.39953/abstract).",Non-OADS,/arxiv_data1/oa_pdf/d3/cc/ART-69-506.PMC5347954.pdf
"For relevant outcome measures such as the ACR20 and ACR50 responsesand a DAS28-hsCRP #3.2, significant heterogeneity was not seen based on glucocorticoid use and nonuse for treatment effects compared to MTX (see Supple-mentary Figures 4–6, http://onlinelibrary.wiley.com/ doi/10.1002/art.39953/abstract).",Non-OADS,/arxiv_data1/oa_pdf/d3/cc/ART-69-506.PMC5347954.pdf
"Efficacy measures are summarized in Supplementary Table 3, http://onlinelibrary.wiley.com/do i/10.1002/art.39953/abstract.",Non-OADS,/arxiv_data1/oa_pdf/d3/cc/ART-69-506.PMC5347954.pdf
"Protocol-defined SAEs through week 52 are shown in Supplementary Table 5, http://onlinelibrary.wiley.com/ doi/10.1002/art.39953/abstract.",Non-OADS,/arxiv_data1/oa_pdf/d3/cc/ART-69-506.PMC5347954.pdf
"No imbalance in protocol-defined throm- bocytosis ( .600,000 cells/mm 3) was seen among groups (see Supplementary Table 5, http://onlinelibrary.wiley.",OADS,/arxiv_data1/oa_pdf/d3/cc/ART-69-506.PMC5347954.pdf
URL: http://www.das-score.nl/das28/.,Non-OADS,/arxiv_data1/oa_pdf/d3/cc/ART-69-506.PMC5347954.pdf
https://doi.org/10.1111/cmi.12682wileyonlinelibrary.com/journal/cmi 1o f1 1,Non-OADS,/arxiv_data1/oa_pdf/f8/37/CMI-19-na.PMC5347955.pdf
https://doi.org/10.1111/cmi.12682MALET ET AL.,OADS,/arxiv_data1/oa_pdf/f8/37/CMI-19-na.PMC5347955.pdf
"An ambitious treatment target to help end the AIDS epidemic; 2014. http://www.unaids.org/sites/default/ﬁles/media_asset/90-90-90_en_0.pdf, October, 2014.",Non-OADS,/arxiv_data1/oa_pdf/63/6b/HIV-18-305.PMC5347969.pdf
"Stockholm: ECDC; 2015. http://ecdc.europa.eu/en/ publications/Publications/dublin-declaration-continuum-of- care-2014.pdf, September, 2015.",Non-OADS,/arxiv_data1/oa_pdf/63/6b/HIV-18-305.PMC5347969.pdf
"http://www.sls.se/Global/RAV/ Dokument/RAV_HIV_2014_ﬁnal_141114.pdf, October, 2014.",Non-OADS,/arxiv_data1/oa_pdf/63/6b/HIV-18-305.PMC5347969.pdf
"Vol 6. http://www.folkhalsomyndigheten.se/nyheter-och-press/historik-smi-2003-2013/historik-epi-aktuellt/epi-aktuellt-2007/epi-aktuellt-vol-6-nr-42-18-oktober-2007/, October, 2007.",Non-OADS,/arxiv_data1/oa_pdf/63/6b/HIV-18-305.PMC5347969.pdf
"classiﬁcation system, http://www.biomedcentral.com/conte nt/supplementary/1471-2393-9-22-S1.xls (10).",OADS,/arxiv_data1/oa_pdf/5f/14/AOGS-96-326.PMC5347971.pdf
Available online at: http://www.who.int/maternal_child_adolescent/topics/maternal/maternal_perinatal/en/.,Non-OADS,/arxiv_data1/oa_pdf/5f/14/AOGS-96-326.PMC5347971.pdf
"Available online at: https://www.fhi.no/en/hn/cause-of-death-and- life-expectancy/perinatal-mortality-in-norway —fac/ (updated 18 April 2016; accessed August 5, 2016).",Non-OADS,/arxiv_data1/oa_pdf/5f/14/AOGS-96-326.PMC5347971.pdf
"Available online at: https://www.regjeringen.no/contentassets/25a 45886201046488d9c53abc0c8ad3a/no/pdfs/stm200820090012000dddpdfs.pdf (accessed October 29,2016).",Non-OADS,/arxiv_data1/oa_pdf/5f/14/AOGS-96-326.PMC5347971.pdf
"Image analysis: Image analysis was performed using the UCSF Pri- ism environment (http://msg.ucsf.edu/ive), and quantitative analysis software developed in-house.",OADS,/arxiv_data1/oa_pdf/07/0b/CM-74-72.PMC5347972.pdf
Z-stacks were deconvoluted by Del-taVision software (Applied Precision) and visualized by Imaris soft- ware (http://www.bitplane.com/go/products/imaris).,OADS,/arxiv_data1/oa_pdf/07/0b/CM-74-72.PMC5347972.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b9/5e/ott-10-1441.PMC5348058.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1441–1449OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1441Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12416 1 serum liver enzymes serve as prognostic factors  in patients with intrahepatic cholangiocarcinoma chenyue Zhang1,2 haiyong Wang1,3 Zhouyu ning1,2 litao Xu1,2 liping Zhuang1,2 Peng Wang1,2 Zhiqiang Meng1,2 1Department of integrative Oncology,   Fudan University shanghai cancer  center, shanghai, People’s republic  of china; 2Department of Oncology,   shanghai Medical college, Fudan  University, shanghai, People’s  republic of china; 3Department of  radiation Oncology, shandong cancer  hospita  & institute, Jinan, People’s  republic of chinaObjective:  Liver functions, reflective of the overall status of the host, have been reported to be  important factors affecting the prognosis in many types of cancers.",Non-OADS,/arxiv_data1/oa_pdf/b9/5e/ott-10-1441.PMC5348058.pdf
"In clinical practice, we have found that patients with  deteriorated liver functions often have unsatisfactory prognosis compared to those  with tolerable parameters.correspondence: Zhiqiang Meng;  Peng Wang Department of integrative Oncology,  Fudan University shanghai cancer  center, 270 Dong an road, shanghai  200032, People’s republic of china Tel +86 21 6417 5590 ext 3628 Fax +86 21 6443 7657 email mengzhq@yeah.ne t;  wangp413@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Zhang et al Running head recto: Prognostic value of liver enzymes in ICC patients DOI: http://dx.doi.org/10.2147/OTT.S124161",Non-OADS,/arxiv_data1/oa_pdf/b9/5e/ott-10-1441.PMC5348058.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b9/5e/ott-10-1441.PMC5348058.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/5e/ott-10-1441.PMC5348058.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/14/0a/ott-10-1423.PMC5348068.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1423–1431OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1423Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11836 6 Microrna 543 suppresses breast cancer cell  proliferation, blocks cell cycle and induces cell  apoptosis via direct targeting of erK/MaPK Po chen1 Wentao Xu2 Yi luo1 Yi Zhang3 Yi he1 shuo Yang1 Zhijun Yuan1 1Department of Medical Oncology,   hunan cancer hospital, changsha,   2clinical Medical college of an  hui Medical University, hefei,   3Department of Breast surgery, hunan  cancer hospital, changsha, chinaBackground:  Breast cancer affects millions of people with a high mortality rate throughout  the world; microRNA 543 (miR-543) has been reported to suppress progression in some kinds  of cancers, but has not been reported in breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/14/0a/ott-10-1423.PMC5348068.pdf
"MicroRNA is an endogenous RNA which is deemed to be a regulator that  modulates the expression of targeting gene after mRNA transcription.3 Previous studies  indicated that microRNA was closely associated with cell proliferation, apoptosis and  differentiation,3,4 and it was reported that microRNAs were regarded as (a microRNA)  was regarded as natural inhibitors of cancer-causing gene, which was able to inhibit correspondence: Zhijun Yuan Department of Medical Oncology, hunan  cancer hospital, no 582 Xianjiahu road,   changsha, hunan, china Tel +86 130 5417 5986 Fax +86 0731 8891 5811 email yuanzhijun@hnszlyy.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Chen et al Running head recto: miR-543 suppresses breast cancer progression via regulating ERK2 DOI: http://dx.doi.org/10.2147/OTT.S118366",Non-OADS,/arxiv_data1/oa_pdf/14/0a/ott-10-1423.PMC5348068.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/14/0a/ott-10-1423.PMC5348068.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/0a/ott-10-1423.PMC5348068.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/26/36/ott-10-1413.PMC5348069.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1413–1422OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1413Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10681 0 Safety, efficacy, and clinical utility of asparaginase  in the treatment of adult patients with acute  lymphoblastic leukemia Jamie Koprivnikar James McCloskey Stefan Faderl Division of Leukemia, John Theurer  Cancer Center at Hackensack  University Medical Center,   Hackensack, NJ, USAAbstract:  Adults with acute lymphoblastic leukemia (ALL) are known to have inferior outcomes  compared to the pediatric population.",Non-OADS,/arxiv_data1/oa_pdf/26/36/ott-10-1413.PMC5348069.pdf
"Y et, a number of recent studies emphasize the  significance of asparaginase in the context of ALL treatment regimens and provide Correspondence: Jamie Koprivnikar Division of Leukemia, John Theurer  Cancer Center at Hackensack University  Medical Center, 92 Second Street,  Hackensack, NJ 07601, USA Tel +1 551 994 3925 email jamie.koprivnikar@ hackensackmeridian.or g Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2017 Volume: 10 Running head verso: Koprivnikar et al Running head recto: PEG-asparaginase in the treatment of ALL DOI: http://dx.doi.org/10.2147/OTT.S106810",Non-OADS,/arxiv_data1/oa_pdf/26/36/ott-10-1413.PMC5348069.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/26/36/ott-10-1413.PMC5348069.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/36/ott-10-1413.PMC5348069.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bf/87/ijn-12-1815.PMC5348070.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1815–1825International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1815RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S12734 9 Current applications and future prospects of  nanomaterials in tumor therapy Yu Huang1 Chao-Qiang Fan1 Hui Dong1 Su-Min wang1 Xiao-Chao Yang2 Shi-Ming Yang1 1Department of Gastroenterology,   Xinqiao Hospital, Third Military  Medical University, Chongqing,   People’s Republic of China;   2Department of Biomedical Materials  Science, School of Biomedical  engineering, Third Military Medical  University, Chongqing, People’s  Republic of ChinaAbstract:  Tumors are one of the most serious human diseases and cause numerous global  deaths per year.",Non-OADS,/arxiv_data1/oa_pdf/bf/87/ijn-12-1815.PMC5348070.pdf
"Various NMs have performed attractively in  various aspects of antitumor treatment and garnered intense research interest, and Correspondence: Shi-Ming Yang Department of Gastroenterology,  Xinqiao Hospital, Third Military  Medical University, Xinqiao Street,  Shapingba, Chongqing 400037,  People’s Republic of China Tel +86 023 6875 5604 email s himingyang@yahoo.co m  Xiao-Chao Yang Department of Biomedical Materials  Science, School of Biomedical  engineering, Third Military Medical  University, Number 30, Gaotanyan  Street, Shapingba, Chongqing 400038,  People’s Republic of China Tel +86 023 6877 2482 email xcyang@tmmu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Huang et al Running head recto: Nanomaterials in tumor therapy DOI: http://dx.doi.org/10.2147/IJN.S127349",Non-OADS,/arxiv_data1/oa_pdf/bf/87/ijn-12-1815.PMC5348070.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/bf/87/ijn-12-1815.PMC5348070.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/87/ijn-12-1815.PMC5348070.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/be/4c/ott-10-1459.PMC5348071.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1459–1464OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1459Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12055 6 chronological changes in lung cancer surgery  in a single Japanese institution haruhiko nakamura hiroki sakai hiroyuki Kimura T omoyuki Miyazawa hideki Marushima hisashi saji Department of chest surgery,   st Marianna University school of  Medicine, Kawasaki, Kanagawa, JapanBackground:  The aim of this study was to evaluate the chronological changes in epidemiological  factors and surgical outcomes in patients with lung cancer who underwent surgery in a single  Japanese institution.",Non-OADS,/arxiv_data1/oa_pdf/be/4c/ott-10-1459.PMC5348071.pdf
"Recently, ∼120 patients with correspondence: haruhiko nakamura Department of chest surgery,  st Marianna University school of  Medicine, 2-16-1 sugao, Miyamae-ku,  Kawasaki, Kanagawa 216-8511, Japan Tel +81 44 977 8111 ext 3230 Fax +81 44 976 5792 email h-nakamura@marianna-u.ac.j p Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Nakamura et al Running head recto: Chronological changes in lung cancer surgery DOI: http://dx.doi.org/10.2147/OTT.S120556",Non-OADS,/arxiv_data1/oa_pdf/be/4c/ott-10-1459.PMC5348071.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/be/4c/ott-10-1459.PMC5348071.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/4c/ott-10-1459.PMC5348071.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9b/cc/bctt-9-127.PMC5348072.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9b/cc/bctt-9-127.PMC5348072.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 127–132Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 127 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S129746 Recent insights into cigarette smoking as   a lifestyle risk factor for breast cancer Shannon Kispert Jane McHowat Department of Pathology, Saint Louis  University School of Medicine,    St. Louis, MO, USAAbstract:  There have been many cohort studies published reviewing the epidemiological evi- dence that links breast cancer to cigarette smoking, yet the underlying mechanisms are largely  unknown and research studies are few and incomplete.",Non-OADS,/arxiv_data1/oa_pdf/9b/cc/bctt-9-127.PMC5348072.pdf
"2Correspondence: Jane McHowat Department of Pathology, Saint Louis University School of Medicine, 1402   S Grand Blvd, St. Louis, MO 63104, USATel +1 314 977 9295Email mchowaj@slu.eduJournal name: Breast Cancer - Targets and Therapy Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Kispert and McHowatRunning head recto: Cigarette smoking as a lifestyle risk factor for breast cancerDOI: http://dx.doi.org/10.2147/BCTT.S129746",Non-OADS,/arxiv_data1/oa_pdf/9b/cc/bctt-9-127.PMC5348072.pdf
Available from: https://clinicaltrials.gov/ct2/show/study/NCT01434342 NLM Identifier: NCT01434342.,Non-OADS,/arxiv_data1/oa_pdf/9b/cc/bctt-9-127.PMC5348072.pdf
Available from: http://seer.cancer.gov/archive/csr/1975_2012/.,Non-OADS,/arxiv_data1/oa_pdf/9b/cc/bctt-9-127.PMC5348072.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/9b/cc/bctt-9-127.PMC5348072.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 132 Kispert and McHowat 29.,Non-OADS,/arxiv_data1/oa_pdf/9b/cc/bctt-9-127.PMC5348072.pdf
Available from: http://monographs.iarc.fr/ENG/Monographs/vol83/index.php.,Non-OADS,/arxiv_data1/oa_pdf/9b/cc/bctt-9-127.PMC5348072.pdf
Available from: http://monographs.iarc.fr/ENG/Monographs/vol100E/.,Non-OADS,/arxiv_data1/oa_pdf/9b/cc/bctt-9-127.PMC5348072.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/74/72/ott-10-1433.PMC5348073.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1433–1440OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1433Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S13161 1 GSTM1  polymorphism is related to risks of  nasopharyngeal cancer and laryngeal cancer:  a meta-analysis Fengying Zhang1,* Xijiang wu2,* Jinming Niu1 Xiufeng Kang3 Liya Cheng1 Yanchun Lv1 Meimei wu1 1Otorhinolaryngological Department,   wei Fang Traditional Chinese Hospital,   weifang, Shandong Province, China;   2Otorhinolaryngological Department,   Shouguang Peoples Hospital,   Shouguang, Shandong Province, China;   3Medical insurance office, Shouguang  Peoples Hospital, Shouguang,   Shandong Province, China *These authors contributed equally to  this workBackground:  Accumulating data have reported that GSTM1 polymorphism may be related to  nasopharyngeal cancer (NPC) and laryngeal cancer (LC).",Non-OADS,/arxiv_data1/oa_pdf/74/72/ott-10-1433.PMC5348073.pdf
"These  phase II enzymes are involved in the detoxification of benzopyrene and polycyclic  aromatic hydrocarbons (PAHs).6 In addition, GSTM1 and GSTT1 serve as important  factors in metabolizing carcinogens derived from tobacco smoke.7 It has been observed Correspondence: Fengying Zhang Otorhinolaryngological Department,  wei Fang Traditional Chinese Hospital,  1055 weizhou Road, Kuiwen District,  weifang 261000, Shandong Province,  China Tel +86 536 806 0215 email ym00223@126.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2017 Volume: 10 Running head verso: Zhang et al Running head recto: GSTM1  polymorphism and risks of NPC and LC: a meta-analysis DOI: http://dx.doi.org/10.2147/OTT.S131611",Non-OADS,/arxiv_data1/oa_pdf/74/72/ott-10-1433.PMC5348073.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/74/72/ott-10-1433.PMC5348073.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/74/72/ott-10-1433.PMC5348073.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/85/36/ijwh-9-151.PMC5348074.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2017:9 151–155International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  151RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S12981 4 vacuum-assisted cesarean section Ross W McQuivey1 Jon e Block2 1Clinical Innovations, Salt Lake  City, UT, 2Independent consultant,   San Francisco, CA, USAAbstract:  There has been a dramatic rise in the frequency of cesarean sections, surpassing  30% of all deliveries in the US.",Non-OADS,/arxiv_data1/oa_pdf/85/36/ijwh-9-151.PMC5348074.pdf
"Historical perspective To identify published literature relevant to vacuum-assisted cesarean section, a  computer-based electronic search of the PubMed and Web of Science databases up to Correspondence: Jon e Block 2210 Jackson Street, Suite 401,  San Francisco, CA 94115, USA Tel +1 415 775 7947 Fax +1 415 928 0765 email jb@drjonblock.co m Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2017 Volume: 9 Running head verso: McQuivey and Block Running head recto: Vacuum-assisted cesarean section DOI: http://dx.doi.org/10.2147/IJWH.S129814",Non-OADS,/arxiv_data1/oa_pdf/85/36/ijwh-9-151.PMC5348074.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/85/36/ijwh-9-151.PMC5348074.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/36/ijwh-9-151.PMC5348074.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/cd/3d/imcrj-10-077.PMC5348075.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/cd/3d/imcrj-10-077.PMC5348075.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2017:10 77–80International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 77 Case Repo Rt open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S125103a glucokinase gene mutation in a young boy with  diabetes mellitus, hyperinsulinemia, and   insulin resistance andrey o emelyanov1 elena sechko1 ekaterina Koksharova1 Igor sklyanik1 tamara Kuraeva1,2 alexander Mayorov1,2 Valentina p eterkova1,2 Ivan Dedov1 1endocrinology Research Centre,   Moscow, Russian Federation;   2I.M.",Non-OADS,/arxiv_data1/oa_pdf/cd/3d/imcrj-10-077.PMC5348075.pdf
"The patient was diagnosed with DM type 1 (DM1) and prescribed Actrapid HM (3 U/day; NovoNordisk A/S, Bagsværd, Denmark) and Protaphane Correspondence: elena sechko endocrinology Research Centre, 11 Dmitriya Ulyanova street, Moscow, 117036, Russian Federationtel +7 926 904 0191email elena.sechko@bk.ruJournal name: International Medical Case Reports Journal Article Designation: Case ReportY ear: 2017V olume: 10Running head verso: Emelyanov et alRunning head recto: MODY2-child-hyperinsulinemia-insulin resistanceDOI: http://dx.doi.org/10.2147/IMCRJ.S125103",Non-OADS,/arxiv_data1/oa_pdf/cd/3d/imcrj-10-077.PMC5348075.pdf
"International Medical Case Reports Journal 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/cd/3d/imcrj-10-077.PMC5348075.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 80 emelyanov et al are required to study the potential genetic link of DM2 and  MODY .,OADS,/arxiv_data1/oa_pdf/cd/3d/imcrj-10-077.PMC5348075.pdf
Available from: http://exac.broadinstitute.org/variant/7-44187347-G-A.,Non-OADS,/arxiv_data1/oa_pdf/cd/3d/imcrj-10-077.PMC5348075.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/39/44/ott-10-1451.PMC5348076.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1451–1457OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1451Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11783 0 arm lymphoscintigraphy after axillary lymph  node dissection or sentinel lymph node biopsy  in breast cancer almir José sarri1 rogério Dias2 carla elaine laurienzo1 Mônica carboni Pereira  gonçalves3 Daniel spadoto Dias2 sonia Marta Moriguchi4 1Department of Physical Therapy,   Barretos cancer hospital, Barretos,   2Department of Obstetrics,   gynaecology and Mastology, Botucatu  Medical school, são Paulo state  University – UnesP , Botucatu,   3Department of n uclear Medicine,   Barretos cancer hospital, Barretos,   4Department of Tropical Diseases and  Diagnostic imaging, Botucatu Medical  school, são Paulo state University –  UnesP , Botucatu, são Paulo, BrazilPurpose:  Compare the lymphatic flow in the arm after breast cancer surgery and axillary  lymph node dissection (ALND) versus sentinel lymph node biopsy (SLNB) using lymphos - cintigraphy (LS).",Non-OADS,/arxiv_data1/oa_pdf/39/44/ott-10-1451.PMC5348076.pdf
"Prof. Montenegro,  s/n – Distrito de rubião Junior,  ceP 18618-970, Botucatu – sP, Brazil Tel +55 14 3811 6133 Fax +55 14 3815 9898 email soniamoriguchi@gmail.co m;  soniamoriguchi@fmb.unesp.b r Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Sarri et al Running head recto: Arm lymphoscintigraphy after ALND or SLNB in breast cancer DOI: http://dx.doi.org/10.2147/OTT.S117830",Non-OADS,/arxiv_data1/oa_pdf/39/44/ott-10-1451.PMC5348076.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/39/44/ott-10-1451.PMC5348076.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/39/44/ott-10-1451.PMC5348076.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/56/a4/ijn-12-1827.PMC5348077.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1827–1840International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1827OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13053 9 highly effective photothermal chemotherapy  with ph-responsive polymer-coated drug-loaded  melanin-like nanoparticles chengwei Zhang1 Xiaozhi Zhao1 suhan guo2 Tingsheng lin1 hongqian guo1 1Department of Urology, Nanjing  Drum Tower hospital, Medical school  of Nanjing University, Institute of  Urology, Nanjing University, 2school  of Public health, Nanjing Medical  University, Nanjing, People’s republic  of chinaAbstract:  Dopamine is a neurotransmitter commonly used in clinical treatment.",Non-OADS,/arxiv_data1/oa_pdf/56/a4/ijn-12-1827.PMC5348077.pdf
"Polydopamine (PDA) is self-assembled  by oxypolymerization.4 To date, several studies have investigated PDA-based correspondence: hongqian guo Department of Urology, Nanjing Drum  Tower hospital, Medical school of  Nanjing University, Institute of Urology,  Nanjing University, 321 Zhongshan road,  Nanjing 210008, People’s republic of  china Tel +86 25 8310 5107 Fax +86 25 6605 6570 email dr.ghq@nju.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Zhang et al Running head recto: pH-responsive polymer-coated drug-loaded melanin-like nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S130539",Non-OADS,/arxiv_data1/oa_pdf/56/a4/ijn-12-1827.PMC5348077.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/56/a4/ijn-12-1827.PMC5348077.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/a4/ijn-12-1827.PMC5348077.pdf
"https://doi.org/10.1177/1178122X17691261Virology: Research and Treatment  1–5 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178122X17691261 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Dengue is the most prevalent arthropod-borne viral disease  in the world.",Non-OADS,/arxiv_data1/oa_pdf/34/49/10.1177_1178122x17691261.PMC5348084.pdf
http://www.who.int/mediacentre/factsheets/fs117/en/.,Non-OADS,/arxiv_data1/oa_pdf/34/49/10.1177_1178122x17691261.PMC5348084.pdf
"https://doi.org/10.1177/1177932217690136Bioinformatics and Biology Insights  1–8 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1177932217690136 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction The detection of ortholog genes is a relevant issue in molecular  biology useful for structure, functional, and evolutionary infer-ences.",Non-OADS,/arxiv_data1/oa_pdf/3d/31/10.1177_1177932217690136.PMC5348085.pdf
Transcriptologs software is free and available at https://github.com/LucaAmbrosino/Transcriptologs.git.,OADS,/arxiv_data1/oa_pdf/3d/31/10.1177_1177932217690136.PMC5348085.pdf
http://www.arabidopsis.org/.,Non-OADS,/arxiv_data1/oa_pdf/3d/31/10.1177_1177932217690136.PMC5348085.pdf
ftp://ftp.jgi-psf.org/pub/JGI_data/Sorghum_bi - color/v1.0/Sbi/annotation/Sbi1.4/.,OADS,/arxiv_data1/oa_pdf/3d/31/10.1177_1177932217690136.PMC5348085.pdf
"https://doi.org/10.1177/1178636117691253Microbiology Insights  1–8 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178636117691253 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Reliable laboratory diagnostics is the basis of good patient  care and safety.",Non-OADS,/arxiv_data1/oa_pdf/23/38/10.1177_1178636117691253.PMC5348086.pdf
http://www.kunnat.net/fi/asiantuntijapalvelut/soster/nimikkeis - tot-luokitukset/laboratoriotutkimusnimikkeisto.,Non-OADS,/arxiv_data1/oa_pdf/23/38/10.1177_1178636117691253.PMC5348086.pdf
http://urn.fi/URN:ISBN:   978-952-302-485-4.,Non-OADS,/arxiv_data1/oa_pdf/23/38/10.1177_1178636117691253.PMC5348086.pdf
http://urn.fi/URN:ISBN:978-952-302-496-0.,Non-OADS,/arxiv_data1/oa_pdf/23/38/10.1177_1178636117691253.PMC5348086.pdf
